Sentence,class,file
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.10.002 2049-0801/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/10/72/main.PMC5072144.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Trachelectomy Neuroendocrine cervical carcinomaLarge cellFertility sparing surgery 1.,Non-OADS,/arxiv_data1/oa_pdf/7d/37/main.PMC5072145.pdf
http://dx.doi.org/10.1016/j.gore.2016.10.002 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/37/main.PMC5072145.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7d/37/main.PMC5072145.pdf
Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious DiseasesThis is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) http://dx.doi.org/10.1016/j.nmni.2016.09.007,Non-OADS,/arxiv_data1/oa_pdf/1b/9b/main.PMC5072152.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 8–105 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1b/9b/main.PMC5072152.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 8–105 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1b/9b/main.PMC5072152.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 8–105 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1b/9b/main.PMC5072152.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 8–105 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1b/9b/main.PMC5072152.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 8–105 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1b/9b/main.PMC5072152.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 8–105 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1b/9b/main.PMC5072152.pdf
"Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases, NMNI ,14,9 8–105 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/1b/9b/main.PMC5072152.pdf
"Studies showed that taurine did not only protect neurons against glutamate-induced cytotoxicity [11], but also prevented ar- senite-treated SH-SY5Y cells viamaintaining mitochondrial membrane http://dx.doi.org/10.1016/j.redox.2016.10.004 Received 28 August 2016; Received in revised form 8 October 2016; Accepted 11 October 2016⁎Correspondence to: Department of Human Anatomy, Histology and Embryology, Xi ’an Jiaotong University, Health Science Center, No.",Non-OADS,/arxiv_data1/oa_pdf/80/fc/main.PMC5072153.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 13 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/80/fc/main.PMC5072153.pdf
Available at: http://www.justice.gov/opa/pr/justice-department-and-federal-partners-announce-en-forcement-actions-dietary-supplement-cases [23 November 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.fda.gov/downloads/ Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafely/MedicationHealthFrau d/UCM236985.pdf [06 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.fda.gov/ ohrms/dockets/98fr/cf0441.pdf p. 400 [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.fda.gov/iceci/enforce- mentactions/warningletters/2014/ucm406488.htm [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.fda.gov/Drugs/DrugSafety/ucm385964.htm [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.fda.gov/Food/ DietarySupplements/QADietarySu pplements/ucm346576.htm [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://vorige.nrc.nl/multimedia/archive/00213/ 370030002_213599a.pdf [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.usp.org/sites/default/files/usp_pdf/ EN/dietarySupp/admissiondsguide line_vers_1.1.pdf [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.fda.gov/Safety/MedWatch/ default.htm [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.dsld.nlm.nih.gov/dsld/rptQSearch.jsp?item=ginkgo&db= adsld [6 August 2015].,OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.fda.gov/RegulatoryI nformation/Legislation/Federal FoodDrugandCosmeticActFDCAct/F DCActChaptersIandIIShortTitle andDefinitions/ucm086297.htm [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.usp.org/news/united-states- pharmacopeial-convention-urges-scientific-validation-dna-test-methods-regulating-quality-herbal-supplements.,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: https://ods.od.nih.gov/Research/ AMRMProgramWebsite.aspx [23 November 2015].,OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.fda.gov/ohrms/dockets/98fr/cf0441.pdf; pp 402 and563 [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Available at: http://www.usp.org/ food-ingredients/food-fraud-database [6 August 2015].,Non-OADS,/arxiv_data1/oa_pdf/56/f2/DTA-8-418.PMC5072169.pdf
Results— Patients cared for in hospitals where a high proportion of RNs reported excellent  quality of care (the highest third of hospitals) had 23% lower odds of 30-day inpatient mortality  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5f/5f/nihms820408.PMC5072172.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1501695/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/68/55/1501695.PMC5072179.pdf
"World Health Organization (WHO), The World Health Report 2002: Reducing Risks, Promoting Healthy Life (WHO, 2002); http://www.who.int/whr/2002/en/.",Non-OADS,/arxiv_data1/oa_pdf/68/55/1501695.PMC5072179.pdf
"J. J. P. Stewart, MOPAC2012 (Stewart Computational Chemistry, 2008); http://openmopac.net.",OADS,/arxiv_data1/oa_pdf/68/55/1501695.PMC5072179.pdf
"U.S. Geological Survey (USGS) and California Geological Survey, Quaternary Fault and Fold Database of the United States (USGS, 2010); http://earthquake.usgs.gov/ hazards/qfaults/.",OADS,/arxiv_data1/oa_pdf/5c/c4/1601441.PMC5072180.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1600855/DC1fig.,Non-OADS,/arxiv_data1/oa_pdf/49/04/1600855.PMC5072181.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1600689/DC1 Nanochannel fabrication Ionic current recordingsThe cycling performanceNumerical simulation model Fig.,Non-OADS,/arxiv_data1/oa_pdf/d3/ba/1600689.PMC5072182.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org/cgi/ content/full/2/10/e1600992/DC1 Supplementary Resultsfig.,Non-OADS,/arxiv_data1/oa_pdf/26/db/1600992.PMC5072183.pdf
"By the prediction of TFSEARCH (http://www.cbrc.jp/ research/db/TFSEARCH.html), there were three transcription  factors, namely, GATA‑1, GATA‑2, and GATA‑3, binding on  the SNP of g.4543T>C.",Non-OADS,/arxiv_data1/oa_pdf/94/78/CMJ-129-2403.PMC5072250.pdf
Available from: http://www.news.xinhuanet.,Non-OADS,/arxiv_data1/oa_pdf/37/5f/CMJ-129-2409.PMC5072251.pdf
"icmje.org/journals-following-the-icmje-recommendations/),  NIHPG (http://www.nih.gov/about/endorsing-jounals.",Non-OADS,/arxiv_data1/oa_pdf/0f/4d/CMJ-129-2491.PMC5072263.pdf
"htm), and CONSORT  (http://www.consort-statement.",Non-OADS,/arxiv_data1/oa_pdf/0f/4d/CMJ-129-2491.PMC5072263.pdf
Available  from: http://www.icmje.com.,Non-OADS,/arxiv_data1/oa_pdf/0f/4d/CMJ-129-2491.PMC5072263.pdf
Available from: http://www.nih.gov/about/ endorsing-jounals.htm.,Non-OADS,/arxiv_data1/oa_pdf/0f/4d/CMJ-129-2491.PMC5072263.pdf
"Despite these promising preclinical results, clini-cal development of these compounds, however, was halted because of the inherent bleeding risks (30, 31) (http://hugin.info/137912/R/ 1562875/484367.pdf).",Non-OADS,/arxiv_data1/oa_pdf/e6/5c/HI-11-1-10.PMC5072291.pdf
http://www.who.int/nutgrowthdb/ summary_jme_2013.pdf?ua=1.,OADS,/arxiv_data1/oa_pdf/45/0f/10.1177_2333794X16672528.PMC5072332.pdf
http://www.who.int/dietphysicalactivity/childhood/en/.,Non-OADS,/arxiv_data1/oa_pdf/45/0f/10.1177_2333794X16672528.PMC5072332.pdf
"Royal College of Psychiatrists, 2010, http://www.rcpsych.ac.uk/pdf/ Position%20Statement%204%20website.pdf  2.",Non-OADS,/arxiv_data1/oa_pdf/c9/55/10.1177_2050312116669613.PMC5072333.pdf
"McCrone P. Paying the price: the cost of mental health care  in England to 2026, 2008, http://www.kingsfund.org.uk/sites/files/kf/Paying-the-Price-the-cost-of-mental-health-care- England-2026-McCrone-Dhanasiri-Patel-Knapp-Lawton- Smith-Kings-Fund-May-2008_0.pdf  3.",Non-OADS,/arxiv_data1/oa_pdf/c9/55/10.1177_2050312116669613.PMC5072333.pdf
"CareLoop, http://www.population-health.manchester.ac.uk/healthinformatics/research/Careloop (accessed 24 May 2016).",Non-OADS,/arxiv_data1/oa_pdf/c9/55/10.1177_2050312116669613.PMC5072333.pdf
"Good Clinical Practice  (GCP) pocket guide, https://drive.google.com/file/d/0B-EwP8Oxl7jdM005QS0wMlRJZ3c/view (2014, accessed 13  July 2015).",Non-OADS,/arxiv_data1/oa_pdf/c9/55/10.1177_2050312116669613.PMC5072333.pdf
Retrieved from http://www.dnb.com,Non-OADS,/arxiv_data1/oa_pdf/27/53/10.1177_2333721416655966.PMC5072399.pdf
Retrieved from http://uli.org/wp-content/uploads/ULI- Documents/America-in-2013-Final-Report.pdf U.S. Department of Health and Human Services.,Non-OADS,/arxiv_data1/oa_pdf/27/53/10.1177_2333721416655966.PMC5072399.pdf
"Retrieved from http://www.aoa.gov/ Aging_Statistics/Profile/2011/4.aspx Van Dyck, D., Teychenne, M., McNaughton, S. A., De  Bourdeaudhuij, I., & Salmon, J.",Non-OADS,/arxiv_data1/oa_pdf/27/53/10.1177_2333721416655966.PMC5072399.pdf
"Retrieved from http://www.aarp.org/content/dam/ aarp/research/public_policy_institute/econ_sec/2013/ sources-of-income-for-older-americans-2012-fs-AARP-ppi-econ-sec.pdf Yen, I. H., Flood, J. F., Thompson, H., Anderson, L. A, &  Wong, G. (2014).",Non-OADS,/arxiv_data1/oa_pdf/27/53/10.1177_2333721416655966.PMC5072399.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2016 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Metabolic reprogramming in neurons M Agostini et al 1514 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/2c/7d/cdd201636a.PMC5072427.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2016 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)β-Arrestin-2 increases intestinal progenitor/stem cell apoptosis Z Liu et al 1541 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/b8/db/cdd201638a.PMC5072429.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2016 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Oxidative metabolism mediates platinum resistance DS Matassa et al 1554 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/ef/d1/cdd201639a.PMC5072430.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2016 Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Roles of RIPK1, RIPK3, and MLKL in disease models K Newton et al 1576 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/a8/23/cdd201646a.PMC5072432.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)TNFα-induced PML mRNA translation by IRES and p38 –MNK1 axis K-S Hsu et al 483 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/b7/c8/cdd2015114a.PMC5072441.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Novel p53 targets in non-cell-autonomous regulation M Charni et al 520 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/3d/61/cdd2015119a.PMC5072444.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Male sterility in mice with Mdm2−/−Sertoli cells S Fouchécourt et al 530 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/57/1c/cdd2015120a.PMC5072445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/MicroRNA-125b regulates microglia in ALS C Parisi et al 541 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/fe/1b/cdd2015153a.PMC5072447.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/21/main.PMC5072452.pdf
http://dx.doi.org/10.1016/j.scog.2016.04.003 2215-0013/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/6a/21/main.PMC5072452.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/6a/21/main.PMC5072452.pdf
Contents lists available at ScienceDirect Schizophrenia Research: Cognition journal homepage: http://www.schizrescognition.com/,Non-OADS,/arxiv_data1/oa_pdf/6a/21/main.PMC5072452.pdf
2015. http://dx.doi.org/10.1155/ 2015/804385 (17 pages).,Non-OADS,/arxiv_data1/oa_pdf/6a/21/main.PMC5072452.pdf
http://dx.doi.org/10.1016/j.pscychresns.2009.08.003 .,OADS,/arxiv_data1/oa_pdf/6a/21/main.PMC5072452.pdf
http://dx.doi.org/10.1093/schbul/sbq037 .,Non-OADS,/arxiv_data1/oa_pdf/6a/21/main.PMC5072452.pdf
http://dx.doi.org/10.3390/bs3020206 .,Non-OADS,/arxiv_data1/oa_pdf/6a/21/main.PMC5072452.pdf
"‡http://orcid.org/0000-0003-3603-1733 Abstract To design effective eradication strategies, it may be necessary to target HIV reservoirs in anatomic compartments other than blood.",Non-OADS,/arxiv_data1/oa_pdf/8e/9d/vew020.PMC5072458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/9d/vew020.PMC5072458.pdf
"The pipeline is available at https://github.com/veg/HIV-NGS and consists of the following key steps: 1.Baseline quality control : Reads that are too short ( /C2050 base- pairs [bp]) or have too many low quality bases ( /C218 bases with quality scores q /C2015) are removed, and all remaining bases with low scores are masked with the Ncharacter [missing data].",Non-OADS,/arxiv_data1/oa_pdf/8e/9d/vew020.PMC5072458.pdf
Sequences obtained from this step can be downloaded from https://goo.gl/DZhzh1 [see README.md for formatexplanations] 4.Compartmentalization analysis: We compute the ﬁxation index (Hudson et al.,OADS,/arxiv_data1/oa_pdf/8e/9d/vew020.PMC5072458.pdf
Structure of the rebounding HIV RNA populations A complete set of interactive phylogenetic trees showing the re-lationships between the samples (distinguishing up to the 25 most frequent viral haplotypes per sample) are available at http://bit.ly/gianella-pond-ellis-trees.,OADS,/arxiv_data1/oa_pdf/8e/9d/vew020.PMC5072458.pdf
"Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunologicalconstraints for vaccine and drug development Lize Cuypers,1,*,†,§Guangdi Li,1,2,§Christoph Neumann-Haefelin,3 Supinya Piampongsant,1,4Pieter Libin,5,1Kristel Van Laethem,1 Anne-Mieke Vandamme,1,6,‡and Kristof Theys1 1KU Leuven, University of Leuven, Department of Microb iology and Immunology, Rega Institute for Medical Research, Clinical and Epidemiological Virology, Minderbroedersstraat 10, 3000 Leuven, Belgium, 2Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology, Ministry of Education, National Clinical Research Center for Metabolic Diseases, the Second Xiangya Hospital, Central SouthUniversity, Changsha, Hunan, China, 3Department of Medicine II, Freiburg University Medical Center, University of Freiburg, Freiburg, Germany,4Department of Electrical Engineering ESAT, STADIUS Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven, University of Leuven, KasteelparkArenberg 10, B-3001 Heverlee, Belgium, 5Artiﬁcial Intelligence Lab, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium and6Center for Global Health and Tropical Medicine, Microbiology Unit, Institute for Hygiene and Tropical Medicine, University Nova de Lisboa, Rua da Junqueira 100, Lisbon, 1349-008, Portugal *Corresponding author: E-mail: lize.cuypers@kuleuven.be †http://orcid.org/0000-0002-9433-8752 ‡http://orcid.org/0000-0002-6594-2766 §These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/26/bf/vew024.PMC5072459.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/bf/vew024.PMC5072459.pdf
"Methods 2.1 Full-length genome sequence dataset Full-length sequences (9,000 nt or more) of HCV GT1a and GT1b were downloaded from the Los Alamos HCV Sequence Database (LANL, http://hcv.lanl.gov) ( Kuiken et al.",OADS,/arxiv_data1/oa_pdf/26/bf/vew024.PMC5072459.pdf
2.4 Structural and immunological constraints Linear HCV epitopes of T and B cells from assays that were able to identify epitopes were collected according to the ImmuneEpitope Database (IEDB) (http://www.iedb.org/) and mapped totheir corresponding positions based on the reference sequenceH77.,OADS,/arxiv_data1/oa_pdf/26/bf/vew024.PMC5072459.pdf
"Inner circle: 3D structures of proteins for which PDB resolution covers more than 50 % of the protein (PyMOL V1.5 (http://www.pymol.org/), Circos V0.62 (http://circos.ca/; Krzywinski et al.",OADS,/arxiv_data1/oa_pdf/26/bf/vew024.PMC5072459.pdf
"Identifying predictors of time-inhomogeneous viral evolutionary processes Filip Bielejec1,*, Guy Baele1, Allen G. Rodrigo2,†, Marc A. Suchard3,4, and Philippe Lemey1,‡ 1Department of Microbiology and Immunology, Rega Institute, KU Leuven, Leuven, Belgium,2Research School of Biology, Australian National University, Canberra, ACT, Australia,3Department of Biomathematics and Human Genetics, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA 90095,USA and 4Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, CA 90095, USA *Corresponding author : E-mail: ﬁlip.bielejec@rega.kuleuven.be †http://orcid.org/0000-0002-8327-7317 ‡http://orcid.org/0000-0003-2826-5353 Abstract Various factors determine the rate at which mutations are generated and ﬁxed in viral genomes.",Non-OADS,/arxiv_data1/oa_pdf/3e/45/vew023.PMC5072463.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/45/vew023.PMC5072463.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/df/50/mder-9-371.PMC5072507.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/df/50/mder-9-371.PMC5072507.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 371–376Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 371 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S116666 Comparison of rechargeable versus battery- operated insulin pumps: temperature fluctuations Paul Vereshchetin Thomas W McCann Jr Navdeep Ojha Ramakrishna VenugopalanBrian L Levy Johnson & Johnson Diabetes Care  Companies, Chesterbrook, PA, USAAbstract:  The role of continuous subcutaneous insulin infusion (insulin pumps) has become  increasingly important in diabetes management, and many different types of these systems are  currently available.",Non-OADS,/arxiv_data1/oa_pdf/df/50/mder-9-371.PMC5072507.pdf
"8 Therefore, temperature fluctuations in rechargeable Correspondence: Paul Vereshchetin Johnson & Johnson Diabetes Care Companies, 965 Chesterbrook Boulevard, Chesterbrook, PA 19087, USATel +1 484 328 6229Email pvereshc@its.jnj.comJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Vereshchetin et alRunning head recto: Heating in rechargeable vs battery-operated insulin pumpsDOI: http://dx.doi.org/10.2147/MDER.S116666",Non-OADS,/arxiv_data1/oa_pdf/df/50/mder-9-371.PMC5072507.pdf
Available from: http://pi.lilly.com/us/humalog-pen-pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/50/mder-9-371.PMC5072507.pdf
Available from: http://www.novo-pi.com/novolog.pdf.,OADS,/arxiv_data1/oa_pdf/df/50/mder-9-371.PMC5072507.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/df/50/mder-9-371.PMC5072507.pdf
Available from: https://www.tandemdiabetes.com/docs/default-source/product-documents/tslim-insulin-pump/updated-t-slim-user-guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/df/50/mder-9-371.PMC5072507.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ott-9-6325.PMC5072508.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6325–6332OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6325Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11409 0 hERG1 positivity and Glut-1 negativity identifies  high-risk TnM stage i and ii colorectal cancer  patients, regardless of adjuvant chemotherapy leonardo Muratori,1,*  giulia Petroni,1,* lorenzo  antonuzzo,2,3 luca Boni,4  Jessica iorio,1,3 elena lastraioli,1  gianluca Bartoli,1 luca  Messerini,1 Francesco Di  costanzo,2 annarosa arcangeli1 1Department of experimental and clinical  Medicine, University of Florence, 2Medical  Oncology, azienda Ospedaliero-Universitaria  careggi, Florence, 3Department of Medical  Biotechnologies, University of siena, siena,   4clinical Trials coordinating center, istituto  T oscano T umori, azienda Ospedaliero- Universitaria careggi, Florence, italy *These authors contributed equally  to this workBackground:  The identification of early-stage colorectal cancer (CRC) with high risk of  progression is one major clinical challenge, mainly due to lack of validated biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ott-9-6325.PMC5072508.pdf
"Patients with early-stage CRC could expect a long survival with surgery alone,  nevertheless ~50% of stage III and 25% of stage II will relapse.2 Adjuvant chemotherapy  is the standard of care for patients with stage III, while the real benefit in stage II is not still  clear and the routine use of chemotherapy is not recommended.3 As no validated biomarker  is available for routinely assessing patients’ risk stratification, the decision on whether to  accomplish chemotherapy or not for stage II CRC patients currently relies on clinical fea - tures as T4, number of lymph nodes analyzed, perforation or obstruction, and grading.4correspondence: annarosa arcangeli Department of experimental and clinical Medicine,  University of Florence, Viale gB Morgagni 50,  50134 Florence, italy Tel +39 055 275 1283 Fax +39 055 275 1281 email annarosa.arcangeli@unifi.i t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Muratori et al Running head recto: hERG1 and Glut-1 in nonmetastatic CRC DOI: http://dx.doi.org/10.2147/OTT.S114090 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ott-9-6325.PMC5072508.pdf
Or use: http://youtu.be/wJZR_fRXUw gVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ott-9-6325.PMC5072508.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ott-9-6325.PMC5072508.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/e0/ott-9-6325.PMC5072508.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ef/54/ott-9-6337.PMC5072509.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6337–6342OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6337Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10874 9 rare frequency of gene variation and survival  analysis in thymic epithelial tumors Zhengbo song1,2,* Xinmin Yu1,2,* Yiping Zhang1,2 1Department of Medical Oncology,   Zhejiang cancer hospital, 2Key  laboratory Diagnosis and Treatment  T echnology on Thoracic Oncology,   Zhejiang Province, hangzhou, People’s  republic of china *These authors contributed equally  to this workObjective:  Thymic epithelial tumor (TET) is a rare mediastinal neoplasm and little is known  about its genetic variability and prognostic factors.",Non-OADS,/arxiv_data1/oa_pdf/ef/54/ott-9-6337.PMC5072509.pdf
"However, the role of other factors, including histological subtypes and  myasthenia gravis, remains controversial.16–17correspondence: Zhengbo song Department of Medical Oncology,  Zhejiang cancer hospital, 38  guangji road, hangzhou 310022,  People’s republic of china Tel +86 571 8812 2082 Fax +86 571 8812 2088 email songzhengbo83@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Song et al Running head recto: Gene variation and survival analysis in thymic epithelial tumors DOI: http://dx.doi.org/10.2147/OTT.S108749",Non-OADS,/arxiv_data1/oa_pdf/ef/54/ott-9-6337.PMC5072509.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ef/54/ott-9-6337.PMC5072509.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ef/54/ott-9-6337.PMC5072509.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a9/30/ott-9-6305.PMC5072510.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6305–6314OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6305Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11337 4 Comparison of the efficacy and tolerability of  gefitinib with pemetrexed maintenance after  first-line platinum-based doublet chemotherapy  in advanced lung adenocarcinoma: single-center  experience liping lin1,2,* Juanjuan Zhao3,* Jiazhu hu1,2 Fuxi huang1,2 Jianjun han1,2 Yan he1,2 Xiaolong cao1,2 1Department of Oncology, Panyu  central hospital, 2cancer institute of  Panyu, 3School of Nursing, Sun Yat-sen  University, guangzhou, People’s  Republic of China *These authors contributed equally  to this workPurpose:  Both gefitinib and pemetrexed maintenance were effective therapies for advanced  lung adenocarcinoma, but which is better is unclear.",Non-OADS,/arxiv_data1/oa_pdf/a9/30/ott-9-6305.PMC5072510.pdf
"Keywords:  gefitinib, pemetrexed, lung adenocarcinoma, maintenance therapy Introduction Lung cancer is the main cause of cancer-related deaths worldwide.1 About 80%–85%  of the cases are non-small-cell lung cancer (NSCLC), and 30%–40% of patients have  advanced disease at the time of diagnosis.2 Epidermal growth factor receptor (EGFR) correspondence: Xiaolong cao Department of Oncology, Panyu central  hospital, no 8 Fuyu road east, Panyu,  guangzhou, guangdong province,  511400, People’s Republic of China Tel +86 20 3485 9213 Fax +86 20 3485 8309 email pyzhl616@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lin et al Running head recto: Gefitinib versus pemetrexed maintenance DOI: http://dx.doi.org/10.2147/OTT.S113374",Non-OADS,/arxiv_data1/oa_pdf/a9/30/ott-9-6305.PMC5072510.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/pdf/ nscl.pd f. Accessed January 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/a9/30/ott-9-6305.PMC5072510.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a9/30/ott-9-6305.PMC5072510.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/30/ott-9-6305.PMC5072510.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/58/ott-9-6315.PMC5072511.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6315–6324OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6315Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11383 2 18F-fludrodeoxyglucose maximal standardized  uptake value and metabolic tumor burden are  associated with major chemotherapy-related  tumor markers in nsclc patients lu Bai1,* chihua guo2,* Jiansheng Wang3 Xiang liu1 Yang li1 Miao li1 Y oumin guo2 Xiaoyi Duan2 1Department of Medical imaging,   2Department of Orthopedics,   3Department of Oncological  surgery, First affiliated hospital  of Xi’an Jiaotong University, Xi’an,   People’s republic of china *These authors contributed equally  to this workObjective:  Metabolic activity and tumor burden are significant for prognosis and metastasis of  non-small cell lung cancer (NSCLC), including maximum standardized uptake value (SUVmax),  metabolic tumor volume (MTV), and total lesion glycolysis (TLG).",Non-OADS,/arxiv_data1/oa_pdf/9a/58/ott-9-6315.PMC5072511.pdf
"Keywords:  non-small cell lung cancer, tumor markers, 18F-fludrodeoxyglucose, total lesion  glycolysis, metabolic tumor volume, maximal standardized uptake values Introduction Lung cancer causes almost 1.38 million deaths a year worldwide, and nearly 85%  are represented by non-small cell lung cancer (NSCLC).1 Chemotherapy is the  most important treatment for NSCLC patients, not only for early-stage patients  who have been operated as adjuvant, but also for patients with advanced disease  who cannot undergo surgery.2 The combination of cisplatin and gemcitabine correspondence: Xiaoyi Duan;   Youmin guo Department of Medical imaging,  First Affiliated Hospital of Xi’an Jiaotong  University, 277 West Yanta road, Xi’an  710061, People’s republic of china Tel +86 137 2043 3707 email duanxyi@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Bai et al Running head recto: FDG parameters are related with chemo-related markers in NSCLC patients DOI: http://dx.doi.org/10.2147/OTT.S113832",Non-OADS,/arxiv_data1/oa_pdf/9a/58/ott-9-6315.PMC5072511.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9a/58/ott-9-6315.PMC5072511.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/58/ott-9-6315.PMC5072511.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/a1/ccid-9-357.PMC5072512.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/a1/ccid-9-357.PMC5072512.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 357–366Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 357 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S111999 Reduction of facial wrinkles by hydrolyzed water- soluble egg membrane associated with reduction  of free radical stress and support of matrix  production by dermal fibroblasts Gitte S Jensen1  Bijal Shah2  Robert Holtz3  Ashok Patel4  Donald C Lo2 1NIS Labs, Klamath Falls, OR,   2Department of Neurobiology,   Center for Drug Discovery, Duke  University Medical Center, Durham,  NC,  3BioInnovation Laboratories, Inc.,   Lakewood, CO, 4Centre Manufacturing  LLC, Eden Prairie, MN, USAObjective: The aim of this study was to evaluate the effects of water-soluble egg membrane  (WSEM) on wrinkle reduction in a clinical pilot study and to elucidate specific mechanisms of  action using primary human immune and dermal cell-based bioassays.",Non-OADS,/arxiv_data1/oa_pdf/95/a1/ccid-9-357.PMC5072512.pdf
"Age-related wrinkling in the skin is promoted Correspondence: Gitte S Jensen   Natural Products Research, NIS  Laboratories, 1437 Esplanade, Klamath Falls, OR 97601, USA Tel +1 541 884 0112 Fax +1 403 441 5236   Email gitte@nislabs.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Jensen et alRunning head recto: Wrinkle reduction by hydrolyzed egg membraneDOI: http://dx.doi.org/10.2147/CCID.S111999 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/95/a1/ccid-9-357.PMC5072512.pdf
Or use: http://youtu.be/fY5oJHQ95vQ,Non-OADS,/arxiv_data1/oa_pdf/95/a1/ccid-9-357.PMC5072512.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/95/a1/ccid-9-357.PMC5072512.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 366 Jensen et al,Non-OADS,/arxiv_data1/oa_pdf/95/a1/ccid-9-357.PMC5072512.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0a/a1/ccid-9-339.PMC5072514.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0a/a1/ccid-9-339.PMC5072514.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 339–345Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 339 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S111729 Hard water softening effect of a baby cleanser Russel M Walters Emmanuel Anim-Danso Stephanie M Amato Kimberly A CaponeM Catherine MackLorena S T elofski David A Mays Skin Care Research & Development,   Johnson & Johnson Consumer Inc.,  Skillman, NJ, USABackground: Hard water is associated with atopic dermatitis (eczema).",Non-OADS,/arxiv_data1/oa_pdf/0a/a1/ccid-9-339.PMC5072514.pdf
"5 Water alone is limited in its ability to gently and effectively cleanse, particularly for  the removal of oily or fatty substances like feces and associated enzymes.5–7 Cleansers  can emulsify and dislodge oily materials, soils, and microorganisms more effectively than Correspondence: Russel M Walters Johnson & Johnson Consumer Inc., 199 Grandview Road, Skillman, NJ 08558, USATel +1 908 635 3238Fax +1 908 874 2615Email rwalter2@its.jnj.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Walters et alRunning head recto: Hard water softening and baby cleanserDOI: http://dx.doi.org/10.2147/CCID.S111729",Non-OADS,/arxiv_data1/oa_pdf/0a/a1/ccid-9-339.PMC5072514.pdf
Available from: http://water.usgs.gov/owq/hardness-alkalinity.html.,OADS,/arxiv_data1/oa_pdf/0a/a1/ccid-9-339.PMC5072514.pdf
Available from: http://www.unwater.org/wwd10/downloads/water_quality_human_health.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/a1/ccid-9-339.PMC5072514.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/0a/a1/ccid-9-339.PMC5072514.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 345 Hard water softening and baby cleanser,Non-OADS,/arxiv_data1/oa_pdf/0a/a1/ccid-9-339.PMC5072514.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/f4/a5/ott-9-6187.PMC5072515.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6187–6193OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6187Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11501 1 sensitivity value of hematological markers  in patients receiving chemoradiotherapy for  esophageal squamous cell carcinoma shan Zhu1,2,* chuan-Wang Miao1,2,* Zhong-Tang Wang2 li Peng3 Baosheng li2 1school of Medicine and life  sciences, shandong academy of  Medical sciences, University of  Jinan, 2Department of radiotherapy,   3Department of clinical laboratory,   shandong cancer hospital affiliated  to shandong University, Jinan, People’s  republic of china *These authors contributed equally  to this workBackground:  Hematological markers of the systemic inflammatory response (SIR) including the  neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and the combination  of NLR with PLR (CNP) are associated with prognosis of patients with esophageal squamous  cell carcinoma (ESCC).",Non-OADS,/arxiv_data1/oa_pdf/f4/a5/ott-9-6187.PMC5072515.pdf
"However, the evidence-based model is derived from statistical correspondence: Bao-sheng li Department of radiotherapy, shandong  Cancer Hospital Affiliated to Shandong  University, Jiyan road 440, Jinan 250117,  shandong Province, People’s republic  of china Tel/fax +86 531 6762 6161 email baoshli1963@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhu et al Running head recto: Hematological markers DOI: http://dx.doi.org/10.2147/OTT.S115011",Non-OADS,/arxiv_data1/oa_pdf/f4/a5/ott-9-6187.PMC5072515.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f4/a5/ott-9-6187.PMC5072515.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/a5/ott-9-6187.PMC5072515.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/87/2b/amep-7-587.PMC5072516.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/87/2b/amep-7-587.PMC5072516.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 587–592Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 587 PERSPECTIVES open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S115789 Applying a reflexive framework to evaluate a  communication skills curriculum Lawrence Cheung Department of Medicine, University  of Alberta, Edmonton, AB, CanadaAbstract:  After creating and delivering an educational curriculum, medical educators must  ultimately evaluate the effectiveness of the implemented curriculum.",Non-OADS,/arxiv_data1/oa_pdf/87/2b/amep-7-587.PMC5072516.pdf
"8,9 For our 2-year subspecialty residency program in respirology, we first Correspondence: Lawrence Cheung Department of Medicine, University of Alberta, 3-129, 11350 83 Avenue, Edmonton, AB T6G 2G3, Canada   Tel +1 780 492 4039   Fax +1 780 492 4483   Email lcheung@ualberta.caJournal name: Advances in Medical Education and Practice Article Designation: PERSPECTIVESY ear: 2016V olume: 7Running head verso: CheungRunning head recto: Applying a reflexive framework to evaluate a communication skills curriculumDOI: http://dx.doi.org/10.2147/AMEP .S115789",Non-OADS,/arxiv_data1/oa_pdf/87/2b/amep-7-587.PMC5072516.pdf
Available from: http://canmeds.royalcollege.ca/uploads/en/framework/CanMEDS%202015%20Framework_EN_Reduced.pdf.,OADS,/arxiv_data1/oa_pdf/87/2b/amep-7-587.PMC5072516.pdf
Available from: http://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/CPRs_07012016.pdf.,Non-OADS,/arxiv_data1/oa_pdf/87/2b/amep-7-587.PMC5072516.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/87/2b/amep-7-587.PMC5072516.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 592 Cheung  66.,Non-OADS,/arxiv_data1/oa_pdf/87/2b/amep-7-587.PMC5072516.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8a/f4/ott-9-6281.PMC5072517.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6281–6290OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6281Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10902 3 Prognostic value of fever grade combined  with neutrophil percentage in hepatocellular  carcinoma patients presenting fever as the  initial manifestation Zi-Jun gong1,2 Wei guo1–3 Yun-Fan sun1,2 Xin Zhang1,2 shuang-Jian Qiu1,2 Jian Zhou1,2,4 Jia Fan1,2,4 Xin-rong Yang1,2 1liver cancer institute, Zhongshan  hospital, Fudan University, shanghai,   People’s republic of china; 2Key  laboratory of carcinogenesis  and cancer invasion (Ministry  of education), Fudan University,   shanghai, People’s republic of china;   3Department of laboratory Medicine,   Zhongshan hospital, Fudan University,   shanghai, People’s republic of china;   4institutes of Biomedical sciences,   Fudan University, shanghai, People’s  republic of chinaBackground:  Hepatocellular carcinoma (HCC) patients with fever as the initial presentation  are extremely rare.",Non-OADS,/arxiv_data1/oa_pdf/8a/f4/ott-9-6281.PMC5072517.pdf
"Keywords:  hepatocellular carcinoma, fever, neutrophils, prognosis, hepatectomy Introduction Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and  its incidence has increased in recent years.1,2 HCC patients with fever as the initial  presentation are extremely rare and only a few cases have been reported.3,4 These HCC  patients present with symptoms that mimic liver abscess, as both share similar clinical  symptoms and laboratory findings, which makes differential diagnosis a challenge.5,6  Due to its rarity and diagnostic difficulties, most HCC patients with fever are already correspondence: Xin-rong Yang liver cancer institute, Zhongshan  hospital, shanghai Medical school, Fudan  University, 180 Fenglin road, shanghai  200032, People’s republic of china Tel/fax +86 21 6403 7181 email yxr_2@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Gong et al Running head recto: HCC with fever has a poor prognosis DOI: http://dx.doi.org/10.2147/OTT.S109023",Non-OADS,/arxiv_data1/oa_pdf/8a/f4/ott-9-6281.PMC5072517.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8a/f4/ott-9-6281.PMC5072517.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/f4/ott-9-6281.PMC5072517.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/12/80/vhrm-12-379.PMC5072518.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/12/80/vhrm-12-379.PMC5072518.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Vascular Health and Risk Management  2016:12 379–385Vascular Health and Risk Management Dovepress submit your manuscript | www.dovepress.com Dovepress  379 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S112948Carbohydrate composition of circulating   multiple-modified low-density lipoprotein Emile R Zakiev1  Igor A Sobenin1,2  Vasily N Sukhorukov1  Veronika A Myasoedova1  Ekaterina A Ivanova3  Alexander N Orekhov1,4 1Laboratory of Angiopathology,   Institute for General Pathology and  Pathophysiology, 2Laboratory of  Medical Genetics, Russian Cardiology Research and Production Complex,  Moscow, Russia;  3Department of  Development and Regeneration, KU Leuven, Leuven, Belgium;  4Skolkovo  Innovative Center, Institute for Atherosclerosis Research, Moscow,  RussiaAbstract: Atherogenic modification of low-density lipoprotein (LDL) plays a crucial role in  the pathogenesis of atherosclerosis, as modified LDL, but not native LDL, induces pronounced  accumulation of cholesterol and lipids in the arterial wall.",Non-OADS,/arxiv_data1/oa_pdf/12/80/vhrm-12-379.PMC5072518.pdf
"2 Total LDL preparation was applied on column with RCA120 immobilized on  Correspondence: Ekaterina A Ivanova Department of Development and Regeneration, KU Leuven, 3000 Leuven, Herestraat 49, O&N3, Belgium   Tel +32 488 46 16 92Email kate.ivanov@gmail.com Alexander N Orekhov Laboratory of Angiopathology, Institute for General Pathology and Pathophysiology, 125315 Moscow, Russia   Email a.h.opexob@gmail.comJournal name: Vascular Health and Risk Management  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 12Running head verso: Zakiev et alRunning head recto: Carbohydrate composition of LDLDOI: http://dx.doi.org/10.2147/VHRM.S112948",Non-OADS,/arxiv_data1/oa_pdf/12/80/vhrm-12-379.PMC5072518.pdf
"Vascular Health and Risk Management  2016:12submit your manuscript | www.dovepress.com Dovepress Dovepress Vascular Health and Risk Management  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/vascular-health-and-risk-management-journal Vascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on concise rapid reporting of clinical studies on the processes involved in the maintenance of vascular health; the monitoring, prevention and treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/12/80/vhrm-12-379.PMC5072518.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 385 Carbohydrate composition of LDL 13.,Non-OADS,/arxiv_data1/oa_pdf/12/80/vhrm-12-379.PMC5072518.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/96/a2/tcrm-12-1553.PMC5072519.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1553–1562Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1553Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S10370 9 Use of ICS/LABA (extra-fine and non-extra-fine)  in elderly asthmatics Alida Benfante Marco Basile Salvatore Battaglia Mario Spatafora Nicola Scichilone Biomedical Department of internal  and Specialist Medicine, University of  Palermo, Palermo, italyAbstract:  Age represents an exclusion criterion in randomized clinical trials designed to test  the efficacy and safety of inhaled drugs in asthma.",Non-OADS,/arxiv_data1/oa_pdf/96/a2/tcrm-12-1553.PMC5072519.pdf
"Again, not taking these changes into consideration  when approaching asthma in older ages may cause erroneous decisions in the choice  of proper treatment.Correspondence: Nicola Scichilone Dipartimento Biomedico di Medicina  interna e Specialistica, University of  Palermo, via Trabucco 180, 90146  Palermo, italy Tel +39 91 680 2655 Fax +39 91 688 2842 email nicola.scichilone@unipa.i t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Benfante et al Running head recto: Inhaled treatment of asthma in the elderly DOI: http://dx.doi.org/10.2147/TCRM.S103709",Non-OADS,/arxiv_data1/oa_pdf/96/a2/tcrm-12-1553.PMC5072519.pdf
Available  from: http://www.ginasthma.org /.,Non-OADS,/arxiv_data1/oa_pdf/96/a2/tcrm-12-1553.PMC5072519.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/96/a2/tcrm-12-1553.PMC5072519.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/96/a2/tcrm-12-1553.PMC5072519.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/Post - marketDrugSafetyInformationforPatientsandProviders/ucm213836.,Non-OADS,/arxiv_data1/oa_pdf/96/a2/tcrm-12-1553.PMC5072519.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 575–584Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 575 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S117915 Emotional maturity of medical students impacting  their adult learning skills in a newly established  public medical school at the east coast of  Malaysian Peninsula Vidya Bhagat1  Mainul Haque2  Yasrul Izad Bin Abu Bakar3  Rohayah Husain1  Che Mat Khairi1 1The Unit of Psychological Medicine,   Faculty of Medicine, Universiti Sultan  Zainal Abidin, Kuala T erengganu,  T erengganu, Malaysia;  2The Unit of  Pharmacology, Faculty of Medicine and Defense Health, National Defense University of Malaysia, Kuala Lumpur,  Malaysia;  3The Unit of Anatomy,   Faculty of Medicine, Universiti Sultan Zainal Abidin, Kuala T erengganu,  T erengganu, MalaysiaAbstract:  Emotional maturity (EM) is defined as the ability of an individual to respond to  situations, control emotions, and behave in an adult manner when dealing with others.",Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
"1,3 Consequently, emotionally intelligent people  possess professional personalities needed, especially, in medical education, to ensure Correspondence: Mainul Haque The Unit of Pharmacology, Faculty of Medicine and Defense Health, National Defense University of Malaysia, Kem Sungai Besi, 57000 Kuala Lumpur, Malaysia   Email runurono@gmail.comJournal name: Advances in Medical Education and Practice Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 7Running head verso: Bhagat et alRunning head recto: EM of medical students impacting adult learning skillsDOI: http://dx.doi.org/10.2147/AMEP .S117915 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Or use: http://youtu.be/1AqgVbzYK4g,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: https://www.psycholo-gytoday.com/basics/emotional-intelligence.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: https://belleville.lindenwood.edu/education/andragogy/andragogy/2011/Esposito_2005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: https://www.quora.com/Emotional-Intelligence-Whats-the-difference-between-maturity-and-EQ.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.truenorthpartnering.com/sites/default/files/Emotional%20%20intelligence%20vs.emotional%20maturity.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.yourdictionary.com/emotional-maturity.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.management-issues.com/opinion/6811/emotional-intelligence-or-emotional-maturity/.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://languageforwork.ecml.at/Portals/48/documents/lfw-web_item-3a_nrdc_european-adult-learning-glossary-rept_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://edc.tbzmed.ac.ir/uploads/39/CMS/user/file/56/scholarship/ABC-LTM.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://files.eric.ed.gov/fulltext/ED084368.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Avail-able from: https://teal.ed.gov/sites/default/files/Fact-Sheets/11_%20TEAL_Adult_Learning_Theory.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: https://www.lindenwood.edu/education/andragogy/andragogy/2011/Clardy_2005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: https://www.lindenwood.edu/education/andragogy/andragogy/2011/Clardy_2005.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://infed.org/mobi/andragogy-what-is-it-and-does-it-help-thinking-about-adult-learning/.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://web.cortland.edu/frieda/id/IDtheories/42.html.,OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: https://www.lindenwood.edu/education/andragogy/andragogy/2011/Nottingham_1983.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.literacy.ca/professionals/professional-development-2/principles-of-adult-learning/.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://digitalcommons.uconn.edu/cgi/viewcontent.cgi?article= 1050&context= uchcgs_masters.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.rcpsych.ac.uk/pdf/Andragogy%20and%20WPBAs%20-%20RCPsych%20in%20Wales%20%20summer%20newsletter%202015%20Victor%20Aziz.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.truenorthpartnering.com/sites/default/files/Emotional%20%20intelligence%20and%20emotional%20maturity_0.pdf.,OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
"2012. http://inspirebusinesssolutions.com/blog/what-is-the-difference-between-emotional-intelligence-and-emotional-maturity.Accessed August 28, 2016.",Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
"Washington, DC: George Washington University; Available from: http://web.stanford.edu/dept/SUSE/projects/ireport/articles/general/Educational%20Theories%20Summary.pdf.",Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 584 Bhagat et al 48.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.media.gwu.edu/~tip/.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.gwu.edu/~tip/index.html.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://www.npcindia.com/.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: http://learn.coleggwent.ac.uk/pluginfile.php/86374/course/sec-tion/7450/adult_learning.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Available from: https://www.nationalcollege.org.uk/cm-andragogy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
Accessed from: http://www.dehfsupport.com/Andragogy.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/d5/amep-7-575.PMC5072520.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Risk Management and Healthcare Policy 2016:9 231–241Risk Management and Healthcare Policy Dovepress submit your manuscript | www.dovepress.com Dovepress 231 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S108586 Quality measure attainment with dapagliflozin  plus metformin extended-release as initial  combination therapy in patients with type 2  diabetes: a post hoc pooled analysis of two clinical studies Kelly F Bell Arie Katz John J Sheehan AstraZeneca, Wilmington, DE, USABackground: The use of quality measures attempts to improve safety and health outcomes  and to reduce costs.",Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
"Keywords: dapagliflozin, metformin, quality measures, type 2 diabetes Introduction Diabetes is a prevalent disease, estimated to affect more than 29 million people in  the USA.3 In adults, type 2 diabetes (T2D) accounts for up to 95% of diagnosed  cases.3 Total annual health care costs for diabetes in the USA are estimated to reach Correspondence: Kelly Bell Health Economics and Outcomes Research, AstraZeneca, US Medical Affairs, 1800 Concord Pike, PO Box 15437, Wilmington, DE, 19850, USATel + 1 267-417-6220Email Kelly.Bell@astrazeneca.comJournal name: Risk Management and Healthcare Policy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Bell et alRunning head recto: Quality measures with dapagliflozin plus metformin XRDOI: http://dx.doi.org/10.2147/RMHP .S108586",Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualitymeasures.ahrq.gov/tutorial/index.aspx.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualitymeasures.ahrq.gov/browse/by-topic-detail.aspx?id= 44003&ct= 1.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.cdc.gov/nhsn/nqf/.,OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.quali- tyforum.org/story/About_Us.aspx.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualityforum.org/Measur - ing_Performance/Endorsed_Performance_Measures_Maintenance.aspx.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualitymeasures.ahrq.gov/content.aspx?id= 48628&search= hba1c+ %3C7.,OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualitymeasures.ahrq.gov/content.aspx?id= 27623&search= blood+ pressure+ %3C130.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.quali-tymeasures.ahrq.gov/content.aspx?id= 27624&search= ldl+%3C100.,OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualityforum.org/ProjectMeasures.aspx?projectID=73652.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualityforum.org/ProjectMeasures.aspx?projectID= 73652.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualityforum.org/ProjectMeasures.aspx?projectID=73652.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualityforum.org/ProjectMeasures.aspx?projectID= 73652.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
"Risk Management and Healthcare Policy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/risk-management-and-healthcare-policy-journalRisk Management and Healthcare Policy is an international, peer-reviewed,  open access journal focusing on all aspects of public health, policy, and preventative measures to promote good health and improve morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 241 Quality measures with dapagliflozin plus metformin XR  24.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.qualitymeasures.ahrq.gov/content.aspx?id =27634&search=weight+loss+and +diabetes.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
Available from: http://professional.diabetes.org/ResourcesFor - Professionals.aspx?cid= 91777&loc= dorg-statistics.,Non-OADS,/arxiv_data1/oa_pdf/71/a2/rmhp-9-231.PMC5072521.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 349–354International Journal of General Medicine Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
"Or use: http://youtu.be/wgDR3yVFJVY Dovepress submit your manuscript | www.dovepress.com Dovepress 349 RevIew open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S116608Morgellons disease: a filamentous borrelial  dermatitis Marianne J Middelveen  Raphael B Stricker International Lyme and Associated  Diseases Society, Bethesda, MD, USA Abstract:  Morgellons disease (MD) is a dermopathy characterized by multicolored filaments  that lie under, are embedded in, or project from skin.",Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
"10–13Correspondence:  Raphael B Stricker ILADS, 450 Sutter Street, Suite 1504,   San Francisco, CA 94108, USATel +1 415 399 1035Fax +1 415 399 1057email rstricker@usmamed.comJournal name: International Journal of General Medicine Article Designation: ReviewY ear: 2016V olume: 9Running head verso: Middelveen and StrickerRunning head recto: Morgellons DiseaseDOI: http://dx.doi.org/10.2147/IJGM.S116608",Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 354 Middelveen and Stricker  13.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
Available from: http://www.thecehf.org/jyotsna-s-shahphd.html.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
Available from: http://www.thecehf.org/resources/OSU%20_2015%20_Research.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
Available from: http://www.thecehf.org/cheryl-bandoski.html.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
Available from: http://www.cdc.gov/lyme/healthcare/.,Non-OADS,/arxiv_data1/oa_pdf/b5/61/ijgm-9-349.PMC5072536.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2d/2a/pgpm-9-107.PMC5072537.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/2d/2a/pgpm-9-107.PMC5072537.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Pharmacogenomics and Personalized Medicine 2016:9 107–116Pharmacogenomics and Personalized Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress  107 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PGPM.S117014Pharmacogenetic polymorphism as an  independent risk factor for frequent  hospitalizations in older adults with  polypharmacy:  a pilot study Joseph Finkelstein1 Carol Friedman1 George Hripcsak1 Manuel Cabrera2 1Department of Biomedical  Informatics, 2Department of  Medicine,  Columbia University  College of Physicians and Surgeons,   New Y ork, NY,  USAAbstract: Pharmacogenetic testing identifies genetic biomarkers that are predictive of individual  sensitivity to particular drugs.",Non-OADS,/arxiv_data1/oa_pdf/2d/2a/pgpm-9-107.PMC5072537.pdf
"Keywords: urgent care utilization, risk factors, personalized medicine, elderly, case–control  studyCorrespondence: Joseph Finkelstein Department of Biomedical Informatics, Columbia University College of Physicians and Surgeons, 622 West 168th Street, PH-20, Room 401A, New York, NY 10032, USATel +1 917 477 3909Email jf193@cumc.columbia.eduJournal name: Pharmacogenomics and Personalized Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Finkelstein et alRunning head recto: Pharmacogenetic polymorphism and frequent hospitalizationsDOI: http://dx.doi.org/10.2147/PGPM.S117014",Non-OADS,/arxiv_data1/oa_pdf/2d/2a/pgpm-9-107.PMC5072537.pdf
Available from:  https://www.hcup-us.ahrq.gov/reports/statbriefs/sb6.jsp.,OADS,/arxiv_data1/oa_pdf/2d/2a/pgpm-9-107.PMC5072537.pdf
"Pharmacogenomics and Personalized Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Pharmacogenomics and Personalized Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/pharmacogenomics-and-personalized-medicine-journalPharmacogenomics and Personalized Medicine is an international, peer- reviewed, open access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.",Non-OADS,/arxiv_data1/oa_pdf/2d/2a/pgpm-9-107.PMC5072537.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 116 Finkelstein et al  38.,Non-OADS,/arxiv_data1/oa_pdf/2d/2a/pgpm-9-107.PMC5072537.pdf
"Anglemeasurements were determined using Image J (version 1.43; http://imagej.nih.gov/ij/; provided in the public domain by theNational Institutes of Health, Bethesda, MD, USA) following exportation of tif ﬁles.",OADS,/arxiv_data1/oa_pdf/eb/e9/i1552-5783-57-13-5479.PMC5072538.pdf
"Band intensites were measured using ImageJ (http://imagej.nih.gov/ ij/; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA) and the percentage of indel formation was calculated using the equation: indel% ¼1003(1 –[ 1–f cut]1/2), where fcut(cut fraction) is the total relative density of the cleavage bands divided by the sum of the relative density of the cleavage and uncut bands, as previously described.20 DNA Sequencing Sanger sequencing of PCR products ampliﬁed from genomicDNA, using sequencing primers approximately 200 to 250 bp upstream from predicted cut sites (Supplemental Table S1), were performed by the UC Davis DNA sequencing facility.",OADS,/arxiv_data1/oa_pdf/e5/0e/i1552-5783-57-13-5490.PMC5072539.pdf
Available at: http://crispr.mit.edu/.,Non-OADS,/arxiv_data1/oa_pdf/e5/0e/i1552-5783-57-13-5490.PMC5072539.pdf
Retrievedfrom http://www.zeiss.com/meditec/en_de/ products—solutions/ophthalmology-optometry/cataract/iol-implantation/mics-platform/mics-preloaded-trifocal-iol/at-lisa-tri-family/at-lisa-tri-family-product-details.html #technical-data 29.,Non-OADS,/arxiv_data1/oa_pdf/13/b1/i2164-2591-5-5-13.PMC5072543.pdf
Retrieved fromhttp://www.hanitalenses.com/blog/product/seelensmf/ 33.,Non-OADS,/arxiv_data1/oa_pdf/13/b1/i2164-2591-5-5-13.PMC5072543.pdf
"In particular, the ET-1  gene  (Gene ID 1906, OMIM 131240 ) maps to chromosome Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > Received 4 February 2016 | Accepted 18 October 2016 | Published 20 October 2016© 2016 Molecular Vision 1256Plasma endothelin-1 and single nucleotide polymorphisms of  endothelin-1 and endothelin type A receptor genes  as risk factors for  normal tension glaucoma Ewa Kosior-Jarecka,1 Dominika Wróbel-Dudzińska,1 Urszula Łukasik,1 Tin Aung,2,3,4 Chiea Chuen Khor,5,6  Janusz Kocki,7 Tomasz Żarnowski1 1Department of Diagnostics and Microsurgery of Glaucoma, Medical University, Lublin, Poland; 2Department of Ophthalmology,  National University Health System, National University of Singapore; 3Singapore Eye Research Institute, Singapore; 4Singapore  National Eye Center, Singapore; 5Genome Institute of Singapore, Singapore; 6Singapore Eye Research Institute, Singapore,  Singapore; 7Department of Clinical Genetics, Medical University, Lublin, Poland Purpose:  The purpose of this study was to determine whether four single nucleotide polymorphisms (SNPs) of endo - thelin and endothelin receptor type A genes  can constitute a risk factor for normal tension glaucoma (NTG) and high  tension glaucoma (HTG).",Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  12576 (6p23-p24) in humans and consists of five exons and four  introns [ 2].,Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  1258to elevated levels of ET-1 results in time-dependent retinal  ganglion cell loss [ 15].,Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  1259The microtiter plate was tightly covered with plastic film  and incubated overnight (20 h) at room temperature (22 °C).,Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  1260We found no statistically significant correlation between  the maximum IOP and the plasma ET levels in either group.,Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  1261open-angle glaucoma (NTG and HTG) and the controls (p =  0.035 and p = 0.0011).,Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  1262C1222T polymorphisms is still unknown: the polymorphism  itself may be nonfunctional or might be linked to unchar - acterized functional mutations that modify the expression  or structure of the gene.,Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
"Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  1263controls 75.7%, p = 0.27).",Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
"Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  1264between ET levels and age at diagnosis in patients with  NTG (p = 0.042); that is, the older the patient, the higher  the ET concentration in plasma.",Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  12654.,Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
Molecular Vision  2016; 22:1256-1266 <http://www.molvis.org/molvis/v 22/1256 > © 2016 Molecular Vision  126629.,Non-OADS,/arxiv_data1/oa_pdf/62/e1/mv-v22-1256.PMC5072545.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/39/fd/clep-8-381.PMC5072551.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/39/fd/clep-8-381.PMC5072551.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 381–387Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 381 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S113211 Nationwide trends in glucose-lowering drug use,  Denmark, 1999–2014 Diana Hedevang  Christensen1  Jørgen Rungby2,3  Reimar Wernich Thomsen1 1Department of Clinical  Epidemiology, Aarhus University  Hospital, Denmark; 2Department of  Pharmacology, University of Aarhus,  Aarhus, Denmark;  3Department of  Endocrinology, Gentofte University Hospital, Copenhagen, DenmarkPurpose: The objective of this study was to examine nationwide population-based time trends  in the utilization of all glucose-lowering drugs in Denmark from 1999 to 2014.",Non-OADS,/arxiv_data1/oa_pdf/39/fd/clep-8-381.PMC5072551.pdf
"With an estimated 320,000 people currently living with diabetes in Denmark (≈6% of the population; >90% with type 2DM),  Correspondence: Diana Hedevang  Christensen Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, DK-8200 Aarhus Nord, Denmark Tel +45 8716 8248 Fax +45 8716 7215 Email dhcr@clin.au.dkJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Christensen et alRunning head recto: Nationwide trends in glucose-lowering drug useDOI: http://dx.doi.org/10.2147/CLEP .S113211",Non-OADS,/arxiv_data1/oa_pdf/39/fd/clep-8-381.PMC5072551.pdf
Available from: http://www.diabetes.dk/presse/diabetes-i-tal/det-nationale-diabetesregister.aspx.,Non-OADS,/arxiv_data1/oa_pdf/39/fd/clep-8-381.PMC5072551.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/39/fd/clep-8-381.PMC5072551.pdf
Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/07/news_detail_001311.jsp&mid= WC0b01ac058004d5c1.,Non-OADS,/arxiv_data1/oa_pdf/39/fd/clep-8-381.PMC5072551.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/44/cia-11-1451.PMC5072552.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1451–1453Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1451Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S12153 5 Usefulness of anti-vascular endothelial growth  factor combined with dexamethasone implant  for retinal vein occlusion Moosang Kim Department of Ophthalmology,   School of Medcine, Kangwon  National University, Chuncheon,   Kangwon, KoreaDear editor I read with great interest the recent study by Michalska-Małecka et al1 published in  the journal Clinical Interventions in Aging .",Non-OADS,/arxiv_data1/oa_pdf/95/44/cia-11-1451.PMC5072552.pdf
"Disclosure The author reports no conflict of interest in this communication.Correspondence: Moosang Kim Department of Ophthalmology, School of  Medicine, Kangwon National University,  156 Baengnyeong-ro, Chuncheon,  Kangwon 200-722, Korea tel +82 33 258 2014 Fax +82 33 258 2000 email kimmoo-79@hanmail.ne t Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2016 Volume: 11 Running head verso: Kim Running head recto: Anti-VEGF combined with dexamethasone implant for RVO DOI: http://dx.doi.org/10.2147/CIA.S121535",Non-OADS,/arxiv_data1/oa_pdf/95/44/cia-11-1451.PMC5072552.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/95/44/cia-11-1451.PMC5072552.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/95/44/cia-11-1451.PMC5072552.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f8/58/jpr-9-819.PMC5072553.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f8/58/jpr-9-819.PMC5072553.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 819–823Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  819 Edito Rial open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org10.2147/JPR.S122147the hardest thing to see is what is in front of  your eyes – quo vadis placebo analgesia?",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jpr-9-819.PMC5072553.pdf
"Since the beginning of modern medicine, the Hippocratic Oath has been seen as the basis of a salutary doctor–patient relationship: “I will use treatment to Correspondence: Rupert Conrad department of Psychosomatic Medicine and Psychotherapy, University of Bonn, Sigmund-Freud-Straße 25, d-53105 Bonn, Germanytel +49 228 2871 6299Email Rupert.Conrad@ukb.uni-bonn.deJournal name: Journal of Pain Research  Article Designation: EditorialY ear: 2016V olume: 9Running head verso: ConradRunning head recto: Quo vadis placebo analgesia?DOI: http://dx.doi.org10.2147/JPR.S122147",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jpr-9-819.PMC5072553.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/f8/58/jpr-9-819.PMC5072553.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 823 Quo vadis placebo analgesia?,Non-OADS,/arxiv_data1/oa_pdf/f8/58/jpr-9-819.PMC5072553.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/86/99/ceg-9-325.PMC5072556.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/86/99/ceg-9-325.PMC5072556.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 325–335Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  325 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S96676Managing inflammatory bowel disease   in pregnancy: current perspectives Matthew Pinder1 Katie Lummis1 Christian P Selinger1,2 1Leeds Gastroenterology Institute,   Leeds T eaching Hospitals NHS Trust,   2University of Leeds, Leeds, UKAbstract:  Inflammatory bowel disease (IBD) affects many women of childbearing age.",Non-OADS,/arxiv_data1/oa_pdf/86/99/ceg-9-325.PMC5072556.pdf
"4 These direct effects of IBD may influence Correspondence: Christian P Selinger Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, St James University Hospital, Bexley Wing, Beckett Street, Leeds LS9 7TF, UKTel +44 113 206 8768Email Christian.selinger@web.deJournal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Pinder et alRunning head recto: Managing inflammatory bowel disease in pregnancyDOI: http://dx.doi.org/10.2147/CEG.S96676",Non-OADS,/arxiv_data1/oa_pdf/86/99/ceg-9-325.PMC5072556.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/86/99/ceg-9-325.PMC5072556.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 335 Managing inflammatory bowel disease in pregnancy  98.,Non-OADS,/arxiv_data1/oa_pdf/86/99/ceg-9-325.PMC5072556.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d4/77/ijn-11-5221.PMC5072557.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5221–5236International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5221OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10654 0 comparison of cellular effects of starch-coated  sPIONs and poly(lactic-co-glycolic acid) matrix  nanoparticles on human monocytes correspondence: Kristina riehemann center for Nanotechnology,  Institute of Physics, University of  Münster, heisenbergstrasse 11,  48149 Münster, germany Tel +49 251 836 3837 Fax +49 251 836 3883 email k.riehemann@uni-muenster.d e Dominik gonnissen1 Ying Qu1,2 Klaus langer3 cengiz Öztürk4 Yuliang Zhao2 chunying chen2 guiscard seebohm5 Martina Düfer6 harald Fuchs1 hans-Joachim galla7 Kristina riehemann1 1center for Nanotechnology, Institute  of Physics, University of Münster,   Münster, germany; 2National center  for Nanoscience and T echnology,   chinese academy of sciences, Beijing,   People’s republic of china; 3Institute  of Pharmaceutical T echnology  and Biopharmacy, University of  Münster, Münster, 4chemicell  gmbh, Berlin, 5Department of  cardiovascular Medicine, Institute  for genetics of heart Diseases,   University hospital Münster,   6Department of Pharmacology,   Institute of Pharmaceutical and  Medicinal chemistry, 7Department  of cell Biology/Biophysics, Institute  of Biochemistry, University of  Münster, Münster, germanyAbstract:  Within the last years, progress has been made in the knowledge of the properties of  medically used nanoparticles and their toxic effects, but still, little is known about their influ - ence on cellular processes of immune cells.",Non-OADS,/arxiv_data1/oa_pdf/d4/77/ijn-11-5221.PMC5072557.pdf
"The matrix nanoparticles on the other hand  consist of a component where the active agent is entrapped.5 In our work, we used Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Gonnissen et al Running head recto: Comparison of nanoparticle effects on human monocytes DOI: http://dx.doi.org/10.2147/IJN.S106540",OADS,/arxiv_data1/oa_pdf/d4/77/ijn-11-5221.PMC5072557.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/d4/77/ijn-11-5221.PMC5072557.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/77/ijn-11-5221.PMC5072557.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/d2/dddt-10-3363.PMC5072558.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3363–3378Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3363Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11483 2 Diminazene aceturate: an antibacterial agent for  shiga-toxin-producing Escherichia coli  O157:h7 si-Ying Wu1 gil-Y ong Park1 so-hee Kim2 John hulme1 seong soo a an1 1Department of Bio nano T echnology,   gachon Bio nano research institute,   gachon University, seongnam-si,   2seoul national University Bundang  hospital, gyeonggi-do, republic  of KoreaAbstract:  The aim of this study was to investigate the bacteriostatic and bactericidal effects  of diminazene aceturate (DA) against five strains of pathogenic bacteria and two strains of  nonpathogenic bacteria.",Non-OADS,/arxiv_data1/oa_pdf/ae/d2/dddt-10-3363.PMC5072558.pdf
"In addition, reports from the microbiological community show that extracellular ROS correspondence: John hulme; seong soo a an Department of Bionano Technology,  gachon Bionano research institute,  gachon University, seongnam-si 461-701,  republic of Korea Tel/fax +82 31 750 8550; +82 31 750 8755 email johnhulme21@gmail.co m;  seongaan@gachon.ac.k r Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Wu et al Running head recto: Antibacterial agent for STEC DOI: http://dx.doi.org/10.2147/DDDT.S114832",Non-OADS,/arxiv_data1/oa_pdf/ae/d2/dddt-10-3363.PMC5072558.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ae/d2/dddt-10-3363.PMC5072558.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/d2/dddt-10-3363.PMC5072558.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/90/6f/ijn-11-5361.PMC5072560.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5361–5370International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5361OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10908 1 hepatitis c virus e2 protein encapsulation into  poly d, l-lactic- co-glycolide microspheres could  induce mice cytotoxic T -cell response Piyachat roopngam1,2 Kewei liu1,2 lin Mei2 Yi Zheng2 Xianbing Zhu1,2 hsiang-I Tsai1,2 laiqiang huang1,2 1school of life sciences, Tsinghua  University, Beijing, People’s republic  of china; 2The shenzhen Key  laboratory of gene and antibody  Therapy, center for Biotechnology  and Biomedicine, state Key  laboratory of health sciences and  Technology, Division of life and  health sciences, graduate school  at shenzhen, Tsinghua University,   shenzhen, People’s republic of chinaAbstract:  Hepatitis C virus (HCV) is known to cause hepatitis and hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/90/6f/ijn-11-5361.PMC5072560.pdf
"For HCV core protein, the nucleocapsid component is the correspondence: laiqiang huang The shenzhen Key laboratory of gene  and antibody Therapy, center for  Biotechnology and Biomedicine, state  Key laboratory of health sciences and  Technology, Division of life and health  sciences, graduate school at shenzhen,  Tsinghua University, l411/403 Tsinghua  campus, Xili, shenzhen 518055,  People’s republic of china Tel +86 755 2603 6052 email huanglq@tsinghua.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Roopngam et al Running head recto: Hepatitis C E2 protein encapsulation into PLGA-induced cytotoxic T-cells DOI: http://dx.doi.org/10.2147/IJN.S109081",Non-OADS,/arxiv_data1/oa_pdf/90/6f/ijn-11-5361.PMC5072560.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/90/6f/ijn-11-5361.PMC5072560.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/6f/ijn-11-5361.PMC5072560.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/4b/6f/imcrj-9-317.PMC5072567.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/4b/6f/imcrj-9-317.PMC5072567.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 317–319International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 317 Case Repo Rt open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S115941peters plus anomaly in a Cameroonian child:  a case report Giles Kagmeni1,2 Yannick Bilong2 Cedric Mbogos2 Lucienne Bella assumpta2 1University teaching Hospital, Yaoundé,   Cameroon; 2eye Department,   University of Yaoundé 1, Yaoundé,   CameroonBackground:  Peters’ anomaly (PA) is a rare form of anterior segment dysgenesis characterized  by corneal opacity with varied degree of anterior chamber affection with associated defects in  the posterior layers of the cornea.",Non-OADS,/arxiv_data1/oa_pdf/4b/6f/imcrj-9-317.PMC5072567.pdf
"There was a homogeneous bilateral central   Correspondence: Giles Kagmeni eye Department, University of Yaounde I, Bp 04 Yaounde, Cameroontel +237 6 9951 4473email dr.kagmeni@gmx.netJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Kagmeni et alRunning head recto: Peters plus anomalyDOI: http://dx.doi.org/10.2147/IMCRJ.S115941",Non-OADS,/arxiv_data1/oa_pdf/4b/6f/imcrj-9-317.PMC5072567.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/4b/6f/imcrj-9-317.PMC5072567.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 319 peters plus anomaly syndrome.9 Although genetic diagnosis of PA is not available  in our country, clinical ophthalmic findings and associated  systemic abnormalities led us to classify our patient as Type 1 plus PA.",Non-OADS,/arxiv_data1/oa_pdf/4b/6f/imcrj-9-317.PMC5072567.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/09/14/cia-11-1441.PMC5072569.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1441–1450Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1441ClInICAl TrIAl repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10956 0 Do empowered stroke patients perform better  at self-management and functional recovery after  a stroke?",Non-OADS,/arxiv_data1/oa_pdf/09/14/cia-11-1441.PMC5072569.pdf
"Keywords:  self-management, patient empowerment, stroke, rehabilitation, functional recovery,  activities of daily living Introduction Neurological and neuropsychiatric conditions, such as traumatic brain injury,  Parkinson’s disease, dementia, and stroke, are often characterized by considerable  deficits that significantly reduce patients’ functional abilities and their overall quality Correspondence: Janet WH Sit The nethersole School of nursing,  The Chinese University of Hong Kong,  Shatin, new Territories, Hong Kong,  people’s republic of China email janet.sit@cuhk.edu.h k Journal name: Clinical Interventions in Aging Article Designation: Clinical Trial Report Y ear: 2016 Volume: 11 Running head verso: Sit et al Running head recto: Self-management and functional recovery poststroke DOI: http://dx.doi.org/10.2147/CIA.S109560",Non-OADS,/arxiv_data1/oa_pdf/09/14/cia-11-1441.PMC5072569.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/09/14/cia-11-1441.PMC5072569.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/09/14/cia-11-1441.PMC5072569.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 591–597ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  591 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S108288Disease progression and health care resource  consumption in patients affected by hepatitis   C virus in real practice setting Valentina Perrone Diego Sangiorgi Stefano Buda Luca Degli Esposti CliCon S.r.l.",Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
"3Correspondence: Luca Degli Esposti CliCon S.r.l., Health, Economics and Outcomes Research, Via Salara, 36 - 48100 Ravenna, ItalyTel +39 544 38393Fax +39 544 212 699Email luca.degliesposti@clicon.itJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Perrone et alRunning head recto: Resource consumption in patients treated for HCVDOI: http://dx.doi.org/10.2147/CEOR.S108288",Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
2002 Hepatitis C. Available from: http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/.,Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
Available from: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/.,Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
Available from: http://www.iss.it/seieva/index.php?lang=1&anno=2016&tipo=5.,OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 597 Resource consumption in patients treated for HCV 24.,Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
Available from: https://www.agenziafarmaco.gov.it/ricclin/sites/default/files/files_wysiwyg/files/CIRCULARS/Circular%2031st%20May%202010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
Available from: http://www.iss.it/seieva/index.php?lang= 1&anno= 2014&tipo= 4.,OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
Available from: http://www.uptodate.com/contents/hepatitis-c-beyond-the-basics.,Non-OADS,/arxiv_data1/oa_pdf/27/38/ceor-8-591.PMC5072570.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/copd-11-2563.PMC5072571.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2563–2571International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2563OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10902 6 TRPM8  genetic variations associated with COPD  risk in the Chinese han population Mingmei Xiong* Jian Wang* Meihua guo Qipeng Zhou Wenju lu state Key laboratory of respiratory  Diseases, guangzhou Institute of  respiratory Disease, The First  affiliated hospital, guangzhou Medical  University, guangzhou, guangdong,   People’s republic of China *These authors contributed equally  to this workAbstract:  TRPM8  plays a key role in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/copd-11-2563.PMC5072571.pdf
"However, only 10%–15% of smokers develop clinically significant COPD.11–14 The  role of genetic factors in the development of COPD has been investigated by many Correspondence: Wenju lu state Key laboratory of respiratory  Diseases, guangzhou Institute of  Respiratory Disease, The First Affiliated  hospital, guangzhou Medical University,  no.151 Yanjiang road, Yuexiu district,  guangzhou, guangdong 510120,  People’s republic of China  Tel/fax +86 020 8320 5156 email wenjuluwwl@sina.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Xiong et al Running head recto: TRPM8  genetic variations in COPD DOI: http://dx.doi.org/10.2147/COPD.S109026",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/copd-11-2563.PMC5072571.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/a2/2d/copd-11-2563.PMC5072571.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/2d/copd-11-2563.PMC5072571.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/47/67/ce-11-037.PMC5072572.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/47/67/ce-11-037.PMC5072572.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Core Evidence 2016:11 37–47Core Evidence Dovepress submit your manuscript | www.dovepress.com Dovepress 37 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S93717 Imiglucerase in the management of Gaucher  disease type 1: an evidence-based review of its  place in therapy Christine Serratrice1 Sebastian Carballo2 Jacques Serratrice2 Jérome Stirnemann2 1Department of Internal Medicine  and Rehabilitation, Geneva University  Hospital, Thonex, Switzerland;   2Department of General Internal  Medicine, Geneva University Hospital,  Geneva, SwitzerlandIntroduction: Gaucher disease is the first lysosomal disease to benefit from enzyme replace- ment therapy, thus serving as model for numerous other lysosomal diseases.",Non-OADS,/arxiv_data1/oa_pdf/47/67/ce-11-037.PMC5072572.pdf
"14,15Correspondence: Christine Serratrice Department of Internal Medicine and Rehabilitation, Geneva University Hospital, Chemin du Pont Bochet 3, Thonex CH-1226, SwitzerlandEmail christine.serratrice@hcuge.chJournal name: Core Evidence Article Designation: REVIEWY ear: 2016V olume: 11Running head verso: Serratrice et alRunning head recto: Imiglucerase in the management of Gaucher disease type 1DOI: http://dx.doi.org/10.2147/CE.S93717",Non-OADS,/arxiv_data1/oa_pdf/47/67/ce-11-037.PMC5072572.pdf
"Available from http://www.cerezyme.com, Accessed August 13, 2012.",Non-OADS,/arxiv_data1/oa_pdf/47/67/ce-11-037.PMC5072572.pdf
"US Food and Drug Administration Cerezyme Label Information,  2005.: Available from http://www.accessdata.fda.gov/drugsatfda_docs/label/2005/20367s066lbl.pdf.",OADS,/arxiv_data1/oa_pdf/47/67/ce-11-037.PMC5072572.pdf
"Core Evidence 2016:11submit your manuscript | www.dovepress.com Dovepress Dovepress Core Evidence Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/core-evidence-journalCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of drugs throughout their development lifecycle from preclinical to post launch.",Non-OADS,/arxiv_data1/oa_pdf/47/67/ce-11-037.PMC5072572.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 47 Imiglucerase in the management of Gaucher disease type 1,Non-OADS,/arxiv_data1/oa_pdf/47/67/ce-11-037.PMC5072572.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c1/76/idr-9-243.PMC5072573.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c1/76/idr-9-243.PMC5072573.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Infection and Drug Resistance  2016:9 243–252Infection and Drug Resistance Dovepress submit your manuscript | www.dovepress.com Dovepress 243 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S109485Pharmacist-managed dose adjustment feedback  using therapeutic drug monitoring of vancomycin  was useful for patients with methicillin-resistant  Staphylococcus aureus infections: a single institution experience Ryuichi Hirano1 Yuichi Sakamoto2 Junichi Kitazawa2 Shoji Yamamoto1 Naoki Tachibana2 1Department of Pharmacy,   2Laboratory Medicine and Blood  Transfusion, Aomori Prefectural  Central Hospital, Aomori-shi, JapanBackground: Vancomycin (VCM) requires dose adjustment based on therapeutic drug   monitoring.",Non-OADS,/arxiv_data1/oa_pdf/c1/76/idr-9-243.PMC5072573.pdf
"Keywords: antimicrobial stewardship, prospective audit and feedback, therapeutic drug moni- toring, vancomycin Introduction Vancomycin (VCM), a glycopeptide antibiotic, has antibiotic activity against Gram- positive bacteria, including methicillin-resistant Staphylococcus aureus  (MRSA).1  Acute kidney injury (AKI), which is correlated with high serum VCM concentrations, Correspondence: Ryuichi Hirano Department of Pharmacy, Aomori Prefectural Central Hospital, 2-1-1 Higashi-tsukurimichi, Aomori-shi, Aomori 0308553, JapanTel +81 17 726 8007Fax +81 17 726 8325Email r.hirano1115@gmail.comJournal name: Infection and Drug Resistance  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Hirano et alRunning head recto: Antimicrobial Stewardship Program for VCM therapeutic monitoringDOI: http://dx.doi.org/10.2147/IDR.S109485",Non-OADS,/arxiv_data1/oa_pdf/c1/76/idr-9-243.PMC5072573.pdf
"Infection and Drug Resistance  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Infection and Drug Resistance  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/infection-and-drug-resistance-journalInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte-rial, fungal and viral) and the development and institution of preventive strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/c1/76/idr-9-243.PMC5072573.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 252 Hirano et al,Non-OADS,/arxiv_data1/oa_pdf/c1/76/idr-9-243.PMC5072573.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f2/da/jmdh-9-537.PMC5072574.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f2/da/jmdh-9-537.PMC5072574.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 537–546Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 537 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S116957Enhancing adult therapeutic interpersonal  relationships in the acute health care setting:   an integrative review Rachel Kornhaber1 Kenneth Walsh1,2 Jed Duff1,3 Kim Walker1,3 1School of Health Sciences, Faculty  of Health, University of Tasmania,   Alexandria, NSW, 2Tasmanian Health  Services – Southern Region, Hobart,  TAS,  3St Vincent’s Private Hospital,   Sydney, NSW, AustraliaAbstract: Therapeutic interpersonal relationships are the primary component of all health care  interactions that facilitate the development of positive clinician–patient experiences.",Non-OADS,/arxiv_data1/oa_pdf/f2/da/jmdh-9-537.PMC5072574.pdf
"The concept is also interrelated with that of Correspondence: Rachel Kornhaber School of Health Sciences, Faculty of Health, University of Tasmania, Locked bag 5052, Alexandria, NSW 2015, AustraliaEmail rachel.kornhaber@utas.edu.auJournal name: Journal of Multidisciplinary Healthcare Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Kornhaber et alRunning head recto: Enhancing therapeutic interpersonal relationships in the acute care settingDOI: http://dx.doi.org/10.2147/JMDH.S116957",Non-OADS,/arxiv_data1/oa_pdf/f2/da/jmdh-9-537.PMC5072574.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/f2/da/jmdh-9-537.PMC5072574.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 546 Kornhaber et al 15.,Non-OADS,/arxiv_data1/oa_pdf/f2/da/jmdh-9-537.PMC5072574.pdf
These  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
"Geneva: World Health  Organization; 2011. p. 24Available at: http://www.unaids.org/en/media/unaids/contentassets/ documents/unaid-spublication/2011/20111130_ua_report_en.pdf  [accessed January 12, 2013] 2.",Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1371/journal.pmed.,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1371/journal.pone.0031078 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1371/journal.pmed.1001304 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1080/09540120903193625 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1089/jwh.2007.0670 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1111/j.1365-3156.2008.02029.x .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1097/QAD.0b013e3283471deb .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1371/journal.pone.0022707 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1371/journal.pone.0086305 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
"Geneva: WHO; 2006. p. 13-46.2006 revisionAvailable at: https://extranet.who.int/iris/restricted/ bitstream/10665/43554/1/9789241594677_eng.pdf  [accessed January 12, 2013] 17.",Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
"Available at: http://www2.sas.com/proceedings/sugi23/Posters/p170.pdf  [accessed October 31,  2013] 19.",Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1002/sim.3618 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
2010; 10:416. http://dx.doi.org/10.1186/1471-2458-10-416 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/ 10.1097/00126334-200408010-00009 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1371/journal.pone.0037125 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1093/jac/dkt011 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
2011; 7:13. http://dx.doi.org/10.1186/1744-8603-7-13 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1089/jwh.2012.3585 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1371/journal.pone.0005790 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1093/infdis/jir246 .,OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
http://dx.doi.org/10.1371/ journal.pmed.1001067 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
2009; 6:17. http://dx.doi.org/ 10.1186/1742-6405-6-17 .,Non-OADS,/arxiv_data1/oa_pdf/83/74/nihms769655.PMC5072602.pdf
"Large voltage differences between different points of the structure, which are dangerous to persons and equipment inside the building, canReceived: 22 June 2016 Revised: 14 September 2016 Accepted: 10 October 2016 Heliyon 2 (2016) e00178 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
"Conversely, in this work the frequency domain chain matrix model of eachsegment is obtained, and then the method of chain connection of chain matrices is Article No~e00178 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
(1)) to assemble the network of horizontal Article No~e00178 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
"Network assembly and frequency domain solution Considering a system consisting of Nnodes, the complete metallic structure is described by means of a nodal or admittance matrix model as follows: Article No~e00178 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Ground resistivity and conductors ’radius are Article No~e00178 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
nA (A/μs2) δ(dimensionless) α(1/μs) 1 100500 2 0.99 2 390 2 0.063 3 2100 2 0.18 4 14500 2 0.4 Article No~e00178 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Branch max[ i(t)] Measurement from [3] FD model PSCAD/EMTDC 1 45600 49993.62 53517.44 2 23250 23539.57 22829.80 3 12710 12105.69 12104.51 4 16500 15481.07 14458.61 5 31500 30478.90 28784.32 6 8000 7666.99 7656.407 4750 4592.83 4473.65 8 21000 20010.30 18558.37 Article No~e00178 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Branch max[ i(t)] Measurement from [3] FD model PSCAD/EMTDC 1 45000 48959.87 52757.83 2 22000 22521.83 22077.25 3 8380 9020.12 8819.80 4 11800 12383.68 11789.18 5 31250 30404.74 28723.81 6 9000 9491.77 9417.567 4000 4059.40 3901.14 8 22000 21197.84 19865.75 9 5130 5407.44 5353.06 10 5500 5577.47 5516.27 11 4340 4750.28 4692.4312 690 678.39 683.47 13 6130 6244.15 6181.05 Article No~e00178 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
Article No~e00178 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00178 2405-8440/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d8/f5/main.PMC5072620.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-11-5349.PMC5072627.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5349–5360International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5349OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11626 3 effects of nanoporous anodic titanium oxide on  human adipose derived stem cells Katarzyna Malec1 Joanna góralska1 Magdalena hubalewska- Mazgaj2 Paulina Głowacz1 Magdalena Jarosz3 Pawel Brzewski4 grzegorz D sulka3 Marian Jaskuła3 Iwona Wybrańska1 1Department of clinical Biochemistry,   Jagiellonian University Medical  college, 2Department of genetic  research and Nutrigenomics,   Malopolska centre of Biotechnology,   Jagiellonian University, 3Department  of Physical chemistry and  electrochemistry, Faculty of  chemistry, Jagiellonian University,   4Department of Dermatology,   Jagiellonian University Medical  college, Kraków, PolandAbstract:  The aim of current bone biomaterials research is to design implants that induce  controlled, guided, successful, and rapid healing.",Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-11-5349.PMC5072627.pdf
"Numerous studies have proved that the osteoblastic cells are better  adapted to a nanoscale environment rather than to microscale niche.3,4correspondence: Katarzyna Malec Department of clinical Biochemistry,  Jagiellonian University Medical  college, Ul Kopernika 15a,  31-501 Kraków, Poland Tel +48 12 608 589 386 Fax +48 12 421 4073 email malec.katarzyna@gmail.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Malec et al Running head recto: Nanoporous anodic TiO2 and human ASCs DOI: http://dx.doi.org/10.2147/IJN.S116263",Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-11-5349.PMC5072627.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-11-5349.PMC5072627.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/84/ijn-11-5349.PMC5072627.pdf
Medicine (2016) 95:41(e4605)Received: 5 April 2016 / Received in ﬁnal form: 8 July 2016 / Accepted: 19 July 2016 http://dx.doi.org/10.1097/MD.0000000000004605Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1e/f3/medi-95-e4605.PMC5072926.pdf
Medicine (2016) 95:41(e4714)Received: 6 May 2016 / Received in ﬁnal form: 13 July 2016 / Accepted: 3 August 2016 http://dx.doi.org/10.1097/MD.0000000000004714Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7a/38/medi-95-e4714.PMC5072928.pdf
Medicine (2016) 95:41(e4823)Received: 5 June 2016 / Received in ﬁnal form: 28 July 2016 / Accepted: 18 August 2016 http://dx.doi.org/10.1097/MD.0000000000004823Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6d/41/medi-95-e4823.PMC5072929.pdf
Medicine (2016) 95:41(e4852)Received: 12 November 2015 / Received in ﬁnal form: 17 August 2016 / Accepted: 22 August 2016 http://dx.doi.org/10.1097/MD.0000000000004852Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d3/c8/medi-95-e4852.PMC5072930.pdf
Medicine (2016) 95:41(e4907)Received: 4 April 2016 / Received in ﬁnal form: 16 August 2016 / Accepted: 26 August 2016 http://dx.doi.org/10.1097/MD.0000000000004907Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b1/af/medi-95-e4907.PMC5072931.pdf
Available from: http://www.amedeolucente.it/public/DRI_OCT_Triton_SS_OCT_Angio_Whitepaper_E_201511.pdf.,OADS,/arxiv_data1/oa_pdf/b1/af/medi-95-e4907.PMC5072931.pdf
Medicine (2016) 95:41(e4934)Received: 9 March 2016 / Received in ﬁnal form: 19 June 2016 / Accepted: 30 August 2016 http://dx.doi.org/10.1097/MD.0000000000004934Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/de/c8/medi-95-e4934.PMC5072932.pdf
Medicine (2016) 95:41(e4938)Received: 29 June 2016 / Received in ﬁnal form: 28 August 2016 / Accepted: 30 August 2016 http://dx.doi.org/10.1097/MD.0000000000004938Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/2e/77/medi-95-e4938.PMC5072933.pdf
Medicine (2016) 95:41(e4944)Received: 2 April 2016 / Received in ﬁnal form: 14 August 2016 / Accepted: 30 August 2016 http://dx.doi.org/10.1097/MD.0000000000004944Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/89/fa/medi-95-e4944.PMC5072934.pdf
Medicine (2016) 95:41(e4951)Received: 7 March 2016 / Received in ﬁnal form: 28 July 2016 / Accepted: 1 September 2016 http://dx.doi.org/10.1097/MD.0000000000004951Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f4/3f/medi-95-e4951.PMC5072935.pdf
Medicine (2016) 95:41(e4956)Received: 8 June 2016 / Received in ﬁnal form: 1 September 2016 / Accepted: 2 September 2016 http://dx.doi.org/10.1097/MD.0000000000004956Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/80/1d/medi-95-e4956.PMC5072936.pdf
http://careonline.it/wp-content/uploads/ 2011/07/Safety_walkaround_2_2009.pdf.,Non-OADS,/arxiv_data1/oa_pdf/80/1d/medi-95-e4956.PMC5072936.pdf
Medicine (2016) 95:41(e5015)Received: 12 March 2016 / Received in ﬁnal form: 6 September 2016 / Accepted: 7 September 2016 http://dx.doi.org/10.1097/MD.0000000000005015Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/83/ef/medi-95-e5015.PMC5072937.pdf
Medicine (2016) 95:41(e5027)Received: 24 April 2016 / Received in ﬁnal form: 31 August 2016 / Accepted: 1 September 2016 http://dx.doi.org/10.1097/MD.0000000000005027Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/6b/55/medi-95-e5027.PMC5072938.pdf
Medicine (2016) 95:41(e5034)Received: 22 February 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 9 September 2016 http://dx.doi.org/10.1097/MD.0000000000005034Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f5/74/medi-95-e5034.PMC5072939.pdf
Medicine (2016) 95:41(e5041)Received: 8 April 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 9 September 2016 http://dx.doi.org/10.1097/MD.0000000000005041Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fd/36/medi-95-e5041.PMC5072940.pdf
"and also higher frequencies of current alcohol drinking, diabetes, and hypercholesterolemia, than those without hypertension(Supplementary Table 1, http://links.lww.com/MD/B321).",Non-OADS,/arxiv_data1/oa_pdf/fd/36/medi-95-e5041.PMC5072940.pdf
"Even after excluding people with hypertension, hemoglobin showed similar positive associations with SBP and DBP (SupplementaryTable 2, http://links.lww.com/MD/B321).",Non-OADS,/arxiv_data1/oa_pdf/fd/36/medi-95-e5041.PMC5072940.pdf
"adjust for follow-up time, we also performed Cox proportional hazards regression (Supplementary Table 3, http://links.lww.",OADS,/arxiv_data1/oa_pdf/fd/36/medi-95-e5041.PMC5072940.pdf
"To excludethe effect of hypertensive drugs, we performed a further analysis (Supplementary Table 4, http://links.lww.com/MD/B321).",Non-OADS,/arxiv_data1/oa_pdf/fd/36/medi-95-e5041.PMC5072940.pdf
Medicine (2016) 95:41(e5043)Received: 26 July 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 9 September 2016 http://dx.doi.org/10.1097/MD.0000000000005043Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ae/ff/medi-95-e5043.PMC5072941.pdf
Medicine (2016) 95:41(e5047)Received: 13 July 2016 / Received in ﬁnal form: 6 September 2016 / Accepted: 8 September 2016 http://dx.doi.org/10.1097/MD.0000000000005047Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e0/6c/medi-95-e5047.PMC5072942.pdf
Medicine (2016) 95:41(e5051)Received: 11 May 2016 / Received in ﬁnal form: 8 September 2016 / Accepted: 13 September 2016 http://dx.doi.org/10.1097/MD.0000000000005051Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7e/53/medi-95-e5051.PMC5072944.pdf
Medicine (2016) 95:41(e5055)Received: 10 November 2015 / Received in ﬁnal form: 17 May 2016 / Accepted: 9 September 2016 http://dx.doi.org/10.1097/MD.0000000000005055Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/96/25/medi-95-e5055.PMC5072945.pdf
Available at: http://www.spineuniverse.com/conditions/herniated-disc/cervical-herniated-disc-or-ruptured-disc.,Non-OADS,/arxiv_data1/oa_pdf/96/25/medi-95-e5055.PMC5072945.pdf
Available at: http://www.nhi.gov.tw/webdata/webdata.aspx?menu=17&menu_id= 659&webdata_id=2891.,OADS,/arxiv_data1/oa_pdf/96/25/medi-95-e5055.PMC5072945.pdf
Available at: http://nhird.nhri.org.tw/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/96/25/medi-95-e5055.PMC5072945.pdf
Available at: http://nhird.nhri.org.tw/en/Data_Subsets.html#S3.,OADS,/arxiv_data1/oa_pdf/96/25/medi-95-e5055.PMC5072945.pdf
Available at: http://www.tma.tw/stats/stater.asp [in Chinese] and http://www.tma.tw/EN_tma/index.asp [in English].,Non-OADS,/arxiv_data1/oa_pdf/96/25/medi-95-e5055.PMC5072945.pdf
Available at: http://www.ccohs.ca/oshanswers/diseases/rmirsi.html.,Non-OADS,/arxiv_data1/oa_pdf/96/25/medi-95-e5055.PMC5072945.pdf
Medicine (2016) 95:41(e5058)Received: 21 May 2016 / Received in ﬁnal form: 21 August 2016 / Accepted: 10 September 2016 http://dx.doi.org/10.1097/MD.0000000000005058Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/0e/38/medi-95-e5058.PMC5072946.pdf
Medicine (2016) 95:41(e5060)Received: 24 July 2015 / Received in ﬁnal form: 10 September 2016 / Accepted: 13 September 2016 http://dx.doi.org/10.1097/MD.0000000000005060Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8e/ac/medi-95-e5060.PMC5072947.pdf
[11]Multilocus sequence typing (MLST) was performed for selective strains of each major PFGE type according to the method provided in the MLST Website (http://www.mlst.net).,Non-OADS,/arxiv_data1/oa_pdf/8e/ac/medi-95-e5060.PMC5072947.pdf
Medicine (2016) 95:41(e5061)Received: 9 December 2015 / Received in ﬁnal form: 31 July 2016 / Accepted: 12 September 2016 http://dx.doi.org/10.1097/MD.0000000000005061Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ca/3d/medi-95-e5061.PMC5072948.pdf
Medicine (2016) 95:41(e5068)Received: 30 April 2016 / Received in ﬁnal form: 9 September 2016 / Accepted: 11 September 2016 http://dx.doi.org/10.1097/MD.0000000000005068Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/b0/2b/medi-95-e5068.PMC5072949.pdf
Medicine (2016) 95:41(e5078)Received: 6 May 2016 / Received in ﬁnal form: 9 September 2016 / Accepted: 12 September 2016 http://dx.doi.org/10.1097/MD.0000000000005078Clinical Trial/Experimental Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/7b/a1/medi-95-e5078.PMC5072950.pdf
"The Lokomat (Hocoma AG, Volketswil, Zürich, Switzerland) is an exoskeletal robot-driven gait orthosis that can be controlled using a treadmill and a body-weight support (BWS)system (Video 1, http://links.lww.com/MD/B323).",Non-OADS,/arxiv_data1/oa_pdf/7b/a1/medi-95-e5078.PMC5072950.pdf
Medicine (2016) 95:41(e5087)Received: 1 June 2016 / Received in ﬁnal form: 1 September 2016 / Accepted: 14 September 2016 http://dx.doi.org/10.1097/MD.0000000000005087Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/37/c9/medi-95-e5087.PMC5072952.pdf
"Results Among the 5688 HIV-infected patients who initiated a ﬁrst-line triple antiretroviral treatment during the study period, 2074 hadcART regimen unchanged for at least 12 months, of whom 830 patients had an undetectable HIV-pVL at all assessments, and 605 patients had data on HIV-pVL, CD4 +and CD8+T-cell counts available at the time of cART initiation (Supplementary Figure 1: ﬂowchart, http://links.lww.com/MD/B358).",Non-OADS,/arxiv_data1/oa_pdf/37/c9/medi-95-e5087.PMC5072952.pdf
Medicine (2016) 95:41(e5103)Received: 4 March 2016 / Received in ﬁnal form: 2 September 2016 / Accepted: 18 September 2016 http://dx.doi.org/10.1097/MD.0000000000005103Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/19/1d/medi-95-e5103.PMC5072953.pdf
Medicine (2016) 95:41(e5108)Received: 9 September 2016 / Received in ﬁnal form: 16 September 2016 / Accepted: 19 September 2016 http://dx.doi.org/10.1097/MD.0000000000005108Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/86/1a/medi-95-e5108.PMC5072954.pdf
Medicine (2016) 95:41(e5109)Received: 23 May 2016 / Received in ﬁnal form: 14 September 2016 / Accepted: 15 September 2016 http://dx.doi.org/10.1097/MD.0000000000005109Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/8f/d8/medi-95-e5109.PMC5072955.pdf
"[15,16]Regarding asthma medication, we included only inhaled corticosteroids such as ﬂuticasone, beclomethasone, and budesonide; nasal sprays, tablets, and steroid injections wereexcluded (Appendix 2, http://links.lww.com/MD/B341).",Non-OADS,/arxiv_data1/oa_pdf/8f/d8/medi-95-e5109.PMC5072955.pdf
"Respiratory infection was a major confounder in this study; thus, asthmatic children who were admitted with anacute respiratory illness associated with upper airway infections(ICD-9: 465), common cold (ICD-9: 460), and pneumonia or bronchopneumonia (ICD-9: 480 –485) were excluded (Appendix 1, http://links.lww.com/MD/B341), meaning that all patients withasthma-related hospitalization in the present study were admitted solely because of asthma exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/8f/d8/medi-95-e5109.PMC5072955.pdf
"[17–19]In addition, gastroesophageal re ﬂux dis- ease,[20]which has been correlated with asthma, was included as a variable (Appendix 1, http://links.lww.com/MD/B341).",Non-OADS,/arxiv_data1/oa_pdf/8f/d8/medi-95-e5109.PMC5072955.pdf
"CharacteristicsAll patients (n [%])Antiasthmatic agents alone (n [%])Concurrently using antiasthmatic agents and NSAIDs (n [%])Pvalue of chi-square test Number of patients 29,484 (100%) 19,622 (66.6%) 9862 (33.4%) Gender 0.510 Male 17,049 (57.8%) 11,320 (57.7%) 5729 (58.1%) Female 12,435 (42.2%) 8302 (42.3%) 4133 (41.9%) Mean age, y 0.846 0–2 20,453 (69.4%) 13,621 (69.4%) 6832 (69.3%) 3–5 3301 (11.2%) 2181 (11.1%) 1120 (11.4%) 6–12 3439 (11.7%) 2304 (11.7%) 1135 (11.5%) 13–18 2291 (7.8%) 1516 (7.7%) 775 (7.9%) Insured region 0.666 Taipei City 6593 (22.4%) 4378 (22.3%) 2214 (22.5%) Kaohsiung City 1298 (4.4%) 842 (4.3%) 456 (4.6%)Northern Taiwan 10,628 (36.1%) 7055 (36.0%) 3573 (36.2%) Central Taiwan 4636 (15.7%) 3088 (15.7%) 1548 (15.7%) Southern Taiwan 5534 (18.8%) 3713 (18.9%) 1821 (18.5%)Eastern Taiwan 655 (2.2%) 449 (2.3%) 206 (2.1%)Outlying islands 141 (0.5%) 97 (0.5%) 44 (0.5%) Classi ﬁcation of asthma 0.989 Atopic asthma 7537 (25.6%) 5003 (25.5%) 2534 (25.7%)Nonatopic asthma 1378 (4.7%) 927 (4.7%) 451 (4.6%)Chronic obstructive asthma 1296 (4.4%) 862 (4.4%) 434 (4.4%) Asthma, unspeci ﬁc 18,018 (61.1%) 11,996 (61.1%) 6022 (61.1%) Atopic + chronic obstructive asthma 178 (0.6%) 116 (0.6%) 62 (0.6%)Atopic + nonatopic asthma 1077 (3.7%) 718 (3.7%) 359 (3.6%) Comorbidity variables Allergic rhinitis 0.513 Yes 26,889 (91.2%) 17,901 (91.3%) 8979 (91.1%)No 2595 (8.8%) 1712 (8.7%) 883 (9.0%) Gastroesophageal re ﬂux disease 0.660 Yes 2452 (8.3%) 1622 (8.3%) 830 (8.4%)No 27,032 (91.7%) 18,000 (91.7%) 9032 (91.6%) Atopic dermatitis 0.308 Yes 12,127 (41.1%) 8030 (41.0%) 4097 (41.5%) No 17,357 (58.9%) 11,592 (59.1%) 5765 (58.5%) Urticaria 0.233 Yes 15,372 (52.1%) 10,182 (51.9%) 5190 (52.6%) No 14,112 (47.9%) 9440 (48.1%) 4672 (47.4%) Total numbers of comorbidities 0.591 0 543 (1.8%) 358 (1.8%) 185 (1.9%) 1 4207 (14.3%) 2831 (14.4%) 1376 (14.0%) 2 9079 (30.8%) 6076 (31.0%) 3003 (30.5%)3 9966 (33.8%) 6597 (33.6%) 3369 (34.2%)≧4 5689 (19.3%) 3760 (19.2%) 1929 (19.6%) Type of antiasthmatic agents Controllers ∗<0.0001 Yes 29,254 (99.2%) 19,410 (98.9%) 9844 (99.8%)No 230 (0.8%) 2112 (1.1%) 18 (0.2%) Relievers∗<0.0001 Yes 26,394 (89.5%) 17,136 (87.3%) 9258 (93.9%)No 3090 (10.5%) 2486 (12.7%) 604 (6.1%) NSAIDs =nonsteroidal anti-in ﬂammatory drugs.∗Details of controllers and relievers are listed in Appendix 2, http://links.lww.com/MD/B341.Lo et al.",Non-OADS,/arxiv_data1/oa_pdf/8f/d8/medi-95-e5109.PMC5072955.pdf
"Available from URL: http://nhird.nhri.org.tw/date_03.html [Accessed September 29, 2016].",Non-OADS,/arxiv_data1/oa_pdf/8f/d8/medi-95-e5109.PMC5072955.pdf
Available from URL: http://nhird.nhri.org.tw/ ﬁle_date/en_codeformat.,OADS,/arxiv_data1/oa_pdf/8f/d8/medi-95-e5109.PMC5072955.pdf
Medicine (2016) 95:41(e5111)Received: 29 April 2016 / Received in ﬁnal form: 30 August 2016 / Accepted: 20 September 2016 http://dx.doi.org/10.1097/MD.0000000000005111Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/a7/3c/medi-95-e5111.PMC5072956.pdf
Medicine (2016) 95:41(e5113)Received: 3 April 2016 / Received in ﬁnal form: 11 July 2016 / Accepted: 17 September 2016 http://dx.doi.org/10.1097/MD.0000000000005113Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f4/a4/medi-95-e5113.PMC5072957.pdf
Medicine (2016) 95:41(e5114)Received: 10 May 2016 / Received in ﬁnal form: 12 September 2016 / Accepted: 18 September 2016 http://dx.doi.org/10.1097/MD.0000000000005114Systematic Review And Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/dd/6c/medi-95-e5114.PMC5072958.pdf
Available at: http://www.ispor.org/Health-Economic-Evaluation-Publication-CHEERS-Guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/dd/6c/medi-95-e5114.PMC5072958.pdf
Medicine (2016) 95:41(e5119)Received: 20 May 2016 / Received in ﬁnal form: 26 August 2016 / Accepted: 20 September 2016 http://dx.doi.org/10.1097/MD.0000000000005119Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/01/a3/medi-95-e5119.PMC5072959.pdf
"The estimated bparameter and model ﬁtness were shown in Supplement Table S1A and B, http://links.lww.com/MD/B351.",OADS,/arxiv_data1/oa_pdf/01/a3/medi-95-e5119.PMC5072959.pdf
"The estimated bparameter and model ﬁtness were indicated in Supplement Table S2, http://links.lww.com/MD/B351.",OADS,/arxiv_data1/oa_pdf/01/a3/medi-95-e5119.PMC5072959.pdf
Medicine (2016) 95:41(e5123)Received: 5 November 2015 / Received in ﬁnal form: 8 August 2016 / Accepted: 26 August 2016 http://dx.doi.org/10.1097/MD.0000000000005123Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f9/15/medi-95-e5123.PMC5072961.pdf
Medicine (2016) 95:41(e5125)Received: 14 July 2016 / Received in ﬁnal form: 6 September 2016 / Accepted: 22 September 2016 http://dx.doi.org/10.1097/MD.0000000000005125Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/1f/e2/medi-95-e5125.PMC5072962.pdf
Medicine (2016) 95:41(e5127)Received: 9 May 2016 / Received in ﬁnal form: 27 July 2016 / Accepted: 22 September 2016 http://dx.doi.org/10.1097/MD.0000000000005127Systematic Review And Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/ec/92/medi-95-e5127.PMC5072964.pdf
Available from: http://srdta.cochrane.org/.,OADS,/arxiv_data1/oa_pdf/ec/92/medi-95-e5127.PMC5072964.pdf
Medicine (2016) 95:41(e5129)Received: 7 June 2016 / Received in ﬁnal form: 22 August 2016 / Accepted: 17 September 2016 http://dx.doi.org/10.1097/MD.0000000000005129Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/63/c9/medi-95-e5129.PMC5072965.pdf
Medicine (2016) 95:41(e5133)Received: 11 March 2016 / Received in ﬁnal form: 26 July 2016 / Accepted: 27 July 2016 http://dx.doi.org/10.1097/MD.0000000000005133Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/68/fb/medi-95-e5133.PMC5072966.pdf
2015; http://www.aidsinfo.nih.gov/ContentFiles/Adultan dAdolescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/fb/medi-95-e5133.PMC5072966.pdf
BHIVA guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy 2015.2015; http://www.bhiva.org/HIV-1-treatment-guidelines.aspx.,Non-OADS,/arxiv_data1/oa_pdf/68/fb/medi-95-e5133.PMC5072966.pdf
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection:recommendations for a public health approach June 2013. : Available at http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.,Non-OADS,/arxiv_data1/oa_pdf/68/fb/medi-95-e5133.PMC5072966.pdf
Medicine (2016) 95:41(e5135)Received: 11 September 2016 / Received in ﬁnal form: 19 September 2016 / Accepted: 23 September 2016 http://dx.doi.org/10.1097/MD.0000000000005135Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/d0/94/medi-95-e5135.PMC5072967.pdf
"These clinical features recurred several times during observation (see Video 1, Supplemental Video, which illustrates tongue dystonia, http://links.lww.com/MD/B357).",Non-OADS,/arxiv_data1/oa_pdf/f9/5d/medi-95-e5137.PMC5072968.pdf
Medicine (2016) 95:41(e5137)Received: 18 August 2016 / Received in ﬁnal form: 14 September 2016 / Accepted: 23 September 2016 http://dx.doi.org/10.1097/MD.0000000000005137Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f9/5d/medi-95-e5137.PMC5072968.pdf
Medicine (2016) 95:41(e5139)Received: 26 March 2016 / Received in ﬁnal form: 10 September 2016 / Accepted: 23 September 2016 http://dx.doi.org/10.1097/MD.0000000000005139Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/65/f0/medi-95-e5139.PMC5072969.pdf
Medicine (2016) 95:41(e5140)Received: 10 March 2016 / Received in ﬁnal form: 24 August 2016 / Accepted: 23 September 2016 http://dx.doi.org/10.1097/MD.0000000000005140Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/9a/9b/medi-95-e5140.PMC5072970.pdf
Medicine (2016) 95:41(e5142)Received: 10 June 2016 / Received in ﬁnal form: 14 September 2016 / Accepted: 23 September 2016 http://dx.doi.org/10.1097/MD.0000000000005142Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/e3/3f/medi-95-e5142.PMC5072971.pdf
Medicine (2016) 95:41(e5145)Received: 25 July 2016 / Received in ﬁnal form: 22 September 2016 / Accepted: 26 September 2016 http://dx.doi.org/10.1097/MD.0000000000005145Observational Study Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/98/5d/medi-95-e5145.PMC5072972.pdf
Medicine (2016) 95:41(e5146)Received: 3 June 2016 / Received in ﬁnal form: 21 September 2016 / Accepted: 26 September 2016 http://dx.doi.org/10.1097/MD.0000000000005146Systematic Review and Meta-Analysis Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"1, http://links.lww.com/MD/B360), we included 6 RCTs in this meta-analysis,[14–19]including 5888 patients.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"The characteristics of each study werelisted in Supporting Table 1, http://links.lww.com/MD/B360.",OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"2, http://links.lww.com/MD/B360.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"Among main adverse reactions, TAF and TDF groups were similar in the rates of diarrhea, upper respiratory tract infection, nausea, andnasopharyngitis (see Supporting Figure 3 A –D, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"However, the TAF group had a higher rate of headache than that of the TDF group (see Supporting Figure 3E,http://links.lww.com/MD/B360).",Non-OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"The fasting lipid parameters (see Supporting Table 2, http://links.lww.com/MD/B360) in the TAF group increased from baseline in the TAF group compared with the TDF group at week 48.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"During their studies, 5.7% of all participants in the TAF group and 4.0% of allparticipants in the TDF group started lipid-lowering drugs, and no statistical signi ﬁcant difference was found between the groups (see supporting Figure 3F, http://links.lww.com/MD/B360).",Non-OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"meta-analysis for the safety of treatments, we summarized the bone events reported in each study in Supporting Table 3, http://links.lww.com/MD/B360, and performed the comparisons of continuous data using independent t-test from SPSS between TAF group and TDF group.",OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
"Available athttp://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.Accessed October 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/fd/45/medi-95-e5146.PMC5072973.pdf
Medicine (2016) 95:41(e5157)Received: 8 March 2016 / Received in ﬁnal form: 11 September 2016 / Accepted: 27 September 2016 http://dx.doi.org/10.1097/MD.0000000000005157Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/f3/c0/medi-95-e5157.PMC5072974.pdf
Medicine (2016) 95:41(e5159)Received: 17 July 2016 / Received in ﬁnal form: 15 September 2016 / Accepted: 27 September 2016 http://dx.doi.org/10.1097/MD.0000000000005159Clinical Case Report Medicine® OPEN 1,Non-OADS,/arxiv_data1/oa_pdf/01/07/medi-95-e5159.PMC5072975.pdf
"The patient underwent robot-assisted abdominal laparotomy (Video 1, http://links.lww.com/MD/B361).",Non-OADS,/arxiv_data1/oa_pdf/01/07/medi-95-e5159.PMC5072975.pdf
The origin of the C57BL/ 6JBomTac mice is described at http://www.taconic.com/wmspage.cfm?parm1=764.,Non-OADS,/arxiv_data1/oa_pdf/fd/89/APHA-219-441.PMC5073050.pdf
"The Mann –Whitney two- tailed U-test (http://elegans.som.vcu.edu/~leon/stats/ utest.html) was used to assess whether endothelial slitcalibre or the magnitude of endothelial junctional com-plex differed signiﬁcantly between samples from Wtand Epac1 /C0//C0mice, as such data are not normally dis- tributed.",OADS,/arxiv_data1/oa_pdf/fd/89/APHA-219-441.PMC5073050.pdf
"Editor: Paul Wiseman Biophysical Journal 111, 1785–1796, October 18, 2016 1785http://dx.doi.org/10.1016/j.bpj.2016.09.012 /C2112016 Biophysical Society.",Non-OADS,/arxiv_data1/oa_pdf/c2/e5/main.PMC5073057.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/63/72/40273_2016_Article_421.PMC5073108.pdf
London: NICE; 2013. http://publications.nice.org.uk/pmg9 .,Non-OADS,/arxiv_data1/oa_pdf/63/72/40273_2016_Article_421.PMC5073108.pdf
Shefﬁeld: Decision Support Unit; 2011. http://www.nicedsu.org.uk/TSD11%20Alternatives% 20to%20EQ-5D_ﬁnal.pdf .,OADS,/arxiv_data1/oa_pdf/63/72/40273_2016_Article_421.PMC5073108.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/26/2a/40261_2016_Article_430.PMC5073111.pdf
http://www.ema.europa.eu/ docs/en_GB/document_library/Scie ntiﬁc_guideline/2011/06/WC500 107908.pdf .,Non-OADS,/arxiv_data1/oa_pdf/26/2a/40261_2016_Article_430.PMC5073111.pdf
http://www.fda.gov/downloads/ Drugs/DevelopmentApprovalProcess/DevelopmentResources/ UCM049870.pdf .,Non-OADS,/arxiv_data1/oa_pdf/26/2a/40261_2016_Article_430.PMC5073111.pdf
"1124004, Guideline for Bioequivalence Studies of Generic Products, November 24, 2006. http://www.nihs.go.jp/drug/be- guide(e)/be2006e.pdf .",Non-OADS,/arxiv_data1/oa_pdf/26/2a/40261_2016_Article_430.PMC5073111.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/4.0/ The Supplementary Information that accompanies this paper is available on the Immunology and Cel l Biology website (http://www.nature.com/icb)Role of TAK1 in marginal zone B-cell development H Shinohara and T Kurosaki 829 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/c6/ca/icb201644a.PMC5073155.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ rThe Author(s) 2016Immune response in the purple sea urchin larva ECH Ho et al 874 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/e8/e3/icb201651a.PMC5073156.pdf
"Keywords:  Exosomes, Diabetes mellitus, Biomarkers, Standardization, Metabolic  syndrome XMin-Jae Lee, BS1,2,  Dong-Ho Park, PhD2,  Ju-Hee Kang, MD, PhD1,3 1Department of Pharmacology  and Medicinal Toxicology Research  Center, Inha University School of  Medicine, Incheon, 2Department  of Kinesiology, College of Arts and Sports, Inha University School  of Medicine, Incheon,  3Hypoxia- related Disease Research Center,  Inha University School of Medicine, Incheon, Koreahttp://dx.doi.org/10.6065/apem.2016.21.3.119Ann Pediatr Endocrinol Metab 2016;21:119-125 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 19 August, 2016 Accepted: 25 September, 2016  Address for correspondence:  Ju-Hee Kang, MD, PhD Department of Pharmacology and Medicinal Toxicology Research Center, Inha University School of Medicine, Room 1015, 60th Anniversary Building, 100, Inha-ro, Nam-gu, Incheon 22212, KoreaTel: +82-32-860-9872 Fax: +82-32-887-7488 E-mail: johykang@inha.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Exosomes are a class of extracellular vesicles (EVs), sized around 100 nm (30–120 nm)  in diameter, that are released from many different cell types.",Non-OADS,/arxiv_data1/oa_pdf/5b/e7/apem-21-119.PMC5073157.pdf
"Keywords:  Prader-Willi syndrome, Prader-Willi-like syndrome, Imprinting disorder,  Genetic screeningChong Kun Cheon, MD, PhD Division of Pediatric Endocrinology  and Metabolism, Department of Pediatrics, Pusan National University  Children's Hospital, Pusan National  University School of Medicine,  Yangsan, Koreahttp://dx.doi.org/10.6065/apem.2016.21.3.126Ann Pediatr Endocrinol Metab 2016;21:126-135 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 29 September, 2016  Accepted: 30 September, 2016  Address for correspondence:  Chong Kun Cheon, MD, PhD   Division of Pediatric Endocrinology and Metabolism, Department of Pediatrics, Pusan National University Children's Hospital, Pusan National University School of Medicine, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, KoreaTel: +82-55-360-3158 Fax: +82-55-360-2181 E-mail: chongkun@pusan.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Prader-Willi syndrome (PWS; OMIM #176270) is an imprinted neurobehavioral condition  affecting many organ systems and occurs due to the absence of expression of a cluster of paternally expressed genes located at 15q11-q13 1).",Non-OADS,/arxiv_data1/oa_pdf/e2/f2/apem-21-126.PMC5073158.pdf
"The common etiologies of excessive production of sex hormones by the gonads include McCune-Albright syndrome (MAS), functional ovarian cysts (FOCs), Leydig cell tumors, or familial Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty Eungu Kang, MD, Ja Hyang Cho, MD,Jin-Ho Choi, MD,Han-Wook Yoo, MD, PhD Department of Pediatrics, Asan  Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea Received: 26 January, 2016 Revised: 5 April, 2016 Accepted: 12 April, 2016 Address for correspondence:  Han-Wook Yoo, MD, PhD Department of Pediatrics, Asan Medical Center Children’s Hospital,  University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea Tel: +82-2-3010-3374, Fax: +82-2-473-3725,E-mail: hwyoo@amc.seoul.krhttp://dx.doi.org/10.6065/apem.2016.21.3.136 Ann Pediatr Endocrinol Metab 2016;21:136-142",Non-OADS,/arxiv_data1/oa_pdf/7b/d4/apem-21-136.PMC5073159.pdf
"Therefore, clinical use of these methods is The cutoff values of indirect indices for measuring insulin resistance for metabolic syndrome in Korean children and adolescents Jun Woo Kim, MD, Sang Hoo Park, MD,Yoojin Kim, MD,Minji Im, MD,Heon-Seok Han, MD Department of Pediatrics, Chungbuk  National University Hospital, Chung­buk National University College of Medicine, Cheongju, Korea Received: 29 February, 2016 Revised: 28 March, 2016 Accepted: 4 May, 2016 Address for correspondence:  Heon­Seok Han, MD Department of Pediatrics,  Chungbuk National University Hospital, Chungbuk National  University College of Medicine, 776  1(il)sunhwan ­ro, Heungdeok ­gu,  Cheongju 28644, Korea Tel: +82 ­43­269­6370, Fax: +82 ­43­264­6620, E­mail: hshan@chungbuk.ac.krhttp://dx.doi.org/10.6065/apem.2016.21.3.143 Ann Pediatr Endocrinol Metab 2016;21:143­148",Non-OADS,/arxiv_data1/oa_pdf/d1/38/apem-21-143.PMC5073160.pdf
"Therefore, the prevalence of vitamin D deficiency varies widely from country to Vitamin D deficiency in children aged 6 to 12 years: single center’s experience in Busan Young Eun Roh, MD1, Bo Ryung Kim, MD1, Won Bok Choi, MD1, Young Mi Kim, MD, PhD1, Min-Jung Cho, MD1, Hye-Young Kim, MD, PhD1, Kyung Hee Park, MD1, Kwang Hoon Kim, MD1, Peter Chun, MD1, Su Young Kim, MD, PhD2, Min Jung Kwak, MD, PhD1 1Department of Pediatrics, Pusan  National University Hospital, Pusan  National University School of Medi­cine, Busan,  2Department of Pediatrics,  Pusan National University Children’s Hospital, Pusan National University School of Medicine, Yangsan, Korea  Received: 18 March, 2016 Revised: 14 April, 2016 Accepted: 2 May, 2016 Address for correspondence:  Min Jung Kwak, MD, PhD Department of Pediatrics, Pusan  National University Hospital, Pusan National University School of  Medicine, 179 Gudeok ­ro, Seo ­gu,  Busan 49241, Korea Tel: +82 ­51­240­7298, Fax: +82 ­51­240­6205, E­mail: glorymj0123@gmail.comhttp://dx.doi.org/10.6065/apem.2016.21.3.149 Ann Pediatr Endocrinol Metab 2016;21:149­154",Non-OADS,/arxiv_data1/oa_pdf/47/bc/apem-21-149.PMC5073161.pdf
Seoul: The Korean Nutrition Society; c2017 [cited 2016 Apr 13] Available from: http://www.kns.or.kr/ 26.,Non-OADS,/arxiv_data1/oa_pdf/47/bc/apem-21-149.PMC5073161.pdf
"Eating behavior, perception Body image and depression in girls with idiopathic precocious puberty treated withgonadotropin-releasing hormone analogue Min-Seon Choi, MD, Eun-Young Kim, MD, PhD Department of Pediatrics, Chosun  University School of Medicine, Gwangju, Korea Received: 23 March, 2016 Revised: 6 May, 2016 Accepted: 12 August, 2016 Address for correspondence:  Eun-Young Kim, MD, PhDDepartment of Pediatrics, Chosun  University Hospital, Chosun  University School of Medicine, 365 Pilmun-daero, Dong-gu, Gwangju  61453, Korea Tel: +82-62-220-3055,Fax: +82-62-227-2704, E-mail: sskey@chosun.ac.krhttp://dx.doi.org/10.6065/apem.2016.21.3.155 Ann Pediatr Endocrinol Metab 2016;21:155-160",Non-OADS,/arxiv_data1/oa_pdf/b4/fa/apem-21-155.PMC5073162.pdf
"Keywords: Congenital hypothyroidism, Thyroid stimulation-blocking antibody,  Placental circulationMock Ryeon Kim, MD1, Hye Won Park, MD1,2, Sochung Chung, MD, PhD1,2 1Department of Pediatrics, Konkuk  University Medical Center, 2Konkuk  University School of Medicine, Seoul,  Koreahttp://dx.doi.org/10.6065/apem.2016.21.3.161Ann Pediatr Endocrinol Metab 2016;21:161-163 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 11 May, 2016 Revised: 24 June, 2016 Accepted: 6 August, 2016 Address for correspondence:  Sochung Chung, MD, PhD  Department of Pediatrics, Konkuk University Medical Center, Konkuk  University School of Medicine, 120-1  Neungdong-ro, Gwangjin-gu, Seoul 05030, Korea  Tel: +82-2-2030-7553 Fax: +82-2-2030-7748E-mail: scchung@kuh.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Thyroid stimulating antibody (TS Ab) and thyroid stimulation blocking antibody (TSB  Ab) are 2 types of thyrotropin receptor autoantibodies (TSH receptor Abs).",Non-OADS,/arxiv_data1/oa_pdf/04/bb/apem-21-161.PMC5073163.pdf
"Keywords: Hypothyroidism, Children, Musculoskeletal pain, Pericardial effusion,  Hashimoto thyroiditisBetül Ersoy, MD1,  Kiremitçi Yılmaz Seniha, MD1, Deniz Kızılay, MD1,  Münevver Yılmaz, MD2,  Şenol Coşkun, MD2 1Division of Pediatric Endocrinology,  Department of Pediatrics, School of  Medicine, Celal Bayar University, Manisa,  2Division of Pediatric Cardiology,  Department of Pediatrics, School of Medicine, Celal Bayar University, Manisa, Turkeyhttp://dx.doi.org/10.6065/apem.2016.21.3.164Ann Pediatr Endocrinol Metab 2016;21:164-168 ©2016 Annals of Pediatric Endocrinology & MetabolismReceived: 20 June, 2016 Revised: 6 August, 2016 Accepted: 21 September, 2016 Address for correspondence:  Seniha Kiremitçi Yılmaz Division of Pediatric Endocrinology, Department of Pediatrics, School  of Medicine, Celal Bayar University,  Manisa, Turkey Tel: +905064568872 Fax: +903423600290 E-mail: skyilmaz.dr@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Introduction Hashimoto thyroiditis (HT) is one of the most common autoimmune endocrine diseases  in pediatric age groups1).",Non-OADS,/arxiv_data1/oa_pdf/72/71/apem-21-164.PMC5073164.pdf
"To date, 68 different mutations have been reported worldwide  (http://www.hgmd.org).",Non-OADS,/arxiv_data1/oa_pdf/05/ac/apem-21-169.PMC5073165.pdf
"We describe the clinical features, molecular characteristics, and clinical course of the patient, with a review of the literatures.Long-term clinical outcome and the identification of homozygous CYP27B1  gene mutations in a patient  with vitamin D hydroxylation-deficient rickets type 1A Ja Hyang Cho, MD1, Eungu Kang, MD1, Gu-Hwan Kim, PhD2, Beom Hee Lee, MD1, Jin-Ho Choi, MD1, Han-Wook Yoo, MD, PhD1 1Department of Pediatrics, 2Medical  Genetics Center, Asan Medical Center  Children’s Hospital, University of Ulsan College of Medicine, Seoul, Korea Received: 26 May, 2016 Revised: 3 July, 2016 Accepted: 28 July, 2016 Address for correspondence:  Han-Wook Yoo, MD, PhD Department of Pediatrics, Asan  Medical Center Children’s Hospital, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 05505, KoreaTel: +82-2-3010-3374, Fax: +82-2-473-3725, E-mail: hwyoo@amc.seoul.krhttp://dx.doi.org/10.6065/apem.2016.21.3.169 Ann Pediatr Endocrinol Metab 2016;21:169-173",Non-OADS,/arxiv_data1/oa_pdf/05/ac/apem-21-169.PMC5073165.pdf
"Slip-lamp examination confirmed the deposition of cystine crystals on his Endocrine complications during and after adolescence in a patient with cystinosis Moon Bae Ahn, MD, Sung Eun Kim, MD,Won Kyoung Cho, MD, PhD, Min Ho Jung,  MD, PhD,Byung Kyu Suh, MD, PhD, Department of Pediatrics, College of  Medicine, The Catholic University of Korea, Seoul, Korea Received: 15 June, 2016 Revised: 19 July, 2016 Accepted: 31 August, 2016 Address for correspondence:  Min Ho Jung, MD, PhD Department of Pediatrics, College of  Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu,  Seoul 06591, Korea Tel: +82-2-3779-1131,Fax: +82-2-537-4544, E-mail: jmhpe@catholic.ac.krhttp://dx.doi.org/10.6065/apem.2016.21.3.174 Ann Pediatr Endocrinol Metab 2016;21:174-178",Non-OADS,/arxiv_data1/oa_pdf/b6/4f/apem-21-174.PMC5073166.pdf
"Retraction: Mixed gonadal dysgenesis in 45,X Turner  syndrome with SRY geneRetraction notice  from Journal Editor http://dx.doi.org/10.6065/apem.2016.21.3.179 Ann Pediatr Endocrinol Metab 2016;21:179 ©2016 Annals of Pediatric Endocrinology & MetabolismThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ISSN: 2287-1012(Print)  ISSN: 2287-1292(Online) Jung JY , Y ang S, Jeong EH, Lee HC, Lee YM, Han HS, Yi KH Ann Pediatr Endocrinol Metab 2015 Dec;20(4):226-9. http://dx.doi.org/10.6065/apem.2015.20.4.226.",Non-OADS,/arxiv_data1/oa_pdf/6d/ba/apem-21-179.PMC5073167.pdf
"Diabetes in low -middle -and high - income countries; Accessed May 11, 2015: Avalilable at:  http://www.idf.org/diabetesatlas    2.",Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
Available from:  http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf      5.,Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
Available from: http://www.statcan.gc.ca/pub/91 -551- x/91-551-x2010001 -eng.pdf    6.,OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
2011 Feb;34(2):353 -7.  http://dx.doi.org/10.2337/dc10 -0746    7.,Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
2008;  32(3) : 206-210.   http://dx.doi.org/10.1016/S1499 -2671(08)23011 -X   8.,OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
2009 May 27;301(20):2129 -40.  http://dx.doi.org/10.1001/jama.2009.726    PMid:19470 990  9.,Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
2007  Mar;100(3):115 -6.  http://dx.doi.org/10.1258/jrsm.100.3.115    PMid:17339300 PMCid:PMC1809161,OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
2010 Jan 30;375(9712):408 -18. http://dx.doi.org/   10.1016/  S0140 -6736(09)60937 -5  11.,OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
eCollection  2014.   http://dx.doi.org/10.9778/cmajo.20130064    PMid: 25295238   15.,Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
2001 Nov;86(11):5366 - 71.  http://dx.doi.org/10.12 10/jcem.86.11.7992    PMid:11701707   16.,OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
2013;1281(1):5 1-63.   http://dx.doi.org/10.1111/j.1749 -6632.2012.06838.x    17.,Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
http://dx.doi.org/10.1001/jama.2009.726    PMid:19470990   18.,OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
http://dx.doi.org/10.1093/pubmed/fdh158    PMid:15454592   19.,OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
1994; 11: 208 – 211.  http://dx.doi.org/10.1002/pdi.1960110508   20.,Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
1999 Sep;99(9):1106 -8. http://dx.doi.org/10.1016/S0002 -8223(99)00266 -7   21.,OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
http://dx.doi.org/10.2337/diacare.26.3.725    PMid:12610029   23.,Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
http://dx.doi.org/10.4236/jdm.2012.21017    26.,Non-OADS,/arxiv_data1/oa_pdf/ae/c3/nje-06-548.PMC5073168.pdf
Diabetes Technol Ther 2009; 11(4): 255 -62.  http://dx.doi.org/10.1089/dia.2008.0057  PMid:19344200   2.,Non-OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
http://dx.doi.org/10.1089/dia.2005.7.958   PMid:16386102    3.,OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
Available at :  https://www.nih.gov/health -information/nih -clinical -research - trials -you/list -registries .,Non-OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
Available at :  http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf .,Non-OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
Korean Journal of  Family Medicine 09/2015; 36(5):253 -257.   http://dx.doi.org/10.4082/kjfm.2015.36.5.253    6.,Non-OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
[Cited  on: 31 May 20 16] Available at : http://www.idfce - hk.org/index.php/en/menu -registry .,Non-OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
2014;103(1):79 -87.  http://dx.doi.org/10.1016/j.diabres.2013.11.020   PMid :24369984    8.,OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
http://dx.doi.org/10.1177/1403494811404278   PMid:21775353    9.,Non-OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
"Available at :  https://www.google.ae/url?sa=t&rct=j&q=&esrc=s&source= web&cd=1&cad=rja&uact=8&ved=0ahUKEwiEn4_txs3NAh ULBMAKHT3 - Ag8QFggaMAA&url=http%3A%2F%2Fwww.moh.gov.my% 2Findex.php%2Ffile_manager%2Fdl_item%2F526d6c735a58 5677624739685a43394f5958527062323568624639456157 46 695a58526c633139535a57647063335279655639535a584276 636e5266566d3973587a46664d6a41774f5638794d4445794c 6e426b5a673d3d&usg=AFQjCNFWKbSsYRCgLovbHO27M TLwnvYaRQ&sig2=esPn3mI5qjGwLv2ggRsgoA&bvm=bv.1 25801520,d.ZGg .",OADS,/arxiv_data1/oa_pdf/86/43/nje-06-551.PMC5073169.pdf
http://dx.doi.org/10.1210/jcem -37-5-826  PMid:4749457    4.,Non-OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
http://dx.doi.org/10.1053/j .gastro.2007.03.054   PMid:17498508    6.,OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
2002;87: 1239  – 1246   http://dx.doi.org/10.1210/jcem.87.3.8355   PMid:11889194    7.,Non-OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
2006; 3: 153 – 165.  http://dx.doi.org/10.1016/j.cmet.2006.01.004   PMid:16517403    10.,OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
http://dx.doi.org/10.1210/en.2003 -0323   PMid:12960095   11.,OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
http://dx.doi.org/10.2337/dc11 -0291   PMid:21868779 PMCi d:PMC3161303    12.,Non-OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
J clinEndocrinol Metab.2010 Jun;95(6):2607 - 9.  http://dx.doi.org/10.1210/jc.2009 -2741   PMid:20525907    16.,OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
2012 Jan 17  (1-2) : 89 -95.  http://dx.doi.org/10.1016/j.drudis.2011.08.017   PMid:21920456    17.,OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
"Incretin -based  therapy and risk of acute pancreatitis : a nationwide  population -based case -control study, Diabetes Care 2015 jun  38(6) 1089 – 98.  http://dx.doi.org/10.2337/dc13 -2983   PMid:25633664    19.",Non-OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
2016  Mar 24;374(12):1145 -54.   http://dx.doi.org/10.1056/NEJMoa1506115,Non-OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
http://dx.doi.org/10.1111/j.1463 -1326.2012.01610.x   PMid:22519906,Non-OADS,/arxiv_data1/oa_pdf/3c/ef/nje-06-553.PMC5073170.pdf
[Cited on : 31 May 2016 ] Available at:   http://www.who.int/mediacentre/factsheets/fs312/en/  .,Non-OADS,/arxiv_data1/oa_pdf/c2/59/nje-06-557.PMC5073171.pdf
Available at:    (http://apps.who.int/iris/bitstream/10665/204871/1/978924156 5257_eng.pdf?ua=1 .,OADS,/arxiv_data1/oa_pdf/c2/59/nje-06-557.PMC5073171.pdf
Available at:  http://www.who.int/nmh/events/un_ncd_summit2011/political _declaration_en.pdf?ua=1 .,Non-OADS,/arxiv_data1/oa_pdf/c2/59/nje-06-557.PMC5073171.pdf
Available at:  http://www.who.int/mediacentre/factsheets/fs394/en/  .,Non-OADS,/arxiv_data1/oa_pdf/c2/59/nje-06-557.PMC5073171.pdf
Available from:  http://www.who.int/occupational_health/publications/globstra tegy/en/index4.html .,OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
2016 Jan -Mar; 6(1):25 -32.  http://dx.doi.org/10.4103/2229 -5151.177365   PMid:27051619 PMCid:PMC4795358    3.,Non-OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
http://dx.doi.org/10.1016/j.jsr.2008.12.010   PMid:194 33205    4.,OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
2014;11(5):326 -37.  http://dx.doi.org/10 .1080/15459624.2013.863131   PMid:24219404 PMCid:PMC4003859    5.,Non-OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
Available from:  http://www.bls.gov/opub/mlr/2013/02/art2full.pdf    6.,Non-OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
http://dx.doi.org/10.1007/s10903 -010-9379 -8  PMid:20730494    7.,Non-OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
2014; 2014:430832.   http://dx.doi.org/10.1155/2014/430832   PMid:24734049 PMCid:PMC3964690    8.,OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
Occup Med (Lond)  2009;597:493 –8  http://dx.doi.org/10.1093/occmed/kqp101   PMid:19640929    9.,Non-OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
http://dx.doi.org/10.5001/omj.2011.79   PMid:22125724 PMCid:PMC3215440    10.,OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
"2015  Sep;46(9):1806 -13.  http://dx.doi.org/10 .1016/j.injury.2015.04.023   PMid:25943291       Table 1:  Work -related Injuries and Diseases   Region  Economically  Active Population  Fatal  (Reported)  Fatal  Injuries * Fatal  work - related  diseases  Total work - related  mortality   African Region  251,588,449  759 44,699  336,144  380,843   Eastern  Mediterranean  152,610,995  0 17,912  117,164  135,076   Southeast Asia  642,390,831  81 83,096  523,355  606,451   *ILO estimates   Data are a dopted from Takala et al (ref 4)",Non-OADS,/arxiv_data1/oa_pdf/90/78/nje-06-560.PMC5073172.pdf
2006;42:1505.   http://dx.doi.org/10.1086/503680   PMid:16619174    3.,Non-OADS,/arxiv_data1/oa_pdf/49/3c/nje-06-563.PMC5073173.pdf
2015;92:875 -878.  http://dx.doi.org/10.4269/ajtmh.14 -0709   PMid:25667056 PMCid:PMC4385789    4.,Non-OADS,/arxiv_data1/oa_pdf/49/3c/nje-06-563.PMC5073173.pdf
2003;990:25 -35.  http://dx.doi.org/10.1111/j.1749 -6632.2003.tb073 33.x   5.,Non-OADS,/arxiv_data1/oa_pdf/49/3c/nje-06-563.PMC5073173.pdf
1975;266:80 -90.  http://dx.doi.org/10.1111/j.1749 -6632.1975.tb35090.x   PMid:829478    6.,Non-OADS,/arxiv_data1/oa_pdf/49/3c/nje-06-563.PMC5073173.pdf
Trans Roy Soc Trop Med Hyg  1981;75:586 -587.  http://dx.doi.org/10.1016/0035 -9203(81)90210 -8,Non-OADS,/arxiv_data1/oa_pdf/49/3c/nje-06-563.PMC5073173.pdf
Cancer J Clin 2015;  65:87 -108.  http://dx.doi.org/10.3322/caac.21262     PMid:25651787   2. WHO Cancer Fact sheet No.297: World Health  Organization (February 2015).,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
Available from:  http://www.who.int/mediacentre/factsheets/fs297/en/     3.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
Asian Pac J Cancer Prev 2015;  16(18): 8659 -63.  http://dx.doi.org/10.7314/APJCP.2015.16.18.8659   PMid:26745133    5.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
Asian Pac J Cancer Prev 2009; 10: 259 -62.  http://www.apocpcontrol.org/paper_file/issue_abs/Volume10 _No2/259c_Kishore.pdf    PMid:19537894    6.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
"Population Dynamics,  Government of Nepal, National Planning Commission  Secretariat, Central Bureau of Statistics 2014; I.  http://un.org.np/si tes/default/files/Population%20Monograph %202014%20Volume%201.pdf     8.",OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
https://www.iarc.fr/en/publications/pdfs - online/epi/sp95/SP95.pdf    9.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
Asian Pac J Cancer Prev 2007; 8: 183 -86.  http://www.apocpcontrol.org/paper_file/issue_abs/Volume8_ No2/183_Binu_4.pdf    PMid:17696728   10.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
Asian Pac J Cancer Prev 2009; 10: 205 -08.  http://www.apocpcontrol.org/paper_file/issue_abs/Volume10 _No2/205c%20Bhatt%20.pdf    PMid:19537884    11.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
Asian Pac J Cancer Prev 2015; 16: 6541 -44.  http://www.apocpcontrol.org/paper_file/issue_abs/Volume16 _No15/6541 -6544%206.20%20Krishna%20Koirala.pdf    http://dx.doi.org/10.7314/APJCP.2015.16.15.6541   PMid:26434871    14.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
Otolaryngo Clin N Am 2008; 41: 673 - 95.  http://dx.doi.org/10.1016/j.otc.2008.01.016   PMid:18570953    15.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
Globalisation and Health  2015; 10: 1 -10. http://dx.doi.org/10.1186/s12992 -015-0119 -7   16.,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
"Dhakal HP, Pradhan M. Histological pattern of  Gynecological cancers: J Nepal Med Assoc 2009; 48: 301 -05.  http://www.ncbi.nlm.nih.gov/pubmed/21105554    PMid:21105554    18.",Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
2009 ; 48:  199-202. http://www.ncbi.nlm.nih.gov/pubmed/20795457    PMid:20795457,Non-OADS,/arxiv_data1/oa_pdf/77/55/nje-06-565.PMC5073174.pdf
"2014 Aug 14;14:847. doi:  10.1186/1471 -2458 -14-847.   http://dx.doi.org/10.1186/1471 -2458 -14-847  3.Shankar PR,  Partha P, Shenoy N. Self ‐medication and non - doctor prescription practices in Pokhara valley, Western  Nepal: a questionnaire ‐based study.",Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
"2002  Sep 17;3:17.   http://dx.doi.org/10.1186/1471 -2296 -3-17  PMid:12236905 PMCid:PMC130019   4.Togoobaatar G, Ikeda N, Ali M, Sonomjamts M,  Dashdemberel S, Mori R, Shibuya K. Survey of non - prescribed use of antibiotics for children in an urban  community in Mongolia.",OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
"Epub 2010 Sep 3.  http://dx.doi.org/10.2471/BLT.10.079004   5.Sontakke SD, Bajait CS, Pimpalkhute SA, Jaiswal KM,  Jaiswal SR.",Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
Epub2007Jun12   http://dx.doi.org/10.1345/aph.1K068   PMid:17565044   7.,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
Asian Journal of Medical Sciences 2011;2 (1): 49 -52.  http://dx.doi.org/10.3126/ajms.v2i1.3592   8.,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
2012 Apr - Jun;58(2):127 -31.doi:10.4103/0022 -3859.97175.   http://dx.doi.org/10.4103/0022 -3859.97175   10.,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
2015;2(1):3 -6.  http://dx.doi.org/10.3126/jbs.v2i1.13031   12.,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
http://dx.doi.org/10.7860/JCDR/2014/10579.5313   16.,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
2006;15(4):270 -5.  http://dx.doi.org/10.1159/000092989,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
http://dx.do i.org/10.1371/journal.pone.0114644   18.,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
Int J Environ Res Public Health 9:3519 –29  http://dx.doi.org/ 10.3390/ijerph9103519   PMid:23202760 PMCid:PMC3509469    20.,OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
2014 Aug 14;14:847.   doi: 10.1186/1471 -2458 -14-847.  http://dx.doi.org/10.1186/1471 -2458 -14-847  21.,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
http://dx.doi.org/10.1086/376905,Non-OADS,/arxiv_data1/oa_pdf/3c/14/nje-06-574.PMC5073175.pdf
http://dx.doi.org/10.1016/S2214 -109X(13)70113 -X   3.,OADS,/arxiv_data1/oa_pdf/f0/10/nje-06-582.PMC5073176.pdf
Available  from :  http://www.who.int/blindness/Change%20the%20D efinition% 20of%20Blindness.pdf    4.,Non-OADS,/arxiv_data1/oa_pdf/f0/10/nje-06-582.PMC5073176.pdf
2014;28(2):142 - 146.  http://dx.doi.org/10.1038/eye.2013.256    PMid:24357836 PMCid:PMC3930268,OADS,/arxiv_data1/oa_pdf/f0/10/nje-06-582.PMC5073176.pdf
Mycoses 2015;58 (suppl S5):45 -50.  http://dx.doi.org/10.1111/myc.12393   PMid:26449506   2.,Non-OADS,/arxiv_data1/oa_pdf/f4/bd/nje-06-584.PMC5073177.pdf
Medical Mycology 2015;54:103 - 110.  http://dx.doi.org/10.109 3/mmy/myv075   PMid:26483432,Non-OADS,/arxiv_data1/oa_pdf/f4/bd/nje-06-584.PMC5073177.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY Volume 29, Number 5, 2016Mary Ann Liebert, Inc.Pp.",Non-OADS,/arxiv_data1/oa_pdf/15/cf/jamp.2015.1260.PMC5073218.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any non- commercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.BIOPRESERVATION AND BIOBANKING Volume 14, Number 5, 2016Mary Ann Liebert, Inc.DOI: 10.1089/bio.2015.0100 367",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/bio.2015.0100.PMC5073223.pdf
"Available at: http://ec.europa.eu/ justice/policies/privacy/docs/95-46-ce/dir1995-46_part1_ en.pdf Accessed February 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/bio.2015.0100.PMC5073223.pdf
"Avail- able at: http://ec.europa.eu/justice/data-protection/article- 29/index_en.htm Accessed February 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/bio.2015.0100.PMC5073223.pdf
"Available at: https://stats.oecd.org/glossary/ detail.asp?ID =6961 Accessed February 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/bio.2015.0100.PMC5073223.pdf
"Available at: http://ec.europa.eu/justice/data-protection/ article-29/documentation/opinion-recommendation/ﬁles/2007/ wp136_en.pdf Accessed February 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/bio.2015.0100.PMC5073223.pdf
"Available at: http://ec.europa.eu/justice/ data-protection/article-29/ documentation/opinion-recommendation/index_en.htm Accessed February 22, 2016.",Non-OADS,/arxiv_data1/oa_pdf/5f/e7/bio.2015.0100.PMC5073223.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012798).,Non-OADS,/arxiv_data1/oa_pdf/31/16/bmjopen-2016-012798.PMC5073470.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012084).,Non-OADS,/arxiv_data1/oa_pdf/0b/8b/bmjopen-2016-012084.PMC5073471.pdf
"SecondaryVaporizers, E-Cigarettes, and other Electronic Nicotine Delivery Systems (ENDS) 2016. http://www.fda.gov/TobaccoProducts/Labeling/ProductsIngredientsComponents/ucm456610.htm#regulation 6.",Non-OADS,/arxiv_data1/oa_pdf/0b/8b/bmjopen-2016-012084.PMC5073471.pdf
http://ec.europa.eu/health/tobacco/docs/dir_201440_en.pdf (accessed 25 Sep2015).,Non-OADS,/arxiv_data1/oa_pdf/0b/8b/bmjopen-2016-012084.PMC5073471.pdf
"Stop Smoking Services and Health Inequalities, 2013. http://www.ncsct.co.uk/usr/pub/NCSCT_briefing_effect_of_SSS_on_health_inequalities.pdf 13.",Non-OADS,/arxiv_data1/oa_pdf/0b/8b/bmjopen-2016-012084.PMC5073471.pdf
"Attitudes of Europeans towards tobacco, 2015. http://ec.europa.eu/public_opinion/archives/ebs/ebs_429_en.pdf 15.",Non-OADS,/arxiv_data1/oa_pdf/0b/8b/bmjopen-2016-012084.PMC5073471.pdf
doi:10.1136/bmjopen-2016- 012491 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012491).,Non-OADS,/arxiv_data1/oa_pdf/f1/88/bmjopen-2016-012491.PMC5073472.pdf
"The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.",Non-OADS,/arxiv_data1/oa_pdf/f1/88/bmjopen-2016-012491.PMC5073472.pdf
http://www.larcfirst.com/index.html 39.,Non-OADS,/arxiv_data1/oa_pdf/f1/88/bmjopen-2016-012491.PMC5073472.pdf
http://www.racgp.org.au/your-practice/guidelines/redbook/ 41.,Non-OADS,/arxiv_data1/oa_pdf/f1/88/bmjopen-2016-012491.PMC5073472.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011648).,Non-OADS,/arxiv_data1/oa_pdf/09/cd/bmjopen-2016-011648.PMC5073473.pdf
http://www.R-project.org).,Non-OADS,/arxiv_data1/oa_pdf/09/cd/bmjopen-2016-011648.PMC5073473.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/openhrt-2016- 000500) Received 14 July 2016 Accepted 2 August 2016 For numbered affiliations seeend of article.,Non-OADS,/arxiv_data1/oa_pdf/b9/5a/openhrt-2016-000500.PMC5073474.pdf
"Evidence Development Pilot Project: Transcatheter Aortic Valve Implantationin Scotland, 2010. http://www.gla.ac.uk/media/media_218806_en.pdf(accessed Oct 2016).",Non-OADS,/arxiv_data1/oa_pdf/b9/5a/openhrt-2016-000500.PMC5073474.pdf
"2010; Guies de pràctica clínica,num 15. http://www.gencat.cat/ics/professionals/guies/diabetis/diabetis.htm (accessed 27 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/ab/6c/bmjopen-2016-012463.PMC5073475.pdf
Last updated December 2014. http://guidance.nice.org.uk/CG87/NiceGuidance/pdf/English 36.,Non-OADS,/arxiv_data1/oa_pdf/ab/6c/bmjopen-2016-012463.PMC5073475.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012637).,Non-OADS,/arxiv_data1/oa_pdf/9a/49/bmjopen-2016-012637.PMC5073477.pdf
"The subscales are each scored according to the manual (http://www.sdqinfo.com/) obtaining continuous scores from 0 to 10, with higher scores indicating greater pro-blems and increased odds of mental disorder for each one-point increase on the scale.",Non-OADS,/arxiv_data1/oa_pdf/9a/49/bmjopen-2016-012637.PMC5073477.pdf
Competing interests http://www.icmje.org/coi_disclosure.pdfLH-H reports that she has been employed by H. Lundbeck a/s in the period after drafting the prefinal version until submission of this manuscript.,Non-OADS,/arxiv_data1/oa_pdf/9a/49/bmjopen-2016-012637.PMC5073477.pdf
http://www.sdqinfo.org/DanishNorms/ DanishNorms.html2013 (updated 22 March 2013).,OADS,/arxiv_data1/oa_pdf/9a/49/bmjopen-2016-012637.PMC5073477.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011363).,Non-OADS,/arxiv_data1/oa_pdf/4c/a1/bmjopen-2016-011363.PMC5073479.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.t383q.,OADS,/arxiv_data1/oa_pdf/4c/a1/bmjopen-2016-011363.PMC5073479.pdf
18. http://www.hra.nhs.uk/resources/research-legislation-and- governance/governance-arrangements-for-research-ethics-committees/ (accessed 8 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/4c/a1/bmjopen-2016-011363.PMC5073479.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011539).,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/bmjopen-2016-011539.PMC5073480.pdf
2013. http://www.eunethta.eu/sites/5026.fedimbo.belgium.be/files/Zostavax_main%20report%20including%20appendices_20130922.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/bmjopen-2016-011539.PMC5073480.pdf
http://pti.regione.sicilia.it/portal/page/portal/PIR_PORTALE/PIR_LaStrutturaRegionale/PIR_AssessoratoSalute/PIR_Decreti/PIR_Decreti2015/PIR_Decretiassessorialianno2015/12%2001%202015%20SERV%201%20(38).pdf 23.,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/bmjopen-2016-011539.PMC5073480.pdf
Aggiornamento Piano Regionale Prevenzione 17 dicembre 2014. http://www.bur.liguriainrete.it/ArchivioFile/B_202815032000.pdf 24.,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/bmjopen-2016-011539.PMC5073480.pdf
"Deliberazione della giunta regionale n. 1564,26 agosto 2014. http://bur.regione.veneto.it/BurvServices/pubblica/DettaglioDgr.aspx?id=281075 26.",Non-OADS,/arxiv_data1/oa_pdf/cb/7e/bmjopen-2016-011539.PMC5073480.pdf
30. http://ec.europa.eu/health/documents/community-register/2006/ 2006051911419/anx_11419_it.pdf Summary of product ’s characteristics 31.,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/bmjopen-2016-011539.PMC5073480.pdf
https://www.gov.uk/g overnment/upl oads/ system/uploads/attachment_data/file/383018/ShinglesReport2014.,Non-OADS,/arxiv_data1/oa_pdf/cb/7e/bmjopen-2016-011539.PMC5073480.pdf
2014. http://www.R-project.org/ (accessed 26 Jul 2015)) except for the linear-by-linear asso-ciation test for which SPSS V .22 for Windows was used (IBM Corp.,Non-OADS,/arxiv_data1/oa_pdf/53/95/bmjopen-2016-011754.PMC5073481.pdf
"Armonk, NY: IBM Corp. http://www-01.ibm.com/support/docview.wss?uid=swg21476197 (accessed 30 Apr 2015)).",OADS,/arxiv_data1/oa_pdf/53/95/bmjopen-2016-011754.PMC5073481.pdf
"Lyon, France: International Agency for Research on Cancer, 2013. http://globocan.iarc.fr (accessed 21 Jun 2014).",Non-OADS,/arxiv_data1/oa_pdf/53/95/bmjopen-2016-011754.PMC5073481.pdf
https://www.aadnc-aandc.gc.ca/eng/1291132820288/1291132853616#stats(accessed 15 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/53/95/bmjopen-2016-011754.PMC5073481.pdf
2007. http://www.uvm.edu/~dhowell/methods7/Supplements/OrdinalChiSq.html (accessed 24 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/53/95/bmjopen-2016-011754.PMC5073481.pdf
Apr 2009. http://www.statcan.gc.ca/pub/89-638-x/2009001/article/10832-eng.pdf (accessed 26 Jul 2015).,OADS,/arxiv_data1/oa_pdf/53/95/bmjopen-2016-011754.PMC5073481.pdf
2013. http://www.statcan.gc.ca/pub/82-625-x/2013001/article/11889-eng.htm (accessed27 Apr 2014).44.,OADS,/arxiv_data1/oa_pdf/53/95/bmjopen-2016-011754.PMC5073481.pdf
https://www.cancercare.on.ca/pcs/screening/cervscreening/ screening_guidelines/ (accessed 26 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/53/95/bmjopen-2016-011754.PMC5073481.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012551).,Non-OADS,/arxiv_data1/oa_pdf/6f/4e/bmjopen-2016-012551.PMC5073482.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/4e/bmjopen-2016-012551.PMC5073482.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011067).,Non-OADS,/arxiv_data1/oa_pdf/a4/5f/bmjopen-2016-011067.PMC5073485.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011936).,Non-OADS,/arxiv_data1/oa_pdf/00/10/bmjopen-2016-011936.PMC5073488.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012051).,Non-OADS,/arxiv_data1/oa_pdf/4e/20/bmjopen-2016-012051.PMC5073491.pdf
Updated 2003. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm072123.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/bmjopen-2016-012991.PMC5073492.pdf
Updated 2005. http://www.ema.europa.eu/docs/en_ GB/document_library/Scientific_guideline/2009/09/WC500003122.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/bmjopen-2016-012991.PMC5073492.pdf
http://www.cebm.net/index.aspx?o=5653 18.,Non-OADS,/arxiv_data1/oa_pdf/c1/3a/bmjopen-2016-012991.PMC5073492.pdf
https://www.crediblemeds.org/ (accessed 7 Mar 2016).,OADS,/arxiv_data1/oa_pdf/c1/3a/bmjopen-2016-012991.PMC5073492.pdf
doi:10.1136/openhrt-2016- 000527 Accepted 14 September 2016 ▸http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/87/37/openhrt-2016-000527.PMC5073495.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011038).,Non-OADS,/arxiv_data1/oa_pdf/a7/e3/bmjopen-2016-011038.PMC5073496.pdf
"To support the conclusion, we take in ﬂuenza data as an example and calculate the regional seasonal indices using the monthly data (http://www.phsciencedata.cn/Share/en/ index.jsp) of 31 Chinese provinces from 2009 to 2012(see online supplementary appendix table A1).",OADS,/arxiv_data1/oa_pdf/a7/e3/bmjopen-2016-011038.PMC5073496.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013807).,Non-OADS,/arxiv_data1/oa_pdf/32/42/bmjopen-2016-013807.PMC5073498.pdf
Clinical Integration —The Key to Real Reform [database on the Internet] 2010. http://www.aha.org/ research/reports/tw/10feb-clinicinteg.pdf (accessed 10 Oct 2016).,Non-OADS,/arxiv_data1/oa_pdf/32/42/bmjopen-2016-013807.PMC5073498.pdf
https://tampub.uta.fi/bitstream/handle/10024/67592/951-44-6629-2.pdf?sequence=1 (accessed 27 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/01/84/bmjopen-2016-011099.PMC5073501.pdf
"   Case Rep Oncol 2016;9:537 –542  DOI: 10.1159/000449405   Published online: September 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4 .0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/2b/dc/cro-0009-0537.PMC5073507.pdf
"This studyassesses the UK Clinical Aptitude Test (UKCAT: http://www.ukcat.ac.uk), and 4 of its subscales, along withindividual and contextual socioeconomic backgroundfactors, as predictors of performance during, and onexit from, medical school.",Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
"or socioeconomic classi ﬁcation (SEC), including Index of Multiple Deprivation (IMD) which is based on post- code and where lower quintile scores represent moreafﬂuent areas, and the National Statistics Socioeconomic Classi ﬁcation (NSSEC) which is based on parental occu- pation; domicile (UK, European Union (EU) or over-seas); and academic achievement prior to admission, out of a maximum of 360 points (the Universities and Colleges Admissions Service (UCAS) tariff, which is aUK-wide means of differentiating students based on grades from various quali ﬁcations, in use since 1992 for all British university course applications, see http://web.ucas.com/).",Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
"It is administered to all ﬁnal year medical students in the UK as part of the foundation programme application process, is taken in examination conditions, and consists of 70 questions to be answered in 2 hours 20 min (http://www.foundationprogramme.nhs.uk/pages/medical-students/ SJT-EPM).",Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
"The SJT was designed to measure the attribute domains of commitment to professional-ism, coping with pressure, effective communication, patient focus and working within teams as a ﬁrst year doctor (http://www.isfp.org.uk), and so complement theacademic ranking.",Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
"21 50 51 This requires follow-up, which will now be possible via the advent of the UK Medical Education Database (UKMED: http://www.ukmed.ac.uk/).",Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
A project commissioned by theGeneral Medical Council (GMC) and published in 2013 on the GMCwebsite: http://www.gmc-uk.org/Identifying_best_practice_in_the_selection_of_medical_students.pdf_51119804.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
"Higher Education Founding Council for England (HEFCE), 2013. http://www.hefce.ac.uk/pubs/ rereports/year/2013/wpeffectiveness/ (accessed 29 Sep 2015).",Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
Available via the UK FoundationProgramme Website http://www.foundationprogramme.nhs.uk/pages/home/about-the-foundation-programme (accessed Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
"London: Education Endowment Foundation, 2013. http://educationendowmentfoundation.org.uk/uploads/pdf/Non-cognitive_skills_literature_review.pdf (accessed Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
http://onlinelibrary.wiley.com/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
A project commissioned by theSelecting for Excellence Group (SEEG) and published at http://www.medschools.ac.uk/SiteCollectionDocuments/Selecting-for-Excellence-research-Professor-Jen-Cleland-et-al.pdf (accessed Jul2015).49.,Non-OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
2013.http://www.spa.ac.uk/documents/ContextualData/SPA_ContextualisedAdmissions.July2013.pdf (accessed Sep 2015).,OADS,/arxiv_data1/oa_pdf/3e/6f/bmjopen-2016-011313.PMC5073508.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012981).,Non-OADS,/arxiv_data1/oa_pdf/2f/54/bmjopen-2016-012981.PMC5073509.pdf
"16It has been registered in the PROSPERO International Prospective Register of Systematic Reviews (http://www.crd.york.ac.uk/PROSPERO), registration number CRD42014015376.",Non-OADS,/arxiv_data1/oa_pdf/2f/54/bmjopen-2016-012981.PMC5073509.pdf
http://www.cdc.gov/ncbddd/sicklecell/data.html 4.,OADS,/arxiv_data1/oa_pdf/2f/54/bmjopen-2016-012981.PMC5073509.pdf
http://www.afro.who.int/en/clusters-a-programmes/dpc/non-communicable-diseases-managementndm/programme-components/sickle-cell-disease.html 9.,Non-OADS,/arxiv_data1/oa_pdf/2f/54/bmjopen-2016-012981.PMC5073509.pdf
http://prisma-statement.org/ PRISMAStatement/FlowDiagram.aspx 17.,OADS,/arxiv_data1/oa_pdf/2f/54/bmjopen-2016-012981.PMC5073509.pdf
"We used the PROCESS macro (down-loaded from http://www.afhayes.com/) to perform mediation analyses with the intention to quit smoking as the outcome variable, the educational level as the inde-pendent variable and the elements of the TPB as media- tors, adjusted for age, marital status, the number of cigarettes smoked per day and city.",Non-OADS,/arxiv_data1/oa_pdf/6e/dc/bmjopen-2016-011058.PMC5073514.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.324f2.,OADS,/arxiv_data1/oa_pdf/6e/dc/bmjopen-2016-011058.PMC5073514.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/dc/bmjopen-2016-011058.PMC5073514.pdf
"Mediation analysis was performed using the Process Macros (http://www.afhayes.com/) for SPSS (IBM Corp, Armonk, New York, USA).",OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2016-012339.PMC5073515.pdf
http://ovidsp.ovid.com/ovidweb.cgi?,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2016-012339.PMC5073515.pdf
http://ovidsp.ovid.,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2016-012339.PMC5073515.pdf
http://ovidsp.ovid.,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2016-012339.PMC5073515.pdf
http://data.worldbank.org/topic 29.,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2016-012339.PMC5073515.pdf
http://apps.who.int/gho/data/view.main.IPVWHOINCOME?lang=%20en 31.,OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2016-012339.PMC5073515.pdf
http://apps.who.int/gho/data/view.main.VIOLENCEHOMICIDEv 32.,Non-OADS,/arxiv_data1/oa_pdf/bc/03/bmjopen-2016-012339.PMC5073515.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012404).,Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
"Human Development Report: Government of Kerala, 2005. http://planningcommission.nic.in/plans/stateplan/sdr_pdf/shdr_kerala05.pdf (accessed Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
"Secondary C-14 five year age group data by residence and sex, 2011. http://www.censusindia.gov.in/2011census/C-series/C-14.html (accessedApr 2016).",OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
2012. http://infochangeindia.org/public-health/statistics/life-expectancy-for-males-and-females-in-selected-states-in-india.html (accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
2015. http://www.census2011.co.in/census/district/ (accessed Apr2016).,Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
http://www.who.int/chp/steps/Part3_Section3.pdf (accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
Secondary Global Database on Body MassIndex: BMI classification 2016. http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (accessed Jul 2016).,OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
"18th WHO Model List of Essential Medicines, April 2013. http://apps.who.int/iris/bitstream/10665/93142/1/EML_18_eng.pdf?ua=1 (accessed Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
"National List of Essential Medicines of India, 2011. http://apps.who.int/medicinedocs/documents/s18693en/s18693en.pdf (accessed Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
Essential Medicines List 2010. http://aptribes.gov.in/Health/115_13052010Health.pdf (accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
"Geneva: World Health Organization, 2008. http://www.who.int/medicines/areas/access/OMS_Medicine_prices.",Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
http://www.hqontario.ca/en/ documents/eds/2013/full-report-OCDM-self-management.pdf(accessed Apr 2016).,OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
8. http://mohfw.nic.in/showfile.php?lid=656(accessed Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
"New Delhi, 2013. http://nrhm.gov.in/images/pdf/ communitisation/asha/Orders-Guidelines/Guidelines_for_Community_Processes_2014_English.pdf (accessed Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
"New Delhi: Ministry of Health and Family Welfare, 2013:29. http://nrhm.gov.in/images/pdf/communitisation/vhsnc/order-guidelines/Guidelines_for_Community_Processes_2014%20English.pdf (accessedApr 2016).",Non-OADS,/arxiv_data1/oa_pdf/43/6f/bmjopen-2016-012404.PMC5073516.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012865).,Non-OADS,/arxiv_data1/oa_pdf/c9/30/bmjopen-2016-012865.PMC5073517.pdf
The ﬁndings from the study have informed the development and recent publication of NHS England Think Kidneys guidance (https://http://www.thinkkidneys.nhs.uk/aki/resources/primary- care/).,Non-OADS,/arxiv_data1/oa_pdf/c9/30/bmjopen-2016-012865.PMC5073517.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e1/d2/bmjopen-2016-012231.PMC5073518.pdf
2010. http://evs.nci.nih.gov/ftp1/CTCAE/About.html (last accessed 10 Dec 2015).,OADS,/arxiv_data1/oa_pdf/e1/d2/bmjopen-2016-012231.PMC5073518.pdf
http://www.immunex.com/media/media_pr_detail.jsp?year=2007&releaseID=1083091 (last accessed 10 Dec2015).,Non-OADS,/arxiv_data1/oa_pdf/e1/d2/bmjopen-2016-012231.PMC5073518.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010461).,Non-OADS,/arxiv_data1/oa_pdf/a3/be/bmjopen-2015-010461.PMC5073519.pdf
http://www.shapeoftraining.co.uk/static/documents/content/Shape_of_training_report_Final_Report.pdf_53900462.pdf (accessed 22 Oct2015).,Non-OADS,/arxiv_data1/oa_pdf/a3/be/bmjopen-2015-010461.PMC5073519.pdf
http://www.shapeoftraining.co.uk/static/documents/content/ Annexes_and_Appendices_final.pdf_53854144.pdf (accessed 22Oct 2015).,Non-OADS,/arxiv_data1/oa_pdf/a3/be/bmjopen-2015-010461.PMC5073519.pdf
http://www.who.int/ mediacentre/factsheets/fs400/en 3.,Non-OADS,/arxiv_data1/oa_pdf/f0/c7/bmjopen-2016-012571.PMC5073520.pdf
http://www.cdc.gov/nchs/nhanes/about_nhanes.htm 26.,Non-OADS,/arxiv_data1/oa_pdf/f0/c7/bmjopen-2016-012571.PMC5073520.pdf
http://www.cdc.gov/nchs/nhanes/irba98.htm 27.,Non-OADS,/arxiv_data1/oa_pdf/f0/c7/bmjopen-2016-012571.PMC5073520.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013048).,Non-OADS,/arxiv_data1/oa_pdf/8a/20/bmjopen-2016-013048.PMC5073522.pdf
http://www.who.int/ictrp/network/primary/en/39.,Non-OADS,/arxiv_data1/oa_pdf/8a/20/bmjopen-2016-013048.PMC5073522.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012016).,Non-OADS,/arxiv_data1/oa_pdf/fd/02/bmjopen-2016-012016.PMC5073524.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjdrc-2016- 000197).,Non-OADS,/arxiv_data1/oa_pdf/14/27/bmjdrc-2016-000197.PMC5073526.pdf
"Brussels, Belgium: International Diabetes Federation, 2014. http://www.diabetesatlas.org 2.",Non-OADS,/arxiv_data1/oa_pdf/14/27/bmjdrc-2016-000197.PMC5073526.pdf
2015. http://care.diabetesjournals.org/content/38/ Supplement_1 10.,Non-OADS,/arxiv_data1/oa_pdf/14/27/bmjdrc-2016-000197.PMC5073526.pdf
2014. http://care.diabetesjournals.org/content/suppl/2014/12/ 23/38.Supplement_1.DC1/January_Supplement_Combined_Final.6-99.pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/14/27/bmjdrc-2016-000197.PMC5073526.pdf
2015. http://demo.istat.it/altridati/indicatori/index.html 16.,Non-OADS,/arxiv_data1/oa_pdf/14/27/bmjdrc-2016-000197.PMC5073526.pdf
2013. http://www.salute.gov.it/imgs/C_17_ tavoleRelazione_49_listaTabelle_tabelleItemName_1_fileTabella.pdf 10 BMJ Open Diabetes Research and Care 2016; 4:e000197.,Non-OADS,/arxiv_data1/oa_pdf/14/27/bmjdrc-2016-000197.PMC5073526.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012514).,Non-OADS,/arxiv_data1/oa_pdf/fe/1a/bmjopen-2016-012514.PMC5073527.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012366).,Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
http://www.choosingwisely.org/wp-content/uploads/2015/04/About-Choosing-Wisely.pdf2.,Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
"ICER Baseline Reports [webpage], 2016. http://www.choosingwisely.org/resources/icer-baseline-reports/ 8.",Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
"Gemeinsam Klug Entscheiden[webpage], 2016. http://www.awmf.org/medizin-versorgung/gemeinsam-klug-entscheiden.html 12.",Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
http://www.awmf.org/leitlinien/awmf-regelwerk.html 15.,Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Ständige Kommission Leitlinien.Klassifikation S3-Leitlinien, 2012. http://www.awmf.org/leitlinien/awmf-regelwerk/ll-entwicklung/awmf-regelwerk-01-planung-und-organisation/po-stufenklassifikation/klassifikation-s3.html 17.",Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
"Choosing Wisely —clinician lists, 2015. http://www.choosingwisely.org/wp- content/uploads/2015/01/Choosing-Wisely-Recommendations.pdf 20.",Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 22.",OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
"Manual Entwicklung vonEmpfehlungen im Rahmen der Initiative Gemeinsam KlugEntscheiden (GKE) [webpage], 2016. http://www.awmf.org/fileadmin/user_upload/Medizinische_Versorgung/GKE/Manual_GKE_AWMF_V1.0-Konsultationsfassung.pdf 24.",Non-OADS,/arxiv_data1/oa_pdf/56/48/bmjopen-2016-012366.PMC5073530.pdf
http://www.kenn-dein-limit.de/alkohol/riskanter-konsum/ (accessed 9 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/c9/af/bmjopen-2016-012182.PMC5073532.pdf
"Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011. http://www.samhsa.gov/data/sites/default/files/NSDUHNationalFindingsResults2010-web/2k10ResultsRev/ NSDUHresultsRev2010.pdf (accessed 12 Apr 2015).",Non-OADS,/arxiv_data1/oa_pdf/c9/af/bmjopen-2016-012182.PMC5073532.pdf
http://www.choosingwisely.org/clinician-lists/american-geriatrics-society-benzodiazepines-sedative-hypnotics-for-insomnia-in-older-adults/ (accessed 5 Aug 2016) 42.,Non-OADS,/arxiv_data1/oa_pdf/c9/af/bmjopen-2016-012182.PMC5073532.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012611).,Non-OADS,/arxiv_data1/oa_pdf/56/a8/bmjopen-2016-012611.PMC5073534.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/56/a8/bmjopen-2016-012611.PMC5073534.pdf
2016. http://www.iris-initiative.org.uk/9.,Non-OADS,/arxiv_data1/oa_pdf/56/a8/bmjopen-2016-012611.PMC5073534.pdf
2013. http://www.cppconsortium.nhs.uk/admin/files/1373297630GUIDANCE%20FOR%20USE%20OF%204%20FACTOR%20MODEL%20OF%20HONOS%20AT%20CLUSTER%20EPISODE%20LEVELv2.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/56/a8/bmjopen-2016-012611.PMC5073534.pdf
http://www.psymaptic.org/ (accessed 1 Jan 2016).,Non-OADS,/arxiv_data1/oa_pdf/56/a8/bmjopen-2016-012611.PMC5073534.pdf
"   Case Rep Oncol 2016;9:526 –529  DOI: 10.1159/000447349   Published online: September 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is l icensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/4d/f4/cro-0009-0526.PMC5073535.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012367).,Non-OADS,/arxiv_data1/oa_pdf/5c/2f/bmjopen-2016-012367.PMC5073536.pdf
https://www.sealedenvelope.com/power/ binary-superiority/ (assessed 14 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/5c/2f/bmjopen-2016-012367.PMC5073536.pdf
"REDCap OPEN (Research Electronic Data Capture, Odense Patient data Explorative Network), Department of Clinical Research,University of Southern Denmark (assessed 3 Dec 2015).https://open.rsyd.dk/redcap/ 36.",OADS,/arxiv_data1/oa_pdf/5c/2f/bmjopen-2016-012367.PMC5073536.pdf
http://www.wma.net/en/30publications/10policies/b3/ (assessed 30 Apr 2015).,Non-OADS,/arxiv_data1/oa_pdf/5c/2f/bmjopen-2016-012367.PMC5073536.pdf
http://www.consort-statement.org/media/default/downloads/CONSORT%202010%20Checklist.pdf (assessed 3 Dec 2015).,Non-OADS,/arxiv_data1/oa_pdf/5c/2f/bmjopen-2016-012367.PMC5073536.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013191).,Non-OADS,/arxiv_data1/oa_pdf/c5/68/bmjopen-2016-013191.PMC5073537.pdf
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp 23.,Non-OADS,/arxiv_data1/oa_pdf/c5/68/bmjopen-2016-013191.PMC5073537.pdf
http://cfgd.cochrane.org/search/google-appliance/generic%20inverse%20variance%20method (accessed 28 Jan 2016).,OADS,/arxiv_data1/oa_pdf/c5/68/bmjopen-2016-013191.PMC5073537.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ RMD Open 2016; 2:e000224corr1.,Non-OADS,/arxiv_data1/oa_pdf/33/ca/rmdopen-2015-000224corr1.PMC5073538.pdf
"Outcome measure To help the study team track any variation in dietary pat- terns over the course of the study, all participants were asked to provide information on the foods and bev-erages that they consumed by completing 24-hour recalls using a web-based Automated Self-Administered 24-Hour Recall (ASA24; available from the NationalCancer Institute at http://riskfactor.cancer.gov/tools/ instruments/asa24/), which guided them through the process of completing the recall data.",Non-OADS,/arxiv_data1/oa_pdf/95/6d/bmjdrc-2016-000293.PMC5073539.pdf
See: http:// creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1. http://www.who.int/mediacentre/news/releases/2016/world-health- day/en/ 2.,Non-OADS,/arxiv_data1/oa_pdf/95/6d/bmjdrc-2016-000293.PMC5073539.pdf
"Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2014. http://www.niddk.nih.gov/health-information/health-communication-programs/ndep/am-i-at-risk/diabetes preventable/Pages/diabetesispreventable.aspx 4.",Non-OADS,/arxiv_data1/oa_pdf/95/6d/bmjdrc-2016-000293.PMC5073539.pdf
5. http://www.cdc.gov/diabetes/prevention/index.html6.,Non-OADS,/arxiv_data1/oa_pdf/95/6d/bmjdrc-2016-000293.PMC5073539.pdf
"9. http://www.diabetes.org/advocacy/advocacy-priorities/prevention/ preventing-diabetes-nutrition.html 10. de Koning L, Chiuve SE, Fung TT, et al.",Non-OADS,/arxiv_data1/oa_pdf/95/6d/bmjdrc-2016-000293.PMC5073539.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/da/bmjopen-2016-011730.PMC5073540.pdf
http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/ Topic.aspx?id=200712250014 (accessed 28 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/8c/9d/bmjopen-2016-011897.PMC5073541.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012115).,Non-OADS,/arxiv_data1/oa_pdf/4b/45/bmjopen-2016-012115.PMC5073542.pdf
It wasregistered under http://www.ClinicalTrials.gov(NCT02035059) on 12 January 2014.,Non-OADS,/arxiv_data1/oa_pdf/4b/45/bmjopen-2016-012115.PMC5073542.pdf
The trial was registered under http://www.ClinicalTrials.gov under NCT02035059 on 12 January 2014.,Non-OADS,/arxiv_data1/oa_pdf/4b/45/bmjopen-2016-012115.PMC5073542.pdf
"WHO, 2006. http://www.who.int/diabetes/publications/diagnosis_diabetes2006/en/ 12.",Non-OADS,/arxiv_data1/oa_pdf/4b/45/bmjopen-2016-012115.PMC5073542.pdf
2012. http://www.medical-dictionary.thefreedictionary.com(Last accessed 17 Jul 2016).,Non-OADS,/arxiv_data1/oa_pdf/57/64/bmjopen-2016-012230.PMC5073544.pdf
April 2009. http://www.nice.org.uk/CG85 (accessed 11 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/57/64/bmjopen-2016-012230.PMC5073544.pdf
http://www.icoph.org/ICOGlaucomaGuidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/64/bmjopen-2016-012230.PMC5073544.pdf
"San Francisco: American Academy of Ophthalmology, 2016. http://www.aaojournal.org/article/S0161-6420(15)01276-2/pdf (Last accessed 9 June 2016).",Non-OADS,/arxiv_data1/oa_pdf/57/64/bmjopen-2016-012230.PMC5073544.pdf
http://www.who.int/alliance-hpsr/ resources/9789241563895/en/ (Last accessed 17 Jul 2016).,OADS,/arxiv_data1/oa_pdf/57/64/bmjopen-2016-012230.PMC5073544.pdf
2012. http://www.pbunion.org/files/Full%20Workshop%20report%202%20Mayfinal2docx.pdf (Last accessed 13 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/57/64/bmjopen-2016-012230.PMC5073544.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012160).,Non-OADS,/arxiv_data1/oa_pdf/8e/93/bmjopen-2016-012160.PMC5073548.pdf
http://blogs.mcrmed.manchester.ac.uk/eforms/ (accessed 23 March 2016)).,Non-OADS,/arxiv_data1/oa_pdf/8e/93/bmjopen-2016-012160.PMC5073548.pdf
2010. http://www.thet.org/health- partnership-scheme/resources/publications-old/the-framework- for-nhs-involvement-in-international-development (accessed 14 Jun2016).,Non-OADS,/arxiv_data1/oa_pdf/8e/93/bmjopen-2016-012160.PMC5073548.pdf
Development 2015;48. http://www.popline.org/node/ 252380 19.,Non-OADS,/arxiv_data1/oa_pdf/8e/93/bmjopen-2016-012160.PMC5073548.pdf
"2013. http://www.electronicstaffrecord.nhs.uk/esr-operational/functionality/data-warehouse/ 6 Chatwin J, Ackers L. BMJ Open 2016; 6:e012160.",Non-OADS,/arxiv_data1/oa_pdf/8e/93/bmjopen-2016-012160.PMC5073548.pdf
http://www.knowledge4 change.org.uk/ (accessed 23 Mar 2016) or: Global Medical Projects .,Non-OADS,/arxiv_data1/oa_pdf/8e/93/bmjopen-2016-012160.PMC5073548.pdf
http://www.globalmedicalprojects.co.uk/projects (accessed 23 Mar 2016).25.,Non-OADS,/arxiv_data1/oa_pdf/8e/93/bmjopen-2016-012160.PMC5073548.pdf
doi:10.1136/ rmdopen-2016-000338 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2016-000338).,Non-OADS,/arxiv_data1/oa_pdf/2c/07/rmdopen-2016-000338.PMC5073549.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/rmdopen-2016- 000299).,Non-OADS,/arxiv_data1/oa_pdf/5c/bc/rmdopen-2016-000299.PMC5073550.pdf
"Data sharing statement Data set will be available from the Dryad repository at http://datadryad.org/ Open Access This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.",Non-OADS,/arxiv_data1/oa_pdf/5c/bc/rmdopen-2016-000299.PMC5073550.pdf
doi:10.1136/bmjopen-2016- 013014 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-013014).,Non-OADS,/arxiv_data1/oa_pdf/0d/cf/bmjopen-2016-013014.PMC5073551.pdf
European Respiratory Society conference 2015; Abstract 3552.http://www.ers-education.org/events/international-congress/amsterdam-2015.aspx?idParent=14478517.,Non-OADS,/arxiv_data1/oa_pdf/0d/cf/bmjopen-2016-013014.PMC5073551.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013618).,Non-OADS,/arxiv_data1/oa_pdf/54/63/bmjopen-2016-013618.PMC5073553.pdf
"Equitable access to rehabilitation: realizing potential,promising practices, and policy directions, 2012. http://www.wellesleyinstitute.com/wp-content/uploads/2012/06/Equitable-Access-to-Rehabilitation-Discussion-Paper1.pdf 18.",Non-OADS,/arxiv_data1/oa_pdf/54/63/bmjopen-2016-013618.PMC5073553.pdf
Health topics: physical activity 2013. http://www.who.int/topics/physical_activity/en/ 23.,Non-OADS,/arxiv_data1/oa_pdf/54/63/bmjopen-2016-013618.PMC5073553.pdf
Fitbit Inc. Fitbit® official site 2014. http://www.fitbit.com/ca/zip53.,Non-OADS,/arxiv_data1/oa_pdf/54/63/bmjopen-2016-013618.PMC5073553.pdf
"Summary: estimates of HIV, incidence, prevalence and proportion undiagnosed inCanada, 2014. http://healthycanadians.gc.ca/publications/diseases-conditions-maladies-affections/hiv-aids-estimates-2014-vih-sida-estimations/alt/hiv-aids-estimates-2014-vih-sida- estimations-eng.pdf 89.",Non-OADS,/arxiv_data1/oa_pdf/54/63/bmjopen-2016-013618.PMC5073553.pdf
"Canadian physical activity, and sedentary behaviour guidelines, 2012. http://www.csep.ca/en/guidelines/ 96.",Non-OADS,/arxiv_data1/oa_pdf/54/63/bmjopen-2016-013618.PMC5073553.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013400).,Non-OADS,/arxiv_data1/oa_pdf/b8/3c/bmjopen-2016-013400.PMC5073554.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/3c/bmjopen-2016-013400.PMC5073554.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012298).,Non-OADS,/arxiv_data1/oa_pdf/73/30/bmjopen-2016-012298.PMC5073557.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/73/30/bmjopen-2016-012298.PMC5073557.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-014386).,Non-OADS,/arxiv_data1/oa_pdf/3f/e0/bmjopen-2016-014386.PMC5073558.pdf
"Geneva: WHO, 2013. http://www.who.int/ gard/publications/GARDGMreport2013 3.Global tuberculosis report 2015 .",Non-OADS,/arxiv_data1/oa_pdf/3f/e0/bmjopen-2016-014386.PMC5073558.pdf
"Geneva: World Health Organization, 2015. http://www.who.int/tb/publications/global_report/en/ (accessed 22 Nov 2015).",Non-OADS,/arxiv_data1/oa_pdf/3f/e0/bmjopen-2016-014386.PMC5073558.pdf
"Knox S. Sample calculation in economic evaluation, Cancer Research Economics Support Team (CREST), 2012. http://www.crest.uts.edu.au/pdfs/Factsheet-Sample_Size_in_EE-FINAL.pdf 16. WHO.",Non-OADS,/arxiv_data1/oa_pdf/3f/e0/bmjopen-2016-014386.PMC5073558.pdf
"Washington (DC): TBCTA, 2008. http://www.stoptb.org/ Wg/dots_expansion/tbandpoverty/assets/documents/Tool to estimate Patients ’ Costs.pdf (accessed 13 Mar 2015).",Non-OADS,/arxiv_data1/oa_pdf/3f/e0/bmjopen-2016-014386.PMC5073558.pdf
Introduction to NHS 111. http://systems.hscic.gov.uk/pathways/news/nhs111intro.pdf/view (accessed 8 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/a0/3a/bmjopen-2016-011846.PMC5073559.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b8/b7/openhrt-2015-000328.PMC5073560.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012172).,Non-OADS,/arxiv_data1/oa_pdf/f2/e0/bmjopen-2016-012172.PMC5073561.pdf
CKD and the Swedish National Health Service Sweden had a population of 7.4 million ≥18 years on 31 December 2009 (http://www.scb.se) and comprised 21 counties.,OADS,/arxiv_data1/oa_pdf/79/1f/bmjopen-2016-012062.PMC5073563.pdf
Weretrieved data on ESA use in a subsample of patients on haemodialysis (n=85) and calculated the cost using 2009 drug prices in Sweden (http://www.tlv.se).,OADS,/arxiv_data1/oa_pdf/79/1f/bmjopen-2016-012062.PMC5073563.pdf
"Svensk Njurmedicinsk Förening (SNR),2007. http://www.njur.se/filer/behandlingsriktlinjer/riktlinjer_uremi_2007.pdf (accessed 28 Sep 2016).",OADS,/arxiv_data1/oa_pdf/79/1f/bmjopen-2016-012062.PMC5073563.pdf
"Renal replacement therapy in Sweden 1991 – 2009, 2010. http://www.medscinet.net/snr/rapporterdocs/AKTIV%20UREMIV%C3%85RD%20I%20SVERIGE%201991%20-%202009.pdf (accessed 28 Sep 2016).",Non-OADS,/arxiv_data1/oa_pdf/79/1f/bmjopen-2016-012062.PMC5073563.pdf
"Secondary The National Patient Register, 2011. http://www.socialstyrelsen.se/register/halsodataregister/patientregistret/inenglish 31.",Non-OADS,/arxiv_data1/oa_pdf/79/1f/bmjopen-2016-012062.PMC5073563.pdf
"http://www.skane.se/upload/ webbplatser/skaneportalen-extern/vardhalsa/utredningar_rapporter/ dokument/delrapport1_dialysvarden_i_skane.pdf, 2003.",OADS,/arxiv_data1/oa_pdf/79/1f/bmjopen-2016-012062.PMC5073563.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012070).,Non-OADS,/arxiv_data1/oa_pdf/4e/d3/bmjopen-2016-012070.PMC5073566.pdf
11. http://www.sheffieldbackpain.com/professional-resources/learning/ in-detail/red-flags-in-back-pain.,Non-OADS,/arxiv_data1/oa_pdf/4e/d3/bmjopen-2016-012070.PMC5073566.pdf
12. http://www.sheffieldbackpain.com/professional-resources/learning/ in-detail/yellow-flags-in-back-pain.,Non-OADS,/arxiv_data1/oa_pdf/4e/d3/bmjopen-2016-012070.PMC5073566.pdf
"Washington DC: National Academies Press (US), 2012. http://www.ncbi.nlm.nih.gov/books/NBK109958/ 25.",Non-OADS,/arxiv_data1/oa_pdf/4e/d3/bmjopen-2016-012070.PMC5073566.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/4d/23/bmjdrc-2016-000268.PMC5073569.pdf
http://www.cdc.gov/tb/statistics/default.htm (cited 4 Oct 2015).,OADS,/arxiv_data1/oa_pdf/4d/23/bmjdrc-2016-000268.PMC5073569.pdf
"Nationwide inpatient sample trends supplemental (nis-trends) files, 16 Aug 2012. http://www.hcup-us.ahrq.gov/nisoverview.jsp14.",OADS,/arxiv_data1/oa_pdf/4d/23/bmjdrc-2016-000268.PMC5073569.pdf
"2010 American Community SurveyBriefs, 2011. http://www.census.gov/content/dam/Census/library/publications/2011/acs/acsbr10 –16.pdf (cited 27 Sep 2015).",OADS,/arxiv_data1/oa_pdf/4d/23/bmjdrc-2016-000268.PMC5073569.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.1pm91.,OADS,/arxiv_data1/oa_pdf/76/a2/bmjopen-2016-012257.PMC5073570.pdf
Delivering the Forward view; NHS planning guidance 2016/17 –2020/ 21. https://www.england.nhs.uk/wp-content/uploads/2015/12/ planning-guid-16-17-20-21.pdf (accessed 25 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/76/a2/bmjopen-2016-012257.PMC5073570.pdf
"The National Alliance for Health Information Technology (NAHIT), 2008. http://searchhealthit.techtarget.com/definition/National-Alliance-for-Health-Information-Technology-NAHIT(accessed 24 Mar 2016).",OADS,/arxiv_data1/oa_pdf/76/a2/bmjopen-2016-012257.PMC5073570.pdf
"Evaluation of new features of renal patient view; Phase 1 Report (2011) , 2011. http://webarchive.nationalarchives.",Non-OADS,/arxiv_data1/oa_pdf/76/a2/bmjopen-2016-012257.PMC5073570.pdf
gov.uk/20111114132633/http://kidneycare.nhs.uk/Library/RPVEvaluationPhase1report.pdf (accessed 25 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/76/a2/bmjopen-2016-012257.PMC5073570.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012683).,Non-OADS,/arxiv_data1/oa_pdf/7d/96/bmjopen-2016-012683.PMC5073576.pdf
2015.https://www.R-project.org/).,Non-OADS,/arxiv_data1/oa_pdf/7d/96/bmjopen-2016-012683.PMC5073576.pdf
2014. https://www.ssb.no/en/ befolkning/statistikker/folkfram 13.,Non-OADS,/arxiv_data1/oa_pdf/7d/96/bmjopen-2016-012683.PMC5073576.pdf
Secondary International Classification of Diseases (ICD).2016. http://apps.who.int/classifications/icd10/browse/2010/en 29.,Non-OADS,/arxiv_data1/oa_pdf/7d/96/bmjopen-2016-012683.PMC5073576.pdf
2016. https://www.ssb.no/statistikkbanken/selectvarval/saveselections.asp 36.,Non-OADS,/arxiv_data1/oa_pdf/7d/96/bmjopen-2016-012683.PMC5073576.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012271).,Non-OADS,/arxiv_data1/oa_pdf/ca/ce/bmjopen-2016-012271.PMC5073581.pdf
The protocol is available from http://www.crd.york.ac.uk/PROSPERO/ display_record.asp?ID=CRD42015016813.,Non-OADS,/arxiv_data1/oa_pdf/ca/ce/bmjopen-2016-012271.PMC5073581.pdf
"MEDLINE, EMBASE, PsycInfo and the Cochrane library were searched using search termsdeveloped in collaboration with an information special- ist, designed to include the concepts ‘paediatric ’,‘CFS/ ME ’and ‘depression ’(details of search terms used avail- able via http://dx.doi.org/10.15125/BATH-00127 and as an online supplementary ﬁle).",OADS,/arxiv_data1/oa_pdf/ca/ce/bmjopen-2016-012271.PMC5073581.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012702).,Non-OADS,/arxiv_data1/oa_pdf/93/73/bmjopen-2016-012702.PMC5073583.pdf
2008. http://www.R-project.org).,Non-OADS,/arxiv_data1/oa_pdf/93/73/bmjopen-2016-012702.PMC5073583.pdf
2013. http://www.medpac.gov/ documents/reports/mar13_entirereport.pdf?sfvrsn=0 (accessed 29Jun 2015).,OADS,/arxiv_data1/oa_pdf/93/73/bmjopen-2016-012702.PMC5073583.pdf
2013. http://www.intersocietal.org/echo/standards/IACAdultEchoStandardsJuly2014.pdf (accessed 29 Jun 2015).,OADS,/arxiv_data1/oa_pdf/93/73/bmjopen-2016-012702.PMC5073583.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011755).,Non-OADS,/arxiv_data1/oa_pdf/2b/f1/bmjopen-2016-011755.PMC5073585.pdf
2001. http://censos.ine.pt/ (accessed 28 Jun 2015).,Non-OADS,/arxiv_data1/oa_pdf/2b/f1/bmjopen-2016-011755.PMC5073585.pdf
http://www.medscape.com/viewarticle/842732 (accessed 19 Jul2015).,Non-OADS,/arxiv_data1/oa_pdf/2b/f1/bmjopen-2016-011755.PMC5073585.pdf
http://www.sep.org.pt/files/2014/05/ 290514ERS.pdf (accessed 15 May 2016).,Non-OADS,/arxiv_data1/oa_pdf/2b/f1/bmjopen-2016-011755.PMC5073585.pdf
http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/colorectal-cancer-screening(accessed 24 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/2b/f1/bmjopen-2016-011755.PMC5073585.pdf
Health at a Glance: Europe 2014. http://www.oecd.org/ health/health-at-a-glance-europe-23056088.htm (accessed 24 Sep2015).,Non-OADS,/arxiv_data1/oa_pdf/2b/f1/bmjopen-2016-011755.PMC5073585.pdf
2002. http://www.who.int/diabetes/publications/icccreport/en/(accessed 19 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/2b/f1/bmjopen-2016-011755.PMC5073585.pdf
http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/11/4e/bmjdrc-2016-000286.PMC5073586.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/95/cd/bmjresp-2016-000150.PMC5073587.pdf
2012. http://www.gov.uk/drug-device-alerts/medical-device-alert-oral-swabs-with-a-foam-head-heads-may-detach-during-use (accessed30 Jun 2016).29.,Non-OADS,/arxiv_data1/oa_pdf/95/cd/bmjresp-2016-000150.PMC5073587.pdf
"NHS, 2011. http://www.hscic.gov.uk/pubs/ dentalsurveyfullreport09 (accessed 30 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/95/cd/bmjresp-2016-000150.PMC5073587.pdf
Studies prior to 1990 will not be included because mobile phones were mostly non-existentprior to this date (http://news.bbc.co.uk/2/hi/uk_ news/2538083.stm).,Non-OADS,/arxiv_data1/oa_pdf/09/6a/bmjopen-2016-012723.PMC5073594.pdf
Requirements for author-ship will follow those of the International Committee of Medical Journal Editors (http://www.icmje.org).,Non-OADS,/arxiv_data1/oa_pdf/09/6a/bmjopen-2016-012723.PMC5073594.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/09/6a/bmjopen-2016-012723.PMC5073594.pdf
2015. http://www.who.int/mediacentre/factsheets/fs317/en/index.html (updated September 2009 andaccessed on 5/11/2012).,OADS,/arxiv_data1/oa_pdf/09/6a/bmjopen-2016-012723.PMC5073594.pdf
doi:10.1136/bmjopen-2016- 011407 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011407).,Non-OADS,/arxiv_data1/oa_pdf/cc/fe/bmjopen-2016-011407.PMC5073595.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/72/bmjopen-2016-013103.PMC5073596.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010955).,Non-OADS,/arxiv_data1/oa_pdf/63/c4/bmjopen-2015-010955.PMC5073597.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012839).,Non-OADS,/arxiv_data1/oa_pdf/d7/0e/bmjopen-2016-012839.PMC5073599.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011773).,Non-OADS,/arxiv_data1/oa_pdf/49/ff/bmjopen-2016-011773.PMC5073602.pdf
"February 2016. http://www.cancerresearchuk.org/health-professional/prostate-cancer-statistics 8 Taylor S, et al.BMJ Open 2016; 6:e011773.",Non-OADS,/arxiv_data1/oa_pdf/49/ff/bmjopen-2016-011773.PMC5073602.pdf
2015.http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_4016th February 2016.,Non-OADS,/arxiv_data1/oa_pdf/49/ff/bmjopen-2016-011773.PMC5073602.pdf
2013. https://www.nice.org.uk/article/pmg9/ chapter/forewordFebruary2016 33.,Non-OADS,/arxiv_data1/oa_pdf/49/ff/bmjopen-2016-011773.PMC5073602.pdf
Data Protection Act 1998. http://www.legislation.gov.uk/ ukpga/1998/29/contents (accessed 1 Mar 2016).,Non-OADS,/arxiv_data1/oa_pdf/49/ff/bmjopen-2016-011773.PMC5073602.pdf
"GPI Atlantic and Alberta Cancer Board 2009, http://www.gpiatlantic.org/pdf/health/obesity/alberta/FinalObesityPart1.pdf.",Non-OADS,/arxiv_data1/oa_pdf/f0/1b/bmjopen-2016-012094.PMC5073603.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012101).,Non-OADS,/arxiv_data1/oa_pdf/56/8a/bmjopen-2016-012101.PMC5073609.pdf
http://www.ssb.no/en/ befolkning/statistikker/innvbef 3.,Non-OADS,/arxiv_data1/oa_pdf/56/8a/bmjopen-2016-012101.PMC5073609.pdf
"Classification of centrality, 2013. http://www.ssb.no/metadata/conceptvariable/vardok/927/en Fadnes LT, et al.BMJ Open 2016; 6:e012101.",OADS,/arxiv_data1/oa_pdf/56/8a/bmjopen-2016-012101.PMC5073609.pdf
"Population, 2008. http://ssb.no/en/befolkning/statistikker/folkemengde/aar/ 2008-03-13 14.",OADS,/arxiv_data1/oa_pdf/56/8a/bmjopen-2016-012101.PMC5073609.pdf
"Baltimore, MD: JohnsHopkins Bloomberg School of Public Health, 2011. https://www.healthpartners.com/ucm/groups/public/@hp/@public/documents/documents/cntrb_035024.pdf 16.",Non-OADS,/arxiv_data1/oa_pdf/56/8a/bmjopen-2016-012101.PMC5073609.pdf
2015. https://helsedirektoratet.no/retningslinjer/asylsokere-flyktninger-og-familiegjenforente 19.,Non-OADS,/arxiv_data1/oa_pdf/56/8a/bmjopen-2016-012101.PMC5073609.pdf
2012. http://www.apa.org/topics/immigration/report.aspx22.,Non-OADS,/arxiv_data1/oa_pdf/56/8a/bmjopen-2016-012101.PMC5073609.pdf
"Health accounts, 2015. https://www.ssb.no/en/nasjonalregnskap-og-konjunkturer/statistikker/helsesat/aar/2016-03-14 8 Fadnes LT, et al.BMJ Open 2016; 6:e012101.",OADS,/arxiv_data1/oa_pdf/56/8a/bmjopen-2016-012101.PMC5073609.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012011).,Non-OADS,/arxiv_data1/oa_pdf/b4/7e/bmjopen-2016-012011.PMC5073613.pdf
12. http://www.marina.difesa.it/EN/operations/Pagine/MareNostrum.aspx (accessed 22 Mar 2016).,OADS,/arxiv_data1/oa_pdf/b4/7e/bmjopen-2016-012011.PMC5073613.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 013446).,Non-OADS,/arxiv_data1/oa_pdf/fb/1f/bmjopen-2016-013446.PMC5073614.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fb/1f/bmjopen-2016-013446.PMC5073614.pdf
"http://www.cpregister.com/pubs/ pdf/ACPR-Report_Web_2013.pdf, 2013.",OADS,/arxiv_data1/oa_pdf/fb/1f/bmjopen-2016-013446.PMC5073614.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011797).,Non-OADS,/arxiv_data1/oa_pdf/16/fe/bmjopen-2016-011797.PMC5073616.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010755).,Non-OADS,/arxiv_data1/oa_pdf/3a/15/bmjopen-2015-010755.PMC5073617.pdf
"Funding The protocol reported in this publication was supported by the National Institutes of Health (NIAID 1R01AI114310-01), UNC-South China STD Research Training Center (FIC 1D43TW009532-01), UNC Center for AIDS Research (NIAID 5P30AI050410-13), UCSF Center for AIDS Research (NIAID P30 AI027763), NIMH (R00MH093201), UJMT Fogarty Fellowship (FICR25TW0093), Doris Duke International Clinical Research Fellowship and SESH Global (http://www.seshglobal.org).",Non-OADS,/arxiv_data1/oa_pdf/3a/15/bmjopen-2015-010755.PMC5073617.pdf
"Washington, DC.8 March 2010. https://www.whitehouse.gov/sites/default/files/omb/assets/memoranda_2010/m10-11.pdf (accessed 22 Sept 2016).",Non-OADS,/arxiv_data1/oa_pdf/3a/15/bmjopen-2015-010755.PMC5073617.pdf
http://tech.sina.com.cn/i/2014-12-01/23499842210.shtml 20.,Non-OADS,/arxiv_data1/oa_pdf/3a/15/bmjopen-2015-010755.PMC5073617.pdf
http://weibo.com/ danlanorg 23.,Non-OADS,/arxiv_data1/oa_pdf/3a/15/bmjopen-2015-010755.PMC5073617.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012378).,Non-OADS,/arxiv_data1/oa_pdf/a4/d7/bmjopen-2016-012378.PMC5073619.pdf
doi:10.1136/ bmjopen-2016-012071 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012071).,Non-OADS,/arxiv_data1/oa_pdf/dd/75/bmjopen-2016-012071.PMC5073620.pdf
2015. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&webdata_id=1942&WD_ID=296(accessed 2 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/dd/75/bmjopen-2016-012071.PMC5073620.pdf
2014. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=295&WD_ID=295&webdata_id=2440(accessed 25 Jul 2015).,Non-OADS,/arxiv_data1/oa_pdf/dd/75/bmjopen-2016-012071.PMC5073620.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012087).,Non-OADS,/arxiv_data1/oa_pdf/0e/d6/bmjopen-2016-012087.PMC5073624.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012609).,Non-OADS,/arxiv_data1/oa_pdf/37/20/bmjopen-2016-012609.PMC5073628.pdf
The chart was designed according to CONSORT guidelines (http://www.consort-statement.,Non-OADS,/arxiv_data1/oa_pdf/37/20/bmjopen-2016-012609.PMC5073628.pdf
between clinical and mechanistic arms of the study will follow principles of good Information Governance (www http://systems.hscic.gov.uk/infogov).,Non-OADS,/arxiv_data1/oa_pdf/37/20/bmjopen-2016-012609.PMC5073628.pdf
"Omitted from the diagram are other factors in this relationship that also influence outcomes,namely the treatment given (ICSI/PICSI) and the couples concerned: Nelson and Lawler provide details of nine factors, some ofwhich are non-linear, but for which the chances of outcomes can be derived with an online routine (http://www.ivfpredict.com).We propose to use the Nelson –Lawlor log odds as a single predictor variable rather than the nine factors.",Non-OADS,/arxiv_data1/oa_pdf/37/20/bmjopen-2016-012609.PMC5073628.pdf
"The trial is registered with an authorised registry (ISRCTN99214271) according to the ICMJE Guidelines(http://www.icmje.org), and the authorship credit will be on the substantial contributions as per the same guidelines.",Non-OADS,/arxiv_data1/oa_pdf/37/20/bmjopen-2016-012609.PMC5073628.pdf
The study complies fully with and extends on the NICE call for fert ility guid- ance: (http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/37/20/bmjopen-2016-012609.PMC5073628.pdf
http://www.hfea.gov.uk/docs/Latest_long_term_data_analysis_report_91-06.pdf.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/37/20/bmjopen-2016-012609.PMC5073628.pdf
2016. http://www.hfea.gov.uk/docs/HFEA_Fertility_Trends_and_ Figures_2013.pdf 3.,Non-OADS,/arxiv_data1/oa_pdf/37/20/bmjopen-2016-012609.PMC5073628.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012705).,Non-OADS,/arxiv_data1/oa_pdf/b8/7d/bmjopen-2016-012705.PMC5073633.pdf
https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-reduction-program.html.,Non-OADS,/arxiv_data1/oa_pdf/b8/7d/bmjopen-2016-012705.PMC5073633.pdf
Health Facts Singapore Healthcare Institution Statistics 2012. https://www.moh.gov.sg/content/moh_web/home/statistics/healthcare_institutionstatistics.html (accessed 28 Mar2016).,Non-OADS,/arxiv_data1/oa_pdf/b8/7d/bmjopen-2016-012705.PMC5073633.pdf
2014. http://www.straitstimes.com/singapore/health/singhealths-navigators-steer-patients-through-health-care-system(accessed 1 Apr 2016).,Non-OADS,/arxiv_data1/oa_pdf/b8/7d/bmjopen-2016-012705.PMC5073633.pdf
Medifund 2015. https://www.moh.gov.,Non-OADS,/arxiv_data1/oa_pdf/b8/7d/bmjopen-2016-012705.PMC5073633.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012764).,Non-OADS,/arxiv_data1/oa_pdf/b8/33/bmjopen-2016-012764.PMC5073634.pdf
Data sharing statement Additional data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.5ms8t.,OADS,/arxiv_data1/oa_pdf/b8/33/bmjopen-2016-012764.PMC5073634.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012835).,Non-OADS,/arxiv_data1/oa_pdf/36/b5/bmjopen-2016-012835.PMC5073635.pdf
https://www.nhn.no/Sider/default.aspx 25.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/bmjopen-2016-012835.PMC5073635.pdf
Secondary UpToDate 2013. http://www.uptodate.com/ home 27.,Non-OADS,/arxiv_data1/oa_pdf/36/b5/bmjopen-2016-012835.PMC5073635.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012490).,Non-OADS,/arxiv_data1/oa_pdf/e0/4a/bmjopen-2016-012490.PMC5073636.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e012139corr1.,Non-OADS,/arxiv_data1/oa_pdf/23/9b/bmjopen-2016-012139corr1.PMC5073637.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012761).,Non-OADS,/arxiv_data1/oa_pdf/4e/93/bmjopen-2016-012761.PMC5073643.pdf
doi:10.1136/bmjopen-2016- 012678 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012678).,Non-OADS,/arxiv_data1/oa_pdf/8f/0a/bmjopen-2016-012678.PMC5073644.pdf
Data will be recorded in an anonymised format using a unique alphanumeric study identi ﬁcation number on a secure web-based database (REDCap) designed by Vanderbilt University 47–49(http://www.projectredcap.,Non-OADS,/arxiv_data1/oa_pdf/8f/0a/bmjopen-2016-012678.PMC5073644.pdf
50 Data collection will occur in accordance with Caldicott II principles (http://systems.hscic.gov.uk/infogov/caldicott/caldresources).,Non-OADS,/arxiv_data1/oa_pdf/8f/0a/bmjopen-2016-012678.PMC5073644.pdf
Anticipated recruitment The recent MASDA (MAStectomy Decisions Audit) Study (http://wmresearch.org.uk/) collected data on 1700mastectomies ± IBR from 68 centres over a 3-month period.,Non-OADS,/arxiv_data1/oa_pdf/8f/0a/bmjopen-2016-012678.PMC5073644.pdf
Research ethics approval is not required and this has been con-ﬁrmed by the Health Research Authority (HRA) online decision tool (http://www.hra-decisiontools.org.uk/ research/) and discussion with University of Bristol.,Non-OADS,/arxiv_data1/oa_pdf/8f/0a/bmjopen-2016-012678.PMC5073644.pdf
http://www.cancerresearchuk.org/ health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer (accessed 15 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/8f/0a/bmjopen-2016-012678.PMC5073644.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012399).,Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2016-012399.PMC5073647.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2016-012399.PMC5073647.pdf
2012. http://www.statsnwt.ca/health/health-conditions/ (accessed Feb2016).,Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2016-012399.PMC5073647.pdf
"Department of Health and Human Services USA, 2010. http://www.cdc.gov/std/hiv/stds-and-hiv-fact-sheet-press.pdf (accessed Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2016-012399.PMC5073647.pdf
http://arcticfoxy.com/about-us?/ (accessed Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/86/3f/bmjopen-2016-012399.PMC5073647.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-012153).,Non-OADS,/arxiv_data1/oa_pdf/11/19/bmjopen-2016-012153.PMC5073649.pdf
http://www.genecards.org/cgi-bin/carddisp.pl?,Non-OADS,/arxiv_data1/oa_pdf/1a/36/bmjdrc-2016-000273.PMC5073650.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012219).,Non-OADS,/arxiv_data1/oa_pdf/71/21/bmjopen-2016-012219.PMC5073651.pdf
2010. http://www.zorginstituutnederland.nl (accessed 16 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/71/21/bmjopen-2016-012219.PMC5073651.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-012807).,Non-OADS,/arxiv_data1/oa_pdf/03/69/bmjopen-2016-012807.PMC5073654.pdf
"An online course was created using the edX platform, an open source coursemanagement system created by founding partners Harvard and MIT (http://www.edx.org/).",Non-OADS,/arxiv_data1/oa_pdf/03/69/bmjopen-2016-012807.PMC5073654.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/03/69/bmjopen-2016-012807.PMC5073654.pdf
"   Case Rep Ophthalmol 2016;7:126 –131  DOI: 10.1159/000448730   Published online: September 9, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c5/9d/cop-0007-0126.PMC5073655.pdf
"   Case Rep Dermatol 2016;8:243 –249  DOI: 10.1159/000448163   Published online: September 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/ Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/5c/6d/cde-0008-0243.PMC5073656.pdf
"   Case Rep Neurol 2016;8:193 –198  DOI: 10.1159/000449281   Published online: September 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/8f/5d/crn-0008-0193.PMC5073657.pdf
"   Case Rep Nephrol Dial 2016;6:106 –113  DOI: 10.1159/000449129   Published online: September 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cnd   This article is lic ensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/3a/19/cnd-0006-0106.PMC5073658.pdf
"   Case Rep Ophthalmol 2016;7:138 –141  DOI: 10.1159/000448512   Published online: September 16, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/19/96/cop-0007-0138.PMC5073660.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-013997).,Non-OADS,/arxiv_data1/oa_pdf/65/01/bmjopen-2016-013997.PMC5073662.pdf
"vaginalis in 2014 were found positive (Public Health Laboratory yearly report 2014, http://www.ggd.amsterdam.nl/ggd/publicaties/jaarverslagen);Table 1 Multilocus sequence typing scheme for Trichomonas vaginalis MLST locus Accession number Primer Sequences (5 ′-3 ′)Gene size(bp)5′ positionin gene*Sequence length †Total number ofalleles(previouslyreported) ‡ Tryptophanase (P1) XM_001330582.1Outer Forward GAGATGTTCAAGTATGCCGATG 1451 739 351 6 (6) Outer Reverse CAAGCTGGACTGTGAAGTGG 1356 Inner Forward CGTCAACATCGGTGGCTTCA 792 Inner Reverse GCGACAGCGACGACATTCAT 1261 Glutaminase (p3)XM_001295355.1Outer Forward AAACGCTGGTGCCATTACAAC 886 301 285 13 (5) Outer Reverse AAGGTTCTTGCCACGGATTG 822 Inner Forward TCGTTAATAGTGGGTAAGGACG 326 Inner Reverse CCAAGTATAGCTCCGCTGAC 740 Family T2aparaginase-likethreonine peptidase (P6)XM_001323020.1Outer Forward AAGGCTGTTGAGCGTGGTGC 990 94 318 8 (6) Outer Reverse GGTGTTCCGCCTGTAGAAGTGC 560 Inner Forward GAACAGGAGCACCAGCAGAA 125 Inner Reverse TCTCTAGCAACGCAGCCAAC 517 Alanyl tRNA synthetase(P8)XM_001315470.1Outer Forward AAGGAGGCAGAAGACAAGTGG 3075 2167 430 20 (18) Outer Reverse TGGAGCATACTTAGGAATGTTAGC 2833 Inner Forward TCTGTCCAGGATGGTGTCTT 2332 Inner Reverse ACGCCTTCCTCCTTCATCTT 2806 DNA mismatch repairprotein (P13)XM_001301638.1Outer Forward GGACTATCCTACGATGCTATTGAG 1758 1132 447 14 (12) Outer Reverse GTGACCAAATTTCGCACCAAG 1679 Inner Forward TCAAGGATATGGAAATCATCG 1166Inner Reverse GTCTTCCGTGCGGACAATTC 1656 Serinehydroxymethyltransferase(P14)XM_001322558.1Outer Forward CAGGTGATACATTTATGGGATTG 1356 383 339 2 (2) Outer Reverse GGCTATCTGTTCCTCCACTGAC 985 Inner Forward GCTGAGTGACGGTGGAACATT 408 Inner Reverse GAAGATGAGGTCCTCCTTGA 837 Mannose 6-phosphateisomerase (P16)XM_001325698.1Outer Forward TTACGGTTTTCGTCCATTTG 1128 372 372 5 (6) Outer Reverse GACAACAACACCTCTTCCTGC 1030 Inner Forward AGCCAGTTGGCTTCTGAGTT 538 Inner Reverse AACAATTCCGCAAGCTGGAG 977 Italics: previously published, Cornelius et al.13 *As the exact chromosomal location of each MLST gene is unknown, positions are given in base pairs of each MLST gene relative to the reference sequence G3 (GenBank accession no: NW_001517113.1).†Sequences were trimmed to the previously defined length, specified per locus.13 ‡The total number of alleles found for each locus in this study.",Non-OADS,/arxiv_data1/oa_pdf/65/01/bmjopen-2016-013997.PMC5073662.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/openhrt-2016-000488).,Non-OADS,/arxiv_data1/oa_pdf/cc/08/openhrt-2016-000488.PMC5073663.pdf
http://www.who.int/ mediacentre/factsheets/fs331/en/ (accessed 25 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/c3/08/bmjopen-2016-012488.PMC5073664.pdf
1998. http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines (accessed 10 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/c3/08/bmjopen-2016-012488.PMC5073664.pdf
1996. http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html (accessed 5 Aug 2015).,Non-OADS,/arxiv_data1/oa_pdf/c3/08/bmjopen-2016-012488.PMC5073664.pdf
"   Case Rep Ophthalmol 2016;7:155 –161  DOI: 10.1159/000448943   Published online: September 16, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Servic es/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/5a/5a/cop-0007-0155.PMC5073665.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 012888).,Non-OADS,/arxiv_data1/oa_pdf/91/ce/bmjopen-2016-012888.PMC5073666.pdf
"A 12-lead ECG was recorded by a clinical research assistant at baseline using a QRS Universal ECG device (QRS diagnostics, Plymouth, Minnesota, USA, http://www.qrsdiagnostic.com).",OADS,/arxiv_data1/oa_pdf/91/ce/bmjopen-2016-012888.PMC5073666.pdf
"   Case Rep Nephrol Dial 2016;6:101 –105  DOI: 10.1159/000448731   Published online: September 9, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cnd   This article is licensed under the Creative Commons  Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/e1/7b/cnd-0006-0101.PMC5073675.pdf
"   Case Rep Dermatol 2016;8:227 –238  DOI: 10.1159/000449034   Published online: September 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d0/3b/cde-0008-0227.PMC5073676.pdf
http://www.sg bphotography.com/articles/What_Is_Fine_Art_Photography.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d0/3b/cde-0008-0227.PMC5073676.pdf
"   Case Rep Oncol 2016;9:530 –536  DOI: 10.1159/000449154   Published online: September 13, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This ar ticle is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/fb/24/cro-0009-0530.PMC5073677.pdf
"   Case Rep Ophthalmol 2016;7:148 –154  DOI: 10.1159/000449121   Published online: September 16, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/0c/98/cop-0007-0148.PMC5073679.pdf
"   Case Rep Dermatol 2016;8:239 –242  DOI: 10.1159/000448703   Published online: September 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cde   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/84/2b/cde-0008-0239.PMC5073680.pdf
"   Case Rep Neurol 2016;8:199 –203  DOI: 10.1159/000449282   Published online: September 15, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCo mmercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/92/aa/crn-0008-0199.PMC5073681.pdf
"   Case Rep Neurol 2016;8:185 –192  DOI: 10.1159/000447087   Published online: September 12, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/44/77/crn-0008-0185.PMC5073682.pdf
"   Case Rep Nephrol Dial 2016;6:114 –119  DOI: 10.1159/000449128   Published online: September 20, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cnd   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/5c/c4/cnd-0006-0114.PMC5073683.pdf
"   Case Rep Ophthalmol 2016;7:132 –137  DOI: 10.1159/000447528   Published online: September 16, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/d4/b3/cop-0007-0132.PMC5073688.pdf
"   Case Rep Ophthalmol 2016;7:142 –147  DOI: 10.1159/000449123   Published online: September 16, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAcc essLicense).",Non-OADS,/arxiv_data1/oa_pdf/c8/f8/cop-0007-0142.PMC5073785.pdf
2015. http://www.kingsfund.org.uk/sites/files/kf/ field/field_publication_file/10PrioritiesFinal2.pdf (accessed 26 Nov2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/64/bmjopen-2016-012532.PMC5073802.pdf
2012. http://www.rpharms.com/current-campaigns-pdfs/eas-finalreports.pdf (accessed 13 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/64/bmjopen-2016-012532.PMC5073802.pdf
2014. http://www.rpharms.com/support-pdfs/3649---rps---hospital- toolkit-brochure-web.pdf (accessed 13 Nov 2015).,Non-OADS,/arxiv_data1/oa_pdf/1b/64/bmjopen-2016-012532.PMC5073802.pdf
http://www.codex.vr.,Non-OADS,/arxiv_data1/oa_pdf/5f/8a/bmjopen-2016-011820.PMC5073841.pdf
2006. http://www.who.int/governance/eb/who_constitution_en.pdf27.,Non-OADS,/arxiv_data1/oa_pdf/5f/8a/bmjopen-2016-011820.PMC5073841.pdf
"[http://dx.doi.org/10.1016/j.ridd.2013.05.021 ] [PMID: 23751293 ] [2] Mayes SD, Calhoun SL.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1080/09297040601112773 ] [PMID: 17852125 ] [3] Happé F, Booth R, Charlton R, Hughes C. Executive function deficits in autism spectrum disorders and attention-deficit/hyperactivity disorder: examining profiles across domains and ages.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
[http://dx.doi.org/10.1016/j.bandc.2006.03.004 ] [PMID: 16682102 ] [4] Leitner Y.,OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.3389/fnhum.2014.00268 ] [PMID: 24808851 ] [5] Teder-Sälejärvi WA, Pierce KL, Courchesne E, Hillyard SA.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1016/j.cogbrainres.2004.10.021 ] [PMID: 15820630 ] [6] Corbett BA, Constantine LJ.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1080/09297040500350938 ] [PMID: 16911977 ] [7] Craig F, Margari F, Legrottaglie AR, Palumbi R, de Giambattista C, Margari L. A review of executive function deficits in autism spectrum disorder and attention-deficit/hyperactivity disorder.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1146/annurev.ne.13.030190.000325 ] [PMID: 2183676 ] [9] Posner MI, Fan J.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1162/089892902317361886 ] [PMID: 11970796 ] [11] Fan J, Bernardi S, Van Dam NT, et al.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1002/brb3.90 ] [PMID: 23139910 ] [12] Johnson KA, Robertson IH, Barry E, et al.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1111/j.1469-7610.2008.01936.x ] [PMID: 19120713 ] [13] Keehn B, Lincoln AJ, Müller RA, Townsend J. Attentional networks in children and adolescents with autism spectrum disorder.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1111/j.1469-7610.2010.02257.x ] [PMID: 20456535 ] [14] Mutreja R, Craig C, O’Boyle MW.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[Epub ahead of print] [http://dx.doi.org/10.3109/17518423.2015.1017663 ] [PMID: 25837729 ] [15] Posner MI, Rothbart MK.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1146/annurev.psych.58.110405.085516 ] [PMID: 17029565 ] [16] Rueda MR, Fan J, McCandliss BD, et al.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1016/j.neuropsychologia.2003.12.012 ] [PMID: 15093142 ] [17] Westlye LT, Grydeland H, Walhovd KB, Fjell AM.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
[http://dx.doi.org/10.1093/cercor/bhq101 ] [PMID: 20525771 ] [18] Hill EL.,Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
[http://dx.doi.org/10.1016/j.dr.2004.01.001 ] [19] Stefanatos GA. Regression in autistic spectrum disorders.,OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1007/s11065-008-9073-y ] [PMID: 18956241 ] [20] Anagnostou E, Taylor MJ.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
[http://dx.doi.org/10.1186/2040-2392-2-4 ] [PMID: 21501488 ],Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1212/WNL.59.6.834 ] [PMID: 12297562 ] [22] Kana RK, Keller TA, Minshew NJ, Just MA.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1023/A:1005617831035 ] [PMID: 11439757 ] [24] Reeber SL, Otis TS, Sillitoe RV.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.3389/fnsys.2013.00083 ] [PMID: 24294192 ] [25] Vaidya CJ, Foss-Feig J, Shook D, Kaplan L, Kenworthy L, Gaillard WD.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1111/j.1467-7687.2011.01041.x ] [PMID: 21676110 ] [26] Desmond JE, Gabrieli JD, Glover GH.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1006/nimg.1998.0340 ] [PMID: 9626676 ] [27] Reeber SL, Otis TS, Sillitoe RV.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.3389/fnsys.2013.00083 ] [PMID: 24294192 ] [28] Keehn B, Nair A, Lincoln AJ, Townsend J, Müller RA.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1016/j.dcn.2015.12.002 ] [PMID: 26708773 ] [29] Dosenbach NU, Visscher KM, Palmer ED, et al.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1016/j.neuron.2006.04.031 ] [PMID: 16731517 ] [30] Landry R, Bryson SE.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1111/j.1469-7610.2004.00304.x ] [PMID: 15257668 ] [31] Gottwald B, Mihajlovic Z, Wilde B, Mehdorn HM.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1016/S0028-3932(03)00090-3 ] [PMID: 12849763 ] [32] Schweizer TA, Alexander MP, Cusimano M, Stuss DT.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1016/j.neuropsychologia.2007.05.018 ] [PMID: 17640689 ] [33] Lenroot RK, Yeung PK.",OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
[http://dx.doi.org/10.3389/fnhum.2013.00733 ] [PMID: 24198778 ] © Hames et al.,Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/d5/TONIJ-10-102.PMC5074002.pdf
"[http://dx.doi.org/10.1111/j.1365-2591.1997.tb01092.x ] [PMID: 9477789 ] [2] Ounsi HF, Franciosi G, Paragliola R, et al.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
[http://dx.doi.org/10.1016/j.joen.2011.02.030 ] [PMID: 21787503 ] [3] Peters OA.,OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1097/01.DON.0000129039.59003.9D ] [PMID: 15273636 ] [4] Berutti E, Paolino DS, Chiandussi G, et al.",Non-OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1046/j.1365-2591.2003.00650.x ] [PMID: 12702124 ] [6] González Sánchez JA, Duran-Sindreu F, de Noé S, Mercadé M, Roig M. Centring ability and apical transportation after overinstrumentation with ProTaper Universal and ProFile Vortex instruments.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1111/j.1365-2591.2011.02008.x ] [PMID: 22264187 ] [7] Pedulla E, Lo Savio F, Boninelli S, et al.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1111/iej.12400 ] [PMID: 25353957 ] [8] De-Deus G, Brandão MC, Barino B, Di Giorgi K, Fidel RA, Luna AS.",Non-OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1016/j.tripleo.2010.04.020 ] [PMID: 20727500 ] [9] Bürklein S, Schäfer E. Apically extruded debris with reciprocating single-file and full-sequence rotary instrumentation systems.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1016/j.joen.2012.02.017 ] [PMID: 22595125 ] [10] Bonessio N, Pereira ES, Lomiento G, et al.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1111/j.1365-2591.1985.tb00450.x ] [PMID: 3865899 ] [12] Mandel E, Adib-Yazdi M, Benhamou LM, Lachkar T, Mesgouez C, Sobel M. Rotary Ni-Ti profile systems for preparing curved canals in resin blocks: influence of operator on instrument breakage.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1046/j.1365-2591.1999.00239.x ] [PMID: 10709491 ] [13] Berutti E, Chiandussi G, Paolino DS, et al.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1046/j.1365-2591.2002.00513.x ] [PMID: 12190907 ] [15] Yang GB, Zhou XD, Zhang H, Wu HK.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1111/j.1365-2591.2006.01151.x ] [PMID: 16948665 ] [16] Thompson SA, Dummer PM.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1046/j.1365-2591.2000.00287.x ] [PMID: 11307443 ] [17] Capar ID, Arslan H. A review of instrumentation kinematics of engine-driven nickel titanium instruments.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1016/j.joen.2014.02.015 ] [PMID: 25146029 ] [19] Generali  L,  Righi  E,  Todesca  MV,  Consolo  U.  Canal  shaping  with  WaveOne  reciprocating  files:  influence  of  operator  experience  on instrument breakage and canal preparation time.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"[http://dx.doi.org/10.1007/s10266-013-0118-1 ] [20] McRay B, Cox TC, Cohenca N, Johnson JD, Paranjpe A.",OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/36/6f/TODENTJ-10-546.PMC5074003.pdf
[http://dx.doi.org/10.1016/j.jdent.2006.07.012 ] [PMID: 17030395 ] [2] Ferracane JL.,OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1016/j.dental.2010.10.020 ] [PMID: 21093034 ] [3] Knezević A, Tarle Z, Meniga A, Sutalo J, Pichler G, Ristić M. Degree of conversion and temperature rise during polymerization of composite resin samples with blue diodes.",OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1046/j.1365-2842.2001.00709.x ] [PMID: 11422686 ] [4] Weinmann W, Thalacker C, Guggenberger R. Siloranes in dental composites.",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1016/j.dental.2004.10.007 ] [PMID: 15681004 ] [5] Leprince J, Palin WM, Mullier T, Devaux J, Vreven J, Leloup G. Investigating filler morphology and mechanical properties of new low- shrinkage resin composite types.",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1111/j.1365-2842.2010.02066.x ] [PMID: 20202096 ] [6] Mahendran K, Shanmugam JS, Uma M. Thermographic analysis of temperature rise in the pulp chamber with LED and QTH light curing units: An in vitro  investigation.",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.4103/0976-433X.116820 ] [7] Schneider LF, Consani S, Correr-Sobrinho L, Correr AB, Sinhoreti MA.",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1007/s00784-005-0028-x ] [PMID: 16402230 ] [8] Guiraldo RD, Consani S, Consani RL, et al.",OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1590/S0103-64402010000600010 ] [PMID: 21271045 ] [9] Goodis HE, White JM, Gamm B, Watanabe L. Pulp chamber temperature changes with visible-light-cured composites in vitro .",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1016/S0109-5641(05)80038-7 ] [PMID: 2079178 ] [10] Jandt KD, Mills RW.",OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1016/j.dental.2013.02.003 ] [PMID: 23507002 ] [11] Nomoto R, McCabe JF, Hirano S. Comparison of halogen, plasma and LED curing units.",OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1016/S0109-5641(99)00083-4 ] [PMID: 11203522 ] [13] Guiraldo RD, Consani S, Consani RL, et al.",OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
[http://dx.doi.org/10.1016/0142-9612(91)90022-3 ] [PMID: 1799649 ] [17] Luis Felipe J. Schneider.,OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
[http://dx.doi.org/10.1134/S1054660X08080173 ] [19] Rastelli DP.,Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1134/S1054660X0812030X ] [20] Palin WM, Fleming GJ, Nathwani H, Burke FJ, Randall RC.",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1016/j.dental.2004.05.005 ] [PMID: 15766579 ] [21] Boaro LC, Gonçalves F, Guimarães TC, Ferracane JL, Versluis A, Braga RR.",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1016/j.dental.2010.08.003 ] [PMID: 20832850 ] [22] Weinmann W, Thalacker C, Guggenberger R. Siloranes in dental composites.",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
[http://dx.doi.org/10.1016/j.dental.2004.10.007 ] [PMID: 15681004 ] [23] Miletic V. Vladimir ivanovic.,OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1111/j.1708-8240.2009.00244.x ] [24] Knezević A, Tarle Z, Meniga A, Sutalo J, Pichler G. Influence of light intensity from different curing units upon composite temperature rise.",OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1111/j.1365-2842.2004.01418.x ] [PMID: 15842246 ] [25] Tabtabei M, Motevasselian F. Evaluation of temperature rise and DC in two composites using various curing units.",OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"[http://dx.doi.org/10.1016/S0300-5712(98)00052-9 ] [PMID: 10079630 ] [27] Sakaguchi RL, Douglas WH, Peters MC.",OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
[http://dx.doi.org/10.1016/0300-5712(92)90136-Z ] [PMID: 1624624 ] © Pahlevan et al.,OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/22/TODENTJ-10-538.PMC5074004.pdf
"Published by Grapho Publications, LLC This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).",Non-OADS,/arxiv_data1/oa_pdf/41/e1/tom223.PMC5074084.pdf
ISSN 2379-1381 http://dx.doi.org/10.18383/j.tom.2016.00250 TOMOGRAPHY.ORG | VOLUME 2 NUMBER 3 |SEPTEMBER 2016 223,Non-OADS,/arxiv_data1/oa_pdf/41/e1/tom223.PMC5074084.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/56/main.PMC5074085.pdf
"Altogether, characterization of the developmental andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/bbrepBiochemistry and Biophysics Reports http://dx.doi.org/10.1016/j.bbrep.2016.06.023 2405-5808/ &2016 The Authors.",OADS,/arxiv_data1/oa_pdf/15/56/main.PMC5074085.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/15/56/main.PMC5074085.pdf
Supplementary material Transparency data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.2016.06.023 .,OADS,/arxiv_data1/oa_pdf/15/56/main.PMC5074085.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.bbrep.2016.06.023 .,OADS,/arxiv_data1/oa_pdf/15/56/main.PMC5074085.pdf
"http://www.otago.ac.nz/wellington/departments/publichealth/research/ hirp/otago020541.html#aboutus, Accessed November 16, 2015.Indigenous Cervical Screening Inequities/Whop et al Cancer May 15, 2016 1569",Non-OADS,/arxiv_data1/oa_pdf/42/60/CNCR-122-1560.PMC5074237.pdf
"All cate- gories are listed according to Tuberculist (version 2.6, Release 27 - March 2013, http://tuberculist.epﬂ.ch/).",Non-OADS,/arxiv_data1/oa_pdf/7d/38/PMIC-16-1376.PMC5074239.pdf
Adapted from http://biocyc.org/MTBRV.,Non-OADS,/arxiv_data1/oa_pdf/7d/38/PMIC-16-1376.PMC5074239.pdf
"Available at: http://www.clinicaltrials.gov/ct2/show/NCT00376168,accessed on June 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/86/AJH-91-656.PMC5074246.pdf
"A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjectswith Gaucher Disease NCT01422187; 2013;Available at: http://clinicaltrials.gov/ct2/show/NCT01422187?term 5taliglucerase 1alfa&rank- 3, accessed on June 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/70/86/AJH-91-656.PMC5074246.pdf
bThese values were calculated using the PCModels in Daylight software version 4.93 (http://www.daylight.com/).,OADS,/arxiv_data1/oa_pdf/1d/3b/BDD-37-142.PMC5074247.pdf
Available at: http://www.pmda.go.jp/drugs/2010/P201000029/400256000_22200AMX00309_I100_2.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/1d/3b/BDD-37-142.PMC5074247.pdf
Available at: http://www.pmda.go.jp/drugs/2011/P201100128/530353000_2230 0AMX00605_I100_1.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/1d/3b/BDD-37-142.PMC5074247.pdf
Available at: http://www.pmda.go .jp/drugs/2013/P201300036/ 180078000_22500AMX00877_I100_1.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/1d/3b/BDD-37-142.PMC5074247.pdf
Available at: http://www.pmda.go.jp/ drugs/2009/P200900043/63015 300_22100AMX02257_I100_1.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/1d/3b/BDD-37-142.PMC5074247.pdf
Available at: http://www.pmda.go.jp/drugs/2010/P201000008/30024200_2 2200AMX00233_I100_5.pdf (in Japanese).,Non-OADS,/arxiv_data1/oa_pdf/1d/3b/BDD-37-142.PMC5074247.pdf
Availablefrom URL: http://www.fda.gov/downloads/Drugs/Guidances/ucm071624.pdf.Accessed12October2015.,Non-OADS,/arxiv_data1/oa_pdf/96/32/DOM-18-663.PMC5074260.pdf
"MATERIALS AND METHODS Plant materials and growth conditions The homozygous atbest1-2 (GK-796C09) and atbest2-1 (SALK_114715C) mutants of Arabidopsis thaliana (Columbia, Col-0) obtained from the ABRC ( http://abrc.osu.edu ) and were veri ﬁed by PCR.",OADS,/arxiv_data1/oa_pdf/8a/24/JIPB-58-848.PMC5074266.pdf
"Total RNA was isolated from leavesusing Trizol reagent (Invitrogen, http://www.thermo ﬁsher.",OADS,/arxiv_data1/oa_pdf/8a/24/JIPB-58-848.PMC5074266.pdf
"Proteins weredetected with speci ﬁc antibodies in TTBS buffer with 1% skimmed milk and visualized by the chemiluminescencemethod using LuminoGraph WSE-6100 (ATTO Corporation,http://www.atto.co.jp/ ).ECS measurements Electrochromic shift measurements were performed usingthe Dual-PAM-100 (Walz, Effeltrich, Germany) with theP515/535 module ( Schreiber and Klughammer 2008 ).",OADS,/arxiv_data1/oa_pdf/8a/24/JIPB-58-848.PMC5074266.pdf
"Plastid-targeting signal (cTP)and transmembrane domains of AtBest were predicted byChloroP analysis ( http://www.cbs.dtu.dk/services/ChloroP ) and TMHMM software ( http://www.cbs.dtu.dk/services/ TMHMM-2.0 ), respectively.",OADS,/arxiv_data1/oa_pdf/8a/24/JIPB-58-848.PMC5074266.pdf
The overall structure of AtBest1 was predicted by SwissModel ( http://swissmodel.expasy.org ) using KpBest as a template.,OADS,/arxiv_data1/oa_pdf/8a/24/JIPB-58-848.PMC5074266.pdf
Sequence alignment of bestrophin-like proteins from phototrophic organismsSequences were obtained from GenBank ( http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/8a/24/JIPB-58-848.PMC5074266.pdf
"nlm.nih.gov/ ) or Phytozome ( http://www.phytozome.net/ ) (AtBest1, Arabidopsis thaliana , AT3G61320; AtBest2, AT2G45870; GmaBest1, Glycine max , Glyma03g01281; GmaB- est2, Glycine max , Glyma07g07830; OsaBest1, Oryza sativa , Os03g01570; ZmaBest1, Zea mays , GRMZM2G114469; SmoB- est1, Selaginella moellendorf ﬁi, XP_002962243; PptBest1, Physcomitrella patens , Pp1s13_344V6; CreBest1, Chlamydomo- nas reinhardtii , Cre16.g663400; SynBest1, Synechocystis sp.",Non-OADS,/arxiv_data1/oa_pdf/8a/24/JIPB-58-848.PMC5074266.pdf
Phylogenetic tree of bestrophin superfamily proteinsSequences of bestrophin superfamily proteins were obtainedfrom GenBank ( http://www.ncbi.nlm.nih.gov/ ) or Phytozome (http://www.,OADS,/arxiv_data1/oa_pdf/8a/24/JIPB-58-848.PMC5074266.pdf
"Functional Connectivity The UF2C—user friendly functional connectivity toolbox The UF2C toolbox (http://www.lni.hc.unicamp.br/app/ uf2c/) was developed by the author (Campos, BM) aimingto standardize and facilitate connectivity studies through astraightforward graphical user interface and validated pre-set parameters.",OADS,/arxiv_data1/oa_pdf/2d/51/HBM-37-3137.PMC5074272.pdf
The ROIs ana-tomical labeling was performed using xjView toolbox(http://www.alivelearn.net/xjview).,OADS,/arxiv_data1/oa_pdf/2d/51/HBM-37-3137.PMC5074272.pdf
(2010) Common Terminology Criteria for Adverse Events(CTCAE) Version 4.0. http://www.jcog.jp/doc-tor/tool/CTCAEv4J_20100911.pdf.,Non-OADS,/arxiv_data1/oa_pdf/14/8b/BJH-174-563.PMC5074273.pdf
"(2014) The National Comprehensive Can- cer Network (NCCN) Guidelines (2014); Clini-cal practice guidelines in oncology: myeloid growth factors, version 1. http://www.nccn.org/ professionals/physician_gls/pdf/myeloid_-growth.pdf.",Non-OADS,/arxiv_data1/oa_pdf/14/8b/BJH-174-563.PMC5074273.pdf
"Theoverall best-performing force field, Charmm36H, achieved aremarkable prediction accu- racy of3.8kJmol/C01interms oftheaveraged unsigned error (AUE) with respect tothe experimental measurements (Figure 1b).Ingeneral, predicting thermostability changes[*]Dr.V.Gapsys, Dr.S.Michiel ssens, Dr.B.L.deGroot Computation alBiomole cular Dynamics Group Max Planck Institute forBiophysica lChemist ry AmFassberg 11,37077 Gçttingen (Germany ) E-mail :vgapsys@g wdg.de bgroot@gw dg.de Dr.D.Seeliger Lead Identificati onandOptimiz ation Support Boehringer Ingelheim Pharma GmbH &Co.KG Birkendorfe rStrasse 65,88397 Biberach (Germany ) Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2015100 54.",OADS,/arxiv_data1/oa_pdf/d9/fb/ANIE-55-7364.PMC5074281.pdf
"In the second session conducted inside the scanner, the subjectperformed an object-place paired associate memory task fol-lowed by a simple navigation task (http://inahlee.org/fmri- vr-experiment-sample.html, Fig.",Non-OADS,/arxiv_data1/oa_pdf/80/67/HIPO-26-1061.PMC5074286.pdf
"For anatomical data, the images were processed using FREE- SURFER software (http://surfer.nmr.mgh.harvard.edu, ver.5.1.0) to generate anatomical ROIs, including the hippocam-pus.",OADS,/arxiv_data1/oa_pdf/80/67/HIPO-26-1061.PMC5074286.pdf
"The score has already been integrated into our local clinical database with ease, and we have developed a BETA-2 scoreWeb-based calculator (https://sites.google.com/a/islet.ca/ beta-2/).",Non-OADS,/arxiv_data1/oa_pdf/56/c2/AJT-16-2704.PMC5074289.pdf
"https://clinicaltrials.gov/ct2/show/NCT00344513?term=OPTIMIZE-HF&rank=1 ATTEND11Japan Inpatients with AHFS who met the modi ﬁed Framingham criteria, which only includes variables estimated at admission ( ….)",Non-OADS,/arxiv_data1/oa_pdf/af/a2/EHF2-3-065.PMC5074292.pdf
"Acute heart failure precipitants and infection Many patients with acute heart failure present with speci ﬁc precipitants, which include ACS, arrhythmias, and infection.Typical cases with precipitants have been published online (http://www.eusem.org/onlinecontent/ and http://www.",Non-OADS,/arxiv_data1/oa_pdf/af/a2/EHF2-3-065.PMC5074292.pdf
"A website (http://cmhsweb.uaeu.ac.ae/childbmicalculator) was developed to process BMI values according to the IOTF, WHO and CDC cut-off criteria.",Non-OADS,/arxiv_data1/oa_pdf/61/73/OSP4-2-196.PMC5074293.pdf
17. http://opendata.nbs.gov.ae/search?query=UAE%20population% 20density.,Non-OADS,/arxiv_data1/oa_pdf/61/73/OSP4-2-196.PMC5074293.pdf
18. http://opendata.nbs.gov.ae/iznkglf/united-arab-emirates-regional- statistics-2013 (accessed 14 December 2015).,Non-OADS,/arxiv_data1/oa_pdf/61/73/OSP4-2-196.PMC5074293.pdf
doi:http://dx.doi.org/10.1017/ S1138741600004765.,Non-OADS,/arxiv_data1/oa_pdf/d2/29/DA-33-862.PMC5074295.pdf
http://www.ncbi.nlm.nih.gov/ pmc/articles/PMC495331/.,Non-OADS,/arxiv_data1/oa_pdf/d2/29/DA-33-862.PMC5074295.pdf
Available at: http://www.trialsjournal.com/content/14/1/144.,Non-OADS,/arxiv_data1/oa_pdf/d2/29/DA-33-862.PMC5074295.pdf
Available at: http://psycnet.apa.org/journals/bul/112/1/155/.,Non-OADS,/arxiv_data1/oa_pdf/d2/29/DA-33-862.PMC5074295.pdf
Available at: http://www.r-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/d2/29/DA-33-862.PMC5074295.pdf
"[*]Dr.J.K.Howard, Prof. A.Nelson School ofChemist ryandAstbury Centre forStructural Molecular Biology ,University ofLeeds Leeds, LS29JT(UK) Dr.M.M(o[z[ller,Prof.A.Berry School ofMolecu larandCellular Biology andAstbury Centre for Structural Molecular Biology ,University ofLeeds Leeds, LS29JT(UK) E-mail :a.berry@leed s.ac.uk a.s.nelson@l eeds.ac.uk Supportin ginformation forthisarticle canbefound under : http://dx.do i.org/10.1002/a nie.2016028 52.",Non-OADS,/arxiv_data1/oa_pdf/e6/de/ANIE-55-6767.PMC5074308.pdf
"T.M(o2z2ller Institut f(o2z2rChemie, CarlvonOssietzky Universit(o22wt Oldenb urg Carl von Ossietzk yStr.9-11,26111Oldenb urg(Germany ) E-mail :thoma s.muelle r@uni-old enburg.de [b]Dr.J.Baum gartner Institut f(o2z2rChemie, Univ ersit(o22wt Graz Strema yrgasse 9,8010 Graz (Austr ia) E-mail :baumga rtner@ tugraz.a t [c]Prof. C.Marschne r Institut f(o2z2rAnorg anische Chemi e,Technisch eUniversit(o22wt Graz Strema yrgasse 9,8010 Graz (Austr ia) E-mail :christo ph.marsc hner@tugr az.at Suppo rting informa tion and theORCID identifica tion number(s) fortheau- thor(s) ofthisarticle canbefound under http://dx.do i.org/10 .1002/ chem.2 016001 16.",Non-OADS,/arxiv_data1/oa_pdf/b4/76/CHEM-22-7970.PMC5074309.pdf
"Washington, DC: The National Academies Press; 2009. http://www.iom.edu/Reports/2009/Beyond-the-HIPAA-Privacy-Rule-Enhancing-Privacy-Improving-Health-Through-Re-search.aspx (accessed 18 June 2015).",Non-OADS,/arxiv_data1/oa_pdf/81/aa/PDS-25-960.PMC5074316.pdf
"National Cancer Institute, Bethesda, MD; 2014. http://seer.cancer.gov/registries/index.html (accessed 18 June 2015).",Non-OADS,/arxiv_data1/oa_pdf/81/aa/PDS-25-960.PMC5074316.pdf
"Version of October 4, 2012, 2012. http://www.krothman.org/episheet.xls (accessed 18 June 2015).",Non-OADS,/arxiv_data1/oa_pdf/81/aa/PDS-25-960.PMC5074316.pdf
"(2006) Com- pound for enzyme inhibition (US Patent 2006/0088471 A1), April 27, 2006. http://patents.com/ us-20060088471.html.",Non-OADS,/arxiv_data1/oa_pdf/ae/26/BJH-173-884.PMC5074317.pdf
"(2006) Compounds for enzyme inhibition (US 2006/0030533 A1), February 9, 2006. http://patents.com/us-20060030533.html.",OADS,/arxiv_data1/oa_pdf/ae/26/BJH-173-884.PMC5074317.pdf
Annual report SWEDEHEART 2012. http://www.ucr.uu.se/swedeheart/index.php/dokument-sh/doc_download/253-swedeheart-annual-report-2012-english.,Non-OADS,/arxiv_data1/oa_pdf/e3/26/CLC-39-313.PMC5074319.pdf
http://pi.amgen.com/united_states/repatha/repatha_pi_hcp_english.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e3/26/CLC-39-313.PMC5074319.pdf
Published July 2014. http://www.nice.,Non-OADS,/arxiv_data1/oa_pdf/e3/26/CLC-39-313.PMC5074319.pdf
http://www.who.int/choice/cost- effectiveness/en/.,Non-OADS,/arxiv_data1/oa_pdf/e3/26/CLC-39-313.PMC5074319.pdf
http://cepac.icer-review.org/wp-content/uploads/2015/04/Final-Report-for-Posting-11-24-15.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e3/26/CLC-39-313.PMC5074319.pdf
Supportin ginforma tion andtheORCID identifica tion number(s) for theauthor(s) ofthisarticle canbefound under http://dx.doi.org/ 10.,Non-OADS,/arxiv_data1/oa_pdf/d4/fc/ANIE-55-6423.PMC5074321.pdf
"2.4 Spectra processing and identiﬁcation of spectral components Data processing was performed using MATLAB-based tools (MathWorks, Natick, USA); a complete library of MATLAB commands together with an exemplary dataset was pub- lished at our webpage: http://zaed.aei.polsl.pl/index.php/pl/ oprogramowanie-zaed.",OADS,/arxiv_data1/oa_pdf/09/6f/PMIC-16-1613.PMC5074322.pdf
Available at: “http://www.stats.gov.cn/tjsj/ ndsj/2012(2006)/indexeh.htm ”www.stats.- gov.cn/tjsj/ndsj/2012(2006)/indexeh.htm.,OADS,/arxiv_data1/oa_pdf/7e/b8/ALL-71-1170.PMC5074323.pdf
Available at: http://www.europeristat.com/images/doc/EPHR2010_w_disclaimer.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8e/eb/APA-105-1039.PMC5074324.pdf
"Survey of common verification methods in meteorology, WMO world weather watchtechnicalreport8,wmo/tdno.358Melbourne,1989.Availablefrom:http://www.cawcr.gov.au/projects/verification/Stanski_et_al/Stanski_et_al.html[accessedFebruary 18, 2016].",OADS,/arxiv_data1/oa_pdf/bc/a8/SIM-35-3949.PMC5074325.pdf
Available from: http://www.R-project.org/ [accessed: 28 March 2016].,Non-OADS,/arxiv_data1/oa_pdf/bc/a8/SIM-35-3949.PMC5074325.pdf
Available from: http://CRAN.R-project.org/ package=ranger R package version 0.3.0 [accessed: 28 March 2016].,Non-OADS,/arxiv_data1/oa_pdf/bc/a8/SIM-35-3949.PMC5074325.pdf
Available from: http://CRAN.R-project.org/package=rms R package version 4.4-2 [accessed:26 March 2016].,Non-OADS,/arxiv_data1/oa_pdf/bc/a8/SIM-35-3949.PMC5074325.pdf
"JointStatisticalMeeting ,S e a t t l e ,U n i t e d StatesofAmerica,2015.Availablefrom:https://www.amstat.org/meetings/jsm/2015/onlineprogram/AbstractDetails.cfm?abstractid=317640 [accessed:26 March 2016].",OADS,/arxiv_data1/oa_pdf/bc/a8/SIM-35-3949.PMC5074325.pdf
Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by- nc-nd/4.0/Author af ﬁliations appear at the end of this article.,Non-OADS,/arxiv_data1/oa_pdf/8f/aa/JCO666693.PMC5074347.pdf
https://www.abbottmolecular.com/en-us/ staticAssets/pdfs/us/pathvys ion-watermark-pl-rev-6.pdf 34.DAKO: HER2 IQFISH pharmDx.,OADS,/arxiv_data1/oa_pdf/8f/aa/JCO666693.PMC5074347.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e5/7a/emss-70192.PMC5074363.pdf
"All VIIRS data sets, quality assessment reports, and pro-cessingtoolsarepubliclyavailable(http://viirsland.gsfc.nasa.gov/).",OADS,/arxiv_data1/oa_pdf/5a/6e/EFT2-3-182.PMC5074443.pdf
"Earth’sFuture 10.1002/2014EF000285 setsbeinggeneratedfromSuomi-NPPVIIRSdata.AllMODISdatasets,qualityassessmentreports,andpro- cessing tools used in this study are publicly available (http://modis-land.gsfc.nasa.gov/).",OADS,/arxiv_data1/oa_pdf/5a/6e/EFT2-3-182.PMC5074443.pdf
[Availableathttp://www.energy.ca.gov/ceus/] .,OADS,/arxiv_data1/oa_pdf/5a/6e/EFT2-3-182.PMC5074443.pdf
"Rep.,28June,[Availableat http://www.nationalgridus.com/niagaramohawk/business/rates/5_load_proﬁle.asp] .",OADS,/arxiv_data1/oa_pdf/5a/6e/EFT2-3-182.PMC5074443.pdf
Rep.[Availableathttp://en.openei.org/datasets/node/961.,OADS,/arxiv_data1/oa_pdf/5a/6e/EFT2-3-182.PMC5074443.pdf
Rep.[Availableat http://parliament2011.elections.eg/index.php/statistics/lists-results-on-map](inArabic).,Non-OADS,/arxiv_data1/oa_pdf/5a/6e/EFT2-3-182.PMC5074443.pdf
"EnergyInformationAdministration(EIA)(2014),Frequentlyaskedquestions:Howmuchcarbondioxideisproducedperkilowatthour whengeneratingelectricitywithfossilfuels?[Availableathttp://www.eia.gov/tools/faqs.]Accessed21May2014.",OADS,/arxiv_data1/oa_pdf/e4/e5/EFT2-3-252.PMC5074444.pdf
"(continued) Site CommunityType Latitude(oN) TidalAmp(cm) LossonIgnition(gg−1) BulkDensity(gcm−3) N RushRa,CAlTidalbrackishmarsh, Schoenoplectus spp.38.2 86 0.27 ±0.15 0.38 ±0.19 138 Choptk,MDcTidalfreshmarsh 38.7 16 0.27 ±0.05 0.30 ±0.07 45 PatuxR,MDc,gTidalfreshmarsh,mixed 38.7 28 0.34 ±0.17 0.29 ±0.14 230 GCREW,MDaBrackishtidalmarsh, Schoenoplectus americanus,Spartinapatens38.9 14 0.79 ±0.05 0.12 ±0.02 117 OttCr,MDcTidalfreshmarsh 39.4 19 0.12 ±0.02 0.68 ±0.19 45 DelRiv,DEfTidalfreshmarsh 39.8 91 0.14 ±0.04 0.27 ±0.17 11 JamBay,NYj,kS.alterniﬂora saltmarsh 40.6 80 0.41 ±0.18 0.31 ±0.32 133 NarrBay,RIa,iTidalsaltmarsh ,S.patens, D.spicata,S.alterniﬂora41.6 65 0.28 ±0.19 0.41 ±0.31 127 Hudson,NYcTidalfreshmarsh 42 61 0.16 ±0.1 0.58 ±0.21 103 PlumIs,MAaS.patens,S.alterniﬂora saltmarsh 43 150 0.29 ±0.14 0.26 ±0.12 320 Moody,MEaTidalsaltmarsh, S.patens, D.spicata,S.alterniﬂora43.2 134 0.31 ±0.14 0.34 ±0.22 52 Webhannet,MEaTidalsaltmarsh, S.patens, D.spicata,S.alterniﬂora43.3 134 0.25 ±0.13 0.44 ±0.20 36 Morse,MEaTidalsaltmarsh, S.patens, D.spicata,S.alterniﬂora43.7 139 0.22 ±0.12 0.42 ±0.21 37 Sprague,MEaTidalsaltmarsh, S.patens, D.spicata,S.alterniﬂora43.7 139 0.20 ±0.12 0.43 ±0.24 212 GrandMeans 0.30±0.17 0.36 ±0.14 5075 aoriginaldata;bChambersandPederson ,2006andhttp://fcelter.ﬁu.edu/data/;cMerrill,1999;dWard et al .,1988;eNeubauer ,2000;fChurchetal .,2006;Orsonetal .,1992;gKhanandBrush ,1994; hhttp://cims.coastal.la.gov/monitoring-data/;iWigandetal .,2003;jWigandetal .,2014;kSwansonandWilson ,2008;lCallawayetal .,2012 MORRISETAL.",Non-OADS,/arxiv_data1/oa_pdf/35/6d/EFT2-4-110.PMC5074445.pdf
"Thus, even current rates of SLR along the East Coast (mean =0.34cmyr−1, range=0.18–0.60cmyr−1) (http://tidesandcurrents.noaa.gov/sltrends/sltrends.html) are near the point that will lead to long-termelevationlossandeventualdrowningofcoastalwetlands.",Non-OADS,/arxiv_data1/oa_pdf/35/6d/EFT2-4-110.PMC5074445.pdf
"8, 833 –839 http://dx.doi.org/10.1080/15384047.2016.1195049",Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Ann Oncol 2015; 26:1877-83;PMID:26141208; http://dx.doi.org/10.1093/annonc/mdv276 2.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Cancer 2015; 121:3089-96; PMID:26331815; http://dx.doi.org/10.1002/cncr.29522 5.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
JThorac Oncol 2016; 11:174-86; PMID:26845114; http://dx.doi.org/ 10.1016/j.jtho.2015.10.002 6.,OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Clin Oncol 2004; 22:777-84; PMID:14990632; http://dx.doi.org/10.1200/JCO.2004.08.001 7.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Clin Oncol 2004; 22:785-94; PMID:14990633; http://dx.doi.org/10.1200/JCO.2004.07.215 8.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Clin Oncol 2005; 23:5892-9; PMID:16043829; http://dx.doi.org/10.1200/JCO.2005.02.840 9.,OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Clin Oncol 2007; 25:1545-52; PMID:17442998; http://dx.doi.org/10.1200/JCO.2005.05.1474 10.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Clin Lung Cancer 2006; 7:385-8; PMID:16800963; http://dx.doi.org/10.3816/CLC.2006.n.021 12.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Cancer 2011; 2:435-42; PMID:21850211; http://dx.doi.org/10.7150/jca.2.435 14.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
RadiolOncol 2014; 48:361-8; PMID:25435849; http://dx.doi.org/10.2478/raon-2014-0038 15.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Eur J Cancer 1999; 35:1773-82; PMID:10673991; http://dx.doi.org/10.1016/S0959-8049(99)00229-4 16.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Lancet Oncol 2012; 13:239-6; PMID:22285168; http://dx.doi.org/10.1016/S1470-2045(11)70393-X 17.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Thorac Oncol 2011; 6:2112-9;PMID:21892109; http://dx.doi.org/10.1097/JTO.0b013e31822ae061 18.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Ann Oncol 2013; 24:2860-5; PMID:23986090; http://dx.doi.org/10.1093/annonc/mdt341 19.,OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Phase II studyof pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status.Lung Cancer 2013; 82:271-5; PMID:23993733; http://dx.doi.org/ 10.1016/j.lungcan.2013.07.022 21.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Eur J Cancer 2013; 49:3111-21; PMID:23890768; http://dx.doi.org/10.1016/j.ejca.2013.06.035 22.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Thorac Oncol 2013; 8:96-101; PMID:23207920;http://dx.doi.org/10.1097/JTO.0b013e3182762bfb 23.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Lung Cancer 2014; 85:415-19; PMID:25082565; http://dx.doi.org/ 10.1016/j.lungcan.2014.07.006 24.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Clin Lung Cancer 2015; 16:121-27; PMID:25450874; http://dx.doi.org/10.1016/j.cllc.2014.09.007 25.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
ClinLung Cancer 2015; 16:193-99; PMID:25547902; http://dx.doi.org/10.1016/j.cllc.2014.11.006 26.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Thorac Oncol 2016; 11:420-5; PMID:26725184; http://dx.doi.org/10.1016/j.jtho.2015.11.003 27.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Asia Pac J ClinOncol 2015; 11:4-14; PMID:24575793; http://dx.doi.org/10.1111/ajco.12178 28.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Clin Oncol 2009; 27:5080-7; PMID:19738125; http://dx.doi.org/10.1200/ JCO.2008.21.5541 2 9 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Clin Oncol 2011; 29:3567-73; PMID:21825259; http://dx.doi.org/10.1200/JCO.2010.34.4929 30.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
BMC Cancer 2015; 15:763; PMID:26493267; http://dx.doi.org/10.1186/s12885-015-1714-y 32.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Lancet Oncol 2013; 14:777-86; PMID:23782814; http://dx.doi.org/10.1016/S1470-2045(13)70254-7 33.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Cancer Biol Ther 2014; 15:832-9; PMID:24755888; http://dx.doi.org/10.4161/cbt.2887434.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Ann Oncol 2015; 26:888-94; PMID:25669832; http://dx.doi.org/10.1093/annonc/mdv063 35.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Radiol Oncol 2014; 48:173-83;PMID:24991207; http://dx.doi.org/10.2478/raon-2014-0016 3 6 .,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Lancet Oncol 2011; 12:735-42; PMID:21783417; http://dx.doi.org/10.1016/S1470- 2045(11)70184-X 37.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Lancet Oncol 2000; 1:86-93; PMID:11905673; http://dx.doi.org/10.1016/S1470-2045 (00)00019-X 38.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Lancet Oncol 2014; 15:1236-44; PMID:25175099; http://dx.doi.org/; http://dx.doi.org/10.1016/S1470-2045(14)70381-X 39.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Asian Pac J Cancer Prev 2015; 16:321-6; PMID:25640373;http://dx.doi.org/10.7314/APJCP.2015.16.1.321 40.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
J Thorac Dis 2014; 6:677-83; PMID:24976990; http://dx.doi.org/10.3978/j.issn.2072- 1439.2014.05.10 41.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Radiol Oncol 2015; 49:320-6; PMID:26834517; http://dx.doi.org/10.1515/raon-2015-0043 42.,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
Front Oncol 2014; 4:350; PMID:25538894;http://dx.doi.org/10.3389/fonc.2014.00350CANCER BIOLOGY & THERAPY 839,Non-OADS,/arxiv_data1/oa_pdf/0f/b8/kcbt-17-08-1195049.PMC5074447.pdf
"1521-0111/90/5/674 –688$25.00 http://dx.doi.org/10.1124/mol.116.105361 MOLECULAR PHARMACOLOGY Mol Pharmacol 90:674 –688, November 2016 Copyright ª2016 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/71/ca/mol.116.105361.PMC5074452.pdf
"1521-009X/44/11/1839 –1850$25.00 http://dx.doi.org/10.1124/dmd.116.070615 DRUGMETABOLISM AND DISPOSITION Drug Metab Dispos 44:1839 –1850, November 2016 Copyright ª2016 The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.",Non-OADS,/arxiv_data1/oa_pdf/98/a5/dmd.116.070615.PMC5074467.pdf
"GeneReviews at GeneTests: Medical Genetics In- formation Resource (database online): University of Washington, 1997 ––2015 available at http://www.ncbi.nlm.nih.gov/books/NBK1103/, updated 2015].",Non-OADS,/arxiv_data1/oa_pdf/98/a5/dmd.116.070615.PMC5074467.pdf
A catalog of variants of the FMO3 gene and their effect on the ability of FMO3 to catalyze the oxygenation of TMA and drugsubstrates of the enzyme can be accessed at the FMO3 locus-specific mutation database (http://databases.lovd.nl/shared/genes/FMO3).,OADS,/arxiv_data1/oa_pdf/98/a5/dmd.116.070615.PMC5074467.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial reproduction and distribution of the work, in any medium, pro- vided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/a7/fnw224.PMC5074533.pdf
"The trimmed, rRNA-depleted RNA-Seq reads were mapped against the RAST-annotated RAG-1 genome using the CLC Bio Genomics Workbench 8.0.2 software ( http://www.clcbio.com/products/ clcgenomicsworkbench ), which re-implemented EdgeR RNA quantification workflow (Robinson, McCarthy and Smyth 2010).",OADS,/arxiv_data1/oa_pdf/94/a7/fnw224.PMC5074533.pdf
The data are accessible through GEO Series accession number GSE78186 ( http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/94/a7/fnw224.PMC5074533.pdf
"umaryland.edu Submission: 02-11-2015 Revised: 12-02-2016 Accepted: 23-02-2016Departments of  1Neurosurgery,  2Pathology, 3Physiology  and 4Anesthesiology,  School of Medicine,  University of  Maryland, Baltimore,  Maryland, USAAccess this article online Quick Response Code: Website: http://www.braincirculation.org DOI: 10.4103/2394-8108.178541 How to cite this article:  Iqbal S, Hayman EG,  Hong C, Stokum JA, Kurland DB, Gerzanich V, et al .",Non-OADS,/arxiv_data1/oa_pdf/e4/97/BC-2-8.PMC5074544.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/db/a6/main.PMC5074550.pdf
"The clawing sensations prior to the movements and http://dx.doi.org/10.1016/j.cnp.2016.04.001 2467-981X/Published by Elsevier B.V. on behalf of International Federation of Clinical Neurophysiology.This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: EEG, electroencephalography; EMG, electromyography; ECR, extensor carpi radialis; FCR, ﬂexor carpi radialis; BP, Bereitschaftspotential.",Non-OADS,/arxiv_data1/oa_pdf/db/a6/main.PMC5074550.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.cnp.2016.04.001 .",OADS,/arxiv_data1/oa_pdf/db/a6/main.PMC5074550.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ppa-10-2097.PMC5074702.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2097–2106Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2097Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S9212 3 insulin glargine 300 U/mL in the management of  diabetes: clinical utility and patient perspectives Bastiaan e de Galan Department of internal Medicine,   Radboud University Medical Center,   Nijmegen, the NetherlandsAbstract:  There is ongoing interest in optimizing basal insulin treatment by developing insulins  with a flat pharmacological profile, a long duration of action (typically beyond 24 hours) and  minimum day-to-day variation.",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ppa-10-2097.PMC5074702.pdf
"Parenthetically, it should be acknowledged that the terms “long-acting” Correspondence: Bastiaan e de Galan Department of internal Medicine (463),  Radboud University Medical Center,  PO Box 9101, 6500 HB Nijmegen,  the Netherlands Tel +31 24 361 8819 Fax +31 24 354 1734 email b astiaan.degalan@radboudumc.n l Journal name: Patient Preference and Adherence Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: de Galan Running head recto: Insulin glargine-300 for diabetes management DOI: http://dx.doi.org/10.2147/PPA.S92123",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ppa-10-2097.PMC5074702.pdf
Available from: http://www.cdc.gov/diabetes/statistics/ treating_national .htm.,Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ppa-10-2097.PMC5074702.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6e/c1/ppa-10-2097.PMC5074702.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e6/46/ott-9-6361.PMC5074703.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6361–6376OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6361Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9834 7 Personalized treatment in advanced ALK-positive  non-small cell lung cancer: from bench to clinical  practice Antonio Passaro1 Chiara Lazzari1,2 Niki Karachaliou3 Gianluca Spitaleri1 Alessia Pochesci1 Chiara Catania1 Rafael Rosell4 Filippo de Marinis1 1Division of Thoracic Oncology,   european institute of Oncology,   Milan, italy; 2Department of Medical  Oncology, Division of experimental  Medicine, San Raffaele Scientific  institute, Milan, italy; 3Oncology  institute Dr Rosell, Quiron-Dexeus  University Hospital, Barcelona, Spain;   4Catalan institute of Oncology,   Hospital Germans Trias i Pujol,   Badalona, SpainAbstract:  The discovery of anaplastic lymphoma kinase (ALK) gene rearrangements and the  development of tyrosine kinase inhibitors (TKI) that target them have achieved unprecedented  success in the management of patients with ALK-positive non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/e6/46/ott-9-6361.PMC5074703.pdf
"Molecular  profiling was used to select therapies or enroll patients into clinical trials, and those  patients with oncogenic driver alterations who received a targeted therapy had a sig - nificant improvement in OS compared with either those with genetic alterations but  not treated with targeted agents or those with no druggable target.4 The greatest OS  improvement was observed in the small group of patients harboring EGFR-activating  mutations or the gene rearrangement between echinoderm microtubule-associated  protein like 4 and anaplastic lymphoma kinase (EML4–ALK).4 The EML4–ALK fusion gene was identified for the first time in 2007 in DNA  from a 62-year-old male patient with lung adenocarcinoma.5 In November 2011, Correspondence: Antonio Passaro Division of Thoracic Oncology, european  institute of Oncology, via G Ripamonti,  435, 20141 Milan, italy Tel +39 2 5748 9482 Fax +39 2 9437 9235 email antonio.passaro@ieo.i t Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Passaro et al Running head recto: Personalized treatment in advanced ALK-positive NSCLC DOI: http://dx.doi.org/10.2147/OTT.S98347",Non-OADS,/arxiv_data1/oa_pdf/e6/46/ott-9-6361.PMC5074703.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e6/46/ott-9-6361.PMC5074703.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/46/ott-9-6361.PMC5074703.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/00/copd-11-2553.PMC5074704.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2553–2561International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2553OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11249 0 Chronotropic incompetence can limit exercise  tolerance in COPD patients with lung hyperinflation sébastien hulo1 Jocelyn Inamo2 aurélie Dehon3 Olivier le rouzic4 Jean-louis edme1 remi neviere5 1Université lille, ChU lille, ea 4483,   IMPact de l’environnement Chimique  sur la santé humaine, lille, France;   2Département de Cardiologie – ChU  Fort de France, Martinique – Faculté  de Médecine – Université des  antilles, France; 3Pôle d’ anesthésie  réanimation aDr U, ChU nîmes,   nîmes, France; 4Université lille,   Cnrs, Inserm, ChU lille, Institut  Pasteur de lille, Center for Infection  and Immunity of lille, lille, France;   5Université lille, Inserm, C hU  lille, lille Inflammation research  International Center, lille, FrancePurpose:  Metabolic-chronotropic relationship is the only concept that assesses the entire  chronotropic function during exercise, as it takes into account individual fitness.",Non-OADS,/arxiv_data1/oa_pdf/7f/00/copd-11-2553.PMC5074704.pdf
"Keywords:  COPD, hyperinflation, chronotropic incompetence, exercise Introduction Patients with chronic obstructive pulmonary disease (COPD) have limited exercise  tolerance, which has been related to reduced maximal voluntary ventilation (MMV),  impaired diffusion capacity of the lung and lung hyperinflation.1–3 The major conse - quence of lung hyperinflation is the association of increased ventilatory workload  and decreased inspiratory muscle pressure generating capacity, which contributes to  dyspnea and poor exercise tolerance.2,4 Beyond the lungs, deleterious cardiovascular  consequences of dynamic hyperinflation (DH) have been consistently identified in  COPD patients during incremental exercise.5–7 In these observations, DH was associ - ated with reduced oxygen (O2) uptake efficiency slope and O2 pulse, which nonin - vasively reflect cardiac stroke volume during submaximal exercise.6,8,9 Interestingly,  lung volume reduction surgery has been shown to improve exercise tolerance through  cardiac stroke volume increases.10 Along with cardiac stroke volume impairment is the concept that a contribut - ing factor of reduced cardiac output leading to poor exercise tolerance might be the Correspondence: sébastien hulo Université de lille – IMPeCs – IMPact de  l’environnement Chimique sur la santé  humaine (ea 4483), Faculté de Médecine  de lille – Pôle recherche – 2ème Étage  aile esT 1, Place Verdun 59045 lille  Cedex, France Tel +33 320 627 761 Fax +33 320 627 784 email sebastien.hulo@univ-lille2.f r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hulo et al Running head recto: Chronotropic incompetence among COPD patients DOI: http://dx.doi.org/10.2147/COPD.S112490",Non-OADS,/arxiv_data1/oa_pdf/7f/00/copd-11-2553.PMC5074704.pdf
Patients and methods Patients This study was conducted in accordance with the  amended Declaration of Helsinki ( http://www.wma.net/ en/30publications/10policies/b3 /).,Non-OADS,/arxiv_data1/oa_pdf/7f/00/copd-11-2553.PMC5074704.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/7f/00/copd-11-2553.PMC5074704.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/00/copd-11-2553.PMC5074704.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/61/2c/prbm-9-285.PMC5074705.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/61/2c/prbm-9-285.PMC5074705.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Psychology Research and Behavior Management 2016:9 285–296Psychology Research and Behavior Management Dovepress submit your manuscript | www.dovepress.com Dovepress 285 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S112504 A brief information–motivation–behavioral skills  intervention to promote human papillomavirus  vaccination among college-aged women Giselle K Perez1  Dean G Cruess2  Nicole M Strauss3 1Department of Psychiatry,   Massachusetts General Hospital,   Boston, MA, 2Department of  Psychology, University of Connecticut,  Storrs, CT,  3Mongan Institute for  Health Policy, Massachusetts General Hospital, Boston, MA, USABackground: Human papillomavirus (HPV) is prevalent among college-aged women.",Non-OADS,/arxiv_data1/oa_pdf/61/2c/prbm-9-285.PMC5074705.pdf
"6 Despite these guidelines, HPV  vaccine uptake remains incomplete, and inadequate inoculation rates persist.7 In par - ticular, women aged 18–26 years are less likely to initiate and complete the  three-dose  series than those aged 13–17 years.8 This represents an unmet need for strategies to  improve HPV immunization, particularly among college-aged women.Correspondence: Giselle K Perez   Mongan Institute of Health Policy,  Massachusetts General Hospital, 50 Staniford Street, Ninth Floor, Boston, MA 02114, USA   Tel +1 978 210 6520   Email gperez@mgh.harvard.eduJournal name: Psychology Research and Behavior Management Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Perez et alRunning head recto: IMB intervention to promote HPV vaccinationDOI: http://dx.doi.org/10.2147/PRBM.S112504",Non-OADS,/arxiv_data1/oa_pdf/61/2c/prbm-9-285.PMC5074705.pdf
2014. http://deainfo.nci.nih.gov/advisory/pcp/annualReports/HPV/PDF/PCP_Annual_Report_2012-2013.pdf.,OADS,/arxiv_data1/oa_pdf/61/2c/prbm-9-285.PMC5074705.pdf
2014. http://www.cdc.gov/vac-cines/hcp/vis/about/facts-vis.html#specific-vaccines.,Non-OADS,/arxiv_data1/oa_pdf/61/2c/prbm-9-285.PMC5074705.pdf
"Psychology Research and Behavior Management 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/psychology-research-and-behavior-management-journalPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and its  application in behavior management to develop improved outcomes in the  clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/61/2c/prbm-9-285.PMC5074705.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2e/ba/ccide-8-111.PMC5074706.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Dental management in patients with   hypertension: challenges and solutions Janet H Southerland1 Danielle G Gill1 Pandu R Gangula2–4 Leslie R Halpern1 Cesar Y Cardona5 Charles P Mouton6 1Department of Oral and Maxillofacial  Surgery, 2Department of Oral  Biology and Research, 3Department  of Physiology, 4Center for Women’s  Health Research, 5Department of  Internal Medicine, 6Department of  Family and Community Medicine,   Meharry Medical College, Nashville,   TN, USA Correspondence: Janet H Southerland   Department of Oral and Maxillofacial  Surgery, Meharry Medical College, 1005  Dr DB T odd Boulevard, Nashville, TN  37208, USA   T el +1 615 327 6844   Fax +1 615 327 5722   Email jsoutherland@mmc.ed uAbstract:  Hypertension is a chronic illness affecting more than a billion people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/2e/ba/ccide-8-111.PMC5074706.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/2e/ba/ccide-8-111.PMC5074706.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/2e/ba/ccide-8-111.PMC5074706.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/96/12/jpr-9-825.PMC5074707.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/96/12/jpr-9-825.PMC5074707.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 825–835Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  825 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S114915Impaired psychomotor ability and attention in  patients with persistent pain: a cross-sectional  comparative study Helena Gunnarsson1,2  Birgitta Grahn3–5  Jens Agerström1 1Department of Psychology, Faculty  of Health and Life Sciences, Linnaeus  University, Vaxjo, 2Hälsoringen, Neron  HSU AB, Osby, 3Department of  Clinical Sciences Lund-Orthopedics,  Lund University,  4Epidemiology and  Register Centre South, Region Skåne,  Lund,  5Department of Research and  Development, Region Kronoberg,  Vaxjo, SwedenBackground and aims:  Patients with pain have shown cognitive impairment across various  domains.",Non-OADS,/arxiv_data1/oa_pdf/96/12/jpr-9-825.PMC5074707.pdf
"The current study sought to fill this research Correspondence: Helena Gunnarsson Department of Psychology, Faculty of Health and Life Sciences, Linnaeus University, University Place 1, 35195 Vaxjo, Sweden Tel +46 77 228 8000   Fax +46 470 83217 Email helena.gunnarsson@lnu.seJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Gunnarsson et alRunning head recto: Persistent pain and cognitive impairmentDOI: http://dx.doi.org/10.2147/JPR.S114915",Non-OADS,/arxiv_data1/oa_pdf/96/12/jpr-9-825.PMC5074707.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/96/12/jpr-9-825.PMC5074707.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 835 Persistent pain and cognitive impairment  45.,Non-OADS,/arxiv_data1/oa_pdf/96/12/jpr-9-825.PMC5074707.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7f/9c/opth-10-2021.PMC5074708.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2021–2029Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2021Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S9430 6 Update and clinical utility of the LenSx  femtosecond laser in cataract surgery Timothy v Roberts1,2 Michael Lawless1,2 Gerard Sutton1,2 Chris Hodge1,3 1vision eye institute, Chatswood,   2Sydney Medical School, University  of Sydney, 3Graduate School of  Health Sciences, University of  T echnology, Sydney, NSw , AustraliaAbstract:  The introduction of femtosecond lasers to cataract surgery has been the major disrup - tive technology introduced into ophthalmic surgery in the last decade.",Non-OADS,/arxiv_data1/oa_pdf/7f/9c/opth-10-2021.PMC5074708.pdf
com.a u Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Roberts et al Running head recto: LenSx laser in cataract surgery DOI: http://dx.doi.org/10.2147/OPTH.S94306,Non-OADS,/arxiv_data1/oa_pdf/7f/9c/opth-10-2021.PMC5074708.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/7f/9c/opth-10-2021.PMC5074708.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/9c/opth-10-2021.PMC5074708.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ec/52/opth-10-2031.PMC5074709.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2031–2034Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2031Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11867 7 Single flash electroretinograms of mature  cataractous and fellow eyes Yasuyuki Yamauchi1 Jun-ichi Mochizuki1 akito hirakata2 shigekazu Uda1 1nihonmatsu eye hospital, edogawa,   T okyo, Japan; 2Kyorin eye Center,   Kyorin University School of Medicine,   T okyo, JapanBackground:  It is generally stated that opacities of the ocular media, including senile cataract,  have little effect on the electrical responses of the retina.",Non-OADS,/arxiv_data1/oa_pdf/ec/52/opth-10-2031.PMC5074709.pdf
"The goal of this study was to examine whether single flash ERG was  different between cataractous and fellow eyes in patients with severe cataract.Correspondence: Yasuyuki Yamauchi T ¯132-0035 nihonmatsu eye hospital,  hirai 4-10-7 edogawa-ku, Tokyo, Japan  Tel +81 3 3681 1257 Fax +81 3 5609 1648 email phthisis@nifty.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Y amauchi et al Running head recto: ERG of mature cataract DOI: http://dx.doi.org/10.2147/OPTH.S118677",Non-OADS,/arxiv_data1/oa_pdf/ec/52/opth-10-2031.PMC5074709.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ec/52/opth-10-2031.PMC5074709.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/52/opth-10-2031.PMC5074709.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5d/f4/jep-8-053.PMC5074710.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5d/f4/jep-8-053.PMC5074710.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Experimental Pharmacology 2016:8 53–59Journal of Experimental Pharmacology Dovepress submit your manuscript | www.dovepress.com Dovepress  53 Original rEsEarch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JEP .S116155antidiarrheal activity of methanolic extract of the  root bark of Cordia africana  assefa Belay asrie Mohammedbrhan  abdelwuhab Zewdneh shewamene Desalegn asmelashe  gelayee getnet Mequanint adinew Eshetie Melese Birru Department of Pharmacology,   college of Medicine and health  sciences, University of gondar,   gondar, EthiopiaAbstract: An ethnobotanical study in Agew-Awi and Amhara peoples in northwest Ethiopia  reported that Cordia africana is used traditionally in the treatment of liver disease, amebiasis,  stomachache, and diarrhea.",Non-OADS,/arxiv_data1/oa_pdf/5d/f4/jep-8-053.PMC5074710.pdf
"2 The burden of diarrheal  illness affects more the developing world, in terms of both morbidity and mortality.1correspondence: assefa Belay asrie Department of Pharmacology, college of Medicine and health sciences, University of gondar, chechela street, lideta sub city Kebele 16, gondar, EthiopiaEmail assefabelay@gmail.comJournal name: Journal of Experimental Pharmacology Article Designation: Original ResearchY ear: 2016V olume: 8Running head verso: Asrie et alRunning head recto: Root bark of Cordia africanaDOI: http://dx.doi.org/10.2147/JEP .S116155",Non-OADS,/arxiv_data1/oa_pdf/5d/f4/jep-8-053.PMC5074710.pdf
"Journal of Experimental Pharmacology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Experimental Pharmacology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-experimental-pharmacology-journalThe Journal of Experimental Pharmacology is an international, peer- reviewed, open access journal publishing original research, reports, reviews and commentaries on all areas of laboratory and experimental pharmacology.",Non-OADS,/arxiv_data1/oa_pdf/5d/f4/jep-8-053.PMC5074710.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/f4/jep-8-053.PMC5074710.pdf
Available from: https://ceuaics.ufba.br/sites/ceuaics.ufba.br/files/OECD%20TG%20425.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/f4/jep-8-053.PMC5074710.pdf
(Animal Ethics Infolink) http://www.animalethics.org.au/data/assets/pdf-file/0004/249898/Guideline-22-mouse-housing.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/f4/jep-8-053.PMC5074710.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a6/7a/jpr-9-797.PMC5074711.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a6/7a/jpr-9-797.PMC5074711.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 797–802Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  797 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S117674Local analgesic effect of tramadol is mediated by  opioid receptors in late postoperative pain after  plantar incision in rats José Oswaldo de  Oliveira  Junior1  Milena Fernandes  de Freitas2  Carolina Bullara de Andrade 3  Marucia Chacur2  Hazem Adel Ashmawi1 1Laboratório de Anestesiologia  Experimental, Faculdade de Medicina  da Universidade de São Paulo,   2Departamento de Anatomia do  Instituto de Ciências Biomédicas da Universidade de São Paulo,  3Faculdade  de Medicina da Universidade de São Paulo, São  Paulo,  BrazilAbstract:  Tramadol is a drug used to treat moderate to severe pain.",Non-OADS,/arxiv_data1/oa_pdf/a6/7a/jpr-9-797.PMC5074711.pdf
"6–9 Opioids are potent analgesics that exert pharmacological  and physiological effects due to their interaction with receptors distributed in several Correspondence: Hazem Adel Ashmawi   Avenida Doutor Arnaldo, 455, 2nd Floor,  01246903 São Paulo, Brazil   Email hazem.ashmawi@hc.fm.usp.brJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Oliveira Junior et alRunning head recto: Peripheral opioid tramadol effect and incisionDOI: http://dx.doi.org/10.2147/JPR.S117674",Non-OADS,/arxiv_data1/oa_pdf/a6/7a/jpr-9-797.PMC5074711.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/a6/7a/jpr-9-797.PMC5074711.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 802 Oliveira Junior et al 29.,Non-OADS,/arxiv_data1/oa_pdf/a6/7a/jpr-9-797.PMC5074711.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/78/21/ijn-11-5371.PMC5074712.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5371–5379International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5371OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10833 3 Optimizing superparamagnetic iron oxide  nanoparticles as drug carriers using an in vitro  blood–brain barrier model Di shi1 gujie Mi1 soumya Bhattacharya2 suprabha Nayar2 Thomas J Webster1,3 1Department of chemical engineering,   Northeastern University, Boston,   Ma, Usa; 2Materials science and  Technology Division, council for  scientific and Industrial research- National Metallurgical laboratory,   Jamshedpur, India; 3center of  excellence for advanced Materials  research, King abdulaziz University,   Jeddah, saudi arabiaAbstract:  In the current study, an optimized in vitro blood–brain barrier (BBB) model was  established using mouse brain endothelial cells (b.End3) and astrocytes (C8-D1A).",Non-OADS,/arxiv_data1/oa_pdf/78/21/ijn-11-5371.PMC5074712.pdf
"In addition, on the surface  of the endothelial cell membrane, only a few small lipid-soluble agents, such as  ethanol, which are smaller than 400 Da and/or are less than eight pairs of hydrogen  bonds, and gaseous molecules (such as oxygen and carbon dioxide) can passively  diffuse across this regulated interference by transcellular lipophilic pathways.4 Other  compounds, including nutrients, are transported by specific transport systems on the  membranes.correspondence: Thomas J Webster Department of chemical engineering,  Northeastern University, 313 snell  engineering center, 360 huntington  avenue, Boston, Ma 02115, Usa Tel +1 617 373 2989 email th.webster@neu.ed u Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Shi et al Running head recto: Optimizing SPIONs as drug carriers using an in vitro BBB model DOI: http://dx.doi.org/10.2147/IJN.S108333",Non-OADS,/arxiv_data1/oa_pdf/78/21/ijn-11-5371.PMC5074712.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/78/21/ijn-11-5371.PMC5074712.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/78/21/ijn-11-5371.PMC5074712.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/24/ijwh-8-609.PMC5074728.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 609–615International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  609OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S11757 7 effectiveness of corifollitropin alfa used for  ovarian stimulation of poor responder patients Helmy selman leonardo rinaldi One Day Medical center–IVF Unit,   roma, ItalyPurpose:  To evaluate the efficiency and efficacy of corifollitropin alfa (follicle-stimulating  hormone–carboxy terminal peptide) in the treatment of poor responder patients.",Non-OADS,/arxiv_data1/oa_pdf/9f/24/ijwh-8-609.PMC5074728.pdf
"However, some women exhibit a scarce ovarian  response following controlled ovarian stimulation, and this phenomenon is mainly  observed in the so-called “poor responder” patients.1 Poor ovarian response (POR)  to gonadotropins affects ~9%–24% of IVF patients, and many other causes could be  involved, such as woman’s age, endometriosis, genetic disorders, ovarian surgery, or  even iatrogenic factors.2,3 Until recently, there was insufficient evidence to uniformly  define poor responder patients, and the most common criteria used were based on  the low number of recovered oocytes following an adequate ovarian stimulation.4–8 correspondence: Helmy selman One Day Medical center–IVF Unit, Via  attilio ambrosini 114, 00144 roma, Italy Tel +39 6 4521 2038 email helmy.selman@yahoo.co m Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Selman and Rinaldi Running head recto: Corifollitropin alfa in poor responder patients DOI: http://dx.doi.org/10.2147/IJWH.S117577",Non-OADS,/arxiv_data1/oa_pdf/9f/24/ijwh-8-609.PMC5074728.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/9f/24/ijwh-8-609.PMC5074728.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/24/ijwh-8-609.PMC5074728.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/cia-11-1467.PMC5074729.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1467–1488Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1467RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11621 8 Mutations, associated with early-onset Alzheimer’s  disease, discovered in Asian countries eva Bagyinszky1,* Y oung Chul Y oun2 Seong Soo A An1 SangYun Kim3,* 1Department of BioNano T echnology,   Gachon University, Gyeonggi-do,   2Department of Neurology, College  of Medicine, Chung-Ang University,   Seoul, 3Department of Neurology,   Seoul National University Budang  Hospital, Gyeonggi-do, South Korea *These authors contributed equally  to this workAbstract:  Alzheimer’s disease (AD), the most common form of senile dementia, is a genetically  complex disorder.",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/cia-11-1467.PMC5074729.pdf
"Three main genes are involved in EOAD, APP, PSEN1 , and Correspondence: Seong Soo A An Department of BioNano Technology,  Gachon Medical Research Institute,  Gachon University, 1342 Sungnam  Daero, Sungnamsi, Gyeonggi-do 461-701,  South Korea Tel/fax +82 31 750 8755 email seongaan@gachon.ac.k r  Young Chul Youn Department of Neurology, Chung-Ang  University Hospital, 224-1, Heukseok-1  dong, Dongjak-gu, Seoul 156-755,  South Korea Tel +82 2 6299 1485 Fax +82 2 6299 1493 email neudoc@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Bagyinszky et al Running head recto: The genetics of Alzheimer’s disease in Asia DOI: http://dx.doi.org/10.2147/CIA.S116218",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/cia-11-1467.PMC5074729.pdf
"The  Alzheimer’s Research Forum ( http://www.alzgene.org /)  is an up-to-date database that summarizes all findings and  articles related to AD, including genetic mutations.10 In APP,  Figure 1 Mutation residues in APP discovered in Asian countries.",OADS,/arxiv_data1/oa_pdf/b1/d8/cia-11-1467.PMC5074729.pdf
"Compar - ing the EOAD-associated mutations between Caucasian and  Asian patients, .30 novel Asian mutations were found in  APP, PSEN1, and PSEN2 ( http://www.alzforum.org/muta - tions).",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/cia-11-1467.PMC5074729.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b1/d8/cia-11-1467.PMC5074729.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b1/d8/cia-11-1467.PMC5074729.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/6c/ndt-12-2659.PMC5074730.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2659–2676Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2659OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11805 8 impact of dissociation on treatment of depressive  and anxiety spectrum disorders with and without  personality disorders Jan Prasko1 ales grambal1 Petra Kasalova1 Dana Kamardova1 Marie Ociskova1 Michaela holubova1,2 Kristyna Vrbova1 Zuzana sigmundova1 Klara latalova1 Milos slepecky3 Marta Zatkova3 1Department of Psychiatry, Faculty  of Medicine and Dentistry, Palacky  University in Olomouc, University  hospital Olomouc, Olomouc,   2Psychiatric Department, hospital  liberec, liberec, czech republic;   3Department of Psychology  sciences, Faculty of social science  and health care, constantine the  Philosopher University in Nitra,   Nitra, slovak republicObjective:  The central goal of the study was to analyze the impact of dissociation on the  treatment effectiveness in patients with anxiety/neurotic spectrum and depressive disorders  with or without comorbid personality disorders.",Non-OADS,/arxiv_data1/oa_pdf/eb/6c/ndt-12-2659.PMC5074730.pdf
"Keywords:  depression, anxiety disorders, treatment resistance, panic disorder, GAD, OCD,  social phobia, PTSD, adjustment disorders, personality disorders Introduction Pharmacotherapeutic efficacy in the treatment of anxiety disorders, posttraumatic stress  disorder (PTSD), obsessive compulsive disorder (OCD), and similar conditions, as  well as of major depressive disorder, has been demonstrated by agents from various  drug classes (antidepressants, antipsychotics), and, in addition, in anxiety disorder by correspondence: Jan Prasko Department of Psychiatry, Faculty of  Medicine and Dentistry, Palacky  University Olomouc, University  hospital, iP Pavlova 6, 77520 Olomouc,  czech republic Tel +420 603 414 930 email praskojan@seznam.c z Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Prasko et al Running head recto: Dissociation in depressive and anxiety disorders and PDs DOI: http://dx.doi.org/10.2147/NDT.S118058",Non-OADS,/arxiv_data1/oa_pdf/eb/6c/ndt-12-2659.PMC5074730.pdf
"statistics Statistical analysis was performed using the statistical soft - ware Statistical Package for the Social Sciences 24.0 (IBM  Corporation, Armonk, NY, USA) and the Prism (GraphPad  PRISM version 5.0; http://www.graphpad.com/prism/prism.",OADS,/arxiv_data1/oa_pdf/eb/6c/ndt-12-2659.PMC5074730.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2009/09/WC500003526.pdf.,Non-OADS,/arxiv_data1/oa_pdf/eb/6c/ndt-12-2659.PMC5074730.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/eb/6c/ndt-12-2659.PMC5074730.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/6c/ndt-12-2659.PMC5074730.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 599–611ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  599 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S116570Bringing patient centricity to diabetes medication  access in Canada Judith L Glennie1 Katharina Kovacs Burns2,3 Paul Oh4,5 1J.",Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
"1 According to a 2015 report from the Canadian Diabetes Association (CDA), “Diabetes  prevalence has more than doubled since 2000 (8.9% of the population [ie, 3.34  million  people] in 2015), and will grow by more than 40% by 2025, along with a similar increase Correspondence: Judith L Glennie J. L. Glennie Consulting Inc., 111 Rush Road, Aurora, ON L4G 7G5, CanadaTel +1 905 726 5846Email Judith_glennie@on.aibn.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Glennie et alRunning head recto: Patient-centered diabetes medication accessDOI: http://dx.doi.org/10.2147/CEOR.S116570",Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://secure.cihi.ca/free_products/oecd-diabetes-report-2015_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://www.diabetes.ca/publications-newsletters/advocacy-reports/2015-report-on-diabetes-driving-change.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC2896&lang=en.,OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: http://innovativemedicines.ca/canadians-facing-delayed-access-to-new-innovative-medicines-report.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: http://www.health.gov.on.ca/en/pro/programs/drugs/how_drugs_approv/how_drugs_approv.aspx.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://www.cadth.ca/about-cadth/what-we-do/products-services/cdr.,OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: http://canadaspremiers.ca/en/initiatives/358-pan-canadian-pharmaceutical-alliance.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://www.cadth.ca/sites/default/files/pdf/OP0512_Diabetes%20Update_Third-line_e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://www.cadth.ca/about-cadth/what-we-do/products-services/cdr/reports.,OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://www.cadth.ca/sites/default/files/cdr/complete/SR0462_complete_Trulicity_June_21_16_e.pdf.,OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: http://www.diabetes.ca/publications-newsletters/advocacy-reports/provincial-territorial-formulary-chart.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: http://guidelines.diabetes.ca/?_ga= 1.159114236.730924813.14636693 50.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: http://www.idf.org/diabetesvoice/issues/volume-58-special-issue-2.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Avail-able from http://www23.statcan.gc.ca/imdb/p2SV .pl?Function=getSurvey&SurvId=84769&InstaId=84771&SDDS=5160.,OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: http://www.diabetes.ca/publications-newsletters/advocacy-reports/2015-report-on-diabetes-driving-change.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://www.cadth.ca/sites/default/files/pdf/htis/aug-2015/RC0693%20Glyburide%20Update%20Final.pdf.,OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01032629.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01730534.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://www.nice.org.uk/guidance/ng28.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: https://www.nice.org.uk/guidance/ng28/resources/algorithm-for-blood-glucose-lowering-therapy-in-adults-with-type-2-diabetes-2185604173.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Available from: http://guidelines.diabetes.ca/2016update.,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 611 Patient-centered diabetes medication access,Non-OADS,/arxiv_data1/oa_pdf/1d/ff/ceor-8-599.PMC5074731.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).HIV/AIDS - Research and Palliative Care 2016:8 157–164HIV/AIDS - Research and Palliative Care Dovepress submit your manuscript | www.dovepress.com Dovepress 157 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S97920Profile of cabotegravir and its potential in the  treatment and prevention of HIV-1 infection:  evidence to date Thomas Whitfield   Adele T orkington   Clare van Halsema North West Infectious Diseases Unit,   North Manchester General Hospital,  Manchester, UKAbstract:  Modern antiretroviral therapy has demonstrated effectiveness in preexposure pro- phylaxis (PrEP) and treatment of HIV infection.",Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
"3–8Correspondence: Clare van Halsema   North West Infectious Diseases  Unit, North Manchester General Hospital, Delaunays Road, Manchester M8 5RB, UK   Tel +44 161 720 2733   Email clare.vanhalsema@nhs.netJournal name: HIV/AIDS - Research and Palliative Care Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Whitfield et alRunning head recto: Cabotegravir for HIV treatment and preventionDOI: http://dx.doi.org/10.2147/HIV .S97920",Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
Available from: http://www.medicines.org.uk/emc/medicine/20484/SPC/.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
Available from: http://www.bhiva.org/documents/Guidelines/Treatment/2015/2015-treatment-guidelines.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
Available from: http://www.aidsinfo.nih.gov/ContentFiles/Adultand Adoles-centGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
Available from: https://www.medicines.org.uk/emc/medicine/28545 is dolutegravir spc.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
Available from: http://www.gsk-clinicalstudyregister.com/files2/gsk-117010-clinical-study-result-summary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
"HIV/AIDS - Research and Palliative Care 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hivaids---research-and-palliative-care-journalHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open access journal focusing on advances in research in HIV , its clinical progression and management options including antiviral treatment, palliative care and public healthcare policies to control viral spread.",Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 164 Whitfield et al  45.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
Available from: https://clinicaltrials.gov/show/NCT02720094.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
Available from: https://www.hptn.org/research/studies/153.,Non-OADS,/arxiv_data1/oa_pdf/57/f8/hiv-8-157.PMC5074732.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/82/59/ott-9-6389.PMC5074733.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6389–6397OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6389Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11184 3 Prognostic impact of body mass index stratified  by smoking status in patients with esophageal  squamous cell carcinoma Peng sun1,2,* Fei Zhang1,2,* cui chen3,* chao ren1,2 Xi-Wen Bi1,2 hang Yang1,2 Xin an1,2 Feng-hua Wang1,2 Wen-Qi Jiang1,2 1state Key laboratory of Oncology in  south china, collaborative innovation  center for cancer Medicine,   2Department of Medical Oncology,   sun Yat-sen University cancer center,   3Department of Oncology, the First  affiliated hospital, sun Yat- sen  University, guangzhou, People’s  republic of china *These authors contributed equally  to this workBackground:  As smoking affects the body mass index (BMI) and causes the risk of esophageal  squamous cell carcinoma (ESCC), the prognostic impact of BMI in ESCC could be stratified by  smoking status.",Non-OADS,/arxiv_data1/oa_pdf/82/59/ott-9-6389.PMC5074733.pdf
"Keywords:  esophageal squamous cell carcinoma, ESCC, body mass index, BMI, smoking,  prognosis, survival Introduction Esophageal cancer is one of the most common digestive cancers worldwide and  remains one of the five leading causes of cancer-related deaths in People’s Republic of  China.1–3 In Asian Countries such as People’s Republic of China and Japan, esophageal  squamous cell carcinoma (ESCC) accounts for .90% of all esophageal cancers with  regard to histological classification.4–6 Although a trend toward reduced incidence  of ESCC was observed, ESCC remains a serious threat to public health in People’s  Republic of China with a poor prognosis.1,2,4 Recent evidence has shown that low body  mass index (BMI) increases the risk of developing ESCC, both in the Eastern7 and  Western populations.8,9 Meanwhile, the prognostic effect of BMI has been discussed  in multiple malignant diseases,10–15 and low BMI is seen as an unfavorable prognostic  factor in facilitating appropriate therapeutic strategies for ESCC patients.correspondence: Feng-hua Wang;  Wen-Qi Jiang Department of Medical Oncology,  sun Yat-sen University cancer center,  651 Dong Feng rD east, guangzhou,  guangdong Province 510060, People’s  republic of china Tel/fax +86 20 8734 3351;  +86 20 8734 3363 email wangfh@sysucc.org.c n;  jiangwq@sysuc c.org.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Sun et al Running head recto: BMI and smoking status on ESCC DOI: http://dx.doi.org/10.2147/OTT.S111843",Non-OADS,/arxiv_data1/oa_pdf/82/59/ott-9-6389.PMC5074733.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/82/59/ott-9-6389.PMC5074733.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/82/59/ott-9-6389.PMC5074733.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/90/ca/ijnrd-9-253.PMC5074734.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/90/ca/ijnrd-9-253.PMC5074734.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2016:9 253–256International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 253 RevIew open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S113219 Biomarkers in critical illness: have we made  progress?",Non-OADS,/arxiv_data1/oa_pdf/90/ca/ijnrd-9-253.PMC5074734.pdf
"In this context, biomarkers may have a decisive preemptive role.Correspondence: Patrick M Honore Intensive Care Unit, Universitair Ziekenhuis Brussel, vUB University, 101 Laarbeeklaan, 1090 Brussels, BelgiumTel +32 2 474 9097email Patrick.Honore@az.vub.ac.beJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: ReviewY ear: 2016V olume: 9Running head verso: Honore et alRunning head recto: Biomarkers in critical illnessDOI: http://dx.doi.org/10.2147/IJNRD.S113219",Non-OADS,/arxiv_data1/oa_pdf/90/ca/ijnrd-9-253.PMC5074734.pdf
"International Journal of Nephrology and Renovascular Disease 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/90/ca/ijnrd-9-253.PMC5074734.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 256 Honore et al 14.,Non-OADS,/arxiv_data1/oa_pdf/90/ca/ijnrd-9-253.PMC5074734.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/b6/56/tacg-9-157.PMC5074735.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/b6/56/tacg-9-157.PMC5074735.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2016:9 157–167The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 157 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S86760 Novel treatment options for lysosomal acid lipase  deficiency: critical appraisal of sebelipase alfa Kim Su1 Emma Donaldson1 Reena Sharma2 1Division of Gastroenterology/ Hepatology, 2The Mark Holland  Metabolic Unit, Salford Royal Hospital  NHS Foundation Trust, Salford, UKAbstract:  Lysosomal acid lipase deficiency (LAL-D) is a rare disorder of cholesterol metabo- lism with an autosomal recessive mode of inheritance.",Non-OADS,/arxiv_data1/oa_pdf/b6/56/tacg-9-157.PMC5074735.pdf
"The development of enzyme replacement therapies (ERTs) for lysosomal storage  disorders was first exemplified in the development of treatment for type 1 Gaucher Correspondence: Reena Sharma Salford Royal Hospital, NHS Foundation Trust, Stott Lane, Salford M6 8HD, UKTel +44 161 206 4365Email reena.sharma@srft.nhs.ukJournal name: The Application of Clinical Genetics Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Su et alRunning head recto: Sebelipase alfa for treatment of lysosomal acid lipase deficiencyDOI: http://dx.doi.org/10.2147/TACG.S86760",Non-OADS,/arxiv_data1/oa_pdf/b6/56/tacg-9-157.PMC5074735.pdf
"The Application of Clinical Genetics 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/b6/56/tacg-9-157.PMC5074735.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 167 Sebelipase alfa for treatment of lysosomal acid lipase deficiency 45.,Non-OADS,/arxiv_data1/oa_pdf/b6/56/tacg-9-157.PMC5074735.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 593–596Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 593 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S120726 Modernizing medical school admission processes:  a European perspective Adam K Karlsson Karl O Elmqvist Faculty of Medicine, Imperial College  London, London, UKDear editor We read with keen interest the commentary by Eltorai and Daniels1 wherein they sug- gested a streamlining of the current US medical school admission process, through  the development of a common application system called the National Medical School Matching Program (NMSMP).",Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
"The only costs for a UK applicant are a UCAS application fee (£24), 4 aptitude tests fees (UKCAT Correspondence: Adam K Karlsson Level 2, Faculty Building, South Kensington Campus, Imperial College London, London SW7 2AZ, UKTel +44 744 695 0989Email adam.karlsson12@imperial.ac.ukJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2016V olume: 7Running head verso: Karlsson and ElmqvistRunning head recto: Modernizing medical school admission processesDOI: http://dx.doi.org/10.2147/AMEP .S120726",Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: https://www.ucas.com.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: https://www.bma.org.uk/advice/career/studying-medicine/how-to-become-a-doctor/applying-to-medical-school.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: https://www.ucas.com/ucas/undergraduate/apply-and-track/filling-your-ucas-undergrad - uate-application.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: http://www.ukcat.ac.uk/registration.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: http://www.admissionstestingservice.org/for-test-takers/bmat/dates-and-costs/.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: http://www.kaptest.co.uk/courses/uk-university/bmat/bmat-preparation.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: http://ki.se/utbildning/urval.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: http://www.lakartidningen.se/Functions/OldArticleView.aspx?articleId=18441.,OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 596 Karlsson and Elmqvist experience suggests that an upper limit on applications  per applicant may be required to realize the full efficiency potential of a US NMSMP .,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available  from: https://www.aamc.org/services/eras/stats/359278/stats.html.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Available from: https://www.aamc.org/download/321468/data/factstablea6.pdf.,OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
Participating as a Couple; 2016.Avail-able from: http://www.nrmp.org/match-process/couples-in-the-match/.,Non-OADS,/arxiv_data1/oa_pdf/8f/06/amep-7-593.PMC5074736.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/59/ea/ott-9-6381.PMC5074737.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6381–6388OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6381Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11301 4 synergistic suppression effect on tumor growth  of ovarian cancer by combining cisplatin with  a manganese superoxide dismutase-armed  oncolytic adenovirus shibing Wang1,2,* Jing shu3,* li chen4 Xiaopan chen3 Jianhong Zhao4 shuangshuang li1,2 Xiaozhou Mou1,2 Xiangmin T ong1,2 1clinical research institute, Zhejiang  Provincial People’s hospital, 2Key  laboratory of cancer Molecular  Diagnosis and individualized Therapy  of Zhejiang Province, 3Department  of reproductive endocrinology,   Zhejiang Provincial People’s hospital,   4Department of Obstetrics and  gynecology, hangzhou red cross  hospital, hangzhou, People’s republic  of china *These authors contributed  equally to  this workAbstract:  Gene therapy on the basis of oncolytic adenovirus is a novel approach for human  cancer therapeutics.",Non-OADS,/arxiv_data1/oa_pdf/59/ea/ott-9-6381.PMC5074737.pdf
"Cancer virotherapy is a tumor-specific therapeutic strategy, in which viruses are  engineered to preferentially replicate in tumor cells and destroy it by lysis, either  through targeted alterations in the cancer cells, such as p53 mutation, viral deletion,  tissue-specific transcriptional control, or tumor-specific receptors.2 Among available  virotherapies, conditionally replicating adenovirus is attractive because of its several  attributes, including lytic replication, efficient genome transfer, and excellent patient  safety in clinical trials.3,4 In our previous study, we have developed a cancer-targeting  gene virotherapy strategy5 and generated a novel E1B55K  gene deleted oncolytic correspondence: Xiangmin Tong clinical research institute, Zhejiang  Provincial People’s hospital, 158  shangtang road, hangzhou 310014,  People’s republic of china Tel/fax +86 571 85893012 email tongxiangmin@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Synergistic suppression effect on tumor growth of ovarian cancer  DOI: http://dx.doi.org/10.2147/OTT.S113014",Non-OADS,/arxiv_data1/oa_pdf/59/ea/ott-9-6381.PMC5074737.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/59/ea/ott-9-6381.PMC5074737.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/ea/ott-9-6381.PMC5074737.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b6/33/cia-11-1455.PMC5074738.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1455–1461Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1455OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10565 2 Predictors of quality of life among hospitalized  geriatric patients with diabetes mellitus upon  discharge nuruljannah Johari1 Zahara Abdul Manaf1 norhayati Ibrahim2 suzana shahar1 norlaila Mustafa3 1Dietetics Programme, 2health  Psychology Programme, Faculty of  health sciences, 3Medical Department,   Faculty of Medicine, hospital  Canselor Tuanku Muhriz, Universiti  Kebangsaan Malaysia, Kuala lumpur,   MalaysiaPurpose:  Diabetes mellitus is prevalent among older adults, and affects their quality of life.",Non-OADS,/arxiv_data1/oa_pdf/b6/33/cia-11-1455.PMC5074738.pdf
"Although malnutrition,2  disabilities,3 and depression4 are prevalent among geriatric patients with diabetes  mellitus, hospitalized geriatric patients suffer a gradual decline in their nutritional  status.5 The decline in sense of smell and taste,6 other oral problems,7,8 and inability  to buy or prepare foods lead to a decrease in appetite, thus resulting in the depletion  of energy and nutrient intake.8 Geriatric patients with depression have lower global cognitive function and weaker  verbal and memory learning performance as compared to those without depression.9  Depression in geriatric patients with diabetes also causes disability,3,10 decline of  health, especially for those with chronic diseases,11 such as diabetes, and is closely Correspondence: Zahara Abdul Manaf Dietetics Programme, Faculty of health  sciences, Universiti Kebangsaan Malaysia,  Jalan raja Muda Abdul Aziz, 50300 Kuala  lumpur, Malaysia email zaharamanaf@ukm.edu.m y Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Johari et al Running head recto: Predictors of quality of life among geriatrics with diabetes mellitus DOI: http://dx.doi.org/10.2147/CIA.S105652",Non-OADS,/arxiv_data1/oa_pdf/b6/33/cia-11-1455.PMC5074738.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b6/33/cia-11-1455.PMC5074738.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b6/33/cia-11-1455.PMC5074738.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2833-2839,DOI:http://dx.doi.org/10.19082/2833 Corresponding author: Associate Professor Dr. Hamidreza Kianifar, Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/7e/85/epj-08-2833.PMC5074739.pdf
http://www.ephysician.ir Page28341.,Non-OADS,/arxiv_data1/oa_pdf/7e/85/epj-08-2833.PMC5074739.pdf
http://www.ephysician.ir Page2836Table 2.,Non-OADS,/arxiv_data1/oa_pdf/7e/85/epj-08-2833.PMC5074739.pdf
http://www.ephysician.ir Page2838Trial registration: This study is registered in the Iranian Registry of Clinical Trials with registration number IRCT201509234976N3 Funding: This research was supported financially by the Res earch Council of Mashhad University of Medical Sciences (Grant number: 911048).,Non-OADS,/arxiv_data1/oa_pdf/7e/85/epj-08-2833.PMC5074739.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2840-2848,DOI:http://dx.doi.org/10.19082/2840 Corresponding aut hor: Dr. Leila Abdi, Psychiatric Ward of Golestan Hospital, Jundishapur University of Medical Sciences, Ahvaz, Iran Tel: +98.9166126990, Email: leilaabdi1635@gmail.com Received: February 12, 2016 , Accepted: April 23, 2016 , Published: September 2016 iThenticate screening: April 23, 2016 , English editing: August 01, 2016 , Quality control: August 06, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0d/c9/epj-08-2840.PMC5074740.pdf
Trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the Irct ID: IRCT2015082623766N1.,Non-OADS,/arxiv_data1/oa_pdf/0d/c9/epj-08-2840.PMC5074740.pdf
http://www.ephysician.ir Page28422.4.,Non-OADS,/arxiv_data1/oa_pdf/0d/c9/epj-08-2840.PMC5074740.pdf
http://www.ephysician.ir Page2844 Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/0d/c9/epj-08-2840.PMC5074740.pdf
"http://www.ephysician.ir Page2846can be said that, during the study, both drugs have had the acceptable side effects, although a longer time is needed for performing a better study of metabolic side effects and weight effect of, especially Risperidone.",Non-OADS,/arxiv_data1/oa_pdf/0d/c9/epj-08-2840.PMC5074740.pdf
Trial registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the Irct ID: IRCT2015082623766N1.,Non-OADS,/arxiv_data1/oa_pdf/0d/c9/epj-08-2840.PMC5074740.pdf
"http://www.ephysician.ir Page2848of Childhood Attention -Deficit/Hyperactivity Disorder, Part I.",Non-OADS,/arxiv_data1/oa_pdf/0d/c9/epj-08-2840.PMC5074740.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2849-2854,DOI:http://dx.doi.org/10.19082/ 2849 Corresponding author: Arezoo Afkhami -Ardekani, Medical Student, Faculty of Medicine, Tehran University of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/6e/71/epj-08-2849.PMC5074741.pdf
Trial Registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.irct.ir) with the IRCT ID: 201105176430N1.,Non-OADS,/arxiv_data1/oa_pdf/6e/71/epj-08-2849.PMC5074741.pdf
http://www.ephysician.ir Page28501.,Non-OADS,/arxiv_data1/oa_pdf/6e/71/epj-08-2849.PMC5074741.pdf
http://www.ephysician.ir Page2852 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/71/epj-08-2849.PMC5074741.pdf
Trial Registration: The trial was registered at the Iranian Registry of Clinical Trials (http://www.ir ct.ir) with the IRCT ID: 201105176430N1 .,Non-OADS,/arxiv_data1/oa_pdf/6e/71/epj-08-2849.PMC5074741.pdf
"http://www.ephysician.ir Page28547)Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and Adiponectin receptors in insulin resistance, diabetes, and metabolic syndrome.",Non-OADS,/arxiv_data1/oa_pdf/6e/71/epj-08-2849.PMC5074741.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2855-2859,DOI:http://dx.doi.org/10.19082/ 2855 Correspondin g author: Professor Dr. Seyed Khalil Forouzannia, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/epj-08-2855.PMC5074742.pdf
Clinical trial registration: The trial was registered at the Thai Clinical Trials Registry (TCTR) (http://www.clinicaltrials.in.th) with the TCTR ID: T CTR20160708001.,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/epj-08-2855.PMC5074742.pdf
http://www.ephysician.ir Page28561.,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/epj-08-2855.PMC5074742.pdf
The trial was registered at the Thai Clinical Trials Registry (TCTR) (http://www.clinicaltrials.in.th) with the TCTR ID: TCTR20160708001.,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/epj-08-2855.PMC5074742.pdf
http://www.ephysician.ir Page2858a patient’s increased hospital stay and costs.,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/epj-08-2855.PMC5074742.pdf
Clinical trial registration: The trial was registered at the Thai Clinical Trials Registry (TCTR) (http://www.clinicaltrials.in.th) with the TCTR ID: TCTR20160708001.,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/epj-08-2855.PMC5074742.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2860-2870,DOI:http://dx.doi.org/10.19082/ 2860 Corresponding author: Associate professor Dr.Omid Mehrpour, Medical Toxicology and Drug Abuse Research Center (MT DRC), Birjand University of Medical Sciences (BUMS), Moallem Avenue, Birjand, 9713643138 Iran.",Non-OADS,/arxiv_data1/oa_pdf/00/63/epj-08-2860.PMC5074743.pdf
http://www.ephysician.ir Page2862 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/00/63/epj-08-2860.PMC5074743.pdf
"http://www.ephysician.ir Page2864hospitalization was mainl y due to drug poisoning, on top of which were antidepressants, benzodiazepines, and anticonvulsants (21).",Non-OADS,/arxiv_data1/oa_pdf/00/63/epj-08-2860.PMC5074743.pdf
http://www.ephysician.ir Page2866caused by CO (21).,Non-OADS,/arxiv_data1/oa_pdf/00/63/epj-08-2860.PMC5074743.pdf
"http://www.ephysician.ir Page2868epidemiological data regarding poisoning in all cities, so these studies are recommended to complete the final picture of poisoning in Iran.",Non-OADS,/arxiv_data1/oa_pdf/00/63/epj-08-2860.PMC5074743.pdf
"http://www.ephysician.ir Page287039)Farzaneh E, Mostafazade B, Sh afaiee Y.",Non-OADS,/arxiv_data1/oa_pdf/00/63/epj-08-2860.PMC5074743.pdf
"Electronic Physician (ISSN : 2008-5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2871-2877,DOI:http://dx.doi.org/10.19082/2871 Corresponding author: Assistant Professor Dr. Marzieh Arab an,Social Determinants of Health Research Center, Health Education and Health Prom otion Department, Faculty of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran .",Non-OADS,/arxiv_data1/oa_pdf/8d/37/epj-08-2871.PMC5074744.pdf
"http://www.ephysician.ir Page2872Due to several reasons including: geographic location, proximity to Saudi Arabia, Iraq, and Kuwait, the presence of heavy industries such as steel, pipe mills, and oil refineries, in addition to pollution caused by everyday traffic congestion, makes this problem more critical in Ahvaz..",Non-OADS,/arxiv_data1/oa_pdf/8d/37/epj-08-2871.PMC5074744.pdf
http://www.ephysician.ir Page2874Table 1.Frequency of demogra phic variables in the population of study Variables n% Age(year) 19-15 134 24-20 5617 29-25 16750.6 35-30 7723.3 >35 175.1 Trimester of pregnancy First trimester 8726.3 Second trimester 15045.5 Third trimester 9328.2 Pregnancy orde r First pregnancy 12840 Second  pregnancy 9830 Third  pregnancy 6620 Forth  pregnancy 288 Fifth pregnancy 102 Employment status of pregnant women Employed 285.6 housewife 30294.4 Employment status of pregnant women husbands Employed 5714.7 Unemployed 257.8 Self-employment 24877.5 Table 2.Regression coefficients of EPPM constructs against self -care behavior Variable Regression coefficients SDt-statistics p-value Susceptibility -0.05 0.037-1.,Non-OADS,/arxiv_data1/oa_pdf/8d/37/epj-08-2871.PMC5074744.pdf
"http://www.ephysician.ir Page2876Ahvaz, Iran, from april through september 2010.",Non-OADS,/arxiv_data1/oa_pdf/8d/37/epj-08-2871.PMC5074744.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2878-2887,DOI:http://dx.doi.org/10.19082/XX Corresponding author: Mitra Mohammadi, Department of Environmental Health Engineering , Faculty of Health, Kermanshah University Of Medical Sciences, Kermanshah, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6e/fc/epj-08-2878.PMC5074745.pdf
http://www.ephysician.ir Page2880was developed.,Non-OADS,/arxiv_data1/oa_pdf/6e/fc/epj-08-2878.PMC5074745.pdf
http://www.ephysician.ir Page2882 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/fc/epj-08-2878.PMC5074745.pdf
http://www.ephysician.ir Page2884(150 mg/l) in UV/ WO 3; and Penici llin G concentration (50 mg/l) and ZnO dose ( 400) in UV/ZnO.,Non-OADS,/arxiv_data1/oa_pdf/6e/fc/epj-08-2878.PMC5074745.pdf
"http://www.ephysician.ir Page28865)Peerayeh SN, Karmostaji A, Sarasiabi SS, Javadpour S, Davoodian P, M oradi N. In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran.",Non-OADS,/arxiv_data1/oa_pdf/6e/fc/epj-08-2878.PMC5074745.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2888-2896,DOI:http://dx.doi.org/10.1 9082/2888 Corresponding author: Assistant Professor Dr. Zohreh Mahmoodi, Social Determinant of Health Research Center and Nursing & Midwifery Faculty of Alborz Univers ity of Medical Sciences, Karaj, Iran.",Non-OADS,/arxiv_data1/oa_pdf/8d/34/epj-08-2888.PMC5074746.pdf
"http://www.ephysician.ir Page2890multiple pregnancy, cardiovascular diseases, diabetes, kidney diseases, thyroid diseases, pulmonary diseases, autoimmune diseases, preeclampsia, placental abruption, early rupture of the amniotic sac during or before pregnancy, hepatitis, HIV or TORCH syndrome, as well as not using any medications that might affect birth weight during the gestation, 3) Live birth to a baby weighing less than 2500 gmin the case group and 2500 -4000gm in the control group.",Non-OADS,/arxiv_data1/oa_pdf/8d/34/epj-08-2888.PMC5074746.pdf
http://www.ephysician.ir Page2892Table 3.Path Coefficients for working condition .social -economic -demographic factors on birth weight Predictor variables Effect Model coefficients t-valueR2Errorvar DirectIndirect Total Mother's Education -0.12-0.0502 -0.1702 -0.025 3.04 0.210.44 Age of mother  - -  -  - 0.51 Mother's Weight gain 0.16 - 0.16 0.02 4.26 Husband job -0.20 - -0.20 -0.44 5.26 Husband jobless -0.08 - -0.08 -0.14 2.22 Household income 0.08 - 0.08 0.002 2.23 Job style -0.30 - -0.30 -0.01 7.98 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/34/epj-08-2888.PMC5074746.pdf
http://www.ephysician.ir Page2894Acknowledgments: This study was generated from author's research (number 120 /92/p).,Non-OADS,/arxiv_data1/oa_pdf/8d/34/epj-08-2888.PMC5074746.pdf
"Available from: http://www.who.int/whosis/whostat/2011/en/ 10)Nasseh Lotf Abadi M. Social support, coping, and self -esteem in relation to psychosocial factors: A study of health issues and birth weight in young mothers in Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/8d/34/epj-08-2888.PMC5074746.pdf
"http://www.ephysician.ir Page289642)Jansen PW, Tiemeier H, Jaddoe VW, Hofman A, Steegers EA, Verhulst FC, et al.",Non-OADS,/arxiv_data1/oa_pdf/8d/34/epj-08-2888.PMC5074746.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephy sician.ir September 2016, Volume: 8, Issue:9, Pages:2897-2903,DOI:http://dx.doi.org/10.19082/ 2897 Corresponding author: Mohamed Hamooda, West Yorkshire and the Humber, United Kingdom.",Non-OADS,/arxiv_data1/oa_pdf/26/27/epj-08-2897.PMC5074747.pdf
http://www.ephysician.ir Page2898An autoanti body called anti -cyclic citrullinated peptide (anti -CCP) has been studied.,OADS,/arxiv_data1/oa_pdf/26/27/epj-08-2897.PMC5074747.pdf
"http://www.ephysician.ir Page2900with a striking female predominance in the oligoarticular and polyarticular onset subtypes, an even distribution of sexes in the systemic onset subtype, and a male predominance in the ent hesitis related arthritis subtype (17).",Non-OADS,/arxiv_data1/oa_pdf/26/27/epj-08-2897.PMC5074747.pdf
"http://www.ephysician.ir Page29026)Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.",Non-OADS,/arxiv_data1/oa_pdf/26/27/epj-08-2897.PMC5074747.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysicia n.ir September 2016, Volume: 8, Issue:9, Pages:2904-2910,DOI:http://dx.doi.org/10.19082/ 2904 Corresponding author: Shahnaz Khaledi, School of Nursing and Midwifery, Kurdistan University of Medical Sciences, Pasdaran St., 66177-13446, Sanandaj, Kurdistan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/23/dc/epj-08-2904.PMC5074748.pdf
"http://www.ephysician.ir Page2906collection, due communication with participants, u sing the supplementary views of colleagues, reviewin g the participants’ hand writing and examining the data by all engaged researchers.",Non-OADS,/arxiv_data1/oa_pdf/23/dc/epj-08-2904.PMC5074748.pdf
http://www.ephysician.ir Page2908compulsory limitations.,Non-OADS,/arxiv_data1/oa_pdf/23/dc/epj-08-2904.PMC5074748.pdf
"2000; 1(2), Available from: http://www.qualitative -research.net/fqs -texte/2-00/2-mayring-e.htm 24)Elo S, Kyngas H. The qualitative content analysis process.",Non-OADS,/arxiv_data1/oa_pdf/23/dc/epj-08-2904.PMC5074748.pdf
"http://www.ephysician.ir Page291028)Lawton J, Peel E, Parry O, Araoz G, Douglas M. Lay perceptions of type 2 diabetes in Scotland: bringing health services back in.",Non-OADS,/arxiv_data1/oa_pdf/23/dc/epj-08-2904.PMC5074748.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2911-2917,DOI:http://dx.doi.org/10.19082/ 2911 Corresponding author: Fereshteh Farzianpour, Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/28/7a/epj-08-2911.PMC5074749.pdf
http://www.ephysician.ir Page2912to have adequate number with proper performance of health manpower (1).,Non-OADS,/arxiv_data1/oa_pdf/28/7a/epj-08-2911.PMC5074749.pdf
"http://www.ephysician.ir Page2914useful scenarios is dependent on the quality of the data and the proper selection of the variables for the model in a wayto reflect the entire system (17, 38).",Non-OADS,/arxiv_data1/oa_pdf/28/7a/epj-08-2911.PMC5074749.pdf
"http://www.ephysician.ir Page29164)Anderson GF, Han KC, Miller RH, Johns ME.",Non-OADS,/arxiv_data1/oa_pdf/28/7a/epj-08-2911.PMC5074749.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2918-2923,DOI:http://dx.doi.org/10.19082/2918 Corresponding author: Asiyeh Pormehr Yabandeh, Mother and Child Welfare Research Center, H ormozgan University of Medical Sciences, Bandar Abbas, Iran.",Non-OADS,/arxiv_data1/oa_pdf/1a/f7/epj-08-2918.PMC5074750.pdf
http://www.ephysician.ir Page2920analyzed using SPSS software.,Non-OADS,/arxiv_data1/oa_pdf/1a/f7/epj-08-2918.PMC5074750.pdf
http://www.ephysician.ir Page2922References : 1)Ancel PY.,Non-OADS,/arxiv_data1/oa_pdf/1a/f7/epj-08-2918.PMC5074750.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2924-2930,DOI:http://dx.doi.org/10.19082/ 2924 Corresponding author: Alireza Heidari, Department of Management and Health Economic, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/ec/a5/epj-08-2924.PMC5074751.pdf
http://www.ephysician.ir Page2926for questions with a negative meaning.,Non-OADS,/arxiv_data1/oa_pdf/ec/a5/epj-08-2924.PMC5074751.pdf
http://www.ephysician.ir Page2928education or if they did so but their job remained the same.,Non-OADS,/arxiv_data1/oa_pdf/ec/a5/epj-08-2924.PMC5074751.pdf
"http://www.ephysician.ir Page293032)Khamlub S, Harun -Or-Rashid M, Sarker MA, Hirosawa T, Outavong P, Sakamoto J.",Non-OADS,/arxiv_data1/oa_pdf/ec/a5/epj-08-2924.PMC5074751.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2931-2934,DOI:http://dx.doi.org/10.19082/ 2931 Corresponding author: Assistant Professor Dr. Sirous Hemmatpour, Kurdistan University of Medical Sciences, Sanandaj, Iran.",Non-OADS,/arxiv_data1/oa_pdf/9e/f2/epj-08-2931.PMC5074752.pdf
"http://www.ephysician.ir Page2932increasing survival chances for p remature and low birth weight infants, and the importance of the diagnosis and treatment of retinopathy of prematurity, this study was aimed at determining the prevalence of retinopathy of prematurity and related factors in Sanandaj.",Non-OADS,/arxiv_data1/oa_pdf/9e/f2/epj-08-2931.PMC5074752.pdf
"http://www.ephysician.ir Page29349)Austeng D, Källen KB, Hellström A, Jakobsson PG, Johansson K, Tornqvist K, et al.",OADS,/arxiv_data1/oa_pdf/9e/f2/epj-08-2931.PMC5074752.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2935-2941,DOI:http://dx.doi.org/10.19082/ 2935 Corresponding author: Soheyla Gholami, Health Information Management Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.",Non-OADS,/arxiv_data1/oa_pdf/15/fe/epj-08-2935.PMC5074753.pdf
http://www.ephysician.ir Page29361.,Non-OADS,/arxiv_data1/oa_pdf/15/fe/epj-08-2935.PMC5074753.pdf
http://www.ephysician.ir Page2938at a higher lev el than that in public hospitals.,Non-OADS,/arxiv_data1/oa_pdf/15/fe/epj-08-2935.PMC5074753.pdf
http://www.ephysician.ir Page2940waiting time for services are among factors enhancing loyalty and trust in the system (29).,Non-OADS,/arxiv_data1/oa_pdf/15/fe/epj-08-2935.PMC5074753.pdf
"Available from: http://avab.behdasht.gov.ir/rbp 9)Vali L, Tabatabaee SS, Kalhor R, Amini S, Kiaei MZ.",Non-OADS,/arxiv_data1/oa_pdf/15/fe/epj-08-2935.PMC5074753.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician .ir September 2016, Volume: 8, Issue:9, Pages:2942-2949,DOI:http://dx.doi.org/10.19082/ 2942 Corresponding author: Soheila Esmaili, Kashan University of Medical Sciences, Kashan, Iran.",Non-OADS,/arxiv_data1/oa_pdf/c6/21/epj-08-2942.PMC5074754.pdf
http://www.ephysician.ir Page29442.4.,Non-OADS,/arxiv_data1/oa_pdf/c6/21/epj-08-2942.PMC5074754.pdf
"http://www.ephysician.ir Page2946Table 2.Technical Feasibility Study of Implementation of NCIS Area Needs Assessment Items Status Existence Hardware equipmentManpower Computer Hard ware Engineers Desirable Computer Software Engineers Desirable System Analysis  Engineers Semi- desirable Equipment Auxiliaries Equipment Desirable Portable Computer (Laptop, Tablet) Semi- desirable Workstations and Mainframes Desirable Scanner and Printer Semi- desirable Point-of-Care Mobile Terminals Semi- desirable RFID and Barcode Reader Undesirable Support Backup Tools Desirable Support Services Semi- desirable Training Reducing Nurses Resistance  through the Software TrainingSemi- desirable Existence software equipment Database Desirable Currency Rate Support Desirable Farsi  Language Support Desirable User Interface Desirable Software to Customize User Interface Desirable Software for Sending and Receiving Informat ion Desirable Support for Data Storage Desirable Data Management Tools Desirable Query Offline Semi- desirable Reporting Semi- desirable Support to Integration and Combining Data Desirable Software for Quick Access to Records Desirable Existence network equipment Network Equipment Semi- desirable Cabling Desirable Sufficient Network Speed Semi- desirable Internet and Intranet Desirable Integration with Internal Information Systems Desirable Integration with External Information Systems Semi- desirable Access to External Databases Undesirable Existence Network security system Standards Sending the Message, Security, Confidentiality and Data DefinitionDesirable Methods of Information Protection Desirable User Tracking System Semi- desirable Backup for Security Purposes Desirable",Non-OADS,/arxiv_data1/oa_pdf/c6/21/epj-08-2942.PMC5074754.pdf
"http://www.ephysician.ir Page2948References : 1)Stair R, Reynolds G. Systems Development: Investigation and Analysis In: Stair R, Reynolds G, editors.",Non-OADS,/arxiv_data1/oa_pdf/c6/21/epj-08-2942.PMC5074754.pdf
Available from: http://www.umsl.edu/~sauterv/analysis/F08papers/Katimuneetorn -Feasibility -Study.html#top 4)Samadi A.,Non-OADS,/arxiv_data1/oa_pdf/c6/21/epj-08-2942.PMC5074754.pdf
Available from: http://www.hst.org.za/publications/504.,Non-OADS,/arxiv_data1/oa_pdf/c6/21/epj-08-2942.PMC5074754.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2950-2953,DOI:http://dx.doi.org/10.19082/2950 Corresponding author: Dr. Niloofar Abazarian, Emergency Medicine Mana gement Research Center, Iran University of Medical Sciences, Tehran, Iran, Tel: 98 -3226-3855, E-mail: Abzarian.niloofar@gmail .com Received: November 08, 2015 , Accepted: April 17, 2016 , Published: September 2016 iThenticate screening: April 17, 2016 , English editing: June 17, 2016 , Quality control: August 01, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/56/b7/epj-08-2950.PMC5074755.pdf
"http://www.ephysician.ir Page2952abdominal CT is considered the gold standard, its limitations, such as higher cost and time, the need to transfer the patient out of emergency department and exposure to radiation implies that ultrasound can safely replace it, provided that FAST shows high sensitivity and specificity.",Non-OADS,/arxiv_data1/oa_pdf/56/b7/epj-08-2950.PMC5074755.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2954-2961,DOI:http://dx.doi.org/10.19082/ 2954 Corresponding author: Professor Dr. Mohsen Adib -Hajbaghery, Department of Medical -Surgical Nursing, Faculty of Nursing and Midwifery, Kashan University of Medical Sciences, Kashan, Iran .",Non-OADS,/arxiv_data1/oa_pdf/a5/49/epj-08-2954.PMC5074756.pdf
http://www.ephysician.ir Page29562.3.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/epj-08-2954.PMC5074756.pdf
"http://www.ephysician.ir Page2958Table 3.Factors related to disease in patients with open -angle glaucoma referred to Matini Ophthalmology Center Factors Related To Disease Adherence Yes,n(%)No,n(%)Total,n(%)p-value Stage of disease Elevated IOP 5 (35.7) 9 (64.3) 14 (100) 0.55 Mild 14 (40) 21 (60) 35 (100) Moderate 16 (38.1) 26 (61.9) 42 (100) Severe 10 (25.6) 29 (74.4) 39 (100) Interval between medical visits ≤ Every 6 months 34 (45.3) 41 (54.7) 75 (100) 0.007 Every 7-12 months 8 (25) 24 (75) 32 (100) Every 13-24 months 3 (23.1) 10 (76.9) 13 (100) ≥Every 2 years 0 (0) 10 (100) 10 (100) Time of onset (months) 6-24 14 (48.3) 15 (51.7) 29 (100) 0.15 25-60 10 (37) 17 (63) 27 (100) ≥61 21 (28.4) 53 (71.6) 74 (100) Table 4.Problems related to treatment in patients with open -angle glaucoma referred to Matini Ophthalmology Center Treatment Problems Adherence Yes,n(%)No,n(%)Total,n(%)p-value Problem in scheduling times for medical visits Yes3 (5.3) 54 (94.7) 57 (100) <0.001 No42 (57.5) 31 (42.5)73 (100) Large number of medications Yes5 (10.4) 43 (89.6) 48 (100) <0.001 No40 (48.8) 42 (51.2) 82 (100) Lifelong using of glaucoma medications Yes6 (9.8) 55 (90.2) 61 (100) <0.001 No39 (56.5) 30 (43.5) 69 (100) Drugs for other diseases Yes6 (10.5) 51 (89.5) 57 (100) <0.001 No39 (53.4) 34 (46.6) 73 (100) Side effects of glaucoma medications Yes2 (4.9) 39 (95.1) 41 (100) <0.001 No43 (48.3) 46 (51.7) 89 (100) Answering to thepatientquestions by the ophthalmologistYes2 (8) 23(92) 25 (100) <0.001 No41 (43) 62 (59) 105 (100) Table 5.Individual problems related to treatment in patients with open -angle glaucoma referred to Matini Ophthalmology Center * Individual Problems Adherence Yes,n(%)No,n(%)Total,n(%)p-value Financial problems Yes7 (12.3) 50 (87.7) 57 (100) <0.001 No37 (52.1) 35 (47.9) 73 (100) Travel to and from the doctor's office Yes8 (11.1) 64 (88.9) 72 (100) <0.001 No37 (63.8) 21 (36.2) 58 (100) Forgetting the medications Yes6 (7.7) 72 (92.3) 78 (100) <0.001 No39 (75) 13 (25) 52 (100) Problem in using eye drops Yes2 (3.7) 52 (96.3) 54 (100) <0.001 No43 (56.6) 33 (43.4) 76 (100) Lack of awareness of glaucoma symptoms Yes11 (13.3) 72 (86.7) 83 (100) <0.001 No34 (72.3) 13 (27.7) 47 (100) Lack of awareness of glaucoma complications Yes9 (14.5) 53 (85.5) 62 (100) <0.001 No36 (52.9) 32 (47.1) 68 (100) Fatigue and impatience for using drugs Yes5 (7.7) 60 (92.3) 65 (100) <0.001 No40 (61.5) 25 (38.5) 65 (100) Believing in uselessness of medications Yes1 (2.4) 40 (97.6) 41 (100) <0.001 No44 (49.4) 45 (50.6) 89 (100) Lack of support from family Yes1 (2.7) 36 (97.3) 37 (100) <0.001 No44 (47.3) 49 (52.7) 93 (100)",Non-OADS,/arxiv_data1/oa_pdf/a5/49/epj-08-2954.PMC5074756.pdf
"http://www.ephysician.ir Page2960nursing diagnosis in patients with all diseases and especially in chronic diseases (24) such as glaucoma and, thus, alarms nurses and physician about the need for patient education.",Non-OADS,/arxiv_data1/oa_pdf/a5/49/epj-08-2954.PMC5074756.pdf
"Available from: http://www.aao.org/topic -detail/primary-openangle -glaucoma --europe 2)Lu VH, Goldberg I, Lu CY.",Non-OADS,/arxiv_data1/oa_pdf/a5/49/epj-08-2954.PMC5074756.pdf
Available from: http://www.who.int/chp/knowledge/publications/adherence -full-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/epj-08-2954.PMC5074756.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September2016, Volume: 8, Issue:9, Pages:2962-2969,DOI:http://dx.doi.org/10.19082/ 2962 Corresponding author: Associate Professor Dr. Ali Taghipour , Department of Biostatistics and Epidemiology, Management and Social Determinants of Health Research Center, School of Health, Mashhad Unive rsity of Medical Sciences, Mashhad, Iran Tel: +985118515118, Email: taghipoura@mums.ac.ir Received: May 01, 2016 , Accepted: July 12, 2016 , Published: September 2016 iThenticate screening: July 12, 2016 , English editing: August 02, 2016 , Quality control: September 04, 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/87/a5/epj-08-2962.PMC5074757.pdf
http://www.ephysician.ir Page2964content validity index (S -CVI/Ave) of this scale was estimated as 91.34%.,OADS,/arxiv_data1/oa_pdf/87/a5/epj-08-2962.PMC5074757.pdf
http://www.ephysician.ir Page2966with Constant of 0.998 is as follows: Educational Dimension of Empowerment=0.998+ 0.479 (Participation in prenatal education classes) + 0.347 (Sense of spiritual support) + 0.023 (Mother’s age).,Non-OADS,/arxiv_data1/oa_pdf/87/a5/epj-08-2962.PMC5074757.pdf
"http://www.ephysician.ir Page2968But to plan a comprehensive educational program that covers all aspects of empowerment during pregnancy for all groups of pregnant women, it is important to survey multiparous pregnant women, as well as high risk pregnant women using a larger sample size.",Non-OADS,/arxiv_data1/oa_pdf/87/a5/epj-08-2962.PMC5074757.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September2016, Volume: 8, Issue:9, Pages:2970-2976,DOI:http://dx.doi.org/10.19082/ 2970 Corresponding author: Professor Dr. Ali Shabestani Monfared, Cellul ar and Molecular Biology Research Center, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.",Non-OADS,/arxiv_data1/oa_pdf/8f/2b/epj-08-2970.PMC5074758.pdf
http://www.ephysician.ir Page2972solution of TCA 20 % and centrifuges at 10000 rpm for 10 minutes.,Non-OADS,/arxiv_data1/oa_pdf/8f/2b/epj-08-2970.PMC5074758.pdf
http://www.ephysician.ir Page2974 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/8f/2b/epj-08-2970.PMC5074758.pdf
"http://www.ephysician.ir Page297611)Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarke rs of oxidative stress.",Non-OADS,/arxiv_data1/oa_pdf/8f/2b/epj-08-2970.PMC5074758.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2977-2981,DOI:http://dx.doi.org/10.19082/2977 Corresponding author: Dr. Sahameddin Mortazavi, Student Research Committee, Internati onal Branch, Shiraz University of Medical Sciences, Shiraz, Iran.",Non-OADS,/arxiv_data1/oa_pdf/66/51/epj-08-2977.PMC5074759.pdf
http://www.ephysician.ir Page2978abnormalities in patients with thyroid disease is still unknown.,Non-OADS,/arxiv_data1/oa_pdf/66/51/epj-08-2977.PMC5074759.pdf
http://www.ephysician.ir Page2980treatment group.,Non-OADS,/arxiv_data1/oa_pdf/66/51/epj-08-2977.PMC5074759.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2982-2989,DOI:http://dx.doi.org/10.19082/ 2982 Corresponding author: Dr. Sareh Mousavi, Cardiologist, Department of Cardiology, Facult y of Medicine, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.",Non-OADS,/arxiv_data1/oa_pdf/91/d9/epj-08-2982.PMC5074760.pdf
http://www.ephysician.ir Page29842.7.,Non-OADS,/arxiv_data1/oa_pdf/91/d9/epj-08-2982.PMC5074760.pdf
"http://www.ephysician.ir Page2986The findings of this research regarding the significant relationship between EFT with the existence and severity of CAD is also shown in most other studies, and it seems that the fact that increasing EFT is an important factor in the projecting increase in the severity of CAD is well known (16, 17, 23 -26).",Non-OADS,/arxiv_data1/oa_pdf/91/d9/epj-08-2982.PMC5074760.pdf
http://www.ephysician.ir Page2988population.,Non-OADS,/arxiv_data1/oa_pdf/91/d9/epj-08-2982.PMC5074760.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:2990-2997,DOI:http://dx.doi.org/10.19082/ 2990 Corresponding author: Associate Professor Dr .Ahmad Ameryoun, Health Management Research Center, Baqiyatallah University of Medical Science, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/a2/df/epj-08-2990.PMC5074761.pdf
http://www.ephysician.ir Page2992medical/nursing academic background.,Non-OADS,/arxiv_data1/oa_pdf/a2/df/epj-08-2990.PMC5074761.pdf
http://www.ephysician.ir Page29943.2.,Non-OADS,/arxiv_data1/oa_pdf/a2/df/epj-08-2990.PMC5074761.pdf
"http://www.ephysician.ir Page29969)Arab M, Movahed KE, Mahmoodi M. Surveing Contributory Factors of Clients'satisfaction in Emergency Unit of Selected Hospitals Af filiated with Tehran and Shahid Beheshti University of Medical Sciences.",Non-OADS,/arxiv_data1/oa_pdf/a2/df/epj-08-2990.PMC5074761.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ep hysician.ir September 2016, Volume: 8, Issue:9, Pages:2998-3004,DOI:http://dx.doi.org/10.19082/XX Corresponding author: Assistant Professor Dr.Shima Sheybani, Department of Anesthesiology, Ghaem Hospital , Mashhad University of Medical Sciences, Iran.",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/epj-08-2998.PMC5074762.pdf
"http://www.ephysician.ir Page3000intravenous cocktailoftitratedmidazolam (5mg),fentanyl(7-10µg.kg-1),propofol(1mg.kg-1),andatracurium (0.6 mg.kg-1)following theplacement ofBIS(Covidien Boulder, CO,USA).Afterward, itwasmaintained withpropofol (50mg.kg-1.min-1),fentanyl(1-2µg.kg-1.hr-1),andatrecurium (0.01mg.kg-1.min-1).Routinemonitoring included two‐channelelectrocardiogram (IIandV5),radialarterypressure, pulseoximetry, centralvenouspressure, esophageal temperature, andcapnography andBIS.GroupHunderwent CABGundermoderate hypothermia (28-34 °C)asopposedtogroupN,whichexperienced normothermia, bothbypumpandtheirheartsbeatingduringthe procedure (Figure1).Ifbodytemperature fellbelow36°Cinthenormothermic group,therewarming occurred.",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/epj-08-2998.PMC5074762.pdf
"http://www.ephysician.ir Page3002general anesthesia, namely, throughout cesarean delivery, cardiopulmonary bypass, and surgery for major tra uma (23).",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/epj-08-2998.PMC5074762.pdf
"http://www.ephysician.ir Page300417)Duarte LT, Saraiva RÂ.",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/epj-08-2998.PMC5074762.pdf
"Available from: http://isponline.info/2016/06/comparison -of-the-effects- between-mild-hypothermia -and/ 29)Honan D, Doherty D, Frizelle H. A comparison of the effects on bispectral index of mild vs. moderate hypothermia during cardiopulmonar y bypass.",Non-OADS,/arxiv_data1/oa_pdf/f6/cf/epj-08-2998.PMC5074762.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:3005-3010,DOI:http://dx.doi.org/10.19082/ 3010 Corresponding author: Dr. Saeed Shirali, Research Center of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Scien ces, Ahvaz, Iran .Tel: +98.9124350966, Email: saeed.shirali@gmail.com Received: February 07, 2016 , Accepted: August 24, 2016 , Published: September 2016 iThenticate screening: July 19, 2016 , English editing: September 04, 2016, Quality control: September 18 , 2016 © 2016The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c9/a7/epj-08-3005.PMC5074763.pdf
"http://www.ephysician.ir Page3006Following recent development in TB diagnostics, rapid molecular tests have been used for diagnosis of TB an d drug-resistant TB (4).",Non-OADS,/arxiv_data1/oa_pdf/c9/a7/epj-08-3005.PMC5074763.pdf
http://www.ephysician.ir Page3008monocytes suppress the erythropoietin production leading to anemia (20 -22).,Non-OADS,/arxiv_data1/oa_pdf/c9/a7/epj-08-3005.PMC5074763.pdf
"http://www.ephysician.ir Page301023)Muzaffar TM, Shaifuzain AR, Imran Y, Haslina MN.",Non-OADS,/arxiv_data1/oa_pdf/c9/a7/epj-08-3005.PMC5074763.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysic ian.ir September 2016, Volume: 8, Issue:9, Pages:3011-3014,DOI:http://dx.doi.org/10.19082/ 3011 Corresponding author: Roya Akbarzadeh, Department of Operating Room & Anesthesia, Schoolof Paramedic, Sabzevar University of Medical Sciences, Sabzevar, Iran.",Non-OADS,/arxiv_data1/oa_pdf/dc/9e/epj-08-3011.PMC5074764.pdf
"http://www.ephysician.ir Page3012meta-analysis studies also showed no significant association between breast cancer and intake of fruits and vegetables (8, 9).",Non-OADS,/arxiv_data1/oa_pdf/dc/9e/epj-08-3011.PMC5074764.pdf
"http://www.ephysician.ir Page30148)Dragsted LO, Krath B, Ravn -Haren G, Vogel UB, Vinggaard AM, Bo Jensen P, et al.",OADS,/arxiv_data1/oa_pdf/dc/9e/epj-08-3011.PMC5074764.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:3015-3023,DOI:http://dx.doi.org/10.19082/ 3015 Corresponding author: Associate Professor Dr. Lina Abdul -Fattah Kurdi, Faculty of Sciences, Department of Biology ""Zoology"", Al Faisaliah Campus, King Abdul Aziz University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/98/7f/epj-08-3015.PMC5074765.pdf
"http://www.ephysician.ir Page3016agents, whose efficacy it actually potentiates (4, 7 -11).",Non-OADS,/arxiv_data1/oa_pdf/98/7f/epj-08-3015.PMC5074765.pdf
http://www.ephysician.ir Page3018 Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/98/7f/epj-08-3015.PMC5074765.pdf
http://www.ephysician.ir Page3020mice for five consecutive days.,Non-OADS,/arxiv_data1/oa_pdf/98/7f/epj-08-3015.PMC5074765.pdf
"http://www.ephysician.ir Page30225)Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, et al.",Non-OADS,/arxiv_data1/oa_pdf/98/7f/epj-08-3015.PMC5074765.pdf
"Electronic Physician (ISSN: 2008 -5842) http://www.ephysician.ir September 2016, Volume: 8, Issue:9, Pages:3024-3031,DOI:http://dx.doi.org/10.19082/3024 Corresponding author: Assistant Professor, Dr. Samira Alesaeidi.",Non-OADS,/arxiv_data1/oa_pdf/87/52/epj-08-3024.PMC5074766.pdf
http://www.ephysician.ir Page3026chamomile was investigated.,Non-OADS,/arxiv_data1/oa_pdf/87/52/epj-08-3024.PMC5074766.pdf
"http://www.ephysician.ir Page3028References : 1)Miraj S, Azizi N, Kiani S. A review of chemical components and pharmacological effects of Melissa officinalis L. Der Pharmacia Lettre.",Non-OADS,/arxiv_data1/oa_pdf/87/52/epj-08-3024.PMC5074766.pdf
"http://www.ephysician.ir Page303040)Jabri MA, Sani M, Rtibi K, Marzouki L, El -Benna J, Sakly M, et al.",OADS,/arxiv_data1/oa_pdf/87/52/epj-08-3024.PMC5074766.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/93/df/ott-9-6343.PMC5074768.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6343–6360OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6343HypOTHesisopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S11543 8 Cancer: fundamentals behind pH targeting  and the double-edged approach T omas Koltai Obra social del personal de la  industria Alimenticia, Filial Capital  Federal, Republic of ArgentinaAbstract:  The highly regulated pH of cells and the less-regulated pH of the surrounding  extracellular matrix (ECM) is the result of a delicate balance between metabolic processes and  proton production, proton transportation, chemical buffering, and vascular removal of waste  products.",Non-OADS,/arxiv_data1/oa_pdf/93/df/ott-9-6343.PMC5074768.pdf
"The process of new vessels production achieved Correspondence: Tomas Koltai Maipu 712 7 B. Buenos Aires (1006),  Republic of Argentina email tkoltai@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Hypothesis Y ear: 2016 Volume: 9 Running head verso: Koltai Running head recto: pH targeting and double-edged approach  DOI: http://dx.doi.org/10.2147/OTT.S115438",Non-OADS,/arxiv_data1/oa_pdf/93/df/ott-9-6343.PMC5074768.pdf
Clinical trial NCT02595372 ( https://ClinicalTrials.go v) is  based on a preliminary retrospective study that showed that  PPIs intake in breast cancer patients during chemotherapy  significantly improved overall survival.,Non-OADS,/arxiv_data1/oa_pdf/93/df/ott-9-6343.PMC5074768.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/93/df/ott-9-6343.PMC5074768.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/df/ott-9-6343.PMC5074768.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/31/oarrr-5-077.PMC5074789.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Rheumatology: Research and Reviews 2013:5 77–80Open Access Rheumatology: Research and Reviews Dove press submit your manuscript | www.dovepress.co m Dove press  77CAse RepOR topen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/OARRR.S5152 4Cocaine-induced vasculitis: is this a new trend?,Non-OADS,/arxiv_data1/oa_pdf/bc/31/oarrr-5-077.PMC5074789.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/bc/31/oarrr-5-077.PMC5074789.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/31/oarrr-5-077.PMC5074789.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/c7/oarrr-5-081.PMC5074793.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Rheumatology: Research and Reviews 2013:5 81–91Open Access Rheumatology: Research and Reviews Dove press submit your manuscript | www.dovepress.co m Dove press  81Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S5397 4The pain-relieving qualities of exercise in knee  osteoarthritis Allyn M Susko G Kelley Fitzgerald Department of Physical Therapy,   University of Pittsburgh, Pittsburgh,   PA, USA Correspondence: G Kelley Fitzgerald   University of Pittsburgh Department of  Physical Therapy, 6053 Forbes Tower,  Pittsburgh, PA 15260, USA   Tel +1 412 383 6643   email kfitzger@pitt.ed uAbstract:  The purpose of this review article is to explore the role of therapeutic exercise  in managing the pain associated with knee osteoarthritis (OA).",Non-OADS,/arxiv_data1/oa_pdf/72/c7/oarrr-5-081.PMC5074793.pdf
Available from: http://www.cdc.gov/arthritis/basics/ osteoarthritis .htm.,Non-OADS,/arxiv_data1/oa_pdf/72/c7/oarrr-5-081.PMC5074793.pdf
Available from: http://www.aaos.org/ research/guidelines/guidelineoaknee.asp .,Non-OADS,/arxiv_data1/oa_pdf/72/c7/oarrr-5-081.PMC5074793.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/72/c7/oarrr-5-081.PMC5074793.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/c7/oarrr-5-081.PMC5074793.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5f/40/oarrr-5-093.PMC5074795.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpOpen Access Rheumatology: Research and Reviews 2013:5 93–103Open Access Rheumatology: Research and Reviews Dove press submit your manuscript | www.dovepress.co m Dove press  93Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S3461 6Therapeutic apheresis in autoimmune diseases Rolf Bambauer1 Reinhard Latza2 Carolin Bambauer3 Daniel Burgard4 Ralf Schiel5 1institute for Blood Purification,   Homburg, 2Laboratorium of Medicine,   St ingbert, 3Main Hospital Darmstadt,   Darmstadt, 4Herz Zentrum,   Cardiology, völklingen, 5inselklinik  Heringsdorf GmbH, Seeheilbad  Heringsdorf, Germany Correspondence: Rolf Bambauer   Institute for Blood Purification,   Frankenstrasse 4, 66424 Homburg,   Germany   Tel +49 06 8416 8500   Fax +49 06 8416 8561   email rolf.bambauer@t-online.d eAbstract:  Systemic autoimmune diseases based on an immune pathogenesis produce   autoantibodies and circulating immune complexes, which cause inflammation in the tissues  of various organs.",Non-OADS,/arxiv_data1/oa_pdf/5f/40/oarrr-5-093.PMC5074795.pdf
Available  from: http://www.ejournalofscience.org/archive/vol2no5/vol2no5_1.,Non-OADS,/arxiv_data1/oa_pdf/5f/40/oarrr-5-093.PMC5074795.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5f/40/oarrr-5-093.PMC5074795.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/40/oarrr-5-093.PMC5074795.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0).",Non-OADS,/arxiv_data1/oa_pdf/90/ba/JVR-07-10.PMC5074800.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0).",Non-OADS,/arxiv_data1/oa_pdf/93/f0/JVR-07-16.PMC5074801.pdf
[12] Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.,Non-OADS,/arxiv_data1/oa_pdf/0a/a0/JCTH-4-175.PMC5075002.pdf
[54] Available at: http://www.hcvguidelines.org.,Non-OADS,/arxiv_data1/oa_pdf/13/16/JCTH-4-206.PMC5075004.pdf
"References [1] HCV guidance: Recommendations for testing, managing, and treating hepa- titis C. Available from: http://www.hcvguidelines.org, accessed June 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://www.monogrambio.com/hiv- tests/suppression-management/genosure-archive, accessed June 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://www.merck.com/product/usa/pi_circu- lars/z/zepatier/zepatier_pi.pdf, accessed July 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://www.gilead.com/~/media/Files/pdfs/med- icines/liver-disease/epclusa/epclusa_pi.pdf, accessed June 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://www.gilead.com/ ;/media/Files/pdfs/med- icines/liver-disease/sovaldi/sovaldi_pi.pdf, accessed July 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
Available from: http://packageinserts.bms.com/pi/pi_daklinza.,Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://www.merck.com/product/usa/pi_circu- lars/z/zepatier/zepatier_pi.pdf, accessed July 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://www.gilead.com/ ;/media/Files/pdfs/med- icines/liver-disease/harvoni/harvoni_pi.pdf, accessed July 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://www.accessdata.fda.gov/drugsatfda_ docs/label/2014/206619lbl.pdf, accessed July 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://www.olysio.com/shared/product/ olysio/prescribing-information.pdf, accessed July 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
"Available from: http://aidsinfo.nih.gov/contentfiles/lvguide-lines/adultandadolescentgl.pdf, accessed July 2016.",Non-OADS,/arxiv_data1/oa_pdf/2c/3c/JCTH-4-234.PMC5075006.pdf
Available at: http://www.who.int/mediacentre/factsheets/fs280/en.,Non-OADS,/arxiv_data1/oa_pdf/a2/73/JCTH-4-269.PMC5075011.pdf
Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125476s000 lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/6f/c7/JCTH-4-277.PMC5075012.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/ba/81/40266_2016_Article_405.PMC5075013.pdf
2010.http://www.fda.gov/downloads/Drugs/ …/Guidances/ UCM204959.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ba/81/40266_2016_Article_405.PMC5075013.pdf
1999. http://www.fda.gov/downloads/ Drugs/Guidances/UCM072137.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ba/81/40266_2016_Article_405.PMC5075013.pdf
It was minimally present at rest (resting tremor) and during activities (kinetic tremor)Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and Scholarship Columbia Universit y Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/42/53/tre-06-419-7522-1.PMC5075043.pdf
Prominent Bilateral Hand Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/42/53/tre-06-419-7522-1.PMC5075043.pdf
Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/42/53/tre-06-419-7522-1.PMC5075043.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/78/aa/hepatmon-16-08-38558.PMC5075145.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"(11), and the NCBI 16S rRNA referencesequence set (ftp://ftp.ncbi.nlm.nih.gov/blast/db/16SMicro-bial.tar.gz).",OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
The taxonomyinformation used in this study is available at ftp:// www.homd.org/publicatio n_data/20150519/ for HOM- DEXTGG and ftp://ftp.ncbi.nlm.nih.gov/pub/taxonomyfor the NCBI sequences.,OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
The complete QIIMEresults are available for download at ftp://www.homd.org/ publication_data/20160412.,OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"Composition of the salivary microbiota of pSS with normal salivation Using MC100 as the minimal read count cutoffs, sixdifferent phyla were detected in pSS patients, with DNAMicrobial dysbiosis in Sjo ¨gren’s syndrome Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"Fusobacteria, the smallest of the major phyla depicted, constituted 2% of thetotal.Microbial dysbiosis in Sjo ¨gren’s syndrome Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119 5 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"Red curves and dots represent health samples; blue curves represent pSS samples.Microbial dysbiosis in Sjo ¨gren’s syndrome Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"8 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
http://dx.doi.org/10.1016/j.archoralbio.2016.06.016 References 1.,OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
doi: http://dx.doi.org/10.1136/annrheumdis-2014-20537 5.,Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
BMC Microbiol2011; 11: 244. doi: http://dx.doi.org/10.1186/1471-2180-11-244 11.,OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
J Oral Microbiol 2015; 7: 28934. doi: http://dx.doi.org/10.3402/jom.v7.28934 12.,Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"doi: http://dx.doi.org/10.1038/nmeth.f.303Microbial dysbiosis in Sjo ¨gren’s syndrome Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119 9 (page number not for citation purpose)",OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
doi: http://dx.doi.org/10.1093/ molbev/mst010.2013 16.,Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
doi: http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
Oral Dis 2016. doi: http://dx.doi.org/10.1111/odi.,OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"10 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2016, 8: 31119 - http://dx.doi.org/10.3402/jom.v8.31119",Non-OADS,/arxiv_data1/oa_pdf/c7/9b/JOM-8-31119.PMC5075221.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2016, 6: 32701 - http://dx.doi.org/10.3402/iee.v6.32701 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32701 - http://dx.doi.org/10.3402/iee.v6.32701",Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
"Triangles indicate sampling sites and numbers refer to the study cited (see Table 1).PPRV in Tanzania Citation: Infection Ecology and Epidemiology 2016, 6: 32701 - http://dx.doi.org/10.3402/iee.v6.32701 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
"4 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32701 - http://dx.doi.org/10.3402/iee.v6.32701",Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
"Acknowledgements Research on PPR V in JJW , MB, and GM laboratories is supported by grants from the Swedish Research Council (Grant 348-2013-6402and 348-2014-4293) and the Wellcome Trust (Grant WT087546MA)PPRV in Tanzania Citation: Infection Ecology and Epidemiology 2016, 6: 32701 - http://dx.doi.org/10.3402/iee.v6.32701 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
TransboundEmerg Dis 2015. doi: http://dx.doi.org/10.1111/tbed.12374 12.,OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
Available from: http://www.fao.org/publications/ card/en/c/69a3a465-f2c7-5c92-b87a-0621c419e063/ 13.,Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
Available from: http://www.fao.org/3/a-i4460e.pdf[cited 3 May 2016].,Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
Southern African Development Community (SADC) control strategy for peste des petit ruminants (PPR).Available from: http://www.sadc.in t/documents-publications/show/ SADC%20Control%20Strategy%20for%20Peste%20de%20Petit%20Ruminants%20(PPR) [ci ted 04 September 2015].,Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
Available from: http://www.oie.int/wahis_2/public/wahid.php/Wahidhome/Home [cited 14 September 2016].,Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
Available from: http://www.fao.org/news/story/en/item/150317/icode/ [cited 30 September 2016].,Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
"BioMed Res Int 2016; 2016: 7826245, doi: http://dx.doi.org/10.1155/2016/7826245 26.",OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
"6 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2016, 6: 32701 - http://dx.doi.org/10.3402/iee.v6.32701",Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
Available from: http://openknowledge.worldbank.,Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
"Available from: http://www.fao.org/africa/programmes- and-projects/projects/en/ [cited 29 Agust 2016].PPRV in Tanzania Citation: Infection Ecology and Epidemiology 2016, 6: 32701 - http://dx.doi.org/10.3402/iee.v6.32701 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/e3/93/IEE-6-32701.PMC5075222.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/0c/hepatmon-16-08-37904.PMC5075223.pdf
Available from: http://www.cdc.gov/ hepatitis/statistics/2009surveillance/index.htm .,OADS,/arxiv_data1/oa_pdf/f0/0c/hepatmon-16-08-37904.PMC5075223.pdf
Available from: http://www.cdc.gov/ hepatitis/statistics/2010surveillance/index.htm .,OADS,/arxiv_data1/oa_pdf/f0/0c/hepatmon-16-08-37904.PMC5075223.pdf
Available from: http://www.cdc.gov/ hepatitis/statistics/2011surveillance/index.htm .,OADS,/arxiv_data1/oa_pdf/f0/0c/hepatmon-16-08-37904.PMC5075223.pdf
Available from: http://www.cdc.gov/ hepatitis/statistics/2012surveillance/index.htm .,OADS,/arxiv_data1/oa_pdf/f0/0c/hepatmon-16-08-37904.PMC5075223.pdf
Available from: http://www.cdc.gov/ hepatitis/statistics/2013surveillance/index.htm .,OADS,/arxiv_data1/oa_pdf/f0/0c/hepatmon-16-08-37904.PMC5075223.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/14/hepatmon-16-08-37584.PMC5075224.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/4c/hepatmon-16-08-35953.PMC5075225.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/80/hepatmon-16-08-36821.PMC5075226.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/96/hepatmon-16-08-32692.PMC5075228.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs204/en /.,Non-OADS,/arxiv_data1/oa_pdf/14/96/hepatmon-16-08-32692.PMC5075228.pdf
Available from: http://www.pzh.gov.pl/oldpage/ epimeld/index_p.html .,OADS,/arxiv_data1/oa_pdf/14/96/hepatmon-16-08-32692.PMC5075228.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/6a/hepatmon-16-08-40959.PMC5075356.pdf
Linkage analyses were carried out using the Eazy Linkage 5.05  program package (http://en.freedownloadmanager.org/ Windows-PC/easyLINKAGE-Plus-FREE.html) and  the 2-point logarithm of the odds ratio (LOD score)   were calculated using super link v 1.6 program.,OADS,/arxiv_data1/oa_pdf/0c/d9/SaudiMedJ-37-1068.PMC5075369.pdf
"In order to predict the impact of amino acid  changes resulting from the missense variant mutation  on the 3 dimensional structure of otoferlin protein and its biological function, Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index ),   SMART (http://smart.embl-heidelberg.de/), Rasmol (http://www.openrasmol.org/), and GOR IV (https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_gor4.html) computer protein analysis programs were used.",OADS,/arxiv_data1/oa_pdf/0c/d9/SaudiMedJ-37-1068.PMC5075369.pdf
"The ROC analysis was applied using an easy ROC tool  (http://www.biosoft.hacettepe.edu.tr/easyROC/ ), 10  while the remaining analysis was applied in R 3.1.1 (www.r-project.org) software; p<0.05 was considered  statistically significant.",OADS,/arxiv_data1/oa_pdf/d6/3c/SaudiMedJ-37-1082.PMC5075371.pdf
Available from URL: http://www.biosoft.,OADS,/arxiv_data1/oa_pdf/d6/3c/SaudiMedJ-37-1082.PMC5075371.pdf
"2007, Available from: http://www.cdsi.gov.",Non-OADS,/arxiv_data1/oa_pdf/3a/dd/SaudiMedJ-37-1096.PMC5075373.pdf
Available from URL: http://www.who.int/ageing/ publications/Falls_prevention7March.pdf   6.,Non-OADS,/arxiv_data1/oa_pdf/80/df/SaudiMedJ-37-1101.PMC5075374.pdf
[cited 2016 January 03] Available from URL: http://www.aafp.,Non-OADS,/arxiv_data1/oa_pdf/80/df/SaudiMedJ-37-1101.PMC5075374.pdf
Available from URL: http://www.cdc.gov/HomeandRecreationalSafety/Falls/ adultfalls.html.,Non-OADS,/arxiv_data1/oa_pdf/80/df/SaudiMedJ-37-1101.PMC5075374.pdf
Available from URL: http://www.who.int/disabilities/ technology/po_services_cbr.pdf   9.,Non-OADS,/arxiv_data1/oa_pdf/b8/a1/SaudiMedJ-37-1109.PMC5075375.pdf
Available from:  URL: http://www.cdc.gov/obesity/childhood/defining.html 16.,Non-OADS,/arxiv_data1/oa_pdf/e6/39/SaudiMedJ-37-1120.PMC5075377.pdf
Available from:  URL: https://www.nhlbi.nih.gov/files/docs/ bp_child_pocket.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/e6/39/SaudiMedJ-37-1120.PMC5075377.pdf
Available from URL: https://health.gov/paguidelines/pdf/paguide.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/e6/39/SaudiMedJ-37-1120.PMC5075377.pdf
The full version of obesity management guideline (number 14) can be found at: http://www.moh.gov.sa/ depts/Proofs/Pages/Guidelines.aspx.,Non-OADS,/arxiv_data1/oa_pdf/cd/23/SaudiMedJ-37-1151.PMC5075383.pdf
Available from: http://www.moh.,Non-OADS,/arxiv_data1/oa_pdf/cd/23/SaudiMedJ-37-1151.PMC5075383.pdf
Available from URL: https://www.nhmrc.gov.au/guidelines- publications/n57   9.,Non-OADS,/arxiv_data1/oa_pdf/cd/23/SaudiMedJ-37-1151.PMC5075383.pdf
Available from: http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf  12.,OADS,/arxiv_data1/oa_pdf/cd/23/SaudiMedJ-37-1151.PMC5075383.pdf
Available from:  http://www.who.int/mediacentre/news/statements/2016/zika-fourth-ec/en/ -------------------------------------------------------------------------------,Non-OADS,/arxiv_data1/oa_pdf/93/72/SaudiMedJ-37-1166.PMC5075386.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/48/cardiovascmed-05-03-32645.PMC5075388.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/7a/cardiovascmed-05-03-32459.PMC5075389.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/a5/cardiovascmed-05-03-26494.PMC5075392.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/0e/cardiovascmed-05-03-32512.PMC5075427.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/46/cardiovascmed-05-03-29638.PMC5075428.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/88/cardiovascmed-05-03-32086.PMC5075429.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fc/f3/cardiovascmed-05-03-31546.PMC5075430.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/76/cardiovascmed-05-03-32545.PMC5075431.pdf
BU can be safely combined with MEL 140 and VEL without  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/0a/nihms817383.PMC5075527.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Leontios J Hadjileontiadis, PhD,  Professor, Composer/Musicologist, Director  of the Signal  Processing and Biomedical Technology Unit (SPBTU),  Department of Electrical and Computer Engineering, Aristotle  University of Thessaloniki, University Campus, Build.",Non-OADS,/arxiv_data1/oa_pdf/9b/ee/WJG-22-8641.PMC5075542.pdf
"In this direction, a DIAGNOSTIC ADVANCESSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8641 8641 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8641-8657  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/9b/ee/WJG-22-8641.PMC5075542.pdf
World J Gastroenterol  2016; 22(39): 8641-8657   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i39/8641.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/9b/ee/WJG-22-8641.PMC5075542.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Linda S Lee, Assistant Professor,   Division of Gastroenterology, Hepatology and Endoscopy,  Brigham and Women’s Hospital, Harvard Medical School, 75  Francis St., Boston, MA 02115,  United States.",Non-OADS,/arxiv_data1/oa_pdf/28/be/WJG-22-8658.PMC5075543.pdf
"World J  Gastroenterol  2016; 22(39): 8658-8669  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i39/8658.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i39.8658REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8658 8658 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8658-8669  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/28/be/WJG-22-8658.PMC5075543.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/28/be/WJG-22-8658.PMC5075543.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Andrew Y Wang, MD, AGAF, FACG,  FASGE, Associate Professor  of Medicine, Section Chief  of  Interventional Endoscopy, Division of Gastroenterology and  Hepatology, University of Virginia Health System, Box 800708,  Charlottesville, V A 22908, United States.",Non-OADS,/arxiv_data1/oa_pdf/17/d8/WJG-22-8670.PMC5075544.pdf
"Pre-treatment counseling  is paramount, as the goal of therapy is to improve  swallowing and prevent late manifestations of the REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8670 8670 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8670-8683  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/17/d8/WJG-22-8670.PMC5075544.pdf
World J Gastroenterol  2016; 22(39): 8670 ­8683   Available from: URL: http://www.wjgnet.com/1007 ­9327/full/ v22/i39/8670.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/17/d8/WJG-22-8670.PMC5075544.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/17/d8/WJG-22-8670.PMC5075544.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Marcello Guido, Professor,  Laboratory  of Hygiene, Department of Biological and Environmental  Sciences and Technologies, Faculty of Sciences, University of  Salento, Via Provinciale Lecce-Monteroni, 73100 Lecce,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/76/6b/WJG-22-8684.PMC5075545.pdf
"This review presents the  current knowledge on HBoV genotypes with emphasis  on taxonomy, p hylogenetic relationship and genomic  analysis, biology, epidemiology, pathogenesis and REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8684 8684 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8684-8697  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/76/6b/WJG-22-8684.PMC5075545.pdf
World J Gastroenterol  2016;  22(39): 8684-8697  Available from: URL: http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/76/6b/WJG-22-8684.PMC5075545.pdf
com/1007-9327/full/v22/i39/8684.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/6b/WJG-22-8684.PMC5075545.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/76/6b/WJG-22-8684.PMC5075545.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptCorrespondence to: Julian Swierczynski, Professor, Depart - ment of Biochemistry, Medical University of Gdańsk, ul.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/WJG-22-8698.PMC5075546.pdf
"Thus,  the altera tions in bile flow that result from anatomical  changes caused by bariatric surgery and changes in gut REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8698 8698 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8698-8719  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c8/74/WJG-22-8698.PMC5075546.pdf
World J  Gastroenterol  2016; 22(39): 8698-8719  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i39/8698.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i39.8698 INTRODUCTION The number of overweight and obese individuals  increased worldwide by approximately 28% between  1980 and 2013[1].,Non-OADS,/arxiv_data1/oa_pdf/c8/74/WJG-22-8698.PMC5075546.pdf
Available from:  URL: https://www.idf.org/sites/default/files/IDF T2DM Guideline.,OADS,/arxiv_data1/oa_pdf/c8/74/WJG-22-8698.PMC5075546.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/c8/74/WJG-22-8698.PMC5075546.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Manoochehr Makvandi,  Health  Research Institute, Infectious and Tropical Disease Research  Center, Ahvaz Jundishapur University of Medical Sciences,  Boulevard Golestan, Ahvaz 15794-61357,  Iran.",Non-OADS,/arxiv_data1/oa_pdf/5c/31/WJG-22-8720.PMC5075547.pdf
"manoochehrmakvandi29@yahoo.com Telephone:  +98-9166181683 Fax:  +98-6113738313 Received:  March 28, 2016 Peer-review started:  March 29, 2016 First decision:  May 30, 2016 Revised:  June 13, 2016 Accepted:  July 20, 2016  Article in press:  July 21, 2016 Published online: October 21, 2016 Abstract The event of mutations in the surface antigen gene of  hepatitis B virus (HBV) results in undetectable hepatitis  B surface antigen with positive/negative anti-hepatitis REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8720 8720 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8720-8734  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/5c/31/WJG-22-8720.PMC5075547.pdf
"World  J Gastroenterol  2016; 22(39): 8720-8734  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i39/8720.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i39.8720 INTRODUCTION Hepatitis B virus (HBV) infection is a considerable  global health problem and approximately two billion  of the world population have been infected, of which  250 million live with HBV infection[1].",Non-OADS,/arxiv_data1/oa_pdf/5c/31/WJG-22-8720.PMC5075547.pdf
"Available from: URL: http://www.who.int/mediacentre/ factsheets/fs204/en/ 2 Tabor E , Hoofnagle JH, Smallwood LA, Drucker JA, Pineda- Tamondong GC, Ni LY, Greenwalt TJ, Barker LF, Gerety  RJ.",Non-OADS,/arxiv_data1/oa_pdf/5c/31/WJG-22-8720.PMC5075547.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/5c/31/WJG-22-8720.PMC5075547.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Liang Zhao, MD,  Department of  Pathology, Nanfang Hospital, Southern Medical University,  No.",Non-OADS,/arxiv_data1/oa_pdf/d6/d1/WJG-22-8735.PMC5075548.pdf
"Core tip:  Long non-coding RNAs (lncRNAs), a newly  discovered class of non-cod ing RNA molecules, have  been widely identified as crucial regulators of various REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8735 8735 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8735-8749  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/d6/d1/WJG-22-8735.PMC5075548.pdf
wjgnet.com/1007-9327/full/v22/i39/8735.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d6/d1/WJG-22-8735.PMC5075548.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/d6/d1/WJG-22-8735.PMC5075548.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Pankaj Kumar Garg, Associate  Professor,  Department of Surgery, University College of  Medical Sciences and Guru Teg Bahadur Hospital, University of  Delhi, Dilshad Garden, Delhi 110095,  India.",Non-OADS,/arxiv_data1/oa_pdf/d4/f9/WJG-22-8750.PMC5075549.pdf
"Key words:  Esophageal cancer; Preoperative therapy;  Multimodality treatment; Chemotherapy; Radiotherapy;  ChemoradiotherapyMINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8750 8750 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8750-8759  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/d4/f9/WJG-22-8750.PMC5075549.pdf
World J  Gastroenterol  2016; 22(39): 8750-8759  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i39/8750.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i39.8750 INTRODUCTION The eighth most common cancer in the world is  esophageal cancer.,Non-OADS,/arxiv_data1/oa_pdf/d4/f9/WJG-22-8750.PMC5075549.pdf
"Available from:  URL: http://globocan.iarc.fr 2 Posner MC , Minsky BD, Ilson DH.",Non-OADS,/arxiv_data1/oa_pdf/d4/f9/WJG-22-8750.PMC5075549.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/d4/f9/WJG-22-8750.PMC5075549.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Yaron Ilan, MD,  Gastroenterology  and Liver Units, Department of Medicine, Hadassah Hebrew University Medical Center, Ein ­Karem, POB 1200, Jerusalem  IL91120, Israel.",Non-OADS,/arxiv_data1/oa_pdf/ef/a1/WJG-22-8760.PMC5075550.pdf
"CONCLUSION Orally administered PRX-106 shows biological activity  and exerts an immunomodulatory effect, alleviating liver  8760 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comORIGINAL ARTICLE Oral administration of a non-absorbable plant cell- expressed recombinant anti-TNF fusion protein induces  immunomodulatory effects and alleviates nonalcoholic  steatohepatitisBasic Study Yaron Ilan, Ami Ben Ya'acov, Yehudit Shabbat, Svetlana Gingis-Velitski, Einat Almon, Yoseph ShaaltielSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8760World J Gastroenterol   2016 October 21; 22(39): 8760-8769  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ef/a1/WJG-22-8760.PMC5075550.pdf
World J Gastroenterol  2016; 22(39): 8760 ­8769   Available from: URL: http://www.wjgnet.com/1007 ­9327/full/ v22/i39/8760.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/ef/a1/WJG-22-8760.PMC5075550.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/ef/a1/WJG-22-8760.PMC5075550.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Hao Li, MD, Vice Professor  of Medicine,  Tumor Center, Qilu Hospital of Shandong University, No.",Non-OADS,/arxiv_data1/oa_pdf/fb/ae/WJG-22-8770.PMC5075551.pdf
"In the ROC Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8770 8770 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8770-8778  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/fb/ae/WJG-22-8770.PMC5075551.pdf
World J  Gastroenterol  2016; 22(39): 8770-8778  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i39/8770.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i39.8770 INTRODUCTION Esophageal squamous cell carcinoma (ESCC) is one of the most lethal malignancies[1].,Non-OADS,/arxiv_data1/oa_pdf/fb/ae/WJG-22-8770.PMC5075551.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/fb/ae/WJG-22-8770.PMC5075551.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Hiroshi Kono, MD, PhD,  First Department  of Surgery,  Faculty of Medicine,  University of Yamanashi,  1110  Shimokato, Chuo,  Yamanashi 409-3898, Japan.",Non-OADS,/arxiv_data1/oa_pdf/b4/74/WJG-22-8779.PMC5075552.pdf
"Multivariate analysis revealed Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8779 8779 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8779-8789  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/b4/74/WJG-22-8779.PMC5075552.pdf
"World J Gastroenterol  2016; 22(39): 8779-8789  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i39/8779.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i39.8779 INTRODUCTION Hepatocellular carcinoma (HCC) is a globally common  cancer, resulting over one million deaths every  year[1].",Non-OADS,/arxiv_data1/oa_pdf/b4/74/WJG-22-8779.PMC5075552.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/b4/74/WJG-22-8779.PMC5075552.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Tian-Ming Cheng,  Hui Qiao Medical  Center, Nanfang Hospital, Southern Medical University,  Guangzhou 510515, Guangdong Province,  China.",Non-OADS,/arxiv_data1/oa_pdf/6b/b8/WJG-22-8790.PMC5075553.pdf
"The cytological diagnostic  capacity and sample quality of the slow-pull technique  and suction techniques with 5-m L/10-m L/20-m L  syringes were analyzed.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8790 8790 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8790-8797  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/6b/b8/WJG-22-8790.PMC5075553.pdf
wjgnet.com/1007-9327/full/v22/i39/8790.htm   DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6b/b8/WJG-22-8790.PMC5075553.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/6b/b8/WJG-22-8790.PMC5075553.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr. Bang-De Xiang, Professor, Department  of Hepatobiliary Surgery, Affiliated Tumor Hospital of Guangxi  Medical University, 71 Hedi Road, Nanning 530021, Guangxi  Zhuang Autonomous Region, China.",Non-OADS,/arxiv_data1/oa_pdf/8a/70/WJG-22-8798.PMC5075554.pdf
"yhj894924067@163.co m telephone:  +86-771-5310045 Fax:  +86-771-5312000 Received:  June 15, 2016 Peer-review started:  June 16, 2016 First decision:  July 29, 2016 Revised:  August 15, 2016 Accepted: August 30, 2016 Article in press:  August 30, 2016 Published online: October 21, 2016 Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8798 8798 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8798-8805  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8a/70/WJG-22-8798.PMC5075554.pdf
"World  J Gastroenterol  2016; 22(39): 8798-8805  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i39/8798.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i39.8798 INTRODUCTION Hepatocellular carcinoma (HCC) is one of the most  aggressive tumors and the third most frequent cause  of cancer-related death in the world[1,2].",Non-OADS,/arxiv_data1/oa_pdf/8a/70/WJG-22-8798.PMC5075554.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/8a/70/WJG-22-8798.PMC5075554.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Mei Zhang,  Department of Gastro- enterology, Xuanwu Hospital, Capital Medical University, No.",Non-OADS,/arxiv_data1/oa_pdf/f9/64/WJG-22-8806.PMC5075555.pdf
"There was a positive  correlation between prevalence of constipation and  age, but negative correlations between prevalence of  constipation an d staple food, fish and dietary fibres Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8806 8806 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8806-8811  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/f9/64/WJG-22-8806.PMC5075555.pdf
"World J  Gastroenterol  2016; 22(39): 8806-8811  Available from: URL:  http://www.wjgnet.com/1007-9327/full/v22/i39/8806.htm   DOI:  http://dx.doi.org/10.3748/wjg.v22.i39.8806 INTRODUCTION Constipation is a common gastrointestinal disease  affecting all age groups, elderly individuals suffer  particularly more than younger individuals, among  which females have higher prevalence than males[1,2].",Non-OADS,/arxiv_data1/oa_pdf/f9/64/WJG-22-8806.PMC5075555.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/f9/64/WJG-22-8806.PMC5075555.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Michele Di Martino, PhD, MD, Department of Radiological Sciences,  Oncology and Anatomical Pathology,  “Sapienza” University of Rome, V .le Regina Elena 324, 00161  Roma, Italy.",Non-OADS,/arxiv_data1/oa_pdf/cd/56/WJG-22-8812.PMC5075556.pdf
"Lin coefficient test was used to evaluate the Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8812 8812 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8812-8819  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/cd/56/WJG-22-8812.PMC5075556.pdf
"World J Gastroenterol  2016; 22(39): 8812-8819  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i39/8812.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i39.8812 INTRODUCTION Non-alcoholic fatty liver disease (NAFLD) is emerging  as a leading cause of chronic liver disease in children  and adolescents, with a prevalence in the general  population ranging from 3%-10% in normal weight  children and 80% in obese children[1-2].",Non-OADS,/arxiv_data1/oa_pdf/cd/56/WJG-22-8812.PMC5075556.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/cd/56/WJG-22-8812.PMC5075556.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Athanasios D Sioulas, MD, PhD,  Department of Interdisciplinary Endoscopy, University Hospital  Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg,  Germany.",Non-OADS,/arxiv_data1/oa_pdf/ec/c2/WJG-22-8820.PMC5075557.pdf
"athsioulas@yahoo.g r Telephone:  +49-0-407410 Fax:  +49-0-407410-4442 0 Received:  June 25, 2016 Peer-review started:  June 27, 2016 First decision:  August 8, 2016 Revised:  August 21, 2016 Accepted:  September 14, 2016   Article in press:  September 14, 2016 Published online: October 21, 2016 Abstract   AIM To compare the aspiration needle (AN) and core biopsy  needle (PC) in endoscopic ultrasound-guided fine  needle aspiration (EUS-FNA) of abdominal masses.Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8820 8820 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8820-8830  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ec/c2/WJG-22-8820.PMC5075557.pdf
"World J Gastroenterol  2016; 22(39): 8820-8830  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i39/8820.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i39.8820 INTRODUCTION Endoscopic ultrasound (EUS) has become widely-used  for diagnostic purposes regarding lesions arising from  the pancreas, upper gastrointestinal tract, as well as  adjacent structures, such as the liver and lymph nodes.",Non-OADS,/arxiv_data1/oa_pdf/ec/c2/WJG-22-8820.PMC5075557.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/ec/c2/WJG-22-8820.PMC5075557.pdf
"See: http://creativecommons.org/ licenses/by ­nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Harsha Moole, MD, Clinical Associate,  Department of Medicine, University of Illinois College of  Medicine at Peoria, 1 Illini Dr, Peoria, IL 61637,  United States.",Non-OADS,/arxiv_data1/oa_pdf/17/f2/WJG-22-8831.PMC5075558.pdf
"harsha1778@yahoo.co.in Telephone:  +1­309­6557257 Fax:  +1­844­8936705 Received:  July 11, 2016 Peer-review started:  July 12, 2016 First decision:  August 19, 2016 Revised:  September 4, 2016META-ANALYSISSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8831 8831 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8831-8843  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/17/f2/WJG-22-8831.PMC5075558.pdf
wjgnet.com/1007 ­9327/full/v22/i39/8831.htm   DOI: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/f2/WJG-22-8831.PMC5075558.pdf
"Available  from: URL: http://www.ohri.ca/programs/clinical_epidemiology/ oxford.asp 20 Stuart A , Ord JK.",Non-OADS,/arxiv_data1/oa_pdf/17/f2/WJG-22-8831.PMC5075558.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/17/f2/WJG-22-8831.PMC5075558.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Linda S Yang, MBBS,  Department of  Gastroenterology, St. Vincent’s Hospital, 41 Victoria Pde, Fitzroy,  Victoria 3065, Australia.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/WJG-22-8844.PMC5075559.pdf
"lindaviva0912@gmail.com  Telephone:  +61-3-425726761CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8844 8844 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8844-8848  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/WJG-22-8844.PMC5075559.pdf
World J Gastroenterol  2016; 22(39): 8844-8848   Available from: URL: http://www.wjgnet.com/1007-9327/full/ v22/i39/8844.htm   DOI: http://dx.doi.org/10.3748/wjg.v22.,Non-OADS,/arxiv_data1/oa_pdf/bb/9f/WJG-22-8844.PMC5075559.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/bb/9f/WJG-22-8844.PMC5075559.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Hiroyasu Nakano, MD,  Division of  Gastroenterology and Hepatology, Department of Internal  Medicine, St. Marianna University School of Medicine, 2-16-1,  Sugao, Miyamae-ku, Kawasaki City, Kanagawa 216-8511,  Japan.",Non-OADS,/arxiv_data1/oa_pdf/94/97/WJG-22-8849.PMC5075560.pdf
"World J Gastroenterol  2016; 22(39): 8849-8852  Available from:  URL: http://www.wjgnet.com/1007-9327/full/v22/i39/8849.htm    DOI: http://dx.doi.org/10.3748/wjg.v22.i39.8849CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v22.i39.8849 8849 October 21, 2016 |Volume 22 |Issue 39 | WJG|www.wjgnet.comWorld J Gastroenterol   2016 October 21; 22(39): 8849-8852  ISSN 1007-9327 (print)  ISSN 2219-2840 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/94/97/WJG-22-8849.PMC5075560.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com I S S N  1 0  0 7  -   9  3 2  7 9    7 7 1 0  07   9 3 2 0 453   9",Non-OADS,/arxiv_data1/oa_pdf/94/97/WJG-22-8849.PMC5075560.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Differential sensitivity to the environment E Fox and CG Beevers 1662 Molecular Psychiatry (2016), 1657 –1662",Non-OADS,/arxiv_data1/oa_pdf/ba/4f/mp2016114a.PMC5075581.pdf
"Aided by analyzing software (Image J, NIH, USA,  http://rsb.info.nih.gov), a histogram of the red pixel value  of each slice was created to show the absolute number  of pixel with the same grey scale value.",OADS,/arxiv_data1/oa_pdf/48/63/MGR-6-3.PMC5075680.pdf
http://www.cdc.gov/traumaticbraininjury/pdf/blue_book.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/63/MGR-6-3.PMC5075680.pdf
Wenker O (1999) Review of currently used inhalation anesthetics:  Part I. Int J Anesthesiol 3.  http://ispub.com/IJA/3/2/7433.,Non-OADS,/arxiv_data1/oa_pdf/48/63/MGR-6-3.PMC5075680.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: September 23, 2016 EXTRA  Naida L. Graham   Department of Speech-Language Pathology, Faculty of Medicine   University of Toronto, Rehabilitation Sciences Building   160-500 University Avenue, Toronto, ON M5G 1V7 (Canada)   E-Mail Naida.Graham   @   utoronto.ca www.karger.com/dee DOI: 10.1159/000448944  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/75/39/dee-0006-0407.PMC5075721.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: September 23, 2016 EXTRA  Yong Tae Kwak, MD   Department of Neurology, Hyoja Geriatric Hospital   Sanghari 33, Kuseong-myeon   Yongin-si, Kyeongki-do 449-914 (South Korea)   E-Mail kwakdr   @   gmail.com www.karger.com/dee DOI: 10.1159/000449244  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/41/c7/dee-0006-0437.PMC5075723.pdf
"© 2016 The Author(s) Published by S. Karger AG, Basel  Published online: September 29, 2016 EXTRA  Masayuki Satoh   2-174 Edobashi, Tsu   Mie 514-8507 (Japan)   E-Mail bruckner   @   clin.medic.mie-u.ac.jp    www.karger.com/dee DOI: 10.1159/000449409  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/33/45/dee-0006-0458.PMC5075724.pdf
"   Case Rep Oncol 2016;9:547 –553  DOI: 10.1159/000449370   Published online: September 22, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Com mons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/92/98/cro-0009-0547.PMC5075726.pdf
"   Case Rep Oncol 2016;9:543 –546  DOI: 10.1159/000449125   Published online: September 22, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attributio n-NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/c3/a2/cro-0009-0543.PMC5075727.pdf
http://cancer.sanger.ac.uk/cosmic.,Non-OADS,/arxiv_data1/oa_pdf/c3/a2/cro-0009-0543.PMC5075727.pdf
"   Case Rep Ophthalmol 2016;7:162 –171  DOI: 10.1159/000449122   Published online: September 26, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cop   This article is licensed under the Crea tive Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/27/e2/cop-0007-0162.PMC5075728.pdf
"   Case Rep Oncol 2016;9:554 –558  DOI: 10.1159/000449372   Published online: September 22, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karg er.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/11/a6/cro-0009-0554.PMC5075730.pdf
"   Case Rep Neurol 2016;8:204 –210  DOI: 10.1159/000448473   Published online: October 3, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/crn   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/a1/de/crn-0008-0204.PMC5075733.pdf
"   Case Rep Oncol 2016;9:565 –567  DOI: 10.1159/000449371   Published online: October 4, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under th e Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/0b/3d/cro-0009-0565.PMC5075735.pdf
"Hubertus Axer   Hans Berger Department of Neurology, Jena University Hospital   Am Klinikum 1   DE–07747 Jena (Germany)   E-Mail hubertus.axer   @   med.uni-jena.de www.karger.com/dee DOI: 10.1159/000450602  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/33/cc/dee-0006-0447.PMC5075737.pdf
"   Case Rep Oncol 2016;9:559 –564  DOI: 10.1159/000448653   Published online: September 22, 2016  © 2016 The Author(s)   Published by S. Karger AG, Basel   www.karger.com/cro   This article is licensed under the Creative Commons Attribution -NonCommercial 4.0  International License (CC BY -NC) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/cf/9c/cro-0009-0559.PMC5075740.pdf
"Prof. Masayuki Satoh, MD, PhD    Department of Dementia Prevention and Therapeutics   Graduate School of Medicine, Mie University   2-174, Edobashi, Tsu, Mie 514-8507 (Japan)   E-Mail bruckner   @   clin.medic.mie-u.ac.jp www.karger.com/dee DOI: 10.1159/000449245  This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 Interna- tional License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).",Non-OADS,/arxiv_data1/oa_pdf/88/30/dee-0006-0424.PMC5075750.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/5d/jjm-09-07-35452.PMC5076382.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/98/cardiovascmed-05-03-32619.PMC5076383.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/c4/ircmj-18-08-26065.PMC5076384.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/8c/jjm-09-08-27825.PMC5076385.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/41/f4/nihms823027.PMC5076470.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, five figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2016.06.070 .",OADS,/arxiv_data1/oa_pdf/41/f4/nihms823027.PMC5076470.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/10/jjm-09-08-31338.PMC5076488.pdf
Minor/trace element averages were computed using data available on the Lunar Meteorite Compendium(available at http://curator.jsc.nasa.gov/antmet/lmc/).,OADS,/arxiv_data1/oa_pdf/19/76/JGRE-121-388.PMC5076490.pdf
"Speci ﬁcally, w eu s es a m p l e sf r o mM o n t eS o m m aa n dV e l l e di Fassa, Italy (see http://webmineral.com/data/Anorthite.shtml#.VfG4QaYXq60 for details).",Non-OADS,/arxiv_data1/oa_pdf/19/76/JGRE-121-388.PMC5076490.pdf
Cleft Palate Craniofac J 2015Available at: http://www.cpcjournal.org/doi/pdf/ 10.1597/15-199.,Non-OADS,/arxiv_data1/oa_pdf/e2/2b/jcrsu-27-1884.PMC5076491.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5d/bb/ceor-8-629.PMC5076537.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5d/bb/ceor-8-629.PMC5076537.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 629–639ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  629 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S113448Relative cost-effectiveness of using an extensively  hydrolyzed casein formula in managing infants  with cow’s milk allergy in Brazil Julian F Guest1,2 Ariana C Yang3 Jane Oba4 Maraci Rodrigues5 Rosane Caetano6 Lilian Polster7 1Catalyst Health Economics  Consultants, Northwood, Middlesex,   UK; 2Faculty of Life Sciences and  Medicine, King’s College, London,  UK;  3Universidade de São Paulo, São  Paulo & Universidade Estadual de Campinas, São Paulo, Brazil;  4Hospital  Israelita Albert Einstein, Sã o Paulo,   Brazil & Hospital Municipal Menino Jesus, São Paulo, Brazil;  5Department  of Gastroenterology, University of São Paulo School of Medicine, São Paulo,  Brazil;  6General Pediatrician, Rio de  Janeiro, Brazil; 7General Pediatrician,   São Paulo, BrazilObjective: To estimate the cost-effectiveness of three alternative dietetic strategies for cow’ s  milk allergy in Brazil: 1) using an extensively hydrolyzed casein formula (eHCF;  Nutramigen)   as a first-line formula, but switching to an amino acid formula (AAF) if infants remain symp-tomatic; 2) using an AAF as a first-line formula and then switching to an eHCF after 4 weeks  once infants are symptom-free, but switching back to an AAF if infants become symptomatic;  and 3) using an AAF as a first-line formula and keeping all infants on that formula.",Non-OADS,/arxiv_data1/oa_pdf/5d/bb/ceor-8-629.PMC5076537.pdf
"Keywords: amino acid formula, Brazil, cost-effectiveness, cow’ s milk allergy, extensively  hydrolyzed formula Introduction Cow’ s milk allergy (CMA) is an immunologically mediated reaction to the proteins in  cow’ s milk1 and is the most common food allergy in Brazil.2 CMA has an estimated  annual prevalence of 0.02–0.03 in children <1 year of age.3 The affected children  generally acquire tolerance to cow’ s milk proteins within the first 5 years of life,4  although the allergy can persist until late in life.5,6 Elimination of cow’ s milk proteins  from a child’ s diet and challenge tests are essential for diagnosing and treating this allergy, 7 and for infants this necessitates the use of a hypoallergenic formula instead  of standard infant formulas.7 In a recent observational study in Italy, an extensively hydrolyzed casein for - mula (eHCF; Nutramigen) was found to accelerate the development of tolerance Correspondence: Julian F Guest Catalyst Health Economics Consultants, 34b High Street, Northwood, Middlesex HA6 1BN, UKTel +44 0 1923 450 045Fax +44 0 1923 450 046Email julian.guest@catalyst-health.co.ukJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Guest et alRunning head recto: Cost-effectiveness of an eHCF in managing cow’ s milk allergy in BrazilDOI: http://dx.doi.org/10.2147/CEOR.S113448",Non-OADS,/arxiv_data1/oa_pdf/5d/bb/ceor-8-629.PMC5076537.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/5d/bb/ceor-8-629.PMC5076537.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 639 Cost-effectiveness of an eHCF in managing cow’s milk allergy in Brazil  10.,Non-OADS,/arxiv_data1/oa_pdf/5d/bb/ceor-8-629.PMC5076537.pdf
Available from: http://www.eln.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/5d/bb/ceor-8-629.PMC5076537.pdf
Available from:  http://www.ibge.gov.br/home/estatistica/populacao/registrocivil/2011/default_pdf_vivos.shtm.,Non-OADS,/arxiv_data1/oa_pdf/5d/bb/ceor-8-629.PMC5076537.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bd/56/cmar-8-127.PMC5076538.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bd/56/cmar-8-127.PMC5076538.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Cancer Management and Research 2016:8 127–128Cancer Management and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  127 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S117274Treatment challenges for community oncologists  treating postmenopausal women with endocrine- resistant, hormone receptor-positive, human  epidermal growth factor receptor 2-negative advanced breast cancer Hikmat Abdel-Razeq Department of Internal Medicine,   King Hussein Cancer Center,  Amman,  JordanDear editor I read with great interest the review written elegantly by Gradishar addressing the  challenges that community oncologists face in treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor recep-tor-2 (HER2)-negative advanced breast cancer in your journal.",Non-OADS,/arxiv_data1/oa_pdf/bd/56/cmar-8-127.PMC5076538.pdf
"9 The decision to use hormone-resistance modulators, discussed in detail in the  review, versus chemotherapy depends upon the need to obtain a rapid disease response Correspondence: Hikmat Abdel-Razeq Department of Internal Medicine, King Hussein Cancer Center, 202 Queen Rania Al Abdullah Street, Amman, 11941 JordanTel +962 6 530 0460 ext 1000Email habdelrazeq@khcc.joJournal name: Cancer Management and Research Article Designation: LETTERY ear: 2016V olume: 8Running head verso: Abdel-RazeqRunning head recto: Treatment challenges in breast cancerDOI: http://dx.doi.org/10.2147/CMAR.S117274",Non-OADS,/arxiv_data1/oa_pdf/bd/56/cmar-8-127.PMC5076538.pdf
"Cancer Management and Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Cancer Management and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/cancer-management-and-research-journalCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/bd/56/cmar-8-127.PMC5076538.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 128 Abdel-Razeq and the potential toxicities associated with each approach.,Non-OADS,/arxiv_data1/oa_pdf/bd/56/cmar-8-127.PMC5076538.pdf
Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bd/56/cmar-8-127.PMC5076538.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/69/52/ceor-8-613.PMC5076539.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/69/52/ceor-8-613.PMC5076539.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 613–627ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  613 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S112691The direct health-care burden of valvular heart  disease: evidence from US national survey data Matt Moore1 Jie Chen2 Peter J Mallow3 John A Rizzo4 1Global Health Economic Strategy,   Edwards Lifesciences Inc, Irvine,   CA, 2Department of Health Services  and Administration, University of Maryland, College Park, MD,   3Health Economics and Outcomes  Research, CTI Clinical Trial & Consulting Services Inc, Cincinnati,  OH,  4Department of Preventive  Medicine and Economics, Stony Brook University, Stony Brook, NY, USAPurpose: This study quantified the overall effects of aortic valve disease (A VD) and mitral  valve disease (MVD) by disease severity on direct health-care costs to insurers and patients.",Non-OADS,/arxiv_data1/oa_pdf/69/52/ceor-8-613.PMC5076539.pdf
"The natural history of VHD is most often characterized by a prolonged asymptom- atic period that is frequently managed initially by primary care physicians who play Correspondence: John A Rizzo Department of Preventive Medicine and Economics, Stony Brook University, 100 Nicolls Road, Stony Brook, NY 11790, USATel +1 631 828 6517Email rizzologic@gmail.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Moore et alRunning head recto: Health-care burden of valvular heart diseaseDOI: http://dx.doi.org/10.2147/CEOR.S112691",Non-OADS,/arxiv_data1/oa_pdf/69/52/ceor-8-613.PMC5076539.pdf
Available from: https://www.johnmuirhealth.com/services/cardiovascular-services/intervention/transcatheter-aortic-valve-replace-ment/facts-and-figures.html.,Non-OADS,/arxiv_data1/oa_pdf/69/52/ceor-8-613.PMC5076539.pdf
Available from:  http://www.bls.gov/cpi/home.htm.,Non-OADS,/arxiv_data1/oa_pdf/69/52/ceor-8-613.PMC5076539.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/69/52/ceor-8-613.PMC5076539.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 627 Health-care burden of valvular heart disease Supplementary materials Table S1 ICD-9 codes for identifying aortic valve disease patients Aortic valve disease patients identified by any of these primary  diagnosis codes 395 Diseases of aortic valve 395.0 Rheumatic aortic stenosis 395.2 Rheumatic aortic stenosis with insufficiency 424.1 Aortic valve disorders 746.3 Congenital stenosis of aortic valve; congenital aortic  stenosis Mitral valve disease patients identified by any of these primary diagnosis codes 394.0 Mitral stenosis 394.9 Other, an unspecified mitral valve disease 424.0 Mitral valve disorders 746.5 Congenital stenosis of mitral valve 746.6 Congenital mitral insufficiency Abbreviation:  ICD, International Classification of Diseases .",Non-OADS,/arxiv_data1/oa_pdf/69/52/ceor-8-613.PMC5076539.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cf/5f/clep-8-415.PMC5076540.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/cf/5f/clep-8-415.PMC5076540.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 415–423Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 415 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S108906 Evaluation of algorithms for registry-based  detection of acute myocardial infarction following  percutaneous coronary intervention Gro Egholm1,2,*  Morten Madsen2,*  Troels Thim1  Morten Schmidt2,3  Evald Høj Christiansen1  Hans Erik Bøtker1  Michael Maeng1 1Department of Cardiology,   2Department of Clinical Epidemiology,   Aarhus University Hospital, Aarhus,   3Department of Internal Medicine,   Regional Hospital of Randers,   Denmark *These authors contributed equally to  this workBackground: Registry-based monitoring of the safety and efficacy of interventions in patients  with ischemic heart disease requires validated algorithms.",Non-OADS,/arxiv_data1/oa_pdf/cf/5f/clep-8-415.PMC5076540.pdf
"However, to what Correspondence: Gro Egholm   Department of Cardiology, Aarhus  University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus North, Denmark Tel +45 7845 0000 Email grochi@rm.dkJournal name: Clinical Epidemiology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Egholm et alRunning head recto: Registry-based detection of acute myocardial infarctionDOI: http://dx.doi.org/10.2147/CLEP .S108906",Non-OADS,/arxiv_data1/oa_pdf/cf/5f/clep-8-415.PMC5076540.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/cf/5f/clep-8-415.PMC5076540.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ccid-9-373.PMC5076541.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d5/b2/ccid-9-373.PMC5076541.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 373–381Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 373 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S115256 Safety and performance of cohesive polydensified  matrix hyaluronic acid fillers with lidocaine in the  clinical setting – an open-label, multicenter study Ulrich Kühne1  Jørgen Esmann2  Dennis von Heimburg3  Matthias Imhof1  Petra Weissenberger4  Gerhard Sattler5  On behalf of the BALIA  Study Group 1Aesthetische Dermatologie im  Medico Palais, Bad Soden, Germany;   2Jørgen Esmann Aps, Hellerup,   Denmark; 3Praxisklinik Kaiserplatz,   Frankfurt am Main, Germany;   4Corporate Clinical Research, Merz  Pharmaceuticals GmbH, Frankfurt  am Main, Germany; 5Rosenparkklinik  GmbH, Darmstadt, GermanyAbstract: Cohesive polydensified matrix (CPM®) hyaluronic acid fillers are now available with  or without lidocaine.",Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ccid-9-373.PMC5076541.pdf
"3,4 They are also used to restore volume loss in the cheeks and the chin as well  as to enhance lip fullness.5,6 The monophasic, cohesive polydensified matrix (CPM®)  HA fillers (Belotero®; Anteis S.A., Geneva, Switzerland, a wholly owned subsidiary of  Merz Pharmaceuticals GmbH, Frankfurt am Main, Germany) are manufactured with a patented dynamic two-stage cross-linking technology, which results in cohesive gels with Correspondence: Gerhard Sattler Rosenparkklinik GmbH, Heidelberger Landstraße, 18-20, 64297 Darmstadt, Germany Tel +49 6151 159 883 83   Fax +49 6151 159 883 88   Email gerhard.sattler@rosenparkklinik.deJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Kühne et alRunning head recto: CPM ® hyaluronic acid fillers with lidocaine DOI: http://dx.doi.org/10.2147/CCID.S115256",Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ccid-9-373.PMC5076541.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ccid-9-373.PMC5076541.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 381 CPM® hyaluronic acid fillers with lidocaine12.,Non-OADS,/arxiv_data1/oa_pdf/d5/b2/ccid-9-373.PMC5076541.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/51/cia-11-1463.PMC5076542.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1463–1465Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1463Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/CIA.S12081 3 Nocturia: a bothersome urological symptom  in the elderly Bahram Shekarchi Mohammad Zamani Student research Committee, Babol  University of Medical Sciences,   Babol, IranDear editor We read with great interest the valuable study by Shao et al,1 which has been recently  published in Clinical Interventions in Aging .",Non-OADS,/arxiv_data1/oa_pdf/c8/51/cia-11-1463.PMC5076542.pdf
"2016;11:879–885.Correspondence: Mohammad Zamani Student research Committee, Babol  University of Medical Sciences,  Ganjafrooz Street, Babol, Mazandaran  47176-47745, Iran tel +98 935 9493131 email mzamani20@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Letter Y ear: 2016 Volume: 11 Running head verso: Shekarchi and Zamani Running head recto: Nocturia DOI: http://dx.doi.org/10.2147/CIA.S120813",Non-OADS,/arxiv_data1/oa_pdf/c8/51/cia-11-1463.PMC5076542.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/c8/51/cia-11-1463.PMC5076542.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/c8/51/cia-11-1463.PMC5076542.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8e/d9/ccid-9-367.PMC5076543.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8e/d9/ccid-9-367.PMC5076543.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 367–372Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 367 RevIew open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S93619 Spotlight on adalimumab in the treatment  of active moderate-to-severe hidradenitis  suppurativa Christina Fotiadou  efstratios v akirlis  Dimitrios Ioannides First Department of Dermatology- venereology, Aristotle University  Medical School, Thessaloniki, GreeceAbstract:  Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease  that affects the hair follicles of the aprocrine gland-bearing anatomical areas of the body.",Non-OADS,/arxiv_data1/oa_pdf/8e/d9/ccid-9-367.PMC5076543.pdf
"10Correspondence:  Dimitrios Ioannides First Department of Dermatology- venereology, Aristotle University Medical School, 124 Delfon street, 52440, Thessaloniki, Greece email dem@auth.grJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: REVIEwY ear: 2016V olume: 9Running head verso: Fotiadou et alRunning head recto: Adalimumab in the treatment of hidradenitis suppurativa DOI: http://dx.doi.org/10.2147/CCID.S93619",Non-OADS,/arxiv_data1/oa_pdf/8e/d9/ccid-9-367.PMC5076543.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/8e/d9/ccid-9-367.PMC5076543.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 372 Fotiadou et al  31.,Non-OADS,/arxiv_data1/oa_pdf/8e/d9/ccid-9-367.PMC5076543.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c3/75/amep-7-597.PMC5076544.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/c3/75/amep-7-597.PMC5076544.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 597–602Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 597 OriginAl rEsEArch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S112182 The importance of educating postgraduate  pediatric physicians about food allergy Mehdi Adeli1–3 Mohamed A hendaus1,2 lukman i Abdurrahim1 Ahmed h Alhammadi1,2 1Department of Pediatrics, hamad  Medical corporation, 2Department  of clinical Pediatrics, Weill-cornell  Medical college, 3Department of  Pediatrics, sidra Medical and research  center, Doha, QatarBackground: Food allergy is an increasing public health burden, and is considered among the  most common chronic noncommunicable diseases in children.",Non-OADS,/arxiv_data1/oa_pdf/c3/75/amep-7-597.PMC5076544.pdf
"3 The correspondence: Mehdi Adeli Department of Pediatrics, hamad Medical corporation, PO Box 3050, Doha, QatarTel +974 4439 2239Fax +974 4443 9571Email madeli@hamad.qaJournal name: Advances in Medical Education and Practice Article Designation: ORIGIn Al RESEARCH Y ear: 2016V olume: 7Running head verso: Adeli et alRunning head recto: Educating pediatric physicians about food allergyDOI: http://dx.doi.org/10.2147/AMEP .S112182",Non-OADS,/arxiv_data1/oa_pdf/c3/75/amep-7-597.PMC5076544.pdf
"The AIAP has produced around 20 publications in the last 2 years (http://aiap.hamad.qa), two of which were handed to residents and fellows to improve their knowledge of food allergy in children.",Non-OADS,/arxiv_data1/oa_pdf/c3/75/amep-7-597.PMC5076544.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/c3/75/amep-7-597.PMC5076544.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 602 Adeli et al  4.,Non-OADS,/arxiv_data1/oa_pdf/c3/75/amep-7-597.PMC5076544.pdf
Available from: http://www.fda.gov/Food/IngredientsPack-aginglabeling/FoodAllergens/ucm079311.htm.,Non-OADS,/arxiv_data1/oa_pdf/c3/75/amep-7-597.PMC5076544.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f8/a3/clep-8-389.PMC5076545.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f8/a3/clep-8-389.PMC5076545.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 389–392Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 389 COMMENTARY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S110528 The RECORD reporting guidelines: meeting  the methodological and ethical demands of  transparency in research using routinely-collected  health data Stuart G Nicholls1,2 Sinead M Langan3 Henrik T oft Sørensen4 Irene Petersen4,5 Eric I Benchimol1,6 1Children’s Hospital of Eastern  Ontario (CHEO) Research Institute,   2School of Epidemiology, Public Health  and Preventive Medicine, Faculty  of Medicine, University of Ottawa,  Ottawa, ON, Canada;  3London  School of Hygiene and Tropical Medicine, London, UK;  4Department  of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark;   5Department of Primary Care and  Population Health, University College London, London, UK;  6Department of  Pediatrics and School of Epidemiology,  Public Health and Preventive Medicine, University of Ottawa,  Ottawa, ON, CanadaAbstract:  Routinely-collected health data (RCD) are now used for a wide range of studies,  including observational studies, comparative effectiveness research, diagnostics, studies of  adverse effects, and predictive analytics.",Non-OADS,/arxiv_data1/oa_pdf/f8/a3/clep-8-389.PMC5076545.pdf
"3,4 At the same time, limitations inherent in using data collected without specific a priori  research questions are increasingly recognized.5,6 Concerns have been raised about data  errors,7 missing data,8,9 uncontrolled confounding,10,11 data that are out of date, and data  dredging.12 Moreover, the potential linkage between datasets  creates “myriad opportuni-Correspondence: Henrik Toft Sørensen Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200 Aarhus N, DenmarkTel +45 8716 8215Email hts@clin.au.dkJournal name: Clinical Epidemiology Article Designation: COMMENTAR YY ear: 2016V olume: 8Running head verso: Nicholls et alRunning head recto: The RECORD reporting guidelinesDOI: http://dx.doi.org/10.2147/CLEP .S110528",Non-OADS,/arxiv_data1/oa_pdf/f8/a3/clep-8-389.PMC5076545.pdf
An open discussion forum has been created within the RECORD statement website (http://www.record-statement.org/forum/) 27 as a place for interested individuals  and groups to provide comments.,Non-OADS,/arxiv_data1/oa_pdf/f8/a3/clep-8-389.PMC5076545.pdf
Available from: http://www.record-statement.org/.,Non-OADS,/arxiv_data1/oa_pdf/f8/a3/clep-8-389.PMC5076545.pdf
Available from: http://www.record-statement.org/forum/.,Non-OADS,/arxiv_data1/oa_pdf/f8/a3/clep-8-389.PMC5076545.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/f8/a3/clep-8-389.PMC5076545.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/73/0f/ccid-9-383.PMC5076546.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/73/0f/ccid-9-383.PMC5076546.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical, Cosmetic and Investigational Dermatology 2016:9 383–392Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  383RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S7608 8The psychosocial impact of acne, vitiligo, and  psoriasis: a review Catherine M Nguyen1 Kourosh Beroukhim2 Melissa J Danesh3 Aline Babikian4 John Koo3 Argentina Leon3 1University of California, Irvine  School of Medicine, Irvine, 2David  Geffen School of Medicine at  UCLA, Los Angeles, 3Department of  Dermatology, University of California  San Francisco School of Medicine,   San Francisco, 4Touro University  College of Osteopathic Medicine,   vallejo, CA, USA Correspondence: Catherine M Nguyen   University of California, Irvine School of  Medicine, 1001 Health Sciences Road,  Irvine, CA 92617, USA   email cnguyen2082@gmail.co mIntroduction:  Chronic skin conditions have been well reported to affect a patient’ s quality of  life on multiple dimensions, including the psychosocial domain.",Non-OADS,/arxiv_data1/oa_pdf/73/0f/ccid-9-383.PMC5076546.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/73/0f/ccid-9-383.PMC5076546.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/0f/ccid-9-383.PMC5076546.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ff/85/cia-11-1489.PMC5076547.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1489–1494Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1489OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11353 0 Quality of life of women with breast cancer  undergoing radiotherapy using the Functional  Assessment of Chronic Illness Therapy-Fatigue  questionnaire Marta Muszalik1 Małgorzata Kołucka-Pluta2 Kornelia Kędziora- Kornatowska1 Joanna robaczewska1 1Department and Clinic of geriatrics,   nicolaus Copernicus University,   Collegium Medicum in Bydgoszcz,   2Centrum of Oncology in Bydgoszcz,   Bydgoszcz, PolandObjective:  Breast cancer is one of the most common cancers in women, particularly among older  women.",Non-OADS,/arxiv_data1/oa_pdf/ff/85/cia-11-1489.PMC5076547.pdf
"Correspondence: Marta Muszalik Clinic of geriatrics, nicolaus Copernicus  University, Collegium Medicum in  Bydgoszcz, M sklodowska-Curie 9 street,  85-094 Bydgoszcz, Poland Tel +48 52 585 4900 email muszalik@cm.umk.p l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Muszalik et al Running head recto: Quality of life of women with breast cancer DOI: http://dx.doi.org/10.2147/CIA.S113530",Non-OADS,/arxiv_data1/oa_pdf/ff/85/cia-11-1489.PMC5076547.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ff/85/cia-11-1489.PMC5076547.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ff/85/cia-11-1489.PMC5076547.pdf
Available from: http://onkologia.org.pl/nowotwory-piersi- kobiet /.,Non-OADS,/arxiv_data1/oa_pdf/ff/85/cia-11-1489.PMC5076547.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d3/a8/ccid-9-315.PMC5076548.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d3/a8/ccid-9-315.PMC5076548.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 315–324Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 315 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S118920 Clinical effects of an oral supplement rich   in antioxidants on skin radiance in women Marion Dumoulin David Gaudout Benoit Lemaire Activ’Inside, Libourne, FranceBackground: Environmental factors impact the skin aging resulting in decrease of skin radi- ance.",Non-OADS,/arxiv_data1/oa_pdf/d3/a8/ccid-9-315.PMC5076548.pdf
"Humans attach great importance to a  beautiful, Correspondence: Marion Dumoulin Activ’Inside, Espace Legendre, 33 rue Max Linder, 33500 Libourne, FranceTel +33 535 541 560Email m.dumoulin@activinside.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Dumoulin et alRunning head recto: Effects of an antioxidant-rich oral supplement on skin radianceDOI: http://dx.doi.org/10.2147/CCID.S118920",Non-OADS,/arxiv_data1/oa_pdf/d3/a8/ccid-9-315.PMC5076548.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/d3/a8/ccid-9-315.PMC5076548.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 324 Dumoulin et al,Non-OADS,/arxiv_data1/oa_pdf/d3/a8/ccid-9-315.PMC5076548.pdf
View  Video 2 at http://movie-usa.glencoesoftware.com/video/   10.1530/ERP-16-0032/video-2.Bi-leaflet MechanicalLong Axis Shor t Axis Björk-Shirle y Medtronic-Hall Caged Ball Figure 2 Patterns of normal regurgitation.,Non-OADS,/arxiv_data1/oa_pdf/3d/31/erp-3-R35.PMC5076569.pdf
View  Video 5 at http://movie-usa.glencoesoftware.com/video/   10.1530/ERP-16-0032/video-5.When are other imaging modalities needed?,Non-OADS,/arxiv_data1/oa_pdf/3d/31/erp-3-R35.PMC5076569.pdf
"A King, J Thambyrajah, E Leng  and M J Stewart Cardiothoracic Division, James Cook University Hospital, Middlesbrough, UKID: 16-0022; September 2016 DOI: 10.1530/ERP-16-002210.1530/ERP-16-0022ID: 16-0022; XXX 2016 Correspondence  should be addressed  to A King  Email  Alison.King@stees.nhs.uk Key Words  freproducibility  fejection fraction  f global longitudinal  strain  fherceptin Introduction Breast cancer is the most common cancer in the UK  with over 53,000 cases per year accounting for 15% of  all cancers diagnosed ( http://www.cancerresearchuk.",Non-OADS,/arxiv_data1/oa_pdf/58/38/erp-3-85.PMC5076570.pdf
"DNA sequences were determinated by using an ABI PRISM 3130 Genetic Analyzer (Applied Biosystems, Carlsbad, CA, USA) and compared using a BLAST search in the GenBank/ EMBL/DDBJ database (http://www.ncbi.nlm.",OADS,/arxiv_data1/oa_pdf/3b/15/ijfs-2015-1-4509.PMC5076620.pdf
"Available from: http://www.efsa.europa.eu/it/supporting/pu b/166e.htm EFSA, 2013.",Non-OADS,/arxiv_data1/oa_pdf/21/1f/ijfs-2015-1-4511.PMC5076621.pdf
"Disponibile al sito: http://www.e3s-conferences.org/articles/ e3sconf/abs/2013/01/e3sconf_ichm13_390 05/e3sconf_ichm13_39005.html Fesenko SV, Alexakhin RM, Sanzarova NJ, 1998.",Non-OADS,/arxiv_data1/oa_pdf/8c/f6/ijfs-2015-1-4531.PMC5076622.pdf
"Disponibile al sito:http://www.gazzettaufficiale.it/eli/id/2014/0 6/20/14A04557/sg Salvadori Del Prato O, 1998.",Non-OADS,/arxiv_data1/oa_pdf/1a/f6/ijfs-2015-1-4532.PMC5076623.pdf
Materials and Methods Data were collected using questionnaires available on IZSalimenTO website (http://www.izsalimento.izsto.it/palimenti/) in the period March 2013 - January 2014.,OADS,/arxiv_data1/oa_pdf/22/ed/ijfs-2015-1-4533.PMC5076624.pdf
"Availablefrom: http://greennewdeal.eu/ agricul- ture/publications/2011/en/fish-depen-dence-the-increasing-reliance-of-the-eu- on-fish-from-elsewhere.html Bou G, Saleta JL, Sáez Nieto JA, Tomás M, Valdezate S, Sousa D, Lueiro F, VillanuevaR, Pereira MJ, Llinares P, 2008.",Non-OADS,/arxiv_data1/oa_pdf/7c/d8/ijfs-2015-1-4780.PMC5076627.pdf
"Available from: http://www.globefish.org/tuna-january- 2014.html Figueroa YdVM,  Cabello AM, Villalobos LB, Guevara G, Figuera García BE, Vallenilla González OM, 2006.",Non-OADS,/arxiv_data1/oa_pdf/7c/d8/ijfs-2015-1-4780.PMC5076627.pdf
Available from: http://www.fao.org/docrep/003/ t0007e/t0007e00.HTM                                                                                                                               Article,Non-OADS,/arxiv_data1/oa_pdf/7c/d8/ijfs-2015-1-4780.PMC5076627.pdf
"Available from: https://www.anses.fr/sites/default/files/documents/SANT-Ra-MethodeRisque.pdf Cerf O, 2008.",Non-OADS,/arxiv_data1/oa_pdf/88/2c/ijfs-2015-1-5149.PMC5076628.pdf
"Available from: http://www.fao.org/docrep/008/ae922f/ae92 2f00.htm FAO/OMS, 2002.",Non-OADS,/arxiv_data1/oa_pdf/88/2c/ijfs-2015-1-5149.PMC5076628.pdf
"[Report in French] Available from: http://www.fao.org/publications/card/en/c/9 a4da177-c3dc-5f83-a1a3-428444c4992a/ Lammerding AM, 1997.",Non-OADS,/arxiv_data1/oa_pdf/88/2c/ijfs-2015-1-5149.PMC5076628.pdf
"Available from: http://www.psandman.com/articles/fac- ing.htm Sperber WH, 2001.",Non-OADS,/arxiv_data1/oa_pdf/88/2c/ijfs-2015-1-5149.PMC5076628.pdf
"Availablefrom: http://www.fsis.usda.gov/wps/portal/ fsis/topics/science/risk-assessments/ microbial-risk-assessment-guideline /microbial-risk-assessment-guideline WHO/FAO, 2007.",OADS,/arxiv_data1/oa_pdf/88/2c/ijfs-2015-1-5149.PMC5076628.pdf
"Available from: ftp://ftp.fao.org/docrep/fao/010/a1550t/a155 0t00.pdf WHO/FAO, 2009.",Non-OADS,/arxiv_data1/oa_pdf/88/2c/ijfs-2015-1-5149.PMC5076628.pdf
"Available from: http://www.abipecs.org.br/news/206/135/Fas-da-Linguica-e-Ranking-Domestico.html  Rodriguez MBR, Carneiro CS, Feijó MBS, Conte Júnior CA, Mano SB, 2014.",Non-OADS,/arxiv_data1/oa_pdf/37/e7/ijfs-2015-3-4048.PMC5076629.pdf
Available from: http://revistas.utfpr.edu.br /pb/index.,Non-OADS,/arxiv_data1/oa_pdf/37/e7/ijfs-2015-3-4048.PMC5076629.pdf
"Available from: http://www.fda.gov/food/guidanceregula- tion/guidancedocumentsregulatoryinfor- mation/sanitationtransportation/ucm056174.htm FDLI, 1993.",Non-OADS,/arxiv_data1/oa_pdf/2f/4f/ijfs-2015-3-4504.PMC5076630.pdf
"n° 5.Available (in Italian) from: http://www.gazzettaufficiale.it/eli/id/1999/03/18/099A1923/sg R ASFF, 2012.",Non-OADS,/arxiv_data1/oa_pdf/2f/4f/ijfs-2015-3-4504.PMC5076630.pdf
"Disponibile al sito: http://www.comune.jesi.an.it/ MV/leggi/l689-81.htm Repubblica Italiana, 1990a.",Non-OADS,/arxiv_data1/oa_pdf/d5/a0/ijfs-2015-3-4514.PMC5076632.pdf
"Disponibile al sito: http://www.agcm.it /nor- mativa/concorrenza/4531-legge-10-otto- bre-1990-n-287-norme-per-la-tutela-della- c oncorrenza-e-del-mercato.html Repubblica Italiana, 1990b.",Non-OADS,/arxiv_data1/oa_pdf/d5/a0/ijfs-2015-3-4514.PMC5076632.pdf
"Disponibile al sito: http://www.privacy.it/codiceprivacy.html Repubblica Ital iana, 2011.",Non-OADS,/arxiv_data1/oa_pdf/d5/a0/ijfs-2015-3-4514.PMC5076632.pdf
Disponibile al sito: http://www.garantepri-vacy.it/web/guest/home/docweb/-/docweb- display/docweb/1793203                                                                                                                              Article,Non-OADS,/arxiv_data1/oa_pdf/d5/a0/ijfs-2015-3-4514.PMC5076632.pdf
"Disponibile al sito: http://www.salute.gov.it/imgs/C_17_pub- blicazioni_1150_allegato.pdf Commissione Europea, 2005.",Non-OADS,/arxiv_data1/oa_pdf/ed/61/ijfs-2015-3-4578.PMC5076636.pdf
"Available from: http://www.phac- aspc.gc.ca/fs-sa/phn-asp/2013/ecoli-epi- info-0913-eng.php ISO, 1998a.",OADS,/arxiv_data1/oa_pdf/1d/52/ijfs-2015-3-4585.PMC5076637.pdf
"Governance and food safety in international food chains There are two specific agreements generally dealing with food safety, animal and plant health and product quality policies that are applicable to the Worl d Trade Organization (WTO)’s 160 members as of June 2014 (http://www.wto.org/english/thewto_e/whatis_e /tif_e/org6_e.htm).",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.au-ibar.org/pan- spso/399-second-continental-workshop- on-the-missions-functions-and-structure- of-african-union-food-safet y-authority- a nd-a-rapid-alert-system-for-food-and-feed Bergeron CR, Prussing C, Boerlin P, Daignault D, Dutil L, Reid-Smith RJ, Zhanel GG, Manges AR, 2012.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.cdc.gov/foodborneburden/ DAFF, 2012.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.nda.agric.za/vetweb/VPN%20&% 2 0 S O P / 0 0 4 -VPN%2004%20Standards%20for%20the%20registration%20of%20ostrich%20farm%20for%20export.pdf DAFF, 2013.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.gov.za/documents/meat- safety-act-abattoir-rating-scheme-propos- a l D’Amato ME, Alechine E, Cloete KW, Davison S, Corach D, 2013.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.investigativegenetics.com/con- tent/4/1/6 Dzoma BM, Sejoe S, Segwagwe BV, 2008.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.fao.org/focus/e/right- food/right2.htm FAO, 2010.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.fao.org/docrep/016/ap236e/ap236e.pdf  FAO/WHO, 2003.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"A  vailable from: http://www.fao.org/docrep/006/y8705e/y8705e00.htm FAO/WHO, 2005.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available f r o m : ftp://ftp.fao.org/docrep/fao/meeting/010/j6122e.pdf  Food Law Latest, 2013a.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://foodlawlatest.com/2013/04/09/mafia- shadow-on-the-italian-food-business-eco- nomic-implications  Frean J, Perovic O, Fensham V, M cCarthy K , Von Gottberg A, De Gouveia L, Poonsamy B, Dini L, Rossouw J, Keddy K, Alemu W, Yahaya A, Pierson A, Dolmazon V, Cognat S, Ndihokubwayo JB, 2012.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.fssc22000.com/documents/home.xml?lang=en FVO, 2015.",OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://ec.europa.eu /food/fvo/audit_reports/index.cfm G  ovender R, Katsande TC, 2011.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://mahider.ilri.org/handle/10568/21161  ISO, 2005.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
Available from: http://www.foodsafetymagazine.,Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Ava ilable f rom: http://www.nammic.com.na/fan.php  Mellata M, 2013.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.nicd.ac.za/assets/files/2011_GERMS-SA_Annual_report_pub_final.pdf NHLS, 2012.",OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.nhls.ac.za/assets/files/NICD%20Annual%20Review(1).pdf  NHLS, 2015.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"A vailable from: http://www.nhls.ac.za/?page=news&id=4&rid=35  OECD, 2007.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.oie.int/fileadmin/Home/eng/Support_to_OIE_Members/docs/pdf/Namibia_OIE-PVS_28012009.pdf OIE PVS, 2015a.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.oie.int/support-to-oie-mem- bers/pvs-evaluations/oie-pvs-evaluation- reports/ OIE PVS, 2015b.",OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from:http://www.ers.usda.gov/media/115077/eib82_1_.pdf  Olson ED, 2011.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"A vailable from: http://www.pmg.org.za/report/20130326- meat-inspections-labeling-sa-depts-agri- culture-health-trade-industry  Paulsen P, 2011.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.nda.agric.za/doaDev /sideMenu/APIS/doc/ MEAT SAFETY.pdf Rowe JS, Shah SS, Motlhagodi S, Bafana M, Tawanana E, Truong HT, Wood SM, Zetola NM, Steenhoff AP, 2010.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.sad- cas.org/allnews.php  Samaxa RG, Matsheka MI, Mpoloka SW, Gashe BA, 2012.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://scialert.net/fulltext/?doi=ijmeat.2011.15.26&org=11 STDF, 2011.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http: http://www.oie.int/doc/ged/D13279.PDF Thompson D, Ying H, 2007.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
Available from: http://repository.up.,Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.fsis.usda.gov/wps/portal/fsis/topics/international-affairs/importing-prod- ucts/equivalence/status-of-initial-equiva-lence/namibia-initial-equivalence-status  USDA FSIS, 2013.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.fsis.usda.gov/wps/portal/frame- redirect?url=/wps/wcm/connect/FSIS- Content/fsis-questionable-content/for- e ign-audit-reports-duplicate  Van der Merwe M, Jooste PJ, Hoffman LC, 2011.",OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from: http://www.afro.who.int/en/clusters-a-pro- grammes/hpr/food-safety-and-nutrition- fan/fan-publications.html  W TO, 1995.",Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
Available from: http://www.wto.org/english/tratop_e/sps_e/sps_e.htm                              Article,Non-OADS,/arxiv_data1/oa_pdf/98/d5/ijfs-2015-3-5114.PMC5076638.pdf
"Available from:http://www.geneious.com/ European Commission, 2009.",Non-OADS,/arxiv_data1/oa_pdf/e7/91/ijfs-2015-3-5358.PMC5076639.pdf
Available from: https://www.politicheagricole.,Non-OADS,/arxiv_data1/oa_pdf/e7/91/ijfs-2015-3-5358.PMC5076639.pdf
"A vailable from: https://fas.org/sgp/crs/misc/RL33938.pdf Kanbar G, Engels W, 2003.",Non-OADS,/arxiv_data1/oa_pdf/ad/97/ijfs-2015-3-5364.PMC5076640.pdf
Available from: http://nf-validation.afnor.,Non-OADS,/arxiv_data1/oa_pdf/89/3b/ijfs-2015-3-5370.PMC5076641.pdf
"Available from: http://www.efsa.europa.eu/it/efsajournal/p ub/980.htm European Commission, 2004a.",Non-OADS,/arxiv_data1/oa_pdf/35/94/ijfs-2015-2-4196.PMC5076643.pdf
"Available from: http://www.britishkebabawards.co.uk/win- ners_2013 Cersosimo D, 2011 .",Non-OADS,/arxiv_data1/oa_pdf/5f/7e/ijfs-2015-2-4535.PMC5076648.pdf
"Available from: http://www.food.gov.uk/scotland/regsscot- land/regsguidscot/meatproductguid- ancescot  Greenfield H, Southgate DAT, 2007.",Non-OADS,/arxiv_data1/oa_pdf/5f/7e/ijfs-2015-2-4535.PMC5076648.pdf
"Available from:http://www.lacors.gov.uk/lacors/NewsArticl eDetails.aspx?N=0&Ne=0+20 00+3000+4 0 00+5000+6000+7000+8000+9000+1000 0+11000&id=21002 SINU, 2012.",Non-OADS,/arxiv_data1/oa_pdf/5f/7e/ijfs-2015-2-4535.PMC5076648.pdf
"Available from: http://www.ontit.it/opencms/opencms/ont/it/focus/focus/il_turismo_nelle_citta_ital- iane Paolini D, 2005.",Non-OADS,/arxiv_data1/oa_pdf/5f/7e/ijfs-2015-2-4535.PMC5076648.pdf
"Listeria monocytogenes.Disponibile al sito: http://www.afssa.fr/ Documents/MIC-Fi-ListeriaEN.pdf CDC, 2009.",Non-OADS,/arxiv_data1/oa_pdf/6c/3a/ijfs-2015-2-4567.PMC5076649.pdf
"Disponibile al sito: http://www.cdc.gov/pulsenet/protocols/ pulsenet_listeria_protocol%20.pdf Commissione Europea, 2005.",OADS,/arxiv_data1/oa_pdf/6c/3a/ijfs-2015-2-4567.PMC5076649.pdf
"Disponibile al sito: ftp://ftp.fao.org/es/esn/jemra/mra4 _en.pdf ISO, 2004.",OADS,/arxiv_data1/oa_pdf/6c/3a/ijfs-2015-2-4567.PMC5076649.pdf
"Available from: http://animalhandling.org/ht/a/Get DocumentAction/i/93003 Hui YH, Nip WK, Rogers RW, Young OA, 2001.",Non-OADS,/arxiv_data1/oa_pdf/cc/a5/ijfs-2015-2-4580.PMC5076651.pdf
"Available (in Italian) from: http://www.camera.it/parlam/leggi/06096l.h tm McDowell, S.W., Porter, R., Madden, R., Cooper, B., Neill, S.D., 2007.",Non-OADS,/arxiv_data1/oa_pdf/cc/a5/ijfs-2015-2-4580.PMC5076651.pdf
"Available (in Italian) from: http://www.regione.sardegna.it/j/v/86?v=9&c=72&s=1& file=1998018 Sejian V, Lakritz J, Ezeji T, Lal R, 2011.",Non-OADS,/arxiv_data1/oa_pdf/cc/a5/ijfs-2015-2-4580.PMC5076651.pdf
Sequences were subjected to BLAST search athttp://www.ncbi.nlm.nih.gov/pubmed .,OADS,/arxiv_data1/oa_pdf/b4/ca/ijfs-2015-2-4587.PMC5076652.pdf
"Available from: http://www.izsler.it/izs_bs/ftp//doc/Archiv io /  2007/2007Aprile.pdf Zanetti AR, Schlauder GG, Romanò L, Tanzi E, Fabris P, Dawson GJ, Mushahwar IK, 1999.",Non-OADS,/arxiv_data1/oa_pdf/b4/ca/ijfs-2015-2-4587.PMC5076652.pdf
"Available from: http://www.efsa.europa.eu/it/supporting/do c/33e.pdf Fayer R, 2004.",Non-OADS,/arxiv_data1/oa_pdf/b5/ce/ijfs-2015-2-4626.PMC5076653.pdf
"United Nations Food andAgriculture Organization Available from: http://www.fao.org/3/a-i3720e/index.html IMAFFP, 2011.",Non-OADS,/arxiv_data1/oa_pdf/d9/9b/ijfs-2015-2-4923.PMC5076655.pdf
"Available from: http://www.sardegnaagri- coltura.it/documenti/14_43_20091201175044.pdf Sardegna Salute, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/9b/ijfs-2015-2-4923.PMC5076655.pdf
Available from: http://www.sardeg- nasalute.it/index.php?xsl=316&s=9&v=9&c=4695&na=1&n=10                             Short Communication,Non-OADS,/arxiv_data1/oa_pdf/d9/9b/ijfs-2015-2-4923.PMC5076655.pdf
"Available from: http://www.eurosurveillance.org /images/dynamic/EE/V19N17/art20787.pdfGill A, Huszczynski G, Gauthier M, Blais B, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f0/04/ijfs-2015-2-5156.PMC5076656.pdf
Available from: http://www.ismea.it/flex/AppData/Article Table 1.,OADS,/arxiv_data1/oa_pdf/15/1f/ijfs-2014-1-1526.PMC5076658.pdf
"Disponibile al sito:http://agricoltura.regione.campania.it/comunicati/pdf/DGR_377-04-08-11.pdf Repubblica Italiana, 2006.",Non-OADS,/arxiv_data1/oa_pdf/d3/00/ijfs-2014-1-1661.PMC5076663.pdf
"Il numero dei capi macellati è st ato q uindi esaminato in relazione alle variabili anno di macellazione, provenienza, luogo di macellazione, sesso ed età e correlato al patrimonio zootecnico nazio- nale e regionale acquisibile, quest’ultimo, dal portale del Ministero della Salute (https://www.vetinfo.sanita.it/).",Non-OADS,/arxiv_data1/oa_pdf/7e/b8/ijfs-2014-1-1665.PMC5076664.pdf
"Disponbile al sito: http://www.assocarni.it/pagina13_dos- sier.html ISMEA, 2006.",Non-OADS,/arxiv_data1/oa_pdf/7e/b8/ijfs-2014-1-1665.PMC5076664.pdf
"Disponbile al sito: http://alimvet.sanita.it/NuovoStabilimenti/  Regione Lazio, 2002.",Non-OADS,/arxiv_data1/oa_pdf/7e/b8/ijfs-2014-1-1665.PMC5076664.pdf
"Disponibile al sito: http://www.cdc.gov/pulsenet/proto- cols/pulsenet_listeria_protocol%20.pdf Cecchini S, Palombo B, Briscolini S, Panciotti M, Gattuso A, Gianfranceschi MV, LoschiAR, Blasi G, 2011.",OADS,/arxiv_data1/oa_pdf/b7/e8/ijfs-2014-1-1708.PMC5076667.pdf
"Disponibile al sito: http://spvet.it/arretrati/numero-64/001 Spvet64.html Commissione Europea, 2005.",Non-OADS,/arxiv_data1/oa_pdf/b7/e8/ijfs-2014-1-1708.PMC5076667.pdf
"Disponibile al sito: http://www.izsler.it/izs_bs/allegati/718/09SIEF.pdf  Butzler JP, 2004.",Non-OADS,/arxiv_data1/oa_pdf/b5/3e/ijfs-2014-1-1711.PMC5076668.pdf
"Disponibile al sito: http://cerere.vet.unipi.it/system/files/DGSAN+15990+30+mag+08+Distrib+latte+crudo.pdf Repubblica Italiana, 2007.",Non-OADS,/arxiv_data1/oa_pdf/af/24/ijfs-2014-1-1715.PMC5076670.pdf
"Disponibile al sito: http://www.governo.it/bac koffice/allega- t i/30606-3457.pdf USDA, 2008.",Non-OADS,/arxiv_data1/oa_pdf/af/24/ijfs-2014-1-1715.PMC5076670.pdf
"Available from: http://www.fsai.ie/ uploadedFiles/EU_Guidance_shelflife_lis-teria_monocytogenes_en.pdf Autio T, Säteri T, Fredriksson-Ahomaa M, Rahkio M, Lundén J, Korkeala H, 2000.",OADS,/arxiv_data1/oa_pdf/fc/be/ijfs-2014-1-2231.PMC5076673.pdf
"Availablefrom: http://www.meatami.com/ht/a/Get DocumentAction/i/42348 ISO, 1996.",Non-OADS,/arxiv_data1/oa_pdf/fc/be/ijfs-2014-1-2231.PMC5076673.pdf
"Available at:http://www.ars-alimentaria.it/ars_alimen- taria/00001270_Ars_Alimentaria.html  Bielaszewska M, Janda J, Blahova K, Minarikova H, 1997.",Non-OADS,/arxiv_data1/oa_pdf/9d/b4/ijfs-2014-1-2243.PMC5076674.pdf
"Available at: http://www.ibvr.org EFSA, 2013.",Non-OADS,/arxiv_data1/oa_pdf/9d/b4/ijfs-2014-1-2243.PMC5076674.pdf
"Available from: http://www.efsa.europa.eu/it/efsajournal/doc/3129.pdf European Commission, 2005.",Non-OADS,/arxiv_data1/oa_pdf/9d/b4/ijfs-2014-1-2243.PMC5076674.pdf
"Available from: http://ec.europa.eu/food/ food/rapidalert/index_en.htm Giacometti F, Serraino A, Finazzi G, Daminelli P, Losio MN, Tamba M, Garigliani A, Mattioli R, Riu R, Zanoni RG, 2012.",Non-OADS,/arxiv_data1/oa_pdf/9d/b4/ijfs-2014-1-2243.PMC5076674.pdf
"Available at: http://www.phac-aspc.gc.ca/fs-sa/phn-asp/2013/ecoli-epi-info-0913- eng.php Ramsaran H, Chen J, Brunke B, Hill A, Griffiths MV, 1998.",Non-OADS,/arxiv_data1/oa_pdf/9d/b4/ijfs-2014-1-2243.PMC5076674.pdf
"Available from:http://classwebs.spea.indiana.edu/dhen- shel/sandman.pdf Shaw I, 2003.",Non-OADS,/arxiv_data1/oa_pdf/66/88/ijfs-2014-1-2269.PMC5076675.pdf
Availabl e from: ftp://ftp.fao.org/ ag/agn/jemra/17f.pdfArticle,Non-OADS,/arxiv_data1/oa_pdf/66/88/ijfs-2014-1-2269.PMC5076675.pdf
"A vailable from: http://www.hc- sc.gc.ca/fn-an/legislation/pol/ listeria_monocytogenes-test-eng.php Marino M, Maifreni M, Rondinini G, 2003.",Non-OADS,/arxiv_data1/oa_pdf/3b/25/ijfs-2014-1-2270.PMC5076676.pdf
"Disponibile alsito: http://www.mark-up.it/artico- li/0,1254,41_ART_4296,00.html D’Amico DJ, Silk TM, Wu J, Guo M, 2 006.",Non-OADS,/arxiv_data1/oa_pdf/e9/2c/ijfs-2014-1-955.PMC5076677.pdf
"Disponibile al sito: http://www.fda.gov/ohrms/dockets/98fr/011 901b.htm Villamiel M, de Jong P, 2000.",Non-OADS,/arxiv_data1/oa_pdf/e9/2c/ijfs-2014-1-955.PMC5076677.pdf
"Available from: http://www.crlcefas.org/Content/GPG_Issue4_Aug2010.pdf Cushman-Rosin B, Gacic M, Poulain PM, Artegiani A, 2001.",Non-OADS,/arxiv_data1/oa_pdf/31/e0/ijfs-2014-1-995.PMC5076678.pdf
"The reporton the Rapid Alert System for Food and Feed (RASFF, https://webgate.ec.europa.eu/rasff- window/portal/) of the European Communitygoverning food safety over the last decade con- cerned only n. 8 alerts due to infestation ofinsects and larvae in dried, frozen, pickled and fresh mushrooms from different countries (RASFF Portal).",Non-OADS,/arxiv_data1/oa_pdf/a5/e2/ijfs-2015-4-4523.PMC5076679.pdf
"Available from: http://ec.europa.eu/ ood/food/biosafety/hygienelegislation/com m_rules_en.htm FDA, 1998.",Non-OADS,/arxiv_data1/oa_pdf/a5/e2/ijfs-2015-4-4523.PMC5076679.pdf
"Available from: http://www.sicurezzalimentare.it /index.php/origine-dei-funghi/   Maroli M, Khoury C, Bianchi R, Aureli P, 2002.",Non-OADS,/arxiv_data1/oa_pdf/a5/e2/ijfs-2015-4-4523.PMC5076679.pdf
"Available from: http://www.ispettorimicologi.it Süss L, Sitta N, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a5/e2/ijfs-2015-4-4523.PMC5076679.pdf
"Dispo - nibile al sito: http://www.spvet.it/ arretra- ti/numero-46/001.html Commissione Europea, 2004.",Non-OADS,/arxiv_data1/oa_pdf/e4/bd/ijfs-2015-4-4575.PMC5076680.pdf
"Available from: http://www.card.iastate.edu/publica- tions/DBS/PDFFiles/04mbp7.pdf Barjolle D, 1999.",Non-OADS,/arxiv_data1/oa_pdf/73/45/ijfs-2015-4-4931.PMC5076682.pdf
"Available from: http://eur-lex.europa.eu/legal-con- tent/EN/TXT/?uri=CELEX:51999DC0719 FAO, 2004.",Non-OADS,/arxiv_data1/oa_pdf/73/45/ijfs-2015-4-4931.PMC5076682.pdf
"Available from: http://www.fao.org/ docrep/meeting/008/j2673e/J2673e00.htm FAO, 2011.",Non-OADS,/arxiv_data1/oa_pdf/73/45/ijfs-2015-4-4931.PMC5076682.pdf
"Available from: http://aof.revues.org/7210 WIPO, 2013.",Non-OADS,/arxiv_data1/oa_pdf/73/45/ijfs-2015-4-4931.PMC5076682.pdf
"Available from: http://www.cdc.gov/mmwr/preview/mmwr html/mm6022a5.htm CDC, 2013.",OADS,/arxiv_data1/oa_pdf/4b/92/ijfs-2015-4-5127.PMC5076683.pdf
"US Department of Agriculture, Economic Research Service, Washington, DC, USA.Available from: http://www.ers.usda.gov/data/foodborneil- lness/salm_intro.asp Zou W, Chen HC, Hise KB, Tang H, Foley SL, Meehan J, Lin WJ, Nayak R, Xu J, Fang H, Chen JJ, 2013.",OADS,/arxiv_data1/oa_pdf/4b/92/ijfs-2015-4-5127.PMC5076683.pdf
"Available from: http://www.nationalaglawcenter.org/assets /crs Campagna MC, Marozzi S, Condoleo R, Bottalico N, Nardoni A, Cavallina R, 2011.Nuove frodi alimentari nel settore ittico: gallinella o pangasio?",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ijfs-2015-4-5363.PMC5076684.pdf
"Available from: http://www.gazzettaufficiale.biz/ atti/2011/20110208/sommario.htm IREPA, 2010.",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ijfs-2015-4-5363.PMC5076684.pdf
"Available from: http://www.irepa.org/it/pesca/8-osservato- ri/49-osservatorio-economico-sulle-strut- ture-produttive-della-pesca-marittima-in- italia-2009-xviii-rapporto-edizioni-scienti- fiche-italiane-napoli-isbn-978-88-495- 2118-4-.html IREPA, 2011.",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ijfs-2015-4-5363.PMC5076684.pdf
"Available from: http://www.irepa.org/it/pesca/8-osservato- ri/303-osservatorio-economico-sulle-strut- ture-produttive-della-pesca-marittima-in- italia-2010-edizioni-scientifiche-italiane- napoli-isbn-978-88-495-2235-8.html  IREPA, 2012.",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ijfs-2015-4-5363.PMC5076684.pdf
"Available from: http://www.irepa.org/it/pesca/8-osservato- ri/320-osservatorio-economico-sulle-strut- ture-produttive-della-pesca-marittima-in- italia-2011.html Logan CA, Alter SE, Haupt AJ, Tomalty K, Palumbi SR, 2008.",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ijfs-2015-4-5363.PMC5076684.pdf
"Available from: http://www.ordi- niveterinaripiemonte.it/rivista/05n06/06.h tm Pappalardo AM, Ferrito V, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3c/23/ijfs-2015-4-5363.PMC5076684.pdf
"The questionnaire was developed using the GoogleForms application (www.google.it) and was then made accessible on-line at the follow-ing link: https://docs.google.com/spreadsheet/ viewform?formkey=dElnNFN0cXp4MXVwd2pC NFFiMll0SlE6MQ The participants were mostly of the Christian religion, only 2% of the subjectswere Jewish or Muslim.",Non-OADS,/arxiv_data1/oa_pdf/a2/38/ijfs-2015-4-5504.PMC5076690.pdf
"Available from: http://www.dialrel.eu/ European Commission, 1993.",Non-OADS,/arxiv_data1/oa_pdf/a2/38/ijfs-2015-4-5504.PMC5076690.pdf
Available from: http://www.dialrel.eu/images/recom-light.pdf                             Article,Non-OADS,/arxiv_data1/oa_pdf/a2/38/ijfs-2015-4-5504.PMC5076690.pdf
"Available from: http://www.fda.gov/Food/ResourcesForYou/ Consumers/ucm253954.htm Italian Board of Health, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a1/5e/ijfs-2014-4-4516.PMC5076694.pdf
"Available from:http://www.salute.gov.it/imgs/C_17_opuscoliPoster_147_allegato.pdf Italian Board of Health, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a1/5e/ijfs-2014-4-4516.PMC5076694.pdf
"Available from: http://www.salute.gov.it /portale/news/p3_2_3_1_1.jsp?lingua=italiano&menu=dossier&p=dadossier&id=8 Jay LS, Comar D, Govenlock LD, 1999.",Non-OADS,/arxiv_data1/oa_pdf/a1/5e/ijfs-2014-4-4516.PMC5076694.pdf
"Available from: http://www.foodsafety.gov/blog/per- fectfood.html  Worsfold D, Griffith C, 1997.",Non-OADS,/arxiv_data1/oa_pdf/a1/5e/ijfs-2014-4-4516.PMC5076694.pdf
"Available  from: https://webgate.ec.europa.eu/rasff-  window/portal/  Frobisch RA, Bradley DD, Wagner DD, Long-  Bradley PE, Hairston H, 1986.",Non-OADS,/arxiv_data1/oa_pdf/99/cb/ijfs-2014-4-4517.PMC5076695.pdf
"Available from: http://www.fsai.ie/uploadedFiles/EURL%20  Lm_Technical%20Guidance%20Document  %20Lm%20shelf-life%20studies_V3_2014-  06-06%20(2).pdf  Beumer RR, Te Giffel MC, De Boer E, Rombouts FM, 1996.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
"Available from: http://www.chilled - food.org/MEDIA/NEWS/2010/New+Shelf+L  ife+Guidance+for+Ready+to+Eat+Foods  Codex Alimentarius Commission, 2004.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
Available  from: http://www.codexalimentarius.,Non-OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
"Available from: http://www.fsai.ie/uploadedFiles/EU_Guida  nce_listeria_monocytogenes.pdf  European Commission, 2004.",OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
"Available from: http://www.fsis.usda.gov/OPPDE/rdad/FRP  ubs/97-013F.htm  FSIS, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
"Available from: http://www.fsis.usda.gov/wps/wcm/con - nect/d3373299-50e6-47d6-a577-  e74a1e549fde/Controlling_LM_RTE_Guid  eline_0912?MOD=AJPERES  Fu AH, Sebranek JG, Murano EA, 1995.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
"Available from: http://www.hc-sc.gc.ca/fn-  an/alt_formats/pdf/legislation/pol/liste - ria_monocytogenes-test-eng.pdf  Hereu A, Bover-Cid S, Garriga M, Aymerich T, 2012.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
"                                 [Italian Journal of Food Safety 2014; 3:4518]                                                 [page 237 ]http://www.fda.gov/food/foodsciencere - search/safepracticesforfoodprocesses/ucm  091368.htm  USFDA, 2008.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
"Available  from: http://www.fda.gov/food/guid -anceregulation/guidancedocumentsregu - latoryinformation/foodprocessinghaccp/uc  m073110.htm  Uyttendaele M, Rajkovic A, Benos G, François  K, Devlieghere F, Debevere J, 2004.",Non-OADS,/arxiv_data1/oa_pdf/3f/1f/ijfs-2014-4-4518.PMC5076696.pdf
"Avaiable from: http://ec.europa.eu/agricul- ture/eval/reports/sheep-goat/syn_  sum_en.pdf  Beresford TP, Fitzsimons NA, Brennan NL, Cogan TM, 2001.",Non-OADS,/arxiv_data1/oa_pdf/24/a1/ijfs-2014-4-4586.PMC5076699.pdf
The sequences were compared with those available in the GenBank/EMBL/DDBJ (http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/05/cb/ijfs-2016-1-5503.PMC5076706.pdf
"Available from: http://www.ers.usda.gov/amber- waves/2003-april/weighing-incentives-for-food-safety-in-meat-and- poultry.aspx#.VvPn3z8oOyp Pennings JME, Wansink B, Meulenberg MTG, 2002.",Non-OADS,/arxiv_data1/oa_pdf/97/57/ijfs-2016-1-5580.PMC5076708.pdf
"Available from: http://www.fda.gov/Food/ Food ScienceResearch/LaboratoryMethods/ucm070830.htm  Noguerola I, Blanch AR, 2008.",Non-OADS,/arxiv_data1/oa_pdf/6e/7d/ijfs-2016-1-5709.PMC5076712.pdf
"Available from: http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182  Fortina GM, Ricci G, Acquati A, Zeppa G, Gandini A, Manichini PL, 2003.",OADS,/arxiv_data1/oa_pdf/d8/60/ijfs-2014-3-1696.PMC5076718.pdf
A  vailable from: http://www.agricol - tura.regione.lombardia.it/shared/ccurl/983/569/QdR%20147.pdf                                                                                                                              Article,Non-OADS,/arxiv_data1/oa_pdf/e9/d2/ijfs-2014-3-1705.PMC5076721.pdf
"Available from: http://www.oie.int/manual-of-diag- nostic-tests-and-vaccines-for-terrestrial- animals/ Prencipe V, Parisciani G, Calistri P, Caporale CM, Iannitto G, Morelli D, Pomilio F, Prochowski D, Migliorati G, 2007.",Non-OADS,/arxiv_data1/oa_pdf/c6/76/ijfs-2014-3-1706.PMC5076722.pdf
"Available from: http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=1225&area=sicurezzaAlimentare&menu=igiene Masotti G, Amadei P, Lanni L, Masotti G, Amadei G, 2010.",Non-OADS,/arxiv_data1/oa_pdf/e7/27/ijfs-2014-3-1707.PMC5076723.pdf
"Available from: http://www.anses.fr/Documents/SANT2008sa0240.pdf  AFSCA, 2009.",Non-OADS,/arxiv_data1/oa_pdf/d0/60/ijfs-2014-3-1721.PMC5076724.pdf
"Available from:  http://ec.europa.eu/ food/fvo/act_getPDF.cfm?PDF_ID=9581  European Commission, 2  012a.",Non-OADS,/arxiv_data1/oa_pdf/d0/60/ijfs-2014-3-1721.PMC5076724.pdf
"Available from: http://ec.europa.eu/food/fvo/act_getPDF.cfm?PDF_ID=9709 European Commission, 2012b.",Non-OADS,/arxiv_data1/oa_pdf/d0/60/ijfs-2014-3-1721.PMC5076724.pdf
Available from: http://www.food.gov.,Non-OADS,/arxiv_data1/oa_pdf/d0/60/ijfs-2014-3-1721.PMC5076724.pdf
"Available from: http://www.landkreis-ludwigsburg.de /fileadmin/kreis-lb.de/pdf-dateien/buerger- info/gesundheit/veterinaerangelegenheit- en/lebensmittelueberwachung/fb_lebens- mittelketteninformation.pdf PVE, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d0/60/ijfs-2014-3-1721.PMC5076724.pdf
Available from: http://www.aragon.es/estaticos/ImportFiles /12/docs/Areas/Ganaderia/Informacion_Cadena_Alimentaria/INSTRUCCIONES_CUMPLIMENTACION_INFORMACION_CADENA_ALIMENTARIA_SACRIFICIO.pdf                             Article,Non-OADS,/arxiv_data1/oa_pdf/d0/60/ijfs-2014-3-1721.PMC5076724.pdf
"Available from: http://www.formatex.org/microbiology2/chapters2.html Houa Z, Finka  R C, Radtkea C, Sadowsky MJ, Diez-Gonzalez F, 2013.",Non-OADS,/arxiv_data1/oa_pdf/2c/42/ijfs-2014-3-1733.PMC5076725.pdf
"Available from: http://europa.eu/legis- lation_summaries/maritime_affairs_and_fisheries/fisheries_resources_and_envi- ronment/pe0007_en.htm Gaviglio A, Demartini E, 2009.",Non-OADS,/arxiv_data1/oa_pdf/7b/b4/ijfs-2014-3-1983.PMC5076726.pdf
"Available from: http://zpravy.e15.cz/domaci/ekonomika/ministerstvo-zemedelstvi-spusti-rybu- domaci-2-988405Rajani N, 2010.",Non-OADS,/arxiv_data1/oa_pdf/7b/b4/ijfs-2014-3-1983.PMC5076726.pdf
Available from: http://eagri.cz/pub- lic/web/mze/tiskovy-servis/tiskove- zpravy/x2008_tz-080821-ryba-je-dobra- zdrava-a-domaci.html                             Review,Non-OADS,/arxiv_data1/oa_pdf/7b/b4/ijfs-2014-3-1983.PMC5076726.pdf
Available  from: http://www.antimicrobialresistance.,Non-OADS,/arxiv_data1/oa_pdf/0b/c2/ijfs-2014-3-2246.PMC5076728.pdf
"Available from: http://www.for - mulaires.agriculture.gouv.fr/Bulletin-epidemi - ologique-no-41  ICMSF, 1986.",Non-OADS,/arxiv_data1/oa_pdf/0b/c2/ijfs-2014-3-2246.PMC5076728.pdf
Available from:  http://www.wattagnet.,Non-OADS,/arxiv_data1/oa_pdf/0b/c2/ijfs-2014-3-2246.PMC5076728.pdf
"Data on rainfall and environmental tem- perature were collected from the website http://weather.yahoo.com/italia/emilia- romagna/bologna-711080/ Escherichia coli O157 detection Five g rams of faeces, 25 g of feed and 25 mL of water were diluted tenfold (w/v) in buffered peptone water, and incubated at 37±1°C for21±3 h. Bacterial DNA was extracted from 1 mL of enriched broth using the Gen elute TM                                                 Italian Journal of Food Safety 2014; volume 3:2297 Correspondence: Andrea Serraino, Dipartimento di Scienze Mediche Veterinarie, Università degli Studi di Bologna, via Tolara di Sopra 50, 40064 Ozzano dell’Emilia (BO), Italy.",Non-OADS,/arxiv_data1/oa_pdf/8f/90/ijfs-2014-3-2297.PMC5076729.pdf
Available from: http://ec.europa.,Non-OADS,/arxiv_data1/oa_pdf/ac/ec/ijfs-2014-3-4143.PMC5076730.pdf
"Availablefrom: http://www.cdc.gov/listeria/out-breaks/cheese-09-12/ De Santis EPL, Foddai A, Virdis S, Marongiu P, Pilo AL, Scarano C, 2008.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/ijfs-2016-2-5501.PMC5076733.pdf
"Available from: http://www.sardeg- naagricoltura.it/documenti/14_43_20141006144130.pdf  Pilo AL, Marongiu P, Corgiolu G, Virdis S, Scarano C, De Santis EPL, 2007.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/ijfs-2016-2-5501.PMC5076733.pdf
"Available from:http://ec.europa.eu/food/safety/rasff/docs/rasff_annual_report_2008_en.pdf Scheldeman P, Herman L, Foster L, Heyndrickx M, 2006.",Non-OADS,/arxiv_data1/oa_pdf/8b/1f/ijfs-2016-2-5501.PMC5076733.pdf
"Availablefrom: http://www.iss.it/binary /spva4/cont/CNRB30.000.pdf ISO, 2004.",OADS,/arxiv_data1/oa_pdf/c7/e5/ijfs-2016-2-5564.PMC5076734.pdf
The sequences were analysed and compared to BIBI and NCBI-Blast (http://blast.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/cd/b7/ijfs-2016-2-5620.PMC5076735.pdf
"Available from: ftp://ftp.fao.org/docrep/fao/009/a0699e/a06 99e.pdf Figge MJ, Cleenwerck I, van Uijen A, De Vos P, Huys G, Robertson L, 2014.",Non-OADS,/arxiv_data1/oa_pdf/cd/b7/ijfs-2016-2-5620.PMC5076735.pdf
"Available from:http://www.psandman.com/articles/fac-ing.htm Santé Canada, 2000.",Non-OADS,/arxiv_data1/oa_pdf/4e/cf/ijfs-2016-2-5649.PMC5076736.pdf
"Available from: http://www.anses.fr/en/con- tent/bisphenol-efsa-recommends-lowe- ring-total-daily-intake-tdi-while-conside- ring-current-exposure Arnich N, Canivenc-Lavier MC, Kolf-Clauw M, Coffigny H, Cravedi JP, Grob K, Macherey AC, Masset D, Maximilien R, Narbonne JF, Nesslany F, Stadler J, Tulliez J, 2011.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
"Available from: http://www.food.dtu.dk/english/News/2015/ 02/National-Food-Institute-maintains-its- assessment-of-bisphenol-A?id=1c4245ae- b133-4d8b-9448-faac26ca4b9a EFSA, 2013.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
"Available from: http://www.efsa.europa.eu/en/press/news/1 50121 EFSA, 2015b.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
"Available from: http://www.efsa.europa.eu/sites/default/fil es/corporate_publications/files/factsheetb- pa150121.pdf EFSA, 2015c.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
"Available from: https://www.efsa.europa.eu/sites/default/fil es/scientific_output/files/main_docu- ments/3978.pdf EFSA, 2015d.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
Available from: https://www.efsa.europa.eu/sites/default/fil                                                                                                                             Review,Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
"Available from: https://www.efsa.europa.eu/sites/default/fil es/scientific_output/files/main_docu- ments/3978part2.pdf Engler RE, 2012.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
"Available from: http://www.europarl.europa.eu/sides/getDo c.do?pubRef=-//EP//TEXT+WQ+E-2015- 002007+0+DOC+XML+V0//EN Fasano E, Cirillo T, Esposito F, Lacorte S, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
"Available from: http://www.foodstandards.gov.au/consu- mer/chemicals/bpa/Pages/default.aspx Gatidou G, Vassalou E, Thomaidis NS, 2010.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
"Available from: http://pubchem.ncbi.nlm.nih.gov/com- pound/Bisphenol_A Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, Vandenbergh JG, Walser-Kuntz DR, vom Saal FS, 2007.",Non-OADS,/arxiv_data1/oa_pdf/6c/ea/ijfs-2016-2-5666.PMC5076740.pdf
Available from: http://www.ejpau.,Non-OADS,/arxiv_data1/oa_pdf/53/83/ijfs-2016-2-5691.PMC5076741.pdf
"Available from: http://www.lrrd.org/ lrrd20/10/tufa20165.htm Zicarelli L, 2001.",Non-OADS,/arxiv_data1/oa_pdf/53/83/ijfs-2016-2-5691.PMC5076741.pdf
"Available from: http://www.regione.piemonte.it/sanita/cms 2/alimenti/sorveglianza-delle-malattie- trasmesse-da-alimenti Bianchi DM, Ingravalle F, Adriano D, Gallina S, Gramaglia M, Zuccon F, Astegiano S, Bellio A, Macori G, Ru G, Decastelli L, 2014.",Non-OADS,/arxiv_data1/oa_pdf/78/e5/ijfs-2016-2-5736.PMC5076742.pdf
"Available from: http://www.cdc.gov/botu- lism/ Devriese LA, 1984.",OADS,/arxiv_data1/oa_pdf/78/e5/ijfs-2016-2-5736.PMC5076742.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/75/0a/10.1177_2325967116668782.PMC5076746.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/bb/a5/10.1177_2325967116669309.PMC5076747.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/24/7d/10.1177_2325967116668490.PMC5076751.pdf
"Therapeutic Advances in Gastroenterology806 http://tag.sagepub.comTher Adv Gastroenterol 2016, Vol.",Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
http://tag.sagepub.com 807 reduced overall and cancer-specific mortality  [Chan et  al.,Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
"Therapeutic Advances in Gastroenterology 9(6) 808 http://tag.sagepub.com stomach but did not extend to the esophagogastric  junction or esophagus, was reclassified as a pri-mary gastric cancer and excluded from analysis.",Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
"http://tag.sagepub.com 809 Results We enrolled 159 subjects between January 2009 and August 2014, 29 of whom were excluded due to: enrollment ⩾ 180 days after diagnosis (n  = 16);  coexisting malignancy within 3 years leading up to diagnosis (n = 6); no definitive diagnosis of  cancer (n = 5); reclassification as gastric cancer  (n = 1); and withdrawal from study (n = 1).",Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
Therapeutic Advances in Gastroenterology 9(6) 810 http://tag.sagepub.com survival of 53.7% (95% CI 43.7–62.8%).,Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
http://tag.sagepub.com 811 with increasing doses of prediagnosis aspirin   (p for trend = 0.097).,Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
Therapeutic Advances in Gastroenterology 9(6) 812 http://tag.sagepub.com Nishihara et  al.,Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
"http://tag.sagepub.com 813 Brasky, T., Baik, C., Slatore, C., Alvarado, M. and  White, E. (2012) Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the  vital study.",Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
Therapeutic Advances in Gastroenterology 9(6) 814 http://tag.sagepub.com prognosis in patients with esophageal squamous cell  carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
Visit SAGE journals online  http://tag.sagepub.com SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/06/4b/10.1177_1756283X16657985.PMC5076766.pdf
"Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.nav http://tag.sagepub.com 781 Creative Commons Non Commercial CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/ licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the  SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).",Non-OADS,/arxiv_data1/oa_pdf/b7/48/10.1177_1756283X16658223.PMC5076767.pdf
